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Summary 
Many natural products and bioactive substances bear a stereogenic center 
adjacent to a carbonyl group. Therefore, great efforts have been made to develop 
stereocontrolled methods for the preparation of such structural motifs with a predefined 
configuration. One of the main approaches consists on the stereocontrolled addition of 
an enolate or equivalent species to a suitable electrophile. This approach is extremely 
versatile due to the array of procedures available for the formation of enolate 
equivalents and the set of electrophiles amenable for the reaction. 
The addition of enolizable carbonyl compounds to propargylic imines, aldehydes 
or ketones is an interesting reaction owing to the synthetic versatility of the acetylenic 
adducts formed. Nevertheless, both propargyl imines and aldehydes/ketones have 
remained mostly overlooked in this context. Our group has employed these 
electrophiles in the direct aldol and Mannich reactions for the first time. In both 
reactions, the catalyst developed in the group (see Scheme A) together with 
participation of a Brønsted acid cocatalyst are key for the reactions via enamine to 
proceed smoothly and in high stereoselectivity. 
 
Scheme A 
In this Doctoral Thesis it has been studied, on the one hand, the particular case 
of the use of ω-unsaturated aldehydes as donors in the aldol reaction mentioned above 
and the subsequent Pauson-Khand reaction of the resulting 1,ω-enynes (Scheme Ba). 
On the other hand, the behaviour of alkynyl ketones (ynones) as acceptors in such aldol 
reactions has also been studied (Scheme Bb). 
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Scheme B 
In a second chapter of this Doctoral Thesis, new catalytic systems based on 
Brønsted bases (BB) for the stereoselective generation of new tetrasubstituted carbon 
stereocenters have been studied. Based on previous results in our group using α’-oxy 
enones as acrylate equivalents in metal-catalyzed processes, their use as Michael 
acceptors in Brønsted base-catalyzed enantioselective processes has been studied. 
Specifically, the conjugate addition of oxazolones has been investigated, for which 
catalysts shown in Scheme C happened to be the optimal ones. Three situations have 
been addressed: a) addition to the unsubstituted enone (the O-SiMe3 derivative resulting 
superior), b) addition to β-substituted enones, where not only the attenuated reactivity, 
but also the control of both contiguous stereogenic centers formed should be addressed, 
and c) addition to α-substituted hydroxyenones, in which case the control of 
diastereoselectivity during the generation of two non-adjacent stereocenters must be 
addressed. It should be noted that only scarce direct asymmetric methods exist for the 
access to this type of structures. 
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Scheme C 
After the good results obtained with the α’-hydroxy enone as Michael acceptor, 
the corresponding conjugated α’-hydroxy dienones have been studied with the aim to 
ascertain to which extent both the stereoselectivity, and the regioselectivity (1,4-
addition vs. 1,6-addition) of the process could be controlled. For this purpose, new 
chiral guanidine and phosphanimines were synthetized, which happened to efficiently 
control the regioselectivity, but not stereoselectivity (Scheme D). 
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Scheme D 
In a third chapter of this Thesis, the behaviour of vinylogous ketone enolates 
generated under catalytic conditions has been studied. Our laboratory has found that 
these ketones react in a highly regioselective manner with nitroalkenes and 
vinylsulfones through Cα in the presence of certain Brønsted bases, in contrast to most 
precedents in the literature, that describe reactions through Cγ (Scheme E). By this way 
adducts with two new contiguous stereocenters are accessible in high control, and can 
be subsequently elaborated in diverse ways. 
 
Scheme E. 
In this Thesis, the method has been successfully extended to α-branched cyclic 
ketones giving access to the corresponding α,α-disubstituted (quaternary) ketones in 
good yield and overall high selectivity. The method was demonstrated to be robust, 
admitting cycloalkanones with different ring-sizes (n = 0, 1, 2, 3) and constituting a 
significant advance on scope (Scheme F). 
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Scheme F 
In the same context, the completely regio- and stereoselective functionalization 
of α-substituted β-tetralones through the bifunctional Brønsted base-catalyzed Michael 
reaction with nitroalkenes and addition to azodicarboxylates have been achieved 
(Scheme G). The absence of previous direct and catalytic methods for this 
transformation should be noted. 
 
Scheme G 
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During the last part of this Thesis a short stay was performed in the group of 
Prof. Jonathan Clayden in the School of Chemistry of the University of Bristol, in 
which routes to the synthesis of arogenate from the natural amino acid L-tyrosine have 
been studied (Scheme H). Arogenate is a direct precursor of aromatic amino acids in the 
metabolism of certain plants and its derivatives are potential selective herbicides. 
However, only scarce procedures for its synthesis exist to date. 
 
Scheme H 
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Laburpena 
Produktu natural eta sustantzia bioaktibo askok zentru estereogeniko bat dute 
karbonilo taldearen alboko karbonoan (Cα). Ondorioz, esfortzu handia egin da egitura 
hauen prestaketa ahalbidetuko duten prozedura estereokontrolatuen garapenean. 
Estrategia ohikoenetako bat enolato edo baliokide bat eta elektrozale baten arteko adizio 
estereokontrolatuan datza. Planteamendu hau oso baliagarria suertatzen da enolato eta 
enolato baliokideen sorrerarako prozedura bat baino gehiago daudelako eta parte har 
dezaketen elektrozaleak askotarikoak izan daitezkeelako. 
Konposatu karboniliko enolizagarrien eta imina, aldehido edo zetona 
propargilikoeen arteko adizio erreakzioak interesgarriak dira lortutako produktu 
azetilenikoen erabilgarritasun zabala dela eta. Hala ere, bai imina eta bai 
aldehido/zetona propargilikoak oso gutxi aztertuak izan dira testuinguru honetan. Gure 
ikerketa taldeak elektrozale hauek Mannich erreakzioan eta erreakzio aldolikoan erabili 
ditu lehen aldiz. Bietan, taldean garatutako aminokatalizatzailearen eta Brønsted azido 
kokatalizatzailearen partehartzeak oinarrizkoak dira enamina bidezko erreakzioa modu 
garbian eta estereokontrol onarekin eman dadin (A Eskema). 
 
A Eskema 
Doktore Tesi honetan aztertu da, alde batetik, aldehido ω-asegabeek emaile gisa 
goian aipatutako erreakzio aldolikoan duten portaera, eta, besterik, sortutako produktuen 
(1,ω-eninoen) portaera ondorengo Pauson-Khand erreakzioan (Ba Eskema). Bestalde, 
alkinil zetonen (inonen) portaera aztertu da hartzaile moduan erreakzio aldolikoan (Bb 
Eskema). 
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B Eskema 
Doktore Tesi honen bigarren atal batean, Brønsted baseetan (BB) oinarritutako 
sistema katalitiko berriak aztertu dira tetraordezkatutako zentro estereogenikoen sorrera 
estereoselektiboa bideratzeko. Gure taldean α’-oxi enonak akrilato baliokide gisa aurrez 
aztertuak izan dira metalek katalizatutako erreakzioetan. Honetan oinarriturik, α’-oxi 
enonen erabilera aztertu da Brønsted baseek katalizatutako prozesu 
enantioselektiboetan. Zehazki, oxazolonen adizio konjokatua aztertu da, erreakzio 
honetarako C Eskemako katalizatzaileak izan direlarik eraginkorrenak. Hiru egoera 
aztertu dira: a) enona ordezkatu gabearekin (O-SiMe3 deribatua egokiena delarik), b) 
enona β-ordezkatuekin, erreaktibitate baxuagoa izateaz gain sortutako bi zentro 
estereogeniko jarraien kontrola beharrezkoa delarik, eta c) enona α-ordezkatuekin, bi 
zentro estereogeniko ez jarraien sorreran diastereoselektibitatearen kontrola zailtasun 
gehigarri bat delarik. Esan beharra dago zuzeneko prozedura asimetriko gutxi daudela 
egitura mota hauen sorrerarako. 
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C Eskema 
α’-Hidroxi enonak Michael hartzaile gisa erabiliaz lortutako emaitza hauen 
ondoren, dagokion α’-hidroxi dienonak aztertu dira prozesuaren estereoselektibotasuna 
eta erregioselektibotasuna (1,4-adizioa 1,6-adizioaren aurka) noraino kontrola 
daitezkeen argitzeko asmoz. Honetarako guanidina eta fosfanimina motako molekula 
kiral berriak sintetizatu dira, aipatutako erreakzioen erregioselektibotasunaren 
kontrolean eraginkorrak direla frogatu delarik, baina ez estereoselektibotasunaren 
kontrolean (D Eskema). 
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D Eskema 
Doktore Tesi honen hirugarren atal batean, baldintza katalitikoetan sortutako 
zetona enolato binilogoen jokaera aztertu da. Gure laborategian enolato binilogo hauek 
Brønsted base izaera duten katalizatzaile batzuen eraginez sor daitezkela eta nitroalkeno 
zein binil sulfonekin erregioselektibotasun altuan erreakzionatzen dutela aurkitu da, α-
bidea jarraituz, bibliografian deskribatutako aurrekari gehienek Cγ bidez 
erreakzionatzen duten bitartean (E Eskema). Erreakzioan bi zentro estereogeniko berri 
bata bestearen alboan dituzten aduktuak lor daitezke kontrol maila altuan, ondoren 
modu ezberdinetan eraldatuak izan daitezkeenak. 
 
E Eskema 
Tesi honetan prozedura hau arrakastaz zabaldu da α-adarkatutako zetona 
ziklikoetara, dagokion zetona α,α-biordezkatuak (kuaternarioak) etekin onean eta 
selektibotasun handian lortzea ahalbidetuz. Prozedura honen sendotasuna ere frogatu da 
tamaina ezberdinetako (n = 0, 1, 2, 3) zikloalkanonak erabiliz, garapen honek 
orainarteko esparruaren zabalkuntza nabarmena dakarrelarik (F Eskema). 
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F Eskema 
Testuinguru berean, β-tetralona α-ordezkatuen funtzionalizazio guztiz erregio- 
eta estereoselektiboa lortu da Brønsted baseek katalizatutako Michael erreakzioan 
oinarriturik, nitroalkenoak eta azodikarboxilatoak hartzaile moduan erabiliz (G 
Eskema). Kontuan hartu beharrekoa da oraindaino transformazio hau egiteko prozedura 
katalitikorik ez dagoela deskribatua. 
 
G Eskema 
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Tesi honen azken atalean University of Bristol-eko School of Chemistry-ko 
Jonathan Claydenen taldean egindako egonaldi labur batean garatutako lana biltzen da. 
Bertan L-tirosina aminoazido naturaletik abiatuta arogenateren sintesirako zenbait bide 
aztertu dira (H Eskema). Arogenate amino azido aromatikoen aurrekaria da landare 
batzuen metabolismoan eta bere deribatuak herbizida selektibo potentzialak dira. Hala 
ere, gaur egun bere sintesirako prozedura gutxi dago. 
 
H Eskema 
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Resumen 
Muchos productos naturales y sustancias bioactivas contienen un centro 
estereogénico adyacente a un grupo carbonilo. Como consecuencia, se han realizado 
grandes esfuerzos para desarrollar métodos estereocontrolados que permitan la 
preparación de este tipo de estructuras con una configuración predefinida. Una de las 
aproximaciones más comunes consiste en la reacción estereocontrolada de un anión 
enolato o equivalente con un electrófilo. Esta aproximación resulta extremadamente 
versátil gracias a la variedad de procedimientos disponibles para la formación de 
equivalentes de enolato y el gran número de electrófilos que se prestan para esta 
reacción.  
La adición de compuestos carbonílicos enolizables a iminas y aldehídos/cetonas 
propargílicos es una reacción interesante debido a las posibilidades sintéticas de los 
aductos acetilénicos obtenidos. Sin embargo, tanto las iminas como los 
aldehídos/cetonas propargílicas han sido poco estudiados en este contexto. Nuestro 
grupo ha empleado estos electrófilos por primera vez en las reacciones aldólica y de 
Mannich directas. En ambos casos, para que las reacciones vía enamina transcurran de 
forma limpia y con elevada estereoselectividad ha sido clave el uso del catalizador 
mostrado desarrollado en el grupo (Esquema A) en conjunción con un ácido de 
Brønsted. 
 
Esquema A 
En esta Tesis Doctoral se ha estudiado, por un lado, el caso particular de la 
utilización de aldehídos ω-insaturados como dadores de la reacción aldólica arriba 
mencionada y la posterior reacción de Pauson-Khand de los 1,ω-eninos resultantes 
(Esquema Ba). Por otro lado, se ha estudiado el comportamiento de alquinil cetonas 
(inonas) en dichas reacciones aldólicas vía enamina (Esquema Bb). 
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Esquema B 
En un segundo apartado de esta Tesis Doctoral se han estudiado nuevos sistemas 
catalíticos basados en bases de Brønsted (BB) para la generación enantioselectiva de 
compuestos de interés con un carbono tetrasustituido. Sobre la base de resultados 
previos del grupo en la utilización de α’-oxi enonas como equivalentes de acrilatos en 
procesos catalizados por metales, se ha estudiado su utilización como aceptores de 
Michael en procesos catalizados por bases de Brønsted quirales. De forma específica, se 
ha estudiado la adición conjugada de oxazolonas, reacción para la que han resultado 
óptimos los catalizadores de escuaramida mostrados (Esquema C). Se han abordado tres 
situaciones: a) la adición a la enona no sustituida (en cuyo caso el derivado O-SiMe3 ha 
resultado superior), b) la adición a enonas β-sustituidas, donde además de la atenuada 
reactividad un segundo aspecto crucial ha sido el control de los dos centros 
estereogénicos contiguos que se forman, y c) la adición a hidroxienonas α-sustituidas, 
en cuyo caso ha de abordarse el control de la diastereoselectividad durante la generación 
de dos centros estereogénicos no contiguos. Conviene destacar que apenas existen 
métodos directos y asimétricos para el acceso a este tipo de estructuras. 
Resumen 
 
 
 
Esquema C 
Tras los buenos resultados obtenidos con la α’-hidroxi enona como aceptor de 
Michael, posteriormente se ha explorado el comportamiento de las correspondientes α’-
hidroxi dienonas conjugadas, con objeto de averiguar hasta qué punto se puede 
controlar no sólo la estereoselectividad del proceso con estos sustratos, sino también la 
regioselectividad (adición 1,4 frente a adición 1,6). Para este propósito se han preparado 
nuevas guanidinas y fosfaniminas quirales, las cuales han resultado ser catalizadores 
eficientes en el control de la regioselectividad, pero no en el de la estereoselectividad 
(Esquema D). 
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Esquema D 
En un tercer apartado de esta Tesis, se ha estudiado el comportamiento de 
enolatos de cetona vinílogos generados en condiciones catalíticas. Se ha encontrado que 
estas cetonas en presencia de ciertas bases de Brønsted reaccionan de forma altamente 
regioselectiva con nitroalquenos y vinilsulfonas a través del Cα, en contraste a la 
mayoría de casos previamente descritos en la bibliografía, que lo hacen por Cγ 
(Esquema E). Esta circunstancia permite acceder a aductos con dos nuevos 
estereocentros contiguos con un grado de control notable y que pueden ser 
posteriormente elaborados de diversas maneras. 
 
Esquema E 
Ha sido posible extender esta metodología a cetonas cíclicas con un grupo 
alquenilo en Cα obteniéndose las correspondientes cetonas α,α-disustituidas 
(cuaternarias) con buenos rendimientos y selectividades elevadas en general. El método 
ha resultado ser muy robusto, admitiendo cicloalcanonas con tamaños de ciclo variable 
(n = 0, 1, 2, 3) y constituyendo un avance significativo sobre lo realizado hasta la fecha 
(Esquema F). 
Resumen 
 
 
 
 
Esquema F 
En este mismo contexto, se ha logrado llevar a cabo la funcionalización de 
forma totalmente regio- y estereoselectiva de β-tetralonas α-sustituidas tanto mediante 
reacción de Michael con nitroalquenos como mediante adición a azodicarboxilatos 
catalizadas por bases de Brønsted bifuncionales (Esquema G). Conviene señalar la 
ausencia de métodos directos y catalíticos previos para esta transformación. 
 
Esquema G 
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Durante el último tramo de la Tesis se ha desarrollado una breve estancia en el 
grupo del Prof. Jonathan Clayden del School of Chemistry de la University of Bristol, 
donde se han estudiado algunas rutas de síntesis del arogenate a partir del aminoácido 
natural L-tirosina (Esquema H). El arogenate es un precursor inmediato de aminoácidos 
aromáticos en el metabolismo de algunas plantas y sus derivados son potenciales 
herbicidas selectivos. Sin embargo, hasta la fecha existen escasos procedimientos de 
síntesis. 
 
Esquema H 
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Abbreviations and acronyms 
AAA   Aromatic amino acid 
Ac   Acetyl 
aq.   Aqueous 
Ar   Aryl 
Ǻ   Angstrom 
BA   Benzoic acid 
BB*   Chiral Brønsted base 
BINAP  (1,1′-Binaphthalene-2,2′-diyl)bis(diphenylphosphine) 
BINOL  1,1’-Bi-2-naphthol 
Bn   Benzyl 
Boc   tert-Butoxycarbonyl 
BOX   Bisoxazoline 
nBu   n-Butyl 
iBu   Isobutyl 
tBu   tert-Butyl 
CAN   Cerium(VI) ammonium nitrate 
cat   Catalyst 
Cbz   Bencyloxicarbonyl 
CDI   1,1-Carbonyldiimidazol 
mCPBA  meta-Chloroperbenzoic acid 
CSA   Camphorsulfonic acid 
quant.   Quantitative 
Cy   Cyclohexyl 
DABCO  1,4-Diazabicyclo[2.2.2]octane 
Abbreviations and acronyms 
 
 
DBE   Dibromoethane 
DBU   1,8-Diazabicyclo[5.4.0]undec-7-ene 
DCE   Dichloroethane 
DCM   Dichloromethane 
DEAD   Diethylazodicarboxylate 
(DHQD)2PYR Hydroquinidine-2,5-diphenyl-4,6-pyrimidinediyl diether 
(DHQ)2PHAL  Hydroquinine 1,4-phthalazinediyl diether 
DIBALH  Diisobutylaluminium hydride 
DIPA   Diisopropylamine 
DIPEA  Diisopropylethylamine 
DMAP  4-(Dimethylamino)pyridine 
DME   Dimethoxyethane 
DMF   Dimethylformamide 
DMSO  Dimethyl sulfoxide 
DSC   N,N’-Disuccinimidyl carbonate 
dr   Diastereomeric ratio 
E   Electrophile 
ee   Enantiomeric excess 
equiv.   Equivalent 
Et   Ethyl 
EtOAc   Ethyl acetate 
EWG   Electron-withdrawing group 
h   Hour(s) 
HBTU  N,N,N′,N′-Tetramethyl-O-(1H-benzotriazol-1-yl)uronium 
hexafluorophosphate, O-(Benzotriazol-1-yl)-N,N,N′,N′-
tetramethyluronium hexafluorophosphate 
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HFIP   Hexafluoroisopropanol 
HMDS  bis(Trimethylsilyl)amide 
HOBT   1-hydroxybenzotriazole 
HPLC   High-performance liquid chromatography 
Im   Imidazole 
L   Ligand 
LA   Lewis acid 
LDA   Lithium diisopropylamide 
LG   Leaving group 
M   Metal 
Me   Methyl 
m. p.   Melting point 
min   Minutes 
Ms   Methanesulfonyl 
MS   Mass spectrometry 
M.S.   Molecular sieve 
MTBE   Methyl tert-butyl ether 
MVK   Methyl vinyl ketone 
Naph   Naphthyl 
n. d.   Not determined 
n. r.   No reaction 
pNBA   para-Nitrobenzoic acid 
NCA   N-Carboxyanhydride 
NMM   N-Methylmorpholine 
NMO   N-methylmorpholine N-oxide 
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NMR   Nuclear magnetic resonace 
NOESY  Nuclear Overhauser effect spectroscopy 
Nu   Nucleophile 
o.n.   Overnight 
ORTEP  Oak ridge thermal ellipsoid plot 
PG   Protecting group 
Ph   Phenyl 
Phth   Phthalic anhydride 
nPr   n-Propyl 
iPr   Isopropyl 
pyr   Pyridine 
quant.   Quantitative 
Rac.   Racemic 
Ref.   Reference 
RT   Room temperature 
t   Time 
tR   Retention time 
T   Temperature 
TBAF   Tetrabutylammonium fluoride 
TBDMS  tert-Butyldimethylsilyl 
TEA   Triethylamine 
Tf   Trifluoroacetate 
TFA   Trifluoroacetic acid 
THF   Tetrahydrofuran 
TIPS   Triisopropylsilyl 
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TLC   Thin layer chromatography 
TMANO  Trimethylamine N-oxide 
TMS   Trimethylsilyl 
TMSO   3-(Trimethylsilyl)-2-oxazolidinone 
TPP   Triphenylphosphine 
triton B  Benzyltrimethylammonium hydroxyde 
Ts   para-toluenesulfonyl 
pTSA   para-Toluenesulfonic acid 
UV   Ultraviolet 
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Introduction 
1.1. α-Substituted carbonyl compounds 
Molecules containing carbonyl groups with an adjacent stereocenter are 
widespread within natural products and biologically active compounds, like the ones 
depicted in Figure 1.1 Therefore, methods capable of accessing such moieties in high 
selectivity are most sought after. 
 
Figure 1.  
Three main approaches for the stereoselective formation of a stereogenic center 
in the α-position of a carbonyl compound are shown in Scheme 1. Among them, the 
present thesis is focused on approach c), that is, reaction of an electrophile with an 
enolate anion or equivalent under proton transfer conditions. 
                                                 
1 Aldosterone: F. Jaisser, N. Farman, Farmacol. Rev. 2016, 68, 49–75. (–)-Spirobrassinin: L. Liu, S.-L. 
Zhang, F. Xue, G.-S. Lou, H.-Y. Zhang, S.-C. Ma, W. Duan, W. Wang, Chem. Eur. J. 2011, 17, 7791–
7795. Phenoxymethylpenicillin: J. Colloway, A. Couch, F. Foster, W. Hunter, V. Knight, A. C. White, 
Antibiotics Annu. 1955, 3, 490–501. Chlorogenic acid: W. Boerjan, J. Ralph, M. Baucher, Annu. Rev. 
Plant Biol. 2003, 54, 519–546. Carbidopa: G. C. Davis, A. C. Williams, S. P. Markey, M. H. Ebert, E. D. 
Caine, C. M. Reichert, I. J. Kopin, Psychiatry. Res. 1979, 1, 249–254. 
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Scheme 1.  
Approach c) is extremely versatile owing to three main aspects among others:2 i) 
there are several procedures to generate enolate equivalents (Figure 2); ii) enolates and 
equivalents are highly nucleophilic, so they can react with a variety of electrophiles; and 
iii) the approach is well suited for the generation of two contiguous stereocenters when 
both nucleophile and electrophile are prostereogenic. 
 
Figure 2.  
Two main approaches, namely the use of chiral auxiliaries and catalytic 
methods, are suitable strategies to control the stereogenical outcome of the reactions 
leading to a carbonyl compound with an α-stereocenter. 
As usual, initial developments in this area were based on the use of covalently 
bound chiral auxiliaries. Chiral auxiliaries must be capable of transferring the chiral 
information during the new bond formation event and easily cleavable from the 
obtained adducts for the procedure to be practical. 
Chiral secondary amines were among the first chiral auxiliaries developed for 
this endeavour, which upon condensation with ketones and aldehydes form enamine 
                                                 
2 a) C. Spino, Org. Prep. Proced. Int. 2003, 35, 1–120. a) W. Carruthers, I. Coldham, Modern Methods of 
Organic Synthesis, Ed. Cambridge University Press, Cambridge, 2004, 1–45. b) F.A. Carey, R. J. 
Sundberg, Advanced Organic Chemistry, Ed. Springer, Heildeberg, 2007, vol. B. c) P. Knochel, G. A. 
Molander, Comprehensive Organic Synthesis II, Ed. Elsevier, Amsterdam, 2014, vol. 1. 
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intermediates with enhanced nucleophilicity. In 1969 Yamada et al.3 reported the first 
examples in a series of investigations on the alkylation of chiral enamines derived from 
L-proline esters. With this methodology, the products of the formal addition of 
cyclohexanone to methyl acrylate and acrylonitrile, as well as from the reaction with 
strongly electrophilic alkyl halides were obtained, although unfortunately, with very 
low yields (<25%) and ee values (<60%). Subsequent work by other groups identified 
other chiral amines that performed superior for different asymmetric alkylations. These 
developments were focused on cyclohexanone-derived enamines as substrates almost 
exclusively (Figure 3). 
 
Figure 3. 4567 
Hydrazines are another functional group that can condense with aldehydes and 
ketones, leading to the formation of hydrazones, which are good nucleophiles upon 
deprotonation.8 In this context, Enders9 explored in depth the usefulness of chiral 
hydrazones derived from (S)-1-amino-2-methoxymethylpyrrolidine for the α-
functionalization of aldehydes and ketones (Figure 4). 
                                                 
3 a) S.-I. Yamada, K. Hiroi, K. Achiwa, Tetrahedron Lett. 1969, 10, 4233–4236. For more information on 
the subject see: b) P. W. Hichmott, Tetrahedron. 1982, 38, 1975–2050. 
4 J. K. Whitesell, S. W. Felman, J. Org. Chem. 1977, 42, 1663–1664. 
5 a) S. J. Blarer, W. B. Schweizer, D. Seebach, Helv. Chim. Acta 1982, 65, 1637–1654. For more 
references on the subject see: b) W. Miltz, W. Steglich, Synthesis 1990, 750–751. 
6 Y. Ito, M. Sawamura, K. Kominami, T. Saegusa, Tetrahedron Lett. 1985, 26, 5303–5306. 
7 a) M. Pfau, G. Revial, A. Guigant, J. d’Angelo, J. Am. Chem. Soc. 1985, 107, 273–274. For further 
references on the subject see: b) J. Y. Kang, R. C. Johnson, K. M. Snyder, P. H.-Y. Cheong, R. G. Carter, 
J. Org. Chem. 2016, 81, 3629–3637. 
8 E. J. Corey, D. Enders, Tetrahedron Lett. 1976, 17, 3–6. 
9 For an example of: Alkylation: a) D. Enders, H. Eichenauer, Angew. Chem. Int. Ed. 1976, 15, 549–551. 
Aldol reaction: b) D. Enders D. L. Whitehouse, Synthesis 1996, 38, 621–626 For a review on asymmetric 
reactions of hydrazones see: c) A. Job, C. F. Janeck, W. Bettray, R. Peters, D. Enders, Tetrahedron  2002, 
58, 2253–2329. 
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Figure 4.  
A different strategy to achieve the asymmetric α-functionalization of carbonyl 
compounds is the use of chiral ligand-bearing metal enolates as nucleophilic 
intermediates. An advantage of this approach compared to enamine- and hydrazone-
mediated approaches is that not only aldehydes and ketones, but also carboxylic acid 
derivatives such as esters and thioesters can be used as enolizable substrates. As 
representative examples of this strategy, some boron ligands employed in chiral ligand 
mediated enolate reactions are shown in Figure 5.10 
 
Figure 5.  11121314 
                                                 
10 For further information on the subject see: a) C. J. Cowden, I. Paterson, Org. React. 1997, 51, 1–200. b) 
P. Arya, H. Qin, Tetrahedron 2000, 56, 917–947. c) I. Paterson, C. J. Cowden, D. J. Wallace, Modern 
Carbonyl Chemistry, Ed. Wiley-VCH, Weinheim, 2000, 249–297. d) A. Abiko, Boron Reagents in 
synthesis, Ed. American Chemical Society, Washington DC, 2016, 123–171. 
11  a) I. Paterson, M. S. Lister, C. K. McClure, Tetrahedron Lett. 1986, 27, 4748–4790. b) I. Paterson, J. 
M. Goodman, M. A. Lister, R. C. Schumman, C. K. McClure, R. D. Norcross, Tetrahedron Lett. 1990, 
46, 4663–4684. 
12 For an example of: Aldol reaction of ketones: a) C. Gennari, C. T. Hewkin, F. Molinari, A. Bernardi, A. 
Comotti, J. M. Goodman, I. Paterson, J. Org. Chem. 1992, 57, 5173–5177. Aldol reaction of thioesters: b) 
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For substrates in the carboxylic acid oxidation state, a chiral auxiliary can be 
covalently bound to the acyl system. Upon enolization, subsequent reaction with an 
electrophile would be controlled by the auxiliary intramolecularly (diastereoselective 
process). One advantage of this method is that the removal of the chiral auxiliary can 
afford either carboxylic acid derivatives, aldehydes or ketones depending on the scission 
conditions employed, thus giving access to a broad variety of products from a common 
optically active intermediate (or adduct). 
In 1981, Evans and coworkers15,16 reported the use of chiral oxazolidinones as 
auxiliaries for the asymmetric formation of a stereogenic center in the α-position of acyl 
systems via alkylation and aldol-type reactions. Following this ground marking work, 
many other chiral auxiliaries23-21 were reported for different reactions leading to α-
stereogenic carboxylic acid derivatives (Figure 6).23 
                                                                                                                                               
C. Gennari, A. Vulpetti, D. Moresca, Tetrahedron Lett. 1994, 35, 4857–4860. Mannich reaction of 
thioesters: d) C. Gennari, A. Vulpetti, M. Donghi, N. Mongelli, N. E. Vanotti, Angew. Chem. Int. Ed. 
1996, 35, 1723–1725. For further references see: e) F. Lang, D. Zewge, Z. J. Song, M. Biba, P. Dormer, 
D. Tschaen, R. P. Volate, P. J. Reider, Tetrahedron Lett. 2003, 44, 5285–5288 and references herein. 
13 For an example of: Aldol reaction of ketones: a) E. J. Corey, R. Imwinkelried, S. Pikul, Y. B. Xiang, J. 
Am. Chem. Soc. 1989, 111, 5493–5495. Aldol reaction of esters: b) E. J. Corey, S. S. Kim, J. Am. Chem. 
Soc. 1990, 112, 4976–4977. Mannich reaction of thioesters: c) E. J. Corey, C. P. Decicco, R. C. Newbold, 
Tetrahedron Lett. 1991, 32, 5287–5495. 
14 S. Masamune, T. Sato, B. M. Kim, T. A. Wollman, J. Am. Chem. Soc. 1986, 108, 8279–8281. 
15 D. A. Evans, J. Bartroli, T. L Shih, J. Am. Chem. Soc. 1981, 103, 2127–2129. 
16 For an example of: Aldol reaction: a) D. A. Evans, J. Bartroli, T. L Shih, J. Am. Chem. Soc. 1981, 103, 
2127–2129. Amination: b) D. A. Evans, T. C. Britton, R. L. Dorow, J. F. Dellaria, J. Am. Chem. Soc. 
1986, 108, 6395–6397. Mannich reaction: c) D. A. Evans, F. Urpi, T. C. Somers, J. S. Clark, M. T. 
Bilodeau, J. Am. Chem. Soc. 1990, 112, 8215–8216. For further references see: e) E. H. Tallmadge, J. 
Jermaks, D. B. Collum, 2016, 138, 345–355 and references herein. 
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Figure 6. 17181920212223 
Methods based on covalently bound chiral auxiliaries despite being very 
effective need a stoichiometric amount of the chiral agent and additional steps are 
required for the attachment and ulterior detachment of the auxiliary which compromise  
                                                 
17 D. A. Evans, M. M. Morressey, R. L. Dorow, J. Am. Chem. Soc. 1985, 107, 4346–4348. 
18 For an example of: Alkylation: a) S. D. Bull, S. G. Davies, R. L. Nicholson, H. J. Sanganee, A. D. 
Smith, Tetrahedron: Asymmetry 2000, 11, 3475–3479. Aldol reaction: b) S. G. Davies, I. A. Hunter, R. L. 
Nicholson, P. M. Roberts, E. D. Savory, A. D. Smith, Tetrahedron 2004, 60, 7553–7557. For further 
references see: c) J. Alvarado, A. T. Herrmann, A. Zakarian, J. Org. Chem. 2014, 79, 6206–6220; d) A. 
Gómez-Palomino, M. Pellicena, J. M. Romo, R. Solà, P. Romea, F. Urpí, M. Font-Bardia, Chem. Eur. J. 
2014, 20, 10153–10159 and references herein. 
19 M. T. Crimmins, B. W. King, E. A. Tabet, J. Am. Chem. Soc. 1997, 119, 7883–7884. 
20 a) D. M. Casper, J. R. Burgenson, J. M. Esken, G. M. Ferrence, S. R. Hitchock, Org. Lett. 2002, 4, 
3739–3742. For further references see: A. R. Leise, N. Comas, D. Harrison, D. Patel, E. G. Whitemiller, 
J. Wilson, J. Timms, I. Golighty, C. G. Hamaker, S. R. Hitchock, Tetrahedron: Asynnmetry 2017, 28, 
1154–1162 and references herein. 
21 For an example of: Aldol reaction: a) W. Oppolzer, J. Blagg, I. Rodriguez, E. Walther, J. Am. Chem. 
Soc. 1990, 112, 2767–2772. Amination: b) W. Oppolzer, O. Tamura, J. Deerberg, Hel. Chim. Acta 1992, 
75, 1965–1968. For further references see: L. Zhang, L. Zhu, J. Yang, J. Luo, R. Hong, J. Org. Chem. 
2016, 81, 3890–3900 and references herein. 
22 A. Abiko, J.-F. Liu, S. Masamune, J. Am. Chem. Soc. 1997, 119, 2586–2587. 
23 For further information on the subject see: a) P. Arya, H. Qin, Tetrahedron 2000, 56, 917–947. b) C. 
Palomo, M. Oiarbide, J. M. García, Chem. Soc. Rev. 2004, 33, 65–75. c) L. M. Geary, P. G. Hultin, 
Tetrahedron: Asymmetry 2009, 20, 131–173. d) M. M. Heravi, V. Zadsirjan, Tetrahedron: Asymmetry 
2014, 25, 1061–1090. 
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atom and step economy. Asymmetric catalytic procedures, in which a substoichiometric 
amount of a chiral inductor is enough to accomplish the reaction with high chemo-, 
regio- and stereoselectivity, are more convenient from the point of view of atom 
economy and procedural simplicity.24 
Procedures based on the use of previously generated (preformed) enolates or 
enolate equivalents, namely directed methods, in combination with a chiral Lewis acid 
catalyst have been studied in depth. Among them, silyl enol ethers are by far the most 
prominent, and their addition reaction to carbonyl compounds, namely the Mukaiyama 
aldol reaction, is the most representative example of their potential for the formation of 
C–C bonds in a stereocontrolled manner. 25 
In 1989 Mukaiyama described the first catalytic enantioselective reaction of silyl 
enol ethers derived from esters26 and thioesters27 employing a tin(II)-chiral diamine 
complex as the catalyst. Following this seminal work, several chiral Lewis acids have 
been developed for the catalytic enantioselective Mukaiyama reaction.28 The most 
representatives are shown in Figure 7. 
                                                 
24 For detailed information on this concept see: B. M. Trost, Angew. Chem. Int. Ed. 1995, 34, 259–281. 
25 a) T. Mukaiyama, K. Narasaka, K. Banno, Chem. Lett. 1973, 2, 1011–1014. b) T. Mukaiyama, K. 
Banno, K. Narasaka, J. Am. Chem. Soc. 1974, 96, 7503–7509. For further information on the subject see: 
a) M. B. Boxer, B. J. Albert, H. Yamamoto, Aldrichimi. Act. 2009, 42, 3–15. b) T. Kitanosono, S. 
Kobayashi, Adv. Synth. Catal. 2013, 355, 3095–3118. c) S. B. Jennifer Kan, K. K.-H. Ng, I. Paterson, 
Angew. Chem. Int. Ed. 2013, 52, 9097–9108. d) J.-I. Matsuo, M.  Murakami, Angew. Chem. Int. Ed. 2013, 
52, 9109–9118. 
26 S. Kobayashi, T. Sano, T. Mukaiyama, Chem. Lett. 1989, 1319–1322. 
27 S. Kobayashi, T. Mukaiyama, Chem. Lett. 1989, 297–300. 
28 For reviews on Mukaiyama reaction see: a) E. M. Carreira, Modern Carbonyl Chemistry, Ed. Wiley-
VCH, Winheim, 2000, 227–248. b) G. L. Beutner, S. E. Denmark, Angew. Chem. Int. Ed. 2013, 52, 
9086–9096. c) S. B. Jennifer Kan, K. K.-H. Ng, I. Paterson, Angew. Chem. Int. Ed. 2013, 52, 9097–9108. 
d) J.-I. Matsuo, M.  Murakami, Angew. Chem. Int. Ed. 2013, 52, 9109–9118. e) T. Kitanosono, S. 
Kobayashi, Chem. Rec. 2014, 14, 130–143. f) W. Gati, H. Yamamoto, Acc. Chem. Res. 2016, 49, 1757–
1768. 
Chapter 1 
18 
 
 
Figure 7. 29 303132 33343536 373839 40 
                                                 
29 For pioneering examples of reaction with: Esters: a) S. Kobayashi, I. Shiina, J. Izumu, T. Mukaiyama, 
Chem. Lett. 1992, 373–376. Thioesters: c) T. Mukaiyama, H. Uchiro, S. Kobayashi, Chem. Lett. 1989, 
1757–1760. 
30 For pioneering examples of reaction with: Ketones: a) K. Mikami, S. Matsukawa, J. Am. Chem. Soc. 
1993, 115, 7039–7040. Thioesters: b) K. Mikami, S. Matsukawa, J. Am. Chem. Soc. 1994, 116, 4077–
4078. For further references see: c) F. Fang, F. Xie, H. Yu, H. Zhang, B. Yang, W. Zhang, Tetrahedron 
Lett. 2009, 50, 6672–6675 and references herein. 
31 G. E. Keck, D. Krishnamurthy, J. Am. Chem. Soc. 1995, 117, 2363–2364. 
32 E. M. Carreira, R. A. Singer, W. J. Lee, J. Am. Chem. Soc. 1994, 116, 8837–8838. 
33 K. Furuta, T. Maruyama, H. Yamamoto, J. Am. Chem. Soc. 1991, 113, 1041–1042.  
34 S. Kiyooka, Y. Kaneko, K. Kume, Tetrahedron Lett. 1992, 33, 4927–4930. 
35 E. J. Corey, C. L. Cywin, T. D. Roper, Tetrahedron Lett. 1992, 33, 6907–6910. 
36 K. Ishihara, S. Kondo, H. Yamamoto, J. Org. Chem. 2000, 65, 9125–9128. 
37 a) D. A. Evans, C. Kozlowski, J. A. Murry, J. Am. Chem. Soc. 1996, 121, 669–685. b) J. S. Johnson, D. 
A. Evans, Acc. Chem. Res. 2000, 33, 325–335 and references herein. 
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On the other hand, Denmark and coworkers41 reported a distinct strategy for the 
catalytic asymmetric directed aldol reaction based on the activation of trichlorosilyl enol 
ethers by a chiral phosphoramide Lewis base catalyst. Contrary to the Lewis acid-
catalyzed processes, which tend to provide the syn-adducts, this methodology is 
stereospecific and can provide either syn- or anti-adducts selectively by judicious choice 
of the catalyst or the E or Z configuration of the starting silyl enolate for ketones 
(Scheme 2a) and aldehydes (Scheme 2b) respectively.42 
 
Scheme 2.  
Whereas some methods with the “Mukaiyama reaction scheme” are quite 
efficient and general, and proceed with high stereocontrol (both absolute and relative), 
preparation of the silyl enolate in a previous and irreversible synthetic operation 
employing stoichiometric quantities of reagents constitutes an important drawback.43 In 
                                                                                                                                               
38 For a pioneering example of reaction with β-ketoesters: J. Krüger, E. M. Carreira, J. Am. Chem. Soc. 
1998, 120, 837–838. 
39 K. Oisaki, D. Zhao, M. Kanai, M. Shibasaki, J. Am. Chem. Soc. 2006, 128, 7164–7165. 
40 Y. Yamashita, H. Ishitani, H. Shimizu, S. Kobayashi, S. J. Am. Chem. Soc. 2002, 124, 3292–3302. 
41 a) S. E. Denmark, S. B. D. Winter, X. Su, K.-T. Wong, J. Am. Chem. Soc. 1996, 118, 7404–7405. 
42 For further information on this observation see: a) S. E. Denmark, R. A. Stavenger, K.-T. Wong, X. Su, 
J. Am. Chem. Soc. 1999, 121, 4982–4991. b) S. E. Denmark, S. K. Ghosh, Angew. Chem. Int. Ed. 2001, 
40, 4759–4762. For a review on Lewis base-promoted Mukaiyama reactions see: c) Ref. 28a. 
43 For approaches to catalytic methods see: J. M. García, M. Oiarbide, C. Palomo, Angew. Chem. Int. Ed. 
2011, 50, 8790–8792. 
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contrast, direct methods that allow the reaction of unmodified carbonyl compounds with 
the corresponding electrophiles are particularly attractive, especially if a 
substoichiometric amount of a chiral promoter is sufficient to attain good yield and 
selectivity. An overview of these approaches is described next. 
 
1.2. Direct catalytic asymmetric α-functionalization of carbonyl 
compounds 
It is well known that enzymes are able to trigger the α-functionalization of 
unmodified carbonyl compounds with extremely high efficiency and selectivity. Thus, 
enzymes meet perfectly the atom and step economy principles, doing their work with 
high efficiency and selectivity most often by activating both the donor and acceptor 
components of a given reaction concurrently. Following a similar principle of 
concomitant substrate activation, chemists have developed synthetic catalysts capable of 
promoting α-functionalization of carbonyl compounds leading to the formation of a 
stereogenic center in the α-position in a direct fashion with considerable success. Main 
developments in this field are briefly described next according to two categories: metal-
based methods and organocatalyst-based methods. 
1.2.1. Methods based on metal catalysts 
A significant breakthrough in this area came from the laboratories of Shibasaki 
and Trost, who independently introduced new bifunctional Lewis acid/Brønsted base 
metal complexes capable of catalysing some fundamental C–C bond forming 
reactions.44 
In 1996, Shibasaki45 and coworkers used a bifunctional heterobimetallic catalyst 
to perform the Michael addition of cyclic β-ketoesters to methyl vinyl ketone and 
acrylates obtaining moderate to very good enantioselectivities (Scheme 3a). Later, the 
group developed similar catalysts for the Mannich reaction between aromatic ketones 
and aminoethyl ethers (in low enantioselectivity and high catalyst loading, Scheme 
3b),46 and the aldol reaction of 2-hydroxyacetophenone with aliphatic unbranched 
                                                 
44 For the concept of bifunctional metal complexes see: a) T. Ikariya, K. Murata, R. Noyori, Org. Biomol. 
Chem. 2006, 4, 393–406. b) M. Shibasaki, M. Kanai, S. Matsunaga, Acc. Chem. Res. 2009, 42, 1117–
1127. c) J. Ito, H. Nishiyama, Bifunctional Molecular Catalysis. Topics in organometallic Chemistry, Ed. 
Springer, Berlin 2011, vol. 37. 
45 H. Sasai, E. Emori, T. Arai, M. Shibasaki, Tetrahedron Lett. 1996, 37, 5561–5564. 
46 S. Yamasaki, T. Iida, M. Shibasaki, Tetrahedron Lett. 1999, 40, 307–310. 
Introduction 
 
21 
 
aldehydes (Scheme 3c),47 which had not been previously used in direct aldol reactions, 
presumably due to their tendency towards enolization. The main concept involved in 
these researches is that the metal complexes have a basic site and an acidic site which 
can work in concert for the activation of both the donor and the acceptor reaction 
components. 
 
Scheme 3.  
                                                 
47 N. Yoshikawa, N. Kumagai, S. Matsunaga, G. Moll, T. Ohshima, T. Suzuki, M. Shibasaki, J. Am. 
Chem. Soc. 2001, 123, 2466–2467. 
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On the other hand, Trost and coworkers reported the aldol reaction of 2-
hydroxyacetophenone with aliphatic aldehydes, including the more challenging 
unbranched aldehydes, catalyzed by a bifunctional dinuclear Zn catalyst which proceeds 
with high enantio- and diastereoselectivities (Scheme 4).48 This catalyst could be later 
applied to a related Mannich reaction.49 
 
Scheme 4.  
Following these first examples, there have been several other reports dealing 
with the α-functionalization of enolizable carbonyl compounds based on chiral metallic 
catalysts.50 
Despite several kinds of α-functionalization procedures using metallic catalysts 
have been described to give rise very good yield and stereocontrol, direct procedures are 
still limited to the use of activated carbonyl compounds, mainly those bearing an 
electron withdrawing group at the α-position or in some instance having an aryl 
substituent. Furthermore, many of these methods rely on the use of rare (and toxic) 
metals of limited availability and are often highly sensitive to the presence of traces of 
water or oxygen in the reaction medium.  
                                                 
48 B. M. Trost, H. Ito, E. R. Silcoff, J. Am. Chem. Soc. 2001, 123, 3367–3368. 
49 B. M. Trost, L. M. Terrell, J. Am. Chem. Soc. 2003, 125, 338–339. 
50 For reviews on bifunctional metal complexes see: a) C. Nájera, J. M. Sansano, J. M. Saá, Eur. J. Chem. 
2009, 2385–2400. b) T. Ikariya, I. D. Gridnev, Top. Catal. 2010, 53, 894–901. c) B. Ramasamy, P. 
Ghosh, Eur. J. Inorg. Chem. 2016, 1448–1465. 
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1.2.2. Methods based on organocatalysts 
With the renaissance of organocatalysis at the beginning of this millennium, new 
opportunities appeared for achieving the selective α-functionalization of enolizable 
carbonyl compounds.51 Two main ways for the activation of the enolizable carbonyl 
substrate have been exploited: activation via enamine formation (aminocatalysis) and 
activation via enolization (Brønsted base catalysis). 
1.2.2.1. Activation via enamine formation (covalent) 
Small primary or secondary amines can condense with carbonyl compounds, 
more specifically aldehydes or ketones, leading to enamines which have increased 
nucleophilicity and are capable of reacting with a variety of electrophilic reagents. In 
the classical stoichiometric procedure (see Figure 3 above), the chiral enamine is 
isolated and then reacted with an electrophile. The adduct thus obtained can be 
hydrolysed aftermaths under acidic conditions affording the desired α-substituted 
carbonyl compound and recovering the starting chiral amine.52 
In enamine mediated catalysis, the same process happens within a catalytic cycle 
that contains as the main steps the following (Scheme 5): i) condensation of the chiral 
amine catalyst and the enolizable carbonyl compound, forming an iminium-ion; ii) 
deprotonation of the iminium leading to an enamine intermediate; iii) the 
stereochemistry-determining C–C bond formation by reaction of the enamine with an 
electrophile; and iv) hydrolysis of the resulting iminium species to afford the desired α-
functionalized carbonyl product with regeneration of the chiral amine catalyst, which 
can then re-enter the catalytic cycle.53 
                                                 
51 For reviews on asymmetric organocatalysis see: a) P. I. Dalko, L. Moisan, Angew. Chem. Int. Ed. 2004, 
43, 5138–5175. b) H. Pellissier, Tetrahedron. 2007, 63, 9267–9331. c) A. Dondoni, A. Massi, Angew. 
Chem. Int. Ed. 2008, 47, 4638–4660. d) H, Pellissier, Recent Developments in Asymmetric 
Organocatalysis, ACS Publishing, Cambridge 2010. e) B. List, K. Maruoka, Science of Synthesis: 
Asymmetric Organocatalysis, Ed. Thieme, Stuttgart 2010. 
52 F. A. Carey, R. J. Sundberg, Advanced Organic Chemistry, Ed. Springer, New York 2007, vol. B, 46-
55. 
53 I. Ojima, Catalytic Asymmetric Synthesis, Ed. John Wiley & Sons, New York, 2010. 
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Scheme 5. Catalytic cycle for enamine mediated processes. All reactions are reversible, but one-way 
arrows are depicted for simplicity. 
As established, the rate-determining step of this process is the formation of the 
enamine, which implies the abstraction of an α-proton.54 Thus, protic additives and 
polar solvents play a critical role accelerating the deprotonation and stabilizing ionic 
charges respectively.  
On the other hand, the principles that govern stereochemistry during the key C–
C bond forming step and so determine the configuration of the newly formed α-
stereocenter obey to two general models as represented in Figure 8. According to the 
model on the left (H-bond as control element) the hydrogen-bond donor group of the 
catalyst directs the approach of the electrophile towards one of the sides of the 
prostereogenic Cα, while according to the model on the right (steric control) bulky 
substituents of the catalyst force the approach of the electrophile to be from the side 
opposite to the “obese” substituent of the enamine, with the enamine adopting the E-
anti configuration preferentially. 
                                                 
54 a) K. N. Rankin, J. W. Gaud, R. J. Boyd, J. Phis. Chem. 2002, 106, 5155–5159. b) F. R. Clemente, K. 
N. Houk, Angew. Chem. Int. Ed. 2004, 43, 5766–5768. For a review on mechanisms in aminocatalysis 
see: c) M. Nielsen, D. Worgull, T. Zweifel, B. Gschwend, S. Bertelsen, K. A. Jørgensen Chem. Commun. 
2011, 47, 632–649. 
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Figure 8.  
In these models, an important assumption concerns enamine configuration. From 
the four possible configurations (Figure 9), in the case of aldehydes (R’ = H) the E-anti 
configuration is favoured. For ketones (R’=CH2-), the E-syn configuration is assumed to 
be the most stable.55 
 
Figure 9.  
Following the discovery by List and Barbas in 200056 of the potential of proline 
as a catalyst in the asymmetric intermolecular aldol reaction, the field of aminocatalysis 
has experienced an impressive growth,57 and enamine mediated catalysis has 
demonstrated to be an especially valuable tool for the introduction of α-stereogenicity in 
aldehydes and ketones. 
                                                 
55 a) S. Seebach, J. Golinski, Helv. Chim. Act. 1981, 64, 1413–1423. b) P. Dinér, A. Kjærsgaard, M. A. 
Lie, K. A. Jørgensen, Chem. Eur. J. 2008, 14, 122–127. c) D. Seebach, U. Groselj, D. M. Badine, W. B. 
Schweizer, A. K. Beck, Helv. Chim. Act. 2008, 91, 1999–2034. d) U. Groselj, D. Seebach, D. M. Badine, 
W. B. Schweizer, A. K. Beck, Helv. Chim. Act. 2009, 92, 1225–1259. e) T. Huch, D. Seebach, A. K. 
Beck, M. Reiher, Helv. Chim. Act. 2017, 100, e1700182. 
56 B. List, R. A. Lerner, C. F. Barbas III, J. Am. Chem. Soc. 2000, 122, 2395–2396.  
57 For reviews on aminocatalysis see: a) S. Mukherjee, J. W. Yang, S. Hoffman, B. List, Chem. Rev. 
2007, 107, 5471–5569. b) A. Dondoni, A. Massi, Angew. Chem. Int. Ed. 2008, 47, 4638–4660. c) P. 
Melchiorre, M. Marigo, A. Carlone, G. Bartoli, Angew. Chem. Int. Ed. 2008, 47, 6138–6171. d) M. 
Nielsen, D. Worgull, T. Zweifel, B. Gschwend, S. Bertelsen, K. A. Jørgensen, Chem. Commun. 2011, 47, 
632–649. e) B. M. Paz, H. Jiang, K. A. Jørgensen, Chem. Eur. J. 2015, 21, 1846–1853. 
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Notz and List reported the first example of the enamine-mediated asymmetric 
formation of an α-stereogenic center in an aldol reaction using α-hydroxyacetone as the 
donor compound. Given the easy enolization of aliphatic aldehydes the reaction is 
limited to aromatic or α-branched aldehydes as acceptor components, affording the anti-
aldol products in variable yields and diastereoselectivity, but in an overall excellent 
enantioselectivity (Scheme 6).58 
 
Scheme 6.  
List59 and Maruoka60 extended the method to the addition of cyclic ketones to 
aldehydes and α-ketoesters, respectively, with good results. List et al. were also the first 
to report the proline-catalyzed Michael61 reaction yielding products with a stereogenic 
center in Cα, albeit the enantioselectivity obtained was very low (Scheme 7). 
 
Scheme 7.  
Whereas these first examples demanded the use of a large excess of donor 
ketone compound, high catalyst loadings and prolonged reaction times, they 
demonstrated the true potential of aminocatalysis, and therefore a fast-paced era of 
proline-catalyzed reaction exploration began. In few years, a big amount of relevant 
proline-catalyzed procedures for the asymmetric reactions of ketones and aldehydes 
were disclosed.62 
                                                 
58 W. Notz, B. List, J. Am. Chem. Soc. 2000, 122, 7386–7387.  
59 B. List, P. Pojarliev, C. Castello, Org. Lett. 2001, 3, 573–575.   
60 O. Tokuda, T. Kano, W.-G. Gao, T. Ikemoto, K. Maruoka, Org. Lett. 2005, 7, 5103–5105.   
61 B. List, P. Pojarliev, H. J. Martin, Org. Lett. 2001, 3, 2423–2425.   
62 For reviews on proline-catalyzed reactions see: a) S. S. Mukherjee, J. W. Yang, S. Hoffmann, B. List, 
Chem. Rev. 2007, 107, 5471–5568. b) H. Kotsuki, H. Ikishima, A. Okuyama, Heterocycles 2008, 75, 
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Meanwhile, in an attempt to overcome the limitations encountered when using 
proline, new and more efficient catalysts started to emerge, and the first approaches 
were mainly centered in the modification of the proline structure. The substitution of the 
carboxylic acid of proline for other functional groups resulted in catalysts with 
improved solubility in organic solvents and easier structural fine tune to better adapt to 
each particular substrate, thus improving the reactivity and the stereocontrol. Some of 
the most representative proline-based catalyst families used in the asymmetric α-
functionalization of aldehydes and ketones are shown in Figure 10.63 Of these catalysts, 
prolinol silyl ethers (Figure 10, F) have demonstrated the most versatile and general, 
catalysing a broad array of asymmetric reactions via either enamine or iminium 
activation.64 
 
Figure 10.  
Naturally available primary amines and their derivatives have also been used, 
mainly for asymmetric reactions involving ketones as donors.65 For example, Córdova 
                                                                                                                                               
493–529. c) H. Kotsuki, H. Ikishima, A. Okuyama, Heterocycles 2008, 75, 757–797. c) S. K. Panday, 
Tetrahedron: Asymmetry 2011, 22, 1817–1847. 
63 For a recent review on proline-based secondary amine catalysts see: J. Liu, W. Lei, Synthesis 2017, 49, 
960–972. 
64 For reviews on α,α-diarylprolinol silyl ether catalysts see: a) A. Mielgo, C. Palomo, Angew. Chem. Int. 
Ed. 2006, 45, 7876–7880. b) A. Mielgo, C. Palomo, Chem. Asian J. 2008, 3, 922–948. c) K. Jensen, G. 
Dickmeiss, H. Jiang, L. Albrecht, K. A. Jørgensen, Acc. Chem. Res. 2012, 45, 248–264. d) B. Donslud, T. 
K. Johansen, P. H. Pernille, K. S. Halskov, K. A. Jørgensen, Angew. Chem. Int. Ed. 2015, 54, 13860–
13874. e) L. Klier, F. Tur, P. H. Pernille, K. A. Jørgensen, Chem. Soc. Rev. 2017, 46, 1080–1102. 
65 For reviews on primary amine catalysts see: a) Y.-C. Chen, Synlett 2008, 1919–1930. b) P. Melchiorre, 
Angew. Chem. Int. Ed. 2012, 51, 9748–9770. c) L. Zhang, N. Fu, S. Luo, Acc. Chem. Res. 2015, 48, 986–
997. 
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et al. used a primary amine catalyst derived from the natural amino acid L-alanine for 
the Michael addition of cyclic ketones to aromatic nitroalkenes (Scheme 8).66  
 
Scheme 8.  
De novo design secondary cyclic amines have also been demonstrated useful as 
aminocatalysts for activation via enamine formation. In particular, Maruoka et al. 
developed binaphtyl derived amine catalysts for the anti-Mannich and syn-aldol 
reactions, contributing to fill an important gap in asymmetric synthesis.67 The same 
group later extended the utility of these catalysts to the Michael addition using 
aldehydes as donors.68 
 
Figure 11.  
To sum up, impressive progress has been done during the last two decades in the 
development of enamine-based asymmetric α-functionalization of carbonyl compounds. 
However, some recalcitrant problems regarding substrate scope, regio- and 
stereocontrol as well as some practical issues still remain. Indeed, the procedures 
                                                 
66 Y. Xu, A. Córdova, Chem. Commun. 2006, 42, 460–462. 
67 a) T. Kano, Y. Yamaguchi, O. Tokuda, K. Maruoka, J. Am. Chem. Soc. 2005, 127, 16408–16409. b) T. 
Kano, Y. Yamaguchi, Y. Tanaka, K. Maruoka, Angew. Chem. Int. Ed. 2007, 46, 1738–1740. For reviews 
on these catalysts see: c) T. Kano, K. Maruoka, Chem. Commun. 2008, 44, 5465–5473. d) T. Kano, K. 
Maruoka, Bull. Chem. Soc. Jpn. 2010, 83, 1421–1438. 
68 a) T. Kano, H. Sugimoto, O. Tokuda, K. Maruoka, Chem. Commun. 2013, 49, 7028–7030. b) T. Kano, 
H. Maruyama, R. Sakamoto, K. Maruoka, Chem. Commun. 2015, 51, 10062–10065. c) T. Kano, H. 
Sugimoto, H. Maruyama, K. Maruoka, Angew. Chem. Int. Ed. 2015, 54, 8462–8465. d) S. B. J. Kan, H. 
Maruyama, M. Akakura, T. Kano, K. Maruoka, Angew. Chem. Int. Ed. 2017, 56, 9487–9491. 
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described so far are limited to aldehyde and ketone donors, and the use of sterically 
hindered ketones still remains challenging. Furthermore, unsymmetrical ketones have 
been scarcely used due to the difficulties in controlling the regiochemistry of the 
reaction and low diastereomeric ratios are obtained in many examples where two 
stereogenic centers are formed. 
On the one hand, chemoselectivity is still an issue in cross aldol reactions 
involving aldehydes: these reactions may lead to two homoaldol and two cross-aldol 
products, and so use of large excesses of one of the components is usually required in 
order to obtain good yields and selectivity. On the other hand, sterically hindered 
carbonyl compounds have been scarcely used in enamine catalysis, due to their lower 
tendency towards formation of enamines. 
 
1.2.2.2. Activation via base-promoted enolization (noncovalent) 
The α-deprotonation of enolizable carbonyl compounds by action of a base to 
yield the corresponding enolate is one of the most elemental mechanisms for carbonyl 
compound activation.69 Upon the subsequent reaction of the enolate with a suitable 
electrophile the base might get restored again, allowing to re-enter the activation 
pathway and render the process catalytic. Accordingly, a general catalytic cycle as that 
shown in Figure 12 could be invoked in which proton transfer events occur repeatedly. 
 
Figure 12.  
                                                 
69 For further information on Brønsted base-catalyzed α-functionalization of carbonyls see: a) C. Palomo, 
M. Oiarbide, R. López, Chem. Soc. Rev. 2009, 38, 632–653. b) I. Ojima, Catalytic Asymmetric Synthesis, 
Ed. John Wiley & Sons, New York, 2010. c) A. Ting, J. M. Gross, N. T. McDougal, S. E. Schaus, Top. 
Curr. Chem. 2010, 291, 145–200. d) K. Maruoka, Asymmetric Organocatalysis 2, Brønsted Base and 
Acid Catalysis, and Additional Topics: Science of Synthesis; Ed. Thieme, Stuttgart, 2012. 
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In such a process, the chirality transfer from the base (catalyst) to the product 
takes place during the key Cα-E bond forming reaction and implies information transfer 
throughout a non-covalent substrate-catalyst ion-pairing complex. This constitutes a 
significant difference if compared with enamine catalysis described above, where a 
substrate-catalyst covalent complex is formed. The intrinsic nondirectional nature of 
electrostatic interactions in ion-pairing complexes makes predicting the sense of the 
stereoinduction exerted from the catalyst difficult. In this sense, molecules that combine 
a site acting as a base and another site with hydrogen-bond donor ability, namely 
bifunctional Brønsted base/H-bond donor catalysts,70 can anchor both nucleophilic and 
electrophilic components in the transition state. As a result, more active catalysts are 
obtained, and a higher degree of stereochemical order is achieved in the transition state 
(Figure 13). 
 
Figure 13.  
Different nitrogen-containing functionalities have been employed for the design 
of chiral BB catalysts. Among them, tertiary amines are the most prominent, but also 
guanidines, amidines, and imidazoles are used (Figure 14). 
 
Figure 14.  
The selection of the chiral basic unit is highly dependent on the availability of 
the corresponding optically pure precursors from the chiral pool. In this context, 
alkaloids and in particular cinchona family are a straightforward source of enantiopure 
BB catalyst candidates (Figure 15). Furthermore, simple chemical modifications of the 
                                                 
70 For further information on the concept of bifunctional organocatalysts see: L.-Q. Lu, X.-L. An, J.-R. 
Chen, W.-J. Xiao, Synlett 2012, 23, 490–508. 
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parent alkaloid structure provide a rapid access to stereochemically related 
architectures. Thus, these cinchona and cinchona-derived catalysts were the earliest 
bifunctional BB catalysts applied to the α-functionalization of easily enolizable 
carbonyl compounds, usually bearing an EWG at the α-carbon.71 
 
Figure 15.  
Wynberg and coworkers, in the 70’s were pioneers in this field and recognized 
the activation and stereoinduction capacity of cinchona alkaloid-derived catalysts, 
mainly for the Michael-type reactions. Although they obtained remarkable results for 
some transformations, such as the conjugate addition of thiols,72 poor 
enantioselectivities were reported for the conjugate addition of enolizable C-
nucleophiles (Scheme 9).73 
 
Scheme 9.  
                                                 
71 For reviews on cinchona alkaloids in asymmetric organocatalysis see: a) T. Marcelli, J. H. van 
Maarseveen, H. Hiemstra, Angew. Chem. Int. Ed. 2006, 45, 7496–7504. b) T. Marcelli, H. Hiemstra, 
Synthesis 2010, 1229–1279. c) E. M.O. Yeboah, S. O. Yeboah, G. S. Singh, Tetrahedron. 2011, 1725–
1762. d) L. A. Bryant, R. Fanelli, A. J. A. Cobb, Beilstein J. Org. Chem. 2016, 12, 429–443. 
72 a) H. Hiemstra, H. Wynberg, J. Am. Chem. Soc. 1981, 103, 417–430. b) H. Hiemstra, H. Wynberg, E: 
G. J. Staring, J. Am. Chem. Soc. 1982, 104, 168–173. 
73 a) H. Wynberg, R. Helder, Tetrahedron Lett. 1975, 16, 4057–4058. b) K. Hermann, H. Wynberg, J. 
Org. Chem. 1979, 44, 2238–2244. 
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Some years later, Szöllösi74 tested several cinchona alkaloid derivatives for the 
conjugate addition of different β-dicarbonyl compounds to methyl vinyl ketone, 
obtaining substantially better results (ee up to 83%, Scheme 10). 
 
Scheme 10.  
In a series of papers published from 2004 to 2006, Deng and coworkers75 studied 
the bifunctional BB-catalyzed conjugate addition of easily enolizable carbonyl 
compounds quite extensively employing a broad spectrum of Michael acceptors and 
bifunctional cupreine and derived catalysts (Scheme 11). Excellent yields and diatereo- 
and enantioselectivities were obtained and they demonstrated the critical role of the 6’-
OH group of cupreine as a H-bond donor site, as both catalyst activity and 
enantioselectivity vary drastically when moving from cupreine to quinidine.75a 
 
Scheme 11.  
                                                 
74 G. Szöllösi, M. Bartók, Chirality 2001, 13, 614–618. 
75 a) H. Li, Y. Wang, L. Tang, L. Deng, J. Am. Chem. Soc. 2004, 126, 9906–9907. b) H. Li, Y. Wang, L. 
Tang, F. Wu, X. Liu, C. Guo, B. M. Foxman, L. Deng, Angew. Chem. Int. Ed. 2005, 44, 105–108. c) H. 
Li, J. Song, X. Liu, L. Deng, J. Am. Chem. Soc. 2005, 127, 8948–8949. d) F. Wu, H. Li, R. Hong, L. 
Deng, Angew. Chem. Int. Ed. 2006, 45, 947–950. e) F. Wu, R. Hong, J. Khan, X. Liu, L. Deng, Angew. 
Chem. Int. Ed. 2006, 45, 4301–4305. 
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The use of α-chloroacrylonitrile as Michael acceptor by the same group76 is 
worth of mention. In this reaction two nonadjacent stereogenic centers are formed in a 
domino process with overall excellent results (Scheme 12). According to the authors, 
the cinchona catalyst first directs the addition of the nucleophile and then performs a 
stereoselective protonation of the resulting intermediate. 
 
Scheme 12.  
The α-amination of carbonyl compounds represents another reaction category 
for which BB-catalysis has been successfully applied. Pikho and coworkers77 reported 
the first example with β-ketoesters using dibenzyl azodicarboxylate as the electrophile 
and cinchonine or cinchonidine as the catalyst, although enantioselectivity could not be 
higher than 88% ee. Almost at the same time, the group of Jørgensen78 achieved the 
highly enantioselective α-amination reacting α-aryl-α-cyanoacetates with di-tert-butyl 
azodicarboxylate in the presence of a cinchona-alkaloid derivative. However, they 
obtained slightly lower selectivities when using β-diketones and β-ketoesters as 
pronucleophiles (Scheme 13a). Later Deng and coworkers79 also used these cupreine-
derived catalysts for the same reaction obtainig comparable results (Scheme 13b). 
                                                 
76 Y. Wang, X. Liu, L. Deng, J. Am. Chem. Soc. 2006, 128, 3928–3930. 
77 P. M. Pikho, A. Pohjakallio, Synlett 2004, 2115–2118. 
78 S. Saaby, M. Bella, K. A. Jørgensen, J. Am. Chem. Soc. 2004, 126, 8120–8121. 
79 a) X. Liu, H. Li, L. Deng, Org. Lett. 2005, 7, 167–169. b) X. Liu, B. Sun, L. Deng, Synlett 2009, 1685–
1689. 
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Scheme 13.  
The quest for new and efficient bifunctional catalysts headed to the design and 
synthesis of enantiomerically pure amine derivatives bearing a range of H-bond donor 
sites. The most successful strategies to date merge a readily available chiral amine and 
an efficient H-bond donor group, such as a urea, thiourea, squaramide or sulphonamide 
(Figure 16). These modifications have led to increasingly active and selective 
bifunctional BB catalysts. 
 
Figure 16.  
In 2003, Takemoto et al.80 presented the first highly enantioselective catalyst 
based on these principles, a thiourea derived from 1,2-diaminocyclohexane, for the 
Michael addition of malonates to nitroalkenes. The same group later used the catalyst 
for the Michael and Mannich reactions of cyclic β-ketoesters generating adducts which 
                                                 
80 T. Okino, Y. Hoashi, Y. Takemoto, J. Am. Chem. Soc. 2003, 125, 12672–12673. 
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bear a tertiary or quaternary stereocenter at Cα (Scheme 14).
81  According to the authors, 
the catalyst activates the nucleophile through the amino group while the thiourea moiety 
activates the electrophile, forcing both components to approach in a stereospecific 
manner.82 
 
Scheme 14.  
Other thiourea catalysts derived from diamines with C2-symmetry were also 
developed for the asymmetric α-functionalization of carbonyl compounds,83 but because 
of the availability and versatility of cinchona-alkaloids, the thiourea-cinchona alkaloid 
catalysts soon became the most popular bifunctional catalysts in the area.84 For instance, 
between 2005 and 2006 Connon,85 Deng,86 Dixon,87 Soós88 and Wang89 independently 
                                                 
81 a) T. Okino, Y. Hoashi, T. Furakawa, X. Xu, Y. Takemoto, J. Am. Chem. Soc. 2005, 127, 119–125. b) 
Y. Yamaoka, H. Miyabe, Y. Yasui, Y. Takemoto, Synthesis 2007, 2571–2575. 
82 a) Ref. 81a. Later Pápai and Zhong proposed that the nucleophile coordinates to the NH-bonds of the 
thiourea moiety and the nitrostyrene is activated by the protonated tertiary amine based on DFT and 1H-
NMR studies: b) A. Hamza, G. Schubert, T. Soós, I. Pápai, J. Am. Chem. Soc. 2006, 128, 13151–13160. 
c) B. Tan, Y. Lu, X. Zeng, P. J. Chua, G. Zhong, Org. Lett. 2010, 2682–2685. 
83 For a review on thiourea catalysts derived from diamines with C2-symmetry see: Y. Takemoto, Chem. 
Pharm. Bull. 2010, 58, 593–601. 
84 For reviews on cinchona-based thiourea organocatalysts see: a) S. J. Connon, Chem. Commun. 2008, 
44, 2499–2510. b) Y. Xi, X. Shi, Chem. Commun. 2013, 49, 8583–8585. 
85 A. H. McCooney, S. J. Connon, Angew. Chem. Int. Ed. 2005, 44, 6367–6370, Michael reaction. 
86 a) J. Song, Y. Wang, L. Deng, J. Am. Chem. Soc. 2006, 128, 6084–6085, Mannich reaction. b) Y.-Q. 
Wang, J. Song, R. Hong, H. Li, L. Deng, J. Am. Chem. Soc. 2006, 128, 8156–8157, Friedel-Crafts 
reaction. 
87 A. L. Tillman, J. Ye, D. Dixon, Chem Commun. 2006, 42, 1191–1193, Mannich reaction. 
88 B. Vakulya, S. Varga, A. Csámpai, T. Soós, Org. Lett. 2005, 7, 1967–1969, Michael reaction. 
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reported first thiourea-cinchona alkaloid catalysts for reactions involving soft carbon 
nucleophiles, as summarised in Table 1.  
Table 1. Pioneering thiourea-cinchona alkaloid-catalyzed reactions 
 
                                                                                                                                               
89 J. Wang, H. Li, L. Zu, W. Jiang, H. Xie, W. Duan, W. Wang, J. Am. Chem. Soc. 2006, 128, 12652–
12653, Michael reaction. 
Donor Acceptor Catalyst 
Yield (%) 
dr 
ee (%) 
Author, Ref. 
  
 
88–95% 
>86% ee 
Connon, 85 
(2005) 
 
 
 
>64% 
<3:1 dr 
>89% ee 
Deng, 86 
(2006) 
 
 
 
>81% 
>16:1 dr 
84–97% ee 
Dixon, 87 
(2006) 
MeNO2 
 
 
8094% 
89–98% ee 
Sóos, 88 
(2005) 
  
 
>61% 
<1.5:1 dr 
>95–98% ee 
Wang, 89 
(2006) 
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In 2008, Song and coworkers90 introduced a bifunctional cinchona alkaloid-
sulphonamide catalyst, for the desymmetrization of cyclic anhydrides. However, 
catalysts bearing a sulphonamide group have been scarcely used in the asymmetric α-
functionzalization of enolizable compounds, and so far they have been limited to the 
Michael reaction with nitroolefins.91 Lu et al.91a reported the asymmetric α-
functionzalization of cyclic β-ketoesters derived from 1-indanone using this kind of 
catalyst (Scheme 15). Adducts were obtained in excellent yield and enantioselectivity 
and good diastereoselectivity, although ee’s were eroded when varying the rig-size or 
removing the fused aromatic ring. 
 
Scheme 15.  
The same year, Rawal and coworkers92 introduced the squaramide function as 
efficient double H-bond donor site in asymmetric catalysis. Both (thio)urea and 
squaramides are structurally rigid, although there are some differences. On the one 
hand, squaramides contain two hydrogen-bond donors (N–H) and two carbonyl 
acceptors (C=O), showing one more acceptor than thioureas. On the other hand, the 
cyclobutenedione ring induces a convergent orientation of the N–H groups, and the 
distance between them is estimated to be bigger (2.71 Å)92 than in the case of thioureas 
(2.13 Å) (Figure 17a).93 Both functionalities have the possibility of delocalizing the 
nitrogen lone pair through the carbon-heteroatom double bond, but in the case of 
squaramides further delocalization can occur through the cyclobutenedione system 
                                                 
90 S. H. Oh, H. S. Rho, J. w. Lee, S. H. Youk, J. Chin, C. E. Song, Angew. Chem. Int. Ed. 2008, 47, 7872–
7875. 
91 a) J. Luo, L.-W. Xu, R. A. S. Hay, Y. Lu, Org. Lett. 2009, 11, 437–440. b) H. Y. Bae, S. Some, J. S. 
Oh, Y. S. Lee, C. E. Song, Chem. Commun. 2011, 9621–9623. c) C. Reiter, S. López-Molina, B. Schmid, 
C. Neiss, A. Görling, S. B. Tsogoeva, ChemCatChem. 2014, 6, 1324–1332. 
92 J. P. Malerich, K. Hagihara, V. H. Rawal, J. Am. Chem. Soc. 2008, 130, 14416–14417. 
93 T. Okino, Y. Hoashi, T. Fukurawa, X. N. Xu, Y. Takemoto, J. Am. Chem. Soc. 2005, 127, 119–125. 
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(Figure 17b),94 thus making the N–H acidity of the squaramide catalysts higher 
compared to the thiourea analogs.95 Accordingly, squaramides can form stronger 
hydrogen bonds, which may account for their comparatively higher activity, even at 
relatively low catalyst loadings. 
 
Figure 17.  
Cinchonine derivatives bearing a squaramide group proved to be good promoters 
for the Michael addition of β-ketoesters and β-diketones to β-arylnitroalkenes (Scheme 
16).92 The corresponding adducts were obtained in excellent yield and 
enantioselectivity, but the most remarkable aspect of this reaction is the low catalyst 
loading (as low as 0.1 mol%) needed for effective stereocontrol. 
 
Scheme 16.  
                                                 
94 S. Tomàs, R. Prohens, M. Vega, M. C. Rotger, P. M. Deyá, A. Costa, J. Org. Chem. 1996, 61, 9394–
9401. 
95 X. Ni, X. Li, Z. Wang, J. P. Cheng, Org. Lett. 2014, 16, 1786–1789. 
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Encouraged by this unusual activity, in the following years many new 
squaramide catalysts were employed in different reactions,96 with special success in 
domino and tandem processes.97 
On the other hand, Wang et al. developed a different kind of bifunctional 
organocatalyst based on bifunctional amine-thioureas bearing three hydrogen-bond 
donor sites. The undelaying idea is that one more interaction site would lead to the 
formation of additional hydrogen bonds, thus improving the efficiency of the catalyst.98 
This group demonstrated the utility of these catalysts for the Michael reaction of β-
ketoesters and β-diketones with nitroalkenes, obtaining the corresponding adducts in 
excellent yield, diastereo- and enantioselectivity (Scheme 17).99 
 
Scheme 17.  
Shortly before beginning this Thesis work, our research group introduced a new 
type of bifunctional BB catalyst based on the presence of a ureidopeptide unit as the H-
bond donor site.100 These catalysts were demonstrated to be very efficient in the 
Michael addition to nitroolefins and the amination of 5H-thiazol-4-ones (Scheme 18). 
These catalysts, which offer three independently modifiable parts, outperformed 
cinchona alkaloids and the Takemoto catalyst. It is worth noting that this was the first 
time 5H-thiazol-4-ones were used in asymmetric synthesis. 
                                                 
96 For reviews on squaramide-based catalysts see: a) J. Alemán, H. Jiang, K. A. Jørgensen, Chem. Eur. J. 
2011, 17, 6890–6899. b) X. Han, H.-B. Zhou, C. Dong, Chem. Rec. 2016, 16, 897–906. c) B.-L. Zhao, J.-
H. Li, S.-M. Du, Chem. Rec. 2017, 17, 994–1018. 
97 For a review on squaramide-catalyzed domino and tandem reactions see: P. Chauhan, S. Mahajan, U. 
Kaya, D. Hack, D. Enders, Adv. Synth. Catal. 2015, 357, 254–281. 
98 For a review on these catalysts see: X. Fang, C.-J. Wang, Chem. Commun. 2015, 51, 1185–1197. 
99 Z.-H. Zhang, X.-Q. Dong, C.-J. Wang, Chem. Eur. J. 2008, 14, 8780–8783. 
100 a) S. Diosdado, J. Etxabe, J. Izquierdo, A. Landa, A. Mielgo, I. Olaizaola, R. López, C. Palomo, 
Angew. Chem. Int. Ed. 2013, 52, 11846–11851. For further utility of these catalysts see: Mannich 
reaction: b) S. Diosdado, R. López, C. Palomo, Chem. Eur. J. 2014, 20, 6526–6531. c) I. Bastida, M. San 
Segundo, R. López, C. Palomo, Chem. Eur. J. 2017, 23, 13332–13336. Aldol reaction: d) I. Lapuerta, S. 
Vera, M. Oiarbide, C. Palomo, Chem. Eur. J. 2016, 22, 7229–7237. e) H. Etxabe, R. López, C. Palomo, 
Angew. Chem. Int. Ed. 2016, 55, 3364–3368. 
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Scheme 18.  
On the other hand, guanidines represent another class of BB-catalysts. 
Guanidines can be categorized as organic superbases, owing to the stability of their 
conjugated acids (Figure 18), and therefore they are capable of catalysing various base-
mediated organic reactions.101 Another feature of guanidines is that the bidentate group 
may activate both the nucleophile and the electrophile concomitantly (Figure 18).102 
 
Figure 18.  
                                                 
101 For further information on guanidine-catalyzed reactions see: a) T. Ishikawa, T. Kumamoto, Synthesis 
2006, 737–725. b) D. Leow, C.-H. Tan, Chem. Asian J. 2009, 4, 488–507. c) D. Mailhol, M. M. 
Coquerel, J. Rodriguez, Adv. Synth. Catal. 2012, 354, 3523–3532. 
102 P. I. Dalko, Comprehensive Enantioselective Organocatalysis: Catalysts, Reactions, and Applications; 
Ed. Wiley-VCH Verlag GmbH & Co., 2013. 
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In 2001, Ishikawa and coworkers103 reported the first highly effective BB 
catalyzed Michael reaction using a 1,2-diphenylethylenediamine-derived chiral 
guanidine. The Michel reaction under neat conditions between glycine imine and 
several different acceptors afforded up to 97% ee, but a big excess of the acceptor was 
required in order to obtain a good yield (Scheme 19). 
 
Scheme 19.  
The bicyclic C2-symmetric chiral guanidine introduced by the group of Corey
104 
in 1999 is one of the most popular guanidine catalysts. In 2007, Tan and Jiang105 
reported the Michael reaction between different Michael acceptors and active methylene 
compounds to afford excellent yield and ee values, but zero diastereoselectivity, 
presumably due to subsequent epimerization of the α-carbon (Scheme 20). 
 
Scheme 20.  
To conclude, although BB catalysis has been successfully employed in the α-
functionalization of an array of enolizable carbonyl compounds, most of the methods 
are restricted to easily enolizable nucleophiles typically bearing an EWG at the α-
position like malonates, cyanoacetates, β-ketoesters, etc. In addition, most asymmetric 
                                                 
103 T. Ishikawa, Y. Araki, T. Kumamoto, H. Seki, K. Fukuda, T. Isobe, Chem. Commun. 2001, 245–246. 
104 E. J. Corey, M. J. Grogan, Org. Lett. 1999, 1, 157–160. 
105 a) W. Ye, Z. Jiang, Y. Zhao, S. L. M. Goh, D. Leow, Y.-T. Soh, C.-H. Tan, Adv. Synth. Catal. 2007, 
349, 2452–2458. For further examples by the same group see: b) L. Huang, J. Li, Y. Zhao, X. Ye, Y. Liu, 
L. Yan, C.-H. Tan, H. Liu, Z. Jiang, J. Org. Chem. 2015, 80, 8933–8941 and references herein. 
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procedures reported to date lead to the formation of a single stereogenic center or 
provide two consecutive new stereogenic centers with variable diastereoselectivity. On 
the other hand, among the Michael acceptors used so far, α,β-unsaturated carboxylic 
acid equivalents (enoates) remain little explored. 
 
1.3. Limitations and general objectives 
As can be seen in the previous sections, procedures for the direct asymmetric α-
functionalization of carbonyl compounds still have some important limitations 
regarding the scope of nucleophiles and electrophiles suitable for attaining high 
reactivity and selectivity. 
On the one hand, the enamine mediated cross-aldol reactions between two 
enolizable compounds remain troublesome due to the potential formation of up to four 
distinct aldol products, especially when using aldehydes as nucleophiles (Figure 19a). 
On the other hand, the use of α,β-unsaturated carbonyl compounds as electrophiles in 
asymmetric C–C bond forming catalysis has been little explored, in part owing to 
competitive 1,2- versus 1,4-addition pathways (Figure 19b). 
 
Figure 19.  
These and other yet problematic issues, such as the creation of quaternary 
stereocenters or two adjacent stereocenters in an enatio- and diastereoslective manner, 
have been addressed in the present investigation. More specifically, we hypothesized 
that the use of propargylic carbonyl compounds as acceptors might provide a solution to 
the problematic cross-aldol reaction with enolizable aldehydes. As will be outlined later, 
these aldehydes have not been previously employed as acceptors in direct aldol 
reactions. The total or partial reduction of the triple C≡C bond in adducts should afford 
products that are formally derived from a troublesome cross-aldol reaction. Two 
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additional characteristics of this realization would be: i) the simultaneous formation of 
two contiguous stereogenic centers; and ii) the production of densely functionalized 
building-blocks, appropriate for ulterior application in the synthesis of structurally 
complex molecules. 
 
Figure 20.  
At the outset, this plan faced several challenges: 
- Selective activation of the propargyl aldehyde as electrophile 
- Suppression of the homodimerization of the enolizable aldehyde 
- Control of the 1,2- vs 1,4- addition to ynones 
- Control of the diastereo- and enantioselectivity 
In a second part, we focused on some problems inherent to BB-catalyzed α-
functionalization of carbonyl compounds. In particular, one limitation of the existing 
methods, as mentioned before, is the need for an additional EWG being attached to the 
α-carbon, which makes the α-carbon more acidic (13–18 pKa range)106 and therefore 
suitable for enolization by common organic bases (Table 2). In contrast, unactivated 
carbonyl compounds display higher pKa values and thus are more challenging substrates 
for activation by Brønsted base catalysis.  
  
                                                 
106 For a webpage of Bordwell pKa Table (acidities in DMSO) of different compounds, see: 
http://www.chem.wisc.edu/areas/reich/pkatable/index.htm. 
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Table 2. pKa values in DMSO for representative carbonyl compounds and organic BB.106 
 
 
 
 
 
 
 
 
On the other hand, the regioselective α-functionalization of ketones with two 
enolizable positions (α vs α’), and the stereoselective conjugate additions to enoates or 
equivalents also remain problematic. 
 
Figure 21.  
In this context, our proposal was the use of α’-hydroxy enones in asymmetric 
organocatalysis for the first time. We hypothesized that chiral bifunctional BB catalysts 
might be able to trigger the Michael addition of pronucleophiles like 5H-oxazol-4-ones 
and cyanoacetates to these electrophiles, allowing the generation of chiral tertiary 
alcohols and all-carbon tetrasubstituted stereogenic centers, respectively. 
 
Scheme 21.  
Carbonyls 
pKa 
Bases 
pKa  of 
conjugated acid R = H R = Ph 
 
26.5 19.8 
 
8.9 
 
24.7 17.7 TEA 9.0 
 
35 25.9 
 
9.8 
 
30.3 23.6 
 
12.0 
 
- 16.9 
 
13.6 
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A third problem we addressed during this Thesis concerns the regioselective α-
functionalization of enolizable ketones. Following the work by Seebach107 and 
d’Angelo108 using enamine chemistry, we decided to take β-tetralones as a case study 
for achieving their regio- and stereoselective functionalization with the help of chiral 
bifunctional BB catalysts. The idea was that the fused aromatic ring in the molecule 
would induce preferential enolization at Cα, thus directing the functionalization towards 
that position. 
 
Scheme 22.  
In this particular development, several problems were apparent at the outset: i) 
control of the α/α’ selectivity, ii) suppression of the double addition (over addition 
products), and iii) control of diastereo- and enantioselectivity. 
As another relevant situation where regioselectivity is an issue, we also decided 
to investigate the BB-catalyzed functionalization of alkenyl ketones. Here a vinylogous 
enolate would be formed and so there is a double selectivity problem: α vs α’ vs γ. With 
these types of substrates, enamine-mediated catalysis usually provides the γ-addition 
adducts preferentially. We reasoned that bifunctional Brønsted base/H-bond catalysis 
might direct the approach of the electrophile through the α-position. 
                                                 
107 a) S. J. Blarer, W. D. Seebach, Chem. Ber. 1982, 116, 3086–3096. 
108 a) T. Volpe, G. Revial, M. Pfau, J. d’Angelo, Tetrahedron Lett. 1987, 28, 2367–2370. b) J. d’Angelo, 
G. Revial, T. Volpe, M. Pfau, Tetrahedron Lett. 1988, 29, 4427–4430. 
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Scheme 23.  
In the last part of my Doctoral research period, a short stay was carried out under 
the supervision of Prof. Jonathan Clayden in the School of Chemistry of the University 
of Bristol in the United Kingdom. The research project there was focused on the 
preparation of arogenate derivatives starting from the natural amino acid tyrosine. 
Arogenate derivatives are potential candidates for application as selective herbicides, 
and the development of an efficient and reproducible synthetic route to arogenate 
involving stable and modifiable intermediates is of current interest. 
 
Scheme 24.  
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Enamine-mediated aldol reaction of aldehydes with 
propargylic aldehydes and ketones 
2.1. Precedents and objectives 
Propargylic carbonyl compounds are attractive acceptors in C–C bond forming 
reactions, not only because the acetylenic system in the resulting adduct is an interesting 
scaffold for synthetic purposes, but also because they might be viewed as surrogates of 
simple enolizable aldehydes and α,β-enals given the ease with which the alkyne moiety 
may be easily transformed (upon total or partial reduction of the triple bond) into the 
corresponding alkyl and alkenyl units, respectively. 
Despite the aldol reaction is one of the most extensively studied C–C bond 
forming transformations, at the beginning of this project there were only three examples 
of asymmetric catalytic direct aldol reactions involving propargylic aldehydes. The first 
two examples, reported by the groups of Mahrwald109 and Shair,110 were based on the 
use of metal complexes. Mahrwald used a titanium-BINOL complex for the asymmetric 
addition of a symmetric linear ketone to propargylic aldehyde 1a (Scheme 1a), 
obtaining the corresponding aldol adduct in good yield, low syn/anti selectivity and 
good enantioselectivity. On the other hand, Shair et al. developed a Cu-catalyzed 
decarboxylative aldol addition of a malonic acid half thioester to propargylic aldehyde 
1b (Scheme 1b), which yielded the aldol reaction product in moderate yield, low 
diastereoselectivity and excellent enantioselectivity. 
                                                 
109 a) R. Mahrwald, Org. Lett. 2000, 2, 4011–4012. b) R. Mahrwald, B. Ziemer, Tetrahedron Lett. 2002, 
43, 4459–4461. c) R. Mahrwald, B. Schetter, Org. Lett. 2006, 8, 281–284. d) B. Schetter, B. Ziemer, G. 
Schnakenburg, R. Mahrwald, J. Org. Chem. 2008, 73, 813–819. 
110 D. Magdziak, G. Lalic, H. M. Lee, K. C. Fortner, A. D. Aloise, M. D. Shair, J. Am. Chem. Soc. 2005, 
127, 7284–7285. 
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Scheme 1.  
Li et al.111 reported in 2003 the third and only organocatalytic example described 
before the beginning of this project (Scheme 1c). The L-proline catalyzed reaction of 
TBDMS-protected hydroxyacetone with a propargylic aldehyde afforded a mixture of 
aldol adducts with low selectivity. 
While our investigation was in progress, Ricci, Quignard et al.112 published the 
aldol reaction of cyclohexanone with different aldehydes, including propargylic 
                                                 
111 H. Liu, L. Peng, T. Zhang, Y. Li, New J. Chem. 2003, 27, 1159–1160. 
112 C. Gioia, A. Ricci, L. Bernardi, K. Bourahla, N. Tanchoux, M. Robitzer, F. Quignard, Eur. J. Org. 
Chem. 2013, 588–594. 
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aldehydes, catalyzed by a chitosan aerogel. When phenylpropargyl aldehyde 1a was 
employed, very low diastereoselectivity and moderate ee were obtained (Scheme 2). 
 
Scheme 2.  
The control of chemoselectivity is especially troublesome in aldol reactions 
involving linear aldehydes as donor components, given the likelihood to have 
competitive undesired self-aldol processes. To our knowledge, the sole previous 
example of catalytic asymmetric aldol reaction using enolizable aldehydes as donor 
components was reported by Denmark and Ghosh113 and involves trichlorosilyl enol 
ethers derived from aldehydes as nucleophiles and a phosphoramide catalyst (Scheme 
3). Although cross-aldol products were obtained in excellent yield and 
diastereoselectivity, the enantioselectivity turned out to be of 76% ee at best. 
 
Scheme 3.  
As to the use of propargylic ketones as electrophiles in asymmetric catalytic 
aldol reaction, the only example to date has been reported by Maruoka et al.,114 who 
during the progress of this project documented the aldol reaction of symmetric ketones 
                                                 
113 S. E. Denmark, S. K. Ghosh, Angew. Chem. Int. Ed. 2001, 40, 4759–4762. 
114 S. A. Moteki, J. Han, S. Arimitsu, M. Akakura, K. Nakayama, K. Maruoka, Angew. Chem. Int. Ed. 
2012, 51, 1187–1190. 
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with a single propargylic α-ketoester 2a employing a chiral primary amine catalyst. The 
corresponding adducts were obtained selectively with the Cα-alkyl and the Cβ-OH 
groups in the syn- relative position in excellent yield and enantioselectivity. An 
interesting aspect of this development is that the enantioselectivity could be inverted by 
addition of an achiral Brønsted acid (Scheme 4). 
 
Scheme 4.  
In this same context, I. Otazo and I. Lapuerta during their Thesis work and S. 
Vera, in our group reported a general procedure for the asymmetric direct Mannich 
reaction between aldehydes and unactivated imines,115 including propargylimines 
(Scheme 5), promoted by certain silylprolinol ether catalysts.116 These catalysts, 
exemplified by C1, bear two geminal α,α-alkyl groups instead of the gem-α,α-diaryl 
groups present in the commonly employed α,α-diaryl prolinol ethers (Jørgensen and 
Hayashi catalysts). During this development, it was observed that while these catalysts 
conducted the Mannich reaction with high efficiency and selectivity in the presence of a 
Brønsted acid cocatalyst (i.e. pNBA), no appreciable amounts of self-aldol product was 
formed at the low reaction temperatures utilized (~ –60 ºC). This result was explained 
assuming that the imine component would be selectively activated by the added 
Brønsted acid (protonated imine) even at low temperature, thus skipping the problem of 
aldehyde self-condensation. 
                                                 
115 E. Gómez-Bengoa, S. Jiménez, I. Lapuerta, A. Mielgo, M. Oiarbide, I. Otazo, I. Velilla, S. Vera, C. 
Palomo, I. Velilla, Chem. Sci. 2012, 3, 2949–2957. 
116 For further examples of the use of these catalysts in the group see: a) C. Palomo, S. Vera, I. Velilla, A. 
Mielgo, E. Gómez-Bengoa, Angew. Chem. Int. Ed. 2007, 46, 8054–8056. b) C. Palomo, A. Landa, A. 
Mielgo, M. Oiarbide, Á. Puente, S. Vera, Angew. Chem. Int. Ed. 2007, 46, 8431–8435. c) A. Landa, M. 
Maestro, C. Masdeu, Á. Puente, S. Vera, M. Oiarbide, C. Palomo, Chem. Eur. J. 2009, 7, 1562–1565. d) 
E. Gómez-Bengoa, M. Maestro, A. Mielgo, I. Otazo, C. Palomo, I. Velilla, Chem. Eur. J. 2010, 8, 5333–
5342. e) A. Mielgo, I. Velilla, E. Gómez-Bengoa, C. Palomo, Chem. Eur. J. 2010, 8, 7496–7602. f) S. 
Jiménez, A. Landa, A. Lizarraga, M. Maestro, A. Mielgo, M. Oiarbide, I. Velilla, C. Palomo, J. Org. 
Chem. 2012, 77, 747–753. 
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Scheme 5.  
Following this previous work and taking into consideration the few precedents 
described on the direct asymmetric catalytic aldol reaction involving propargylic 
carbonyl compounds, and especially the lack of methods employing aldehydes as donor 
carbonyl compounds in the direct catalyzed version of the reaction, we set out to study 
the aldol reaction between enolizable aldehydes and propargylic carbonyl compounds 
with the aim of developing an efficient organocatalytic system. However, only moderate 
yield and diastereoselectivity were obtained following the procedure described for 
propargylic imines (Scheme 6). 
 
Scheme 6.  
With the aim to improve this result, it was reasoned that an efficient and 
selective activation of propargylic aldehydes as acceptors might be achieved by a simple 
metal cocatalyst capable of coordinating to ynals. Thus, it was found that when adding 
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10 mol% of the CuI metal salt to the reaction both the yield and the diastereoselectivity 
of the reaction were significantly improved (Scheme 7).117 
 
Scheme 7.  
Some of the most representative examples of the reaction scope, part of the 
doctoral Thesis of I. Lapuerta, are shown in Table 1. As it can be seen, the reaction 
proceeded smoothly and in good yield and the corresponding adducts were isolated 
either as diols or acetals to avoid epimerization of Cα. The reaction tolerated well both 
aromatic (4Aa and 4Ac) and aliphatic (4Ad and 5Ab) propynals and donor ramified 
aldehydes (5Ca) or aldehydes with additional functional groups (4Ad and 5Ba). 
Furthermore, the syn/anti ratios were higher than 1:5 in all cases, and ee values for the 
major isomer (anti) were above 90% ee. 
  
                                                 
117 E. Gómez-Bengoa, J. M. García, S. Jiménez, I. Lapuerta, A. Mielgo, J. M. Odriozola, I. Otazo, J. 
Razkin, I. Urruzuno, S. Vera, M. Oiarbide, C. Palomo, Chem. Sci. 2013, 4, 3198–3204. 
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Table 1. Cross-aldol reaction scope between saturated and propargylic aldehydes[a] 
 
It should be noted that shortly after these preliminary results were disclosed, 
Hayashi and coworkers118 reported the direct aldol reaction between aldehydes and 
propargylic aldehydes employing a prolinol catalyst and water as the only additive 
(Scheme 8). This method, which applies a subsequent Wittig reaction, requires a large 
excess (5 equiv.) of the donor aldehyde and provides modest syn/anti selectivity (1:2–
1:6 while our method afforded typically 1:>9 syn/anti ratios). 
 
Scheme 8.  
                                                 
118 Y. Hayashi, M. Kojima, Y. Yasui, Y. Kanda, T. Mukaiyama, H. Shomura, D. Nakamura, Ritmanleni, 
I. Sato, Chem. Cat. Chem. 2013, 5, 2887–2892. 
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When the donor aldehyde bears a ω-olefin function (i.e. 3b), the resulting adduct 
(i.e. 5Ba) is an 1,ω-enyne and therefore could participate in a Pauson-Khand 
intramolecular reaction. This type of oxygenated 1,ω-enyne systems have been 
previously reported in the literature to provide upon Pauson-Khand reaction bicyclic 
[m.3.0] rings,119 which are found as subunits of natural sesquiterpene products.120 We 
indeed observed that the treatment of the silylated derivative of 5Ba under Pauson-
Khand reaction conditions afforded the corresponding bicyclic [3.3.0] compound in 
moderate yield and as a single isomer (Scheme 9). 
 
Scheme 9.  
Based on these precedents, we set out to study the reaction generality for a range 
of ω-unsaturated aldehydes as donors in order to apply the aldol reaction to the 
preparation of hydroxyl Pauson-Khand precursors, commencing by examining the best 
reaction conditions for these particular substrates. 
 
Scheme 10.  
We planned to study also the suitability of the approach for acetylenic ketones 
(ynones) as acceptors. If successful, this development would considerably expand the 
pool of accessible compounds including those with a tertiary carbinol, which are 
considerably more challenging to obtain in a stereoselective manner.  
                                                 
119 a) C. Mukai, J. S. Kim, H. Sonobe, M. Haneoka, J. Org. Chem. 1999, 64, 6822–6832. b) T. Kozaka, 
N. Miyakoshi, C. Mukai, J. Org. Chem. 2007, 72, 10147–10154. c) Y. Otsuka, F. Inagaki, C. Mukai, J. 
Org. Chem. 2010, 75, 3420–3426. d) M. Turlington, Y. Yue, X.-Q. Yu, L. Pu, J. Org. Chem. 2010, 75, 
6941–6952. e) M. Turlington, Y. Du, S. G. Ostrum, V. Santosh, K. Wren, T. Lin, M. Sabat, L. Pu, J. Am. 
Chem. Soc. 2011, 133, 11780–11754. f) W. Chen, J.-H. Tay, J. Ying, M. Sabat, X.-A. Yu, L. Pu, Chem. 
Commun. 2013, 49, 170–172. g) W. Chen, J.-H. Tay, J. Ying, X.-A. Yu, L. Pu, J. Org. Chem. 2013, 78, 
2256–2265. h) N. Itoh, T. Iwata, H. Sughihara, F. Iragaki, C. Mukai, Chem. Eur. J. 2013, 19, 8665–8672. 
120 a) B. M. Fraga, Nat. Prod. Rep. 1999, 16, 21–38. b) B. M. Fraga, Nat. Prod. Rep. 2003, 20, 392–413. 
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Scheme 11.  
 
2.2. Enamine-mediated aldol reaction of ω-unsaturated aldehydes 
with propargylic aldehydes 
2.2.1. Initial experiments and reaction optimization 
Initially a study of the best reaction conditions for these types of unsaturated 
donor aldehydes was carried out with the reaction between 4-pentenal (3B) and 
phenylpropinal (1a) taken as a model. The data of the most representative experiments 
are shown in Table 2. First reactions were carried out under the general conditions 
previously established in the group for the direct asymmetric reaction of enolizable 
aldehydes with ynals117 (1.5 equiv. of donor aldehyde, 20 mol% C1, 20 mol% benzoic 
acid and 10 mol% CuI at –60 ºC) (Table 2, entry 1) and after 48 h and subsequent 
acetalization, the desired adduct 5Ba was obtained in good yield and very high 
diastereo- and enantioselectivity. When running the reaction without any benzoic acid 
cocatalyst, low conversions (<30 %) were obtained (Table 2, entry 2), corroborating the 
crucial role played by this cocatalyst. However, when running the reaction in the 
absence of CuI (Table 2, entry 3), only a little erosion in diastereoselectivity was 
observed. On the other hand, lowering the loading of the amine catalyst and the benzoic 
acid to 10 mol% resulted in low conversion after 48 h (Table 2, entry 4). 
Next, we studied the performance of the purposely synthesised related amine 
catalysts C2–4, which bear different O-protecting groups. When using catalyst C2 (R = 
SiPh2Me; Table 2, entry 5), the yield and enantioselectivity were similar to those values 
obtained with C1, but the syn/anti ratio turned out to be only moderate (syn/anti = 1:4). 
Moreover, using CuI in combination with C2 the same results were obtained (Table 2, 
entry 6). Amine C3 also rendered adduct 5Ba in similar results (Table 2, entry 7) 
without any metal salt, but when the reaction was run in the presence of CuI (Table 2, 
entry 8) very low conversion of the reaction was observed. The reactivity and selectivity 
observed when using catalyst C4 (Table 2, entry 9) in the absence of the metal was once 
again similar to C2 and C3, but when carrying out the reaction in the presence of CuI 
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(Table 2, entry 10) eroded yields were obtained. These results indicate a correlation 
between the silyl group of the catalyst and the reaction selectivity, given that changing 
the triphenylsily group of C1 for a less sterically demanding silyl group severely eroded 
the syn/anti ratio. Furthermore, whilst the effect of added CuI in the reaction seems to 
vary with the nature of the silyl substituent of the aminocatalyst, in neither case it plays 
a beneficial role in terms of reactivity or selectivity.  
Table 2. Catalyst screening for the reaction between 3B and 1a[a] 
 
We also tested the α,α-diaryl catalysts C5 and C6 (Table 2, entries 11 and 13) 
which indeed did promote the cross-aldol reaction with similar efficiency but with 
 
Entry cat Metal Conv. (%)[b] Yield (%)[c] syn/anti[d] ee (%)[e] 
1 C1 CuI 96 67 1:14 98 
2 C1 CuI <30[f] n.d. n.d. n.d. 
3 C1 - 96 61 1:11 98 
4 C1 - 45[g] n.d. n.d. n.d. 
5 C2 - 90 67 1:4 94 
6 C2 CuI 86 65 1:4 92 
7 C3 - 92 62 1:4 96 
8 C3 CuI 30 n.d. n.d n.d. 
9 C4 - 95 63 1:4 96 
10 C4 CuI 79 53 1:4 94 
11 C5 - 93 68 1:4 99 
12 C5 CuI 72 51 1:1.5 99 
13 C6 - 93 66 1:4 98 
14 C6 CuI 33 n.d. 1:6 91 
[a] Reactions conducted on a 0.5 mmol scale in 0.5 mL of THF (3B/1a/cat/PhCO2H/CuI molar 
ratio = 1.5:1:0.2:0.2:0.1). [b] Determined by 1H NMR spectroscopy on reaction aliquots before 
workup. [c] Combined yield of  syn/anti adducts after chromatography. [d] Determided by 1H 
NMR spectroscopy and corroborated by HPLC. [e] ee of major (anti) isomer, determined by 
chiral HPLC. [f] Reaction conducted without PhCO2H. [g] Reaction conducted with 10 mol% 
of the amine catalyst and PhCO2H. 
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lower syn/anti selectivity as compared with C1. Again, when performing the reaction in 
the presence of 10 mol% CuI (Table 2, entries 12 and 14), a lower reactivity of the 
catalytic system was observed. Moreover, for C5 the use of the metal salt also led to a 
loss of diastereoselectivity (Table 2, entry 12). 
From these results it could be deduced that the amine / Brønsted acid 
combination was crucial for the reaction, being amine catalyst C1 the optimum, and that 
the use of a metal cocatalyst would not lead to any improvement in the case of aldehyde 
3B. 
Both the reaction conversion and syn/anti ratios were determined by 1H NMR 
(300 MHz) analysis of untreated and treated samples of the reaction (Figure 1 and 2, 
respectively). Thus conversions were measured by comparison of the peak areas of the 
protons linked to the carbonyl group of both the propargylic aldehyde 1a (9.43 ppm, 1 
H) and adduct 5Ba (both syn and anti; 9.89 ppm, 1 H) respectively. The signal at 9.78 
ppm corresponds to the donor aldehyde 3B. 
  
Figure 1.  
On the other hand, the syn/anti ratio was determined by comparing the peak 
areas of the protons present in the methoxy groups of the acetal. The signals at 3.470 
ppm (3 H) and 3.458 ppm (3 H) correspond to the anti adduct (major), and the signal at 
3.453 ppm (6 H) corresponds to syn adduct (minor).  
 
Hb 
Ha 
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Figure 2.  
 
2.2.2. Reaction scope 
Once the optimization of the model reaction was performed, the reaction of 
aldehyde 3B with a selection of four propargylic aldehydes was carried out following 
the next standard procedure: the acceptor ynal was dissolved in THF (1 M) at –60 °C 
and 1.5 equivalents of the donor aldehyde and 20 mol% of each the catalyst C1 and  
benzoic acid were added. The reaction mixture was stirred at the same temperature, and 
after verifying by 1H NMR analysis of untreated aliquots that the reaction stopped (24–
48 h), the mixture was treated with HC(OCH3)3 (3 equivalents) in the presence of 20 
mol% pTSA at 0 °C for 2 h. The corresponding dimethyl acetal products were isolated 
by flash column chromatography on silica gel eluting with hexane/EtOAc mixtures. 
The results in Table 3 show that the reactions proceeded in good yield with 
either aromatic (5Ba), aliphatic (5Bb), or heteroaromatic (5Bd) propynals. In addition, 
the reaction was performed in a 5 mmol scale to afford adduct 5c in excellent diastereo- 
and enantioselectivity, although the yield was only moderate due to a lower conversion 
of the reaction. Furthermore, the syn/anti ratio varies from minimum of 1:8 to 1:20, and 
the lowest enantioselectivity for the major isomer (anti) was 96% ee. 
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Table 3. Cross-aldol reaction scope between saturated and propargylic aldehydes[a] 
 
 
2.2.3. Elaboration of the adducts: Pauson-Khand reaction 
The Pauson-Khand reaction, introduced in 1971,121 is a formal [2π + 2π + 2π] 
cycloaddition between an alkyne, an alkene, and carbon monoxide to afford a β-
cyclopentanone, catalyzed by cobalt (usually dicobalt octacarbonyl). 
For the reaction to be efficient, high stereo- and regioselectivity must be 
obtained. In the case of an intramolecular reaction, two isomeric bicyclic products (exo 
and endo) can be formed, as depicted in Figure 3. 
                                                 
121 a) I. U. Khand, G. R. Knox, P. L. Pauson, W. E. Watts, J. Chem. Soc. D. 1971, 36–36b. b) I. U. 
Khand, G. R. Knox, P. L. Pauson, W. E. Watts, J. Chem. Soc. Perkin Trans. 1 1973, 975–977. c) I. U. 
Khand, G. R. Knox, P. L. Pauson, W. E. Watts, M. I. Foreman, J. Chem. Soc. Perkin Trans. 1 1973, 977–
981. 
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Figure 3. General scheme of the intramolecular Pauson-Khand reaction 
At the outset it had been reported that unprotected propargylic alcohols are not 
suitable substrates for the Pauson-Khand reaction,122 and that protection of the alcohol 
as a silyl ether allows the Pauson-Khand reaction to proceed. 
Considering this, a preliminary study to establish the ideal protecting group and 
reaction conditions for the formal [2+2+2] cycloaddition process was performed.123 
Trimethylamine N-oxide (TMANO) was added to oxidize the CO liberated in the 
coordination of the cobalt to the alkyne, forming CO2 and rendering the step 
irreversible, thus allowing the use of milder reaction conditions.124 As the data 
summarized in Table 4 show, the bulkiest silyl groups (SiiPr3, Si(SiMe3)3) turned out to 
be the most efficient, giving rise to the desired cycloadducts essentially as a sole 
diastereomer (Table 4, entries 4 and 5). The reaction also proceeded with yields around 
65–70% when using the less bulky groups (SiMe3, SiPh3, SiMe2tBu) but led to 
diastereomeric mixtures (Table 4, entries 1, 2 and 3). In every case the corresponding 
cycloadducts were obtained in a completely exo-selective manner. 
  
                                                 
122 a) C. Mukai, J. S. Kim, H. Sonobe, M. Haneoka, J. Org. Chem. 1999, 64, 6822–6832. b) M. 
Turlington, Y. Yue, X.-Q. Yu, L. Ou, J. Org. Chem. 2010, 75, 6941–6952. c) N. Itoh, T. Iwata, H. 
Sughihara, F. Iragaki, C. Mukai, Chem. Eur. J. 2013, 19, 8665–8672. 
123 This study was carried out in collaboration with the group of J. M. García, in Universidad Pública de 
Navarra. 
124 S. Shambayani, W. E. Crowe, S. L. Schreiber, Tetrahedron Lett. 1990, 31, 5289–5292. 
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Table 4. Effect of the protecting group in the Pauson-Khand reaction stereoselectivity[a]  
 
Next, the conditions optimized for enyne 5Ba were applied to the adducts 5Bc 
and 5Bd. As shown in Table 5, the desired bicyclic adducts were obtained satisfactorily 
with aliphatic (7c) and heteroaromatic (7d) R groups in good yield and essentially as a 
single diastereomer. 
Table 5. Pauson-Khand reaction scope[a] 
 
The configuration of the major and minor diastereomers was deduced by 1H 
NMR chemical shift correlation (Figure 3). It was previously established that for this 
kind of bicycles with the Ha and Hc in a trans relationship, Ha resonates more up-field 
 
 
Entry Protecting group (PG) Yield (%)[b] 7a/7’a[c] 
1 SiMe3 65 5:1 
2 SiPh3 66 4:1 
3 SiMe2tBu 67 3:1 
4 Si(SiMe3)3 60 >20:1 
5 SiiPr3 65 >20:1 
[a] Reactions conducted on a 0.5 mmol scale in 0.5 mL of CH2Cl2. [b] Combined yield of 
exo/endo adducts after chromatography. [c] Determided by 1H NMR spectroscopy. 
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than in the corresponding cis isomer.125 Accordingly, using the trimethylsilyl protected 
adducts (5:1 dr), the major isomer was assigned as trans Ha-Hc (Ha signal at 4.8 ppm) 
and the minor as cis (Ha signal at 5.2 ppm). Finally, it was observed that Hb also follows 
the same trend (5.1 ppm for the major isomer and 5.6 for the minor). 
 
Figure 4.  
Finally, the unprotected aldehyde 8 was obtained from the cycloadduct 7a upon 
exposure to Mori’s conditions (FeCl3/SiO2)126 in methylene chloride (Scheme 12). 
Although hydrolysis was not complete, the unreacted dimethyl acetals could be easily 
recovered by column chromatography and recycled, obtaining good yields after two 
reaction cycles. Other attempted methods for the hydrolysis were the use of Amberlyst-
15 in acetone, which led to no reaction, and the use of HCl in acetone / water, which led 
to very low yields due to undesired side-reactions. 
 
Scheme 12.  
 
                                                 
125 Similar well-characterized bicyclic products: a) P. Magnus, L. M. Principe, Tetrahedron Lett. 1985, 
26, 4851–4854. b) C. Mukai, M. Uchiyama, S. Sakamoto, M. Hanaoka, Tetrahedron Lett. 1995, 36, 
5761–5764. c) J. Castro, A. Moyano, M. A. Pericas, A. Riera, Tetrahedron 1995, 51, 6541–6556. d) C. 
Mukai, J. S. Kim, M. Uchiyama, S. Sakamoto, M. Hanaoka, J. Chem. Soc. Perkin Trans. 1 1998, 2903–
2915. e) C. Mukai, J. S. Kim, M. Uchiyama, M. Hanaoka, Tetrahedron Lett. 1998, 39, 7909–7912. f) P. 
M. Breczinski, A. Stumpf, H. Hope, M. E. Krafft, J. A. Casalnuovo, N. E. Schore, Tetrahedron 1999, 55, 
6797–6812. 
126 T. Nishimata, Y. Sato, M. Mori, J. Org. Chem. 2004, 69, 1837–1843. 
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2.2.4. Reaction stereochemistry 
The stereochemical results obtained in the aldol reaction can be explained 
through the two competing open models A and B presented in Scheme 13. In B 
overlapping of the bulky substituents of amine C1 and the propargylic group of the 
ynone 1 would lead to an unfavourable approaching, thus leading towards the 
preferential formation of the anti-adduct. 
 
Scheme 13.  
The observed reaction stereochemistry in the Pauson-Khand reaction can be 
explained through the chair-like models C and D presented in Figure 5. A destabilizing 
pseudo-1,3-diaxial interaction between the hydrogen at Cα and the coordinated metal in 
model D could determine the positioning of the metal complex, and thus the final 
configuration of the adduct (7). 
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Figure 5.  
 
2.3. Enamine-mediated cross aldol reaction of aldehydes with 
propargylic α-ketoesters 
2.3.1. Initial experiments and reaction optimization 
The purpose was to explore the possibility of extending the above method to 
ynones as acceptors. Initially, the reaction between hydrocinnamaldehyde (3A) and 
ynone 2a was studied using the conditions developed in the previous section (Table 6, 
entry 1), and low conversions were obtained after 20 h. This result might be ascribed to 
either the lower solubility or the lower inherent reactivity of these ynones as compared 
with the parent ynals. Then the reaction temperature was raised to –40 oC, which 
allowed the reaction conversion to be essentially complete after 48 h (Table 6, entry 2), 
affording, after subsequent acetalization, the desired adduct 9Aa in good yield and high 
diastereo- and enantioselectivity. Further increase in temperature led to a lower ee 
(Table 6, entry 6). Furthermore, no significant improvement of reactivity or 
stereoselectivity was observed when using CuI or Cu(OAc) as additive (Table 6, entries 
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4 and 5 vs. 2). On the other hand, lowering the loading of the amine catalys and the 
benzoic acid to 10 mol% yielded low conversions after 48 h (Table 6, entry 3). 
Next, the performance of the parent α,α-diaryl catalysts C5 and C6 was studied. 
Once again, both were equally efficient in terms of reactivity and enantioselectivity, but 
led to a diminished dr (from 5:1 in entry 2 to nearly equimolecular in entry 7 and 8). 
The yields when employing ynone 2a as the acceptor happened to be higher as 
compared with the parent ynals (see Table 3 for a comparison). This could be attributed 
to a large extent to the higher conversion rates obtained in the reactions involving 
propargylic ketoester 2a. 
Table 6. Catalyst screening for the reaction between 3A and 2a 
 
The conversion was determined by 1H NMR (300 MHz) analysis of untreated 
samples of the reaction (Figure 6) comparing the peak areas of the protons of the methyl 
ester groups of both propargylic ketoester 2a (3.96 ppm, 3 H) and adduct 9Aa (both syn 
and anti, 3.89 ppm, 3 H). 
 
Entry cat Metal T (oC) Conv. (%)[b] Yield (%)[c] syn/anti[d] ee (%)[e] 
1 C1 - –60 33 n.d. n.d. n.d. 
2 C1 - –40 100 83 5:1 93 
3 C1 - –40 62[f] n.d. n.d. n.d. 
4 C1 CuI –40 98 79 6:1 95 
5 C1 Cu(OAc) –40 98 80 6:1 96 
6 C1 - –20 100 81 4:1 90 
7 C5 - –40 86 75 1.5:1 99 
8 C6 - –40 92 78 1.2:1 97 
[a] Reactions conducted on a 0.5 mmol scale in 0.5 mL of THF (3A/2a/cat/PhCO2H/M molar ratio = 
1.5:1:0.2:0.2:0.1). [b] Determined by 1H NMR spectroscopy on reaction aliquots before workup. [c] 
Combined yield of syn/anti adducts after chromatography. [d] Determided by HPLC analysis of the 
reaction crude. [e] ee of major (syn) isomer, determined by chiral HPLC. [f] Reaction conducted with 10 
mol% of the amine catalyst and PhCO2H. 
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Figure 6.  
The syn/anti ratio was determined by chiral HPLC analysis (Chiralpack IA, 
hex:iPr 95:5, 0.5 mL/min, λ = 240 nm) of the reaction crude (Figure 7) comparing the 
peak areas of the syn- (major, 20.9 and 29.3 min) and anti-adduct (minor, 24.7 min and 
32.8 min).  
 
  
Figure 7.  
The absolute configuration of compound 9Aa was established by a single crystal 
X-ray analysis and for the remaining adducts was assumed based on a uniform reaction 
mechanism. The configuration of the molecule happened to be (2S,3S), as it is shown in 
the ORTEP diagram of the molecule in Figure 8. 
Enamine-mediated aldol reaction of aldehydes 
 
71 
 
  
Figure 8.  
 
2.3.2. Reaction scope 
The generality of the method was explored using a selection of propargylic 
ketoesters (2) with a range of enolizable aldehydes (3), under the optimized conditions, 
namely: the acceptor ynone was dissolved in THF (1 M) at –40 °C and 1.5 equivalents 
of the donor aldehyde and 20 mol% of each catalyst C1 and  benzoic acid were added. 
The reaction mixture was stirred at the same temperature, and after verifying by 1H 
NMR analysis of an untreated reaction sample that the reaction finished (48 h), the 
mixture was treated with HC(OCH3)3 (3 equivalents) in the presence of pTSA at 0 °C 
for 2 h. The corresponding dimethyl acetal products were isolated by flash column 
chromatography on silica gel eluting with hexane/THF mixtures. 
As data in Table 7 show, the reactions proceeded smoothly with various donor 
aldehydes 3, affording the corresponding tertiary propargylic alcohols in good yield, 
diastereoselectivity of 1:5 or higher, and enantioselectivities above 93% ee in most 
cases. These examples include ynones bearing substituents at the ortho or metha 
positions of the phenyl ring (Table 7, entries 2 and 3). However, meta-tolyl susbsituted 
ynone 2d (Table 7, entry 4) was an exception and led to the corresponding adduct 9Ad 
with decreased enantioselectivity. 
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Table 7. Cross-aldol reaction scope between enolizable aldehydes and propargylic α-ketoesters[a] 
 
 
2.3.3. Elaboration of adducts 
Once a method for the stereoselective cross-aldol reaction between enolizable 
aldehydes and propargylic α-ketoesters was developed, some possibilities for the 
transformation of the adducts were briefly explored. 
Entry Aldehyde Ynone (R1) Product Yield, %[b] syn/anti[c] ee, %[c] 
1 
 
 
9Aa 83 5:1 93 
2 
 
 
9Ba 74 6:1 94 
3 
 
 
9Bb 77 8:1 93 
4 
 
 
9Bc 65 5:1 94 
5 
 
 
9Bd 72 13:1 80 
6 
 
 
9Ca 65 8:1 93 
7 
 
 
9Da 70 5:1 95 
[a] Reactions conducted on a 0.5 mmol scale in 0.5 mL of THF (3/2/C1/PhCO2H molar ratio = 
1.5:1:0.2:0.2). [b] Combined yield of syn/anti adducts after chromatography. [c] dr values 
determided by HPLC analysis of the crude product. [d] ee of major (syn) isomer, determined by 
chiral HPLC. 
 
Enamine-mediated aldol reaction of aldehydes 
 
73 
 
2.3.3.1. Reduction of adducts 9Aa and 9Ca 
As stated in the Introduction, the alkyne moiety could in principle be 
transformed into the corresponding alkyl and alkenyl units via total or partial reduction, 
respectively. To corroborate this assertion, adduct 9Ca was submitted to hydrogenation 
over Pd on charcoal (Scheme 14) to afford the reduction product 10 in 76% yield. The 
same process applied to adduct 9Ba also produced an identical adduct, which proved 
the stereochemical uniformity of the adducts. It is worth noting that 10 is the adduct 
formally derived from the cross-aldol reaction between two enolizable carbonyl 
compounds, a reaction that cannot be carried out efficiently in a direct manner so far. 
 
Scheme 14.  
2.3.3.2. Pauson-Khand reaction 
Following the successful intramolecular Pauson-Khand cyclization reaction 
developed using secondary propargylic carbinols, the corresponding transformation 
using tertiary alcohol 9Aa was attempted. 
The first problem was the protection of the tertiary alcohol, which turned out to 
be a challenging task. Indeed, we were unable to get the corresponding TIPS derivative, 
even at room temperature. Thus protection of the tertiary alcohol with the TMS group 
was performed instead, using TMSCl, DMAP and TEA (Scheme 15), which led to the 
protected alcohol 11 quantitatively. 
 
Scheme 15.  
Chapter 2 
74 
 
The Pauson-Khand reaction was then performed under the previously described 
conditions, thus treatment of 11 with dicobalt octacarbonyl and TMANO in 
dichloromethane at room temperature afforded a diastereomeric mixture of bicyclic 
products 12 and 12’ in 32% and 21% isolated yields, respectively. 
 
Scheme 16.  
Thus, this study gives a convenient entry to fused cyclopentene rings, structural 
frameworks present in natural sesquiterpene products (Figure 9).120 
 
Figure 9.  
 
2.3.4. Reaction stereochemistry 
Based on previous stereochemical models for related enamine mediated aldol 
reactions,127 we propose an open model similar to that proposed before for ynals 
(Scheme 13, page 67) that explains the observed stereoselectivity (Scheme 17). 
Assuming that the enamine adopts preferentially the most stable E-anti conformation 
two possible approaching orientations A and B should be considered. From these 
models A appears to be sterically less congested owing to the presumed higher 
interaction of the ester group with the bulky substituents of the enamine as compared to 
the alkyne group, with linear geometry. This model is in good agreement with the 
observed preferential formation of the syn-aldol. 
                                                 
127 a) S. A. Moteki, J. Han, S. Arimitsu, M. Akakura, K. Nakayama, K. Maruoka, Angew. Chem. Int. Ed. 
2012, 51, 1187–1190. b) E. Gómez-Bengoa, J. M. García, S. Jiménez, I. Lapuerta, A. Mielgo, J. M. 
Odriozola, I. Otazo, J. Razkin, I. Urruzuno, S. Vera, M. Oiarbide, C. Palomo, Chem. Sci. 2012, 3, 2949–
2957. c) Y-Hua Deng, J.-Q. Chen, L. He, T.-R. Kang, Q.-Z. Liu, S.-W. Luo, W.-C. Yuan, Chem. Eur. J. 
2013, 19, 7143–7150.  
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Scheme 17.  
 
2.4. Conclusions 
In this Chapter we have demonstrated that the direct cross-aldol reaction of 
enolizable aldehydes with propargylic aldehydes can be performed efficiently and with 
very good diastereo- and enantioselectivity via enamine activation. Key for this 
development is the concurrent use of α,α-dialkylprolinol ether / Brønsted acid catalytic 
system. The method is quite general with respect to the propargylic aldehyde substrate, 
and has been extended to the unprecedented reaction of aldehydes with propargylic 
ketoesters, affording the corresponding tertiary propargylic alcohols in good yield and 
selectivity. 
In addition, the observed stereochemical outcome of the aldol reaction can be 
explained by involving open models similar to previously reported for related aldol 
reactions. 
Furthermore, the use of ω-unsaturated aldehydes as nucleophiles afforded the 
corresponding 1,ω-enyne adducts, which bear an additional alkene group compared to 
adducts obtained from simple aliphatic aldehydes, thus making feasible the application 
of these adducts in a wider variety of transformations.  
In this sense, transformation of the resulting 1,6-enyne structures to the 
corresponding polisubstituted bicyclic enones through an intramolecular Pauson-Khand 
reaction has been realized. This reaction proceeds with essentially perfect 
diastereoselectivity in the case of ynal-derived adducts when using the O-TIPS 
protected propargylic alcohols and less selectively with an O-TMS protected tertiary 
enyne alcohol studied. 
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Finally, the hydrogenation of the triple (and double) bonds in adducts have been 
performed successfully, demonstrating the validity of the method for obtaining adducts 
that are formally derived from a cross-aldol reaction that cannot yet be performed 
directly in an efficient manner.  
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Brønsted base-catalyzed α-functionalization of carbonyl 
compounds 
3.1. Development of α’-oxy enones as acrylate equivalents 
3.1.1. Precedents and objectives 
As stated in the introduction, asymmetric catalyzed conjugate additions to 
simple α,β-unsaturated esters and amides remain challenging, mainly due to their 
attenuated reactivity. In order to overcome this limitation, one of the working 
approaches is the development of α,β-unsaturated ester and amide surrogates possessing 
certain qualities: i) enhanced activation of the substrate towards nucleophilic attack, ii) 
improved coordination to the catalyst, and iii) easy removal of the activating group. 
The underlying idea is that coordination of one lone pair of the oxygen in the 
template to the catalyst (a Lewis acid or H-bond donor) would trigger the reaction. In 
this sense, monodentate acyl templates may lead to two possible substrate-catalyst 
geometries, complicating stereocontrol. On the contrary, bidentate templates would not 
only coordinate more efficiently, but also skip such degeneracy forming one preferential 
cyclic geometry, thus facilitating good reaction stereocontrol (Figure 1). 
 
Figure 1.  
Following this idea, several two-point binding α,β-unsaturated acyl templates 
have been developed during the last years,128 which may be divided in two categories: 
heteroatom-linked templates (Figure 2a) and carbon-linked templates (Figure 2b). 
However, at the outset of this project only scarce examples of conjugate addition of 
enolizable carbonyl compounds to these enoate surrogates leading to the formation of a 
stereogenic center at Cα were reported. 
                                                 
128 For a review on the use of these templates in organocatalysis see: D. Monge, H. Jiang, Y. Álvarez-
Casao, Chem. Eur. J. 2015, 21, 4494–4504. 
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Figure 2. 129130131132133134 
Whilst efforts to control stereoselectivity from α,β-unsaturated carbonyl 
compounds have been mainly focused on carboxylic acid derivatives, essentially no 
reports concerning the use of ketones have been described in the literature. One 
exception is the strategy developed by Enders,135 where hydrazones are used as ketone 
surrogates. In this context, some years ago, our group reported chiral α’-oxy ketones 
and enones as acyl equivalents useful for several diastereoselective reactions.136 The 
                                                 
129 E. J. Corey, R. Imwinkelried, S. Pikul, Y. B. Xiang, J. Am. Chem. Soc. 1989, 111, 5493–5495. 
130 a) M. P. Sibi, J. J. Shay, J. Ji, Tetrahedron Lett. 1997, 38, 5955–5958. b) T. Nemoto, T. Ohshima, M. 
Shibasaki, J. Am. Chem. Soc. 2001, 123, 9474–9475. 
131 D. A. Evans, J. S. Hohnson, J. Am. Chem. Soc. 1998, 120, 4895–4896. 
132 D. A. Evans, E. J. Olhava, J. S. Johnson, J. M. Janey, Angew. Chem. Int. Ed. 1998, 37, 3372–3375. 
133 A. Baschieri, L. Bernardi, A. Ricci, S. Suresh, M. F. A. Adamo, Angew. Chem. Int. Ed. 2009, 48, 
9342–9345. 
134 C. Palomo, M. Oiarbide, J. M. García, A. González, E. Arceo, J. Am. Chem. Soc. 2003, 125, 13942–
13943. 
135 For a review on hydrazine chiral auxiliaries see: A. Job, C. F. Janeck, W. Bettray, R. Peters, D. Enders, 
Tetrahedron 2002, 58, 2253–2329. 
136 Aldol reaction: a) C. Palomo, A. González, J. M. García, C. Landa, M. Oiarbide, S. Rodríguez, A. 
Linden, Angew. Chem. Int. Ed.  1998, 37, 180–182. b) C. Palomo, M. Oiarbide, J. M. Aizpurua, A. 
González, J. M. García, C. Landa, I. Odriozola, A. Linden, J. Org. Chem. 1999, 64, 8193–8200. c) C. 
Palomo, M. Oiarbide, E. Gómez-Bengoa, A. Mielgo, M. C. González-Rego, J. M. García, A. González, J. 
M. Odriozola, P. Bañuelos, A. Linden, ARKIVOC 2005, 377–392. Mannich reaction: d) C. Palomo, M. 
Oiarbide, M. C. González-Rego, A. K. Sharma, J. M. García, A. González, C. Landa, A. Linden, Angew. 
Chem. Int. Ed. 2000, 39, 1063–1066. e) C. Palomo, M. Oiarbide, A. Landa, M. C. González-Rego, J. M. 
García, A. González, J. M. Odriozola, M. Martín-Pastor, A. Linden, J. Am. Chem. Soc. 2002, 124, 8637–
8643. Conjugate addition: f) C. Palomo, J. M. Aizpurua, M. Oiarbide, J. M. García, A. González, I. 
Odriozola, A. Linden, Tetrahedron Lett. 2001, 42, 4829–4831. g) C. Palomo, M. Oiarbide, J. M. García, 
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diastereoselective Michael addition of β-ketoesters to chiral α’-hydroxy enones 
resulting on the formation of challenging quaternary stereocenters is shown in Scheme 1 
as a representative example.136g 
 
Scheme 1.  
On the other hand, achiral α’-hydroxy enones have also been developed in our 
group as acrylate equivalents in chiral Lewis acid-catalyzed enantioselective reactions. 
For instance, an enantioselective version of the conjugate addition of β-ketoesters above 
mentioned was reported136g employing a C2-symmetric diamine-copper complex as the 
catalyst (Scheme 2). 
 
Scheme 2.  
This and additional research from this laboratory has revealed that achiral α’-
hydroxy enones are excellent bidentate Michael acceptors for metal-catalyzed 
                                                                                                                                               
A. González, P. Bañuelos, J. M. Odriozola, J. Razkin, A. Linden, Org. Lett. 2008, 10, 2637–2640. h) J. 
M. García, M. A. Maestro, M. Oiarbide, J. M. Odriozola, J. Razkin, C. Palomo, Org. Lett. 2009, 11, 
3826–3829. Diels-Alder reaction: i) C. Palomo, M. Oiarbide, J. M. García, A. González, A. Lecumberri, 
A. Linden, J. Am. Chem. Soc. 2002, 124, 10288–10289. j) P. Bañuelos, J. M. García, E. Gómez-Bengoa, 
A. Herrero, J. M. Odriozola, M. Oiarbide, C. Palomo, J. Org. Chem. 2010, 75, 1458–1473. Alkylation: k) 
C. Palomo, M. Oiarbide, A. Mielgo, A. González, J. M. García, C. Landa, A. Lecumberri, A. Linden, 
Org. Lett. 2001, 3, 3249–3252. Darzens reaction: l) C. Palomo, M. Oiarbide, A. K. Sharma, M. C. 
González-Rego, A. Linden, J. M. García, A. González, J. Org. Chem. 2000, 65, 9007–9012. 
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asymmetric transformations,137 specially for the 1,4-addition of N- and C-centered 
nucleophiles.138 
Interesting features of the α’-hydroxyketone template are: i) The salient 
behaviour in asymmetric catalysis due to the ability of the α-hydroxy carbonyl (or ketol) 
moiety for efficient 1,4-metal binding; ii) the gem-dialkylcarbinol framework of the 
template can be easily modified for optimal performance (Scheme 3a), and ii) the 
Michael adducts can be further elaborated under smooth oxidative conditions (Scheme 
3b) affording carboxylic acids, aldehydes and ketones from a single common 
intermediate. 
 
Scheme 3.  
Despite these features, however, construction of quaternary centers139 through 
Michael reactions was still problematic with these enones, especially under Lewis acid 
catalysis as noted above. In general, this reaction is limited to highly active donor 
substrates, that is, substrates capable of easily generating the enol form, such as β-
ketoesters. Generation of the more nucleophilic enolate species through deprotonation 
by a tertiary amine base is usually unfruitful because of self-quenching of the Lewis 
acid-Lewis base pair. With very few exceptions, this combined use of a base and acid 
for concomitant substrate activation is a general problem that still remains not well 
                                                 
137 For a review on α’-hydroxy ketones see: C. Palomo, M. Oiarbide, J. M. García, Chem. Soc. Rev. 2012, 
41, 4150–4164. 
138 For an example of 1,4-addition reaction with: Carbamates: a) C. Palomo, M. Oiarbide, R. Halder, M. 
Kelso, E. Gómez-Bengoa, J. M. García, J. Am. Chem. Soc. 2004, 126, 9188–9189. Pyrroles/indoles: b) C. 
Palomo, M. Oiarbide, B. Kadar, J. M. García, J. Am. Chem. Soc. 2005, 127, 4154–4155. Nitroalkanes: c) 
C. Palomo, R. Pazos, M. Oiarbide, J. M. García, Adv. Synth. Catal. 2006, 348, 1161–1164. 
139 For reviews on asymmetric synthesis of quaternary stereocenters see: a) J. Christoffers, A. Mann, 
Angew. Chem. Int. Ed. 2001, 40, 4591–4597. b) J. Christoffers, A. Baro, Adv. Synth. Catal. 2005, 347, 
1473–1482. c) B. M. Trost, C. Jiang, Synthesis 2006, 369–396. d) C. Hawner, A. Alexakis, Chem. 
Commun. 2010, 46, 7295–7306. e) K. W. Quasdorf, L. E. Overmann, Nature 2014, 516, 181–191. f) Y. 
Liu, S.-J. Han, W.-B. Liu, B. M. Stolz, Acc. Chem. Rev. 2015, 48, 740–751. g) J. Feng, M. Holmes, M. J. 
Krische, Chem. Rev. 2017, 117, 12564–12580. 
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resolved.140 A practical solution to this problem is suppressing the Lewis acid and 
carrying out the reaction in the presence of a bifunctional Brønsted base/H-bond donor 
catalyst. In this instance, the electrophile would be activated by hydrogen bonding 
whilst the donor substrate would be activated by the Brønsted base through a model that 
resembles that of the Lewis acid, as shown in Figure 3. 
 
Figure 3.  
 
3.1.1.1. Preparation of the α’-oxy enones used in the study 
An interesting practical aspect of these enones is that they may be readily 
prepared from commercially available compounds, in the majority of the cases in few 
steps, and purified by simple flash column chromatography to be obtained as colourless 
oils, which can be stored for several months at –30 ºC. For example, α’-hydroxy enone 
13a was synthesised starting from methoxypropadiene through addition of its lithium 
salt to acetone and subsequent acid treatment  in good yield (Scheme 4, method A).141 
Alternatively, it could also be prepared in high yield from commercially available 3-
hydroxy-3-methyl-2-butanone via aldol condensation with formaldehyde, formed in situ 
from paraformaldehyde142 (Scheme 4, method B). Enone 13a was silylated by mixing it 
with 3-(trimethylsilyl)-2-oxazolidinone (TMSO)143 and a few drops of trifluoroacetic 
acid and stirring at room temperature without any solvent, affording α’-silyloxy enone 
13b in excellent yield. 
                                                 
140 For a review on Lewis acid/Brønsted base cooperative catalysis see: L. Stegbauer, F. Sladojevich, D. J. 
Dixon, Chem. Sci. 2012, 3, 942–958. 
141 C. Palomo, M. Oiarbide, J. M. García, A. González, E. Arceo, J. Am. Chem. Soc. 2003, 125, 13942–
13943. 
142 A. Bugarin, K. D. Jones, B. T. Connell, Chem. Commun. 2010, 46, 1715–1717. 
143 J. M. Aizpurua, C. Palomo, A. L. Palomo, Can. J. Chem. 1984, 62, 336–340. 
Chapter 3 
86 
 
 
Scheme 4.  
The O-triethylsilyl substituted enone 13c was prepared starting from methyl 2-
hydroxyisobutyrate.144 In a first step, the alcohol was protected as the corresponding 
triethyl silyl ether, and the resulting product was converted into the dimethyl 
phosphoester intermediate. The Wittig-Horner reaction with formaldehyde afforded the 
desired enone 13c in good overall yield (Scheme 5). 
 
Scheme 5.  
β-Aryl α’-hydroxyenones 14a-14d were obtained by aldol condensation of the 
commercially available 3-hydroxy-3-methyl-2-butanone with the corresponding aryl 
aldehyde (Scheme 6).144 The reaction was carried out under reflux using lithium 
hydroxide as the base and a mixture of MeOH/water as the solvent, affording 
exclusively the corresponding E-enones in high yield. 
 
Scheme 6.  
                                                 
144 a) C. Palomo, M. Oiarbide, R. Halder, M. Kelso, E. Gómez-Bengoa, J. M. García, J. Am. Chem. Soc. 
2004, 126, 9188–9189. b) C. Palomo, M. Oiarbide, B. G. Kardak, J. M. García, A. Linden, J. Am. Chem. 
Soc. 2005, 127, 4154–4155. 
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β-Alkyl α’-hydroxyenone 14e was obtained in an overall moderate yield 
following the procedure described above for enone 13c, employing trimethylsilyl 
chloride in the first step and performing the Wittig-Horner reaction with propanal, 
followed by desilylation with hydrofluoric acid in methanol (Scheme 7).144 
 
Scheme 7.  
For the synthesis of α-methyl α’-hydroxy enone 15, the commercially available 
2-methoxy-2-propanoate was transformed into the Weinreb amide, which was then 
reacted with isopropenyl magnesium bromide, yielding the desired enone in moderate 
yield after two steps (Scheme 8). Posterior silylation under the conditions previously 
employed for the formation of unsubstituted enone 13b afforded enone 15’ in good 
yield. 
 
Scheme 8.  
Dienone 16 was prepared in good yield starting from 3-hydroxy-3-methyl-2-
butanone through aldol reaction with acrolein and in situ mesylation and elimination. 
The posterior silylation of 16 with TMSO afforded 16’ in excellent yield. 
 
Scheme 9.  
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3.1.2. Conjugate additions: Previous results from this laboratory 
With these templates in hand, their behaviour in organocatalytic reactions with 
several nucleophiles was studied in parallel. Dr. Badiola and Dr. Olaizola from this 
laboratory studied their reactions with α-cyanoacetates, azlactones and 5H-thiazol-4-
ones respectively (Scheme 10).145 
 
Scheme 10.  
 
3.1.3. 1,4-Addition of oxazolones to α’-oxy enones 
To complete these studies and with the aim to show the potential scope of these 
enones in asymmetric conjugate additions, we planned to evaluate the reaction with 5H-
oxazol-4-ones (oxazolones), which would generate α-hydroxy carboxylic acid 
derivatives with a tetrasubstituted stereogenic center. These compounds are important 
                                                 
145 E. Badiola, B. Fiser, E. G-B, A. Mielgo, I. Olaizola, I. Urruzuno, J. M. García, J. M. Odriozola, J. 
Razkin, M. Oiarbide, C. Palomo, J. Am. Chem. Soc. 2014, 136, 17869–17881. 
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building blocks in pharmaceutical products and biologically active compounds.146 5H-
oxazol-4-ones were first introduced in asymmetric catalysis by Trost and subsequently 
used by several other groups. 
In 2004 Trost and coworkers147 reported the Mo-catalyzed asymmetric allylic 
alkylation of oxazolones (Scheme 11), which yielded 5,5-dialkyl oxazol-4-ones in high 
yield, good regio- and diastereoselectivity and high enantioselectivity. Posterior basic 
hydrolysis of the adducts afforded the corresponding chiral α-hydroxyamides. 
 
Scheme 11.  
Examples of catalytic asymmetric aldol148 and Mannich-type149 reactions of 
oxazolones have also been seldom reported. However, the conjugate addition has been 
studied more exhaustively as shown in the examples that follow. 
Misaki and Sugimura150 performed the 1,4-addition of 5H-oxazol-4-ones to 
alkynyl carbonyl compounds catalyzed by chiral guanidines (Scheme 12Table 3), 
                                                 
146 For more information on the subject see: a) S. Masamune, C. U. Kim, K. E. Wilson, G. O. Spessard, P. 
E. Georghiou, G. S. Bates, J. Am. Chem. Soc. 1975, 97, 3512–3513. b) S. Hatakeyama, Y. Matsui, M. 
Suzuki, K. Sakurai, S. Takano, Tetrahedron Lett. 1985, 26, 6485–6488. c) H. Shao, J. K. Rueter, M. 
Goodman, J. Org. Chem. 1998, 63, 5240–5244. 
147 B. M. Trost, K. Dogra, M. Franzini, J. Am. Chem. Soc. 2004, 126, 1944–1945. 
148 T. Misaki, G. Takimoto, T. Sugimura, J. Am. Chem. Soc. 2010, 132, 6286–6287. 
149 For an example of metal catalysis see: a) D. Zhao, L. Eang, D. Yang, Y. Zhang, R. Wang, Angew. 
Chem. Int. Ed. 2012, 51, 7523–7527. For an example of organocatalysis see: b) Z. Han, W. Yang, C.-H. 
Tan, Z. Jiang, Adv. Synth. Catal. 2013, 355, 1505–1511. 
150 a) T. Misaki, K. Kawano, T. Sugimura, J. Am. Chem. Soc. 2011, 133, 5695–5697. For other reports of 
this group concerning the Michael reaction of oxazolones see: b) N. Jin, T. Misaki T. Sugimura, Chem. 
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obtaining the corresponding conjugate addition adducts in moderate yield, variable E/Z 
selectivity and high enantioselectivity. 
 
Scheme 12.  
In another relevant example, Ye et al.151 reported the bifunctional Brønsted base-
catalyzed Michael addition of oxazolones to α,β-unsaturated ketones (Scheme 13). The 
thiourea-sulfonamide catalyst rendered the Michael reaction adducts in excellent yield, 
diastereo- and enantioselectivity. 
 
Scheme 13.  
In 2013 and using a similar thiourea catalyst lacking the sulfonamide group the 
group of Jiang152 reported the conjugate addition of oxazolones to aromatic nitroalkenes 
that proceeds in excellent yield, diastereo- and enantioselectivity (Scheme 14). 
                                                                                                                                               
Lett. 2013, 42, 894–896. c) A. Morita, T. Misaki, T. Sugimura, Tetrahedron Lett. 2015, 56, 264–267. d) 
T. Misaki, N.-R. Choi, A. Morita, T. Sugimura, Tetrahedron Lett. 2015, 56, 5063–5066. 
151 H. Huang, K. Zhu, W. Wu, Z. Jin, J. Ye, Chem. Commun. 2012, 48, 461–463. 
152 a) B. Qiao, Y. An, Q. Liu, W. Yang, H. Liu, J. Shen, L. Yan, Z. Jiang, Org. Lett. 2013, 15, 2358–2361. 
For other reports of this group concerning the Michael reaction of oxazolones see: b) Q. Liu, B. Qiao, K. 
F. Chin, C.-H. Tan, Z. Jiang, Adv. Synth. Catal. 2014, 256, 3777–3783. c) B. Zhu, R. Lee, J. Li, X. Ye, 
S.-N. Hong, S. Qiu, M. L. Coote, Z. Jiang, Angew. Chem. Int. Ed. 2016, 55, 1299–1303. d) J. Li, S. Qui, 
X. Ye, B. Zhu, H. Liu, Z. Jiang, J. Org. Chem. 2016, 81, 11916–11923. 
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Scheme 14.  
However, to the best of our knowledge, at the outset of this project no examples 
had been reported on the catalytic asymmetric conjugate addition of oxazolones to 
unsaturated esters or equivalents. Only two examples were described in the literature 
during the progress of this Thesis. 
In the first one, Misaki and Sugimura150b described the 1,4-addition reaction of 
oxazolones to an allenic phenyl ester catalyzed by a chiral guanidine/alcohol in 
excellent yield and enantioselectivity (Scheme 15). 
 
Scheme 15.  
The second work appeared just after our initial results were published.145 Wang 
et al.153 reported the conjugate addition of oxazolones to α,β-unsaturated acyl 
imidazoles catalyzed by a dinuclear zinc complex, obtaining the corresponding adducts 
in high yield, diastereo- and enantioselectivity (Scheme 16a). They also performed the 
transformation of an adduct to the corresponding carboxylic methyl ester, affording the 
product in low yield (Scheme 16b). 
                                                 
153 B. Zhang, F. Han, L. Wang, D. Li, D. Yang, X. Yang, J. Yang, X. Li, D. Zhao, R. Wang, Chem. Eur. 
J. 2015, 21, 17234–17238. 
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Scheme 16.  
 
3.1.3.1. Unsubstituted α’-oxy enones as electrophiles 
Initially the reaction of oxazolone 17A with a variety of unsubstituted α’-oxy 
enones (13a-13c) catalyzed by a squaramide catalyst was investigated. For this purpose 
C7,154 the optimal catalyst for α-cyanoacetates,145 was taken as a model in order to find 
the optimum structure of the Michael acceptor (Table 1).  Reaction with the free 
hydroxyl enone 13a at –40 oC yielded an almost racemic addition product (Table 1, 
entry 1). In its turn, reaction with the O-TMS substituted enone 13b afforded, after 
subsequent desilylation, the desired adduct 18A in good yield and moderate ee (Table 1, 
entry 2). An increase of the temperature from –40 to –20 oC was found to be beneficial 
both for the yield and enantioselectivity of the reaction (entries 3 and 4), perhaps due to 
the better solubilisation of the catalyst. Enone 13c, bearing a bulkier O-protecting 
group, was also examined but the product was obtained in low enantiomeric excess 
(entry 5). Thus reaction with α’silyloxy enone 13b at RT was selected for further 
optimization. 
  
                                                 
154 a) W. Yang, D. M. Du, Org. Lett. 2010, 12, 5450–5453. For pioneering work on squaramides see: b) J. 
P. Malerich, K. Hagihara, V. H. Rawal, J. Am. Chem. Soc. 2008, 130, 14416–14417. c) V. B. Gondi, K. 
Hagihara, V. H. Rawal, Angew. Chem. Int. Ed. 2009, 48, 776–779. d) Y. Zhu, J. P. Malerich, V. H. 
Rawal, Angew. Chem. Int. Ed. 2010, 49, 153–156. 
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Table 1. Screening of template structure for the C7-catalyzed reaction with oxazolone 17A (R1 = iBu)[a] 
 
Next, a variety of Brønsted base-catalysts for the reaction of oxazolone 17A with 
α’-silyloxy enone 13b were tested at RT (Table 2). Using thiourea catalyst C9,155 
compound 18A was obtained in good yield but in very low ee. Then, other chiral 
scaffolds were tested: Using C10,156 derived from a chiral diamine with C2-symmetry, 
the desired product was obtained in good yield and moderate ee. To our delight catalyst 
C8,157 derived from L-tert-leucine, afforded the Michael reaction adduct 18A in good 
yield and excellent ee. When using (DHQD)2PYR (C11) as the catalyst a very low 
conversion was observed, suggesting that the H-bond donor functionality of the catalyst 
is necessary for the activation of the reaction substrates. 
  
                                                 
155 B. Vakulya, S. Varga, A. Csámpai, T. Soós, Org. Lett. 2005, 7, 1967–1969. 
156 W. Yang, D.-M Du, Adv. Synth. Catal. 2011, 353, 1241–1246. 
157 K. Hu, A. Lu, Y. Wang, Z. Zhou, C. Tang, Tetrahedron: Asymmetry 2013, 24, 953–957. 
 
Entry Enone R T Yield of 18A (%)[b] ee (%)[c] 
1 13a H –40 ºC 68 10 
2 13b SiMe3 –40 ºC 78 60 
3 13b SiMe3 –20 ºC 85 73 
4 13b SiMe3 RT 80 73 
5 13c SiEt3 RT 86 34 
[a] Reactions conducted on a 0.3 mmol scale in 0.9 mL of CH2Cl2 (17A/13/C7 molar ratio = 1:1.5:0.2). 
[b] Isolated yield after chromatography. [c] Determined by chiral HPLC. 
Chapter 3 
94 
 
Table 2. Catalyst screening for the reaction of 17A with α’-oxy enone 13b[a] 
 
After performing the optimization of conditions for the model reaction, the 
reaction of oxazolones 17A-17E with α’-oxy enone 13b was carried out following the 
next standard procedure: the oxazolone was dissolved in CH2Cl2 (0.33 M) and 1.5 
equivalents of the enone and 20 mol% of the catalyst C8 were added. The reaction 
mixture was stirred at room temperature, and after verifying total conversion (TLC 
monitoring, 24–48 h), the mixture was treated with HF 48% (aq.) at the same 
temperature for 45 min. The corresponding Michael reaction adducts were isolated by 
flash column chromatography on silica gel eluting with hexane/acetate mixtures. 
As the results in Table 3 show, the reaction proceeded in good yield with 
different alkyl-substituted oxazolones, including those with n-alkyl (18B-18D) and 
benzyl substituents (18E), and the lowest enantioselectivity was 92% ee. 
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Table 3. Michael reaction scope between oxazolones and α’-oxy enone 13b[a] 
 
 
3.1.3.2. β-Substituted α’-oxy enones as electrophiles 
Following the study on the Michael addition of oxazolones to unsubstituted α’-
oxy enones, we decided to study the addition to β-substitutted α’-oxy enones. Now a 
relatively diminished reactivity of the enone was expected as compared with the 
unsubstituted analogue, and on the other hand, the problem of the relative configuration 
of the newly generated tetra- and trisubstituted contiguous stereocenters arises. This 
time the reaction between oxazolone 17E and β-aryl α’-hydroxy enone 14a was taken as 
a model to test a variety of catalysts (Table 4). 1,2-Dichloroethane was used as the 
solvent so the reaction could be performed at temperatures higher than 40 ºC in order to 
compensate for the expected lower reactivity of β-substitutted α’-oxy enones. When 
using squaramide C7 as the catalyst at room temperature a very low conversion was 
observed after 48 h (Table 4, entry 1). When increasing the temperature from RT to 50 
ºC only moderate conversion was observed after 48 h, but good diastereoselectivity and 
enantioselectivity were obtained (Table 4, entry 2). Very low conversions were obtained 
with the analogous thiourea C9 (entry 4) and also with the L-tert-leucine derived 
squaramide C8 (entry 3). The reaction with catalyst C12154b afforded the Michael 
addition product 19Ea in similar selectivity to catalyst C7, but a slightly lower 
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reactivity was observed (entry 5). On the other hand, increasing the reaction temperature 
to 70 oC when using catalyst C7 allowed the reaction to proceed to complete conversion 
within 48 h affording the desired Michael addition adduct 19Ea in high yield and 
excellent diastereo- and enantioselectivity.  
Table 4. Condition optimization for the reaction of 17E with α’-oxy enone 14a [a] 
 
The conversion was determined by 1H NMR (300 MHz) analysis of untreated 
samples of the reaction (Table 4, entry 4; Figure 4). Comparing the peak areas of the 
 
Entry cat T (oC) Conv. (%)[b] Yield (%)[c] dr[d] ee (%)[e] 
1 C7 15 <20 n.d. n.d. n.d. 
2 C7 50 83 67 11:1 80 
3 C8 50 21 n.d. n.d. n.d. 
4 C9 50 20 n.d. n.d. n.d. 
5 C12 50 50 38 11:1 79 
6 C7 70 100 80 13:1 96 
 
[a] Reactions conducted on a 0.3 mmol scale in 0.9 mL of 1,2-DCE (17E/14a/cat molar ratio = 
1:3:0.1). [b] Determined by 1H NMR spectroscopy on reaction aliquots before workup. [c] 
Combined yield of both isomers after chromatography. [d] Determined by 1H NMR 
spectroscopy. [e] ee of major isomer, determined by chiral HPLC. 
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Cα-proton of oxazolone 17E (4.77 ppm, 1 H), and the protons of the methyl substituent 
at the aromatic ring of adduct 19Ea (2.24 ppm, 3 H). 
 
Figure 4.  
The diastereomeric ratio was determined by 1H NMR (300 MHz) analysis of the 
reaction crude (Figure 5) comparing the peak areas of the protons of the methyl 
substituent at the aromatic ring of the adduct (2.24 ppm for major and 2.21 ppm for 
minor). 
 
 
Figure 5.  
Once the optimized conditions were found, the reaction of oxazolones 17A and 
17E with α’-hydroxy enones 14a-14d was carried out following the next standard 
procedure: the oxazolone was dissolved in 1,2-dichloroethane (0.33 M) and 3 
Ha 
Hb 
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equivalents of the enone and 10 mol% of the catalyst C7 were added. The reaction 
mixture was stirred at 70 oC, and after verifying reaction completion (TLC monitoring, 
48 h), the corresponding Michael adduct was isolated as a mixture of diastereomers by 
flash column chromatography on silica gel eluting with hexane/acetate mixtures. 
The data in Table 5 show that the reaction also proceeded in good yield for the  
5-iso-butyl substituted oxazolone (adduct 19Aa), although a slightly lower yield was 
obtained as a consequence of an incomplete conversion. Higher steric impediment of 
the alkyl chain of 17A as compared to the alkyl chain of 17E could be a possible cause. 
On the other hand, β-aryl α’-hydroxy enones with electron-donor (19Ec) and 
withdrawing (19Eb) groups were well tolerated. Furthermore, the dr was higher than 
12:1 in all cases, and the lowest enantiomeric excess for the major diastereomer was 
96%. Unexpectedly, β-alkyl substituted α’-hydroxy enones seemed to be unreactive 
under these reaction conditions (19Ee). This is especially curious taking into account 
that the trend for the reaction with α-cyanoacetates is just the opposite, with β-alkyl 
substituted α’-hydroxy enones being the most reactive (Scheme 17).158 
  
                                                 
158 For more information on the organocatalytic asymmetric Michael addition of cyanoacetates to α’-
hydroxy enones see the doctoral Thesis of Eider Badiola, UPV/EHU, Donostia, 2016 . 
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Table 5. Michael reaction scope between oxazolones and β-substituted α’-hydroxy enones[a] 
 
 
Scheme 17.  
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3.1.3.3. α-Substituted α’-oxy enones as electrophiles 
The method was also extended to the reaction with α-substituted α’-oxy enones. 
This reaction would lead to the formation of two nonadjacent stereogenic centers which, 
unlike in the case of α’-oxy enones examined above, are created in two different steps. 
The stereogenic center at Cα-atom of oxazolone is formed during the addition step (C–C 
bond forming step), and the second stereocenter is subsequently formed upon 
protonation of the resulting enolate. This is a complication since here asymmetric 
induction from the diol substrate and the catalyst may or may not be convergent. In the 
protonation step, the asymmetric induction of both the catalyst and the stereogenic 
center of the substrate are expected to play an important role (Scheme 18). 
 
Scheme 18. Protonation step 
Initially the reaction between oxazolone 17E and α-methyl α’-oxy enones (15, 
15’) in the presence of catalyst C7 was taken as a model to optimize the Michael 
reaction conditions (Table 6). The reaction at room temperature led to low conversions, 
even after 72 h (Table 6, entry 1). By increasing the temperature to 50 oC better 
conversions were obtained, and the desired adduct 22E was obtained in moderate yield, 
low diastereoselectivity, and moderate enantioselectivity (Table 6, entry 2). Further 
increase of the temperature afforded similar results, but with a slightly lower 
diastereoselectivity (Table 6, entry 3). When the reaction was attempted with the O-
trimethylsilyl derivative 15’ no reaction was observed (Table 6, entry 4). 
Next, we tested a selection of catalysts, starting with the squaramide catalyst C8, 
which afforded the desired adduct 22E in similar selectivity to C7, but in conversions 
lower than 50% (Table 6, entry 5). Thiourea catalyst C9 exhibited an inferior catalytic 
capacity (Table 6, entry 6). It was gratifying to observe that using catalyst C13, which 
bears an additional amide group for further H-bonding, a good conversion was observed 
and the corresponding product was obtained in very good enantioselectivity (92 %) 
(Table 6, entry 7). Unfortunately, none of the tested catalysts afforded diastereomeric 
ratios higher than 2:1. 
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Table 6. Condition optimization for the reaction of 17E with α-methyl α’-oxy enones[a] 
 
The diastereomeric ratio was determined by 1H NMR (300 MHz) analysis of the 
reaction crude (Figure 6) comparing the peak area of the proton at the α-position of the 
diastereomer adducts (3.27 ppm for minor and 3.13 ppm for major). 
 
Entry cat Enone T (oC) Conv. (%)[b] Yield (%)[c] dr[d] ee (%)[e] 
1 C7 15  15 <35 n.d. n.d. n.d. 
2 C7 15 50 70 61 2:1 72 
3 C7 15 70 80 64 1.5:1 72 
4 C7 15’ 50 0 - - - 
5 C8 15 50 42 n.d. 2:1 75 
6 C9 15 50 23 n.d. n.d. n.d. 
7 C13 15 50 89 67 2:1 92 
 
[a] Reactions conducted on a 0.15 mmol scale in 0.45 mL of 1,2-dichloroethane (17E/enone/cat molar 
ratio = 2:1:0.1). [b] Determined by 1H NMR spectroscopy on reaction aliquots before workup. [c] 
Combined yield of both isomers after chromatography. [d] Determined by 1H NMR spectroscopy. [e] 
ee of major isomer, determined by chiral HPLC. 
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Figure 6.  
Catalyst C13 was prepared in good yield in four routinely steps according to the 
method described in Scheme 19.159 
 
Scheme 19.  
As illustrated in Scheme 20, an alternative approach was also developed in our 
group160 for the synthesis of C13. This approach takes the advantage that different 
                                                 
159 For detailed information on the synthesis of catalysts see the Experimental Section. 
160 E. Badiola, I. Olaizola, A. Vázquez, S. Vera, A. Mielgo, C. Palomo, Chem. Eur. J. 2017, 23, 8185–
8195. 
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catalysts of this type may be prepared via a single common squaramide carboxylic acid 
precursor. 
 
Scheme 20.  
Once the optimized conditions were found, the reaction of oxazolones 17B-E 
with α’-hydroxy enone 15 was carried out following the next standard procedure: the 
enone was dissolved in 1,2-dichloroethane (0.33 M) and 2 equivalents of the oxazolone 
and 10 mol% of the catalyst C13 were added. The reaction mixture was stirred at 50 oC, 
and after verifying that the reaction stopped (1H NMR monitoring, 72 h), the crude 
material was purified by flash column chromatography on silica leading to a mixture of 
diastereomers. 
The results in Table 7 show that the reaction proceeded in good yield for the four 
different oxazolones tested. However, enantioselectivity seems to be very substrate-
dependent, as oxazolones with a longer alkyl chain (Bn, 90% ee; hex, 92% ee) provided 
the highest enantioselectivity, while oxazolones with a small side chain afforded lower 
selectivity (Pr, 80% ee; Me, 70%  ee). Furthermore, the dr was lower or equal to 2:1 in 
all cases. 
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Table 7. Michael reaction scope between oxazolones and α-methyl α’-hydroxy enone 15[a] 
 
While this work was ongoing, Misaki and Sugimura161 reported the asymmetric 
conjugate addition of oxazolones to α-chloroacrylonitrile, obtaining the corresponding 
α-chloronitriles in excellent yield and diastereoselectivity and high enantioselectivity 
(Scheme 21). 
  
                                                 
161 T. Misaki, N.-R. Choi, A. Morita, T. Sugimura, Tetrahedron Lett. 2015, 56, 5063–5066. 
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Scheme 21.  
 
3.1.3.4. Elaboration of adducts 
In order to validate the α’-hydroxy ketone functionality as a carboxylic acid 
surrogate, the oxidation of the ketol moiety by using cerium ammonium nitrate (CAN) 
was carried out. The corresponding carboxylic acids 23–26 were obtained in high yield 
and without loss of optical purity (Scheme 22).  
 
Scheme 22.  
Carboxylic acid 23 was further derivatized to afford known γ-lactone 28,162 
which served to determine the configuration of adduct 23 and its precursor 18C as R 
(Scheme 23). Configuration of the remaining adducts 18 was assigned by assuming a 
uniform reaction mechanism. 
                                                 
162 A. Paju, M. Laos, A. Jõgi, M. Päri, R. Jäälaid, T. Pehk, T. Kanger, M. Lopp, Tetrahedron Lett. 2006, 
47, 4491–4493. 
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Scheme 23.  
A crystalline sample of adduct 19Eb was obtained by crystallisation from a 
mixture of hexane/ethyl acetate and then its absolute configuration was established by a 
single crystal X-ray analysis thus confirming initial assignment (Figure 7). 
 
Figure 7.  
On the other hand, chemical correlation between adduct 18E and 22E as 
indicated in Scheme 24 demonstrated again that the newly generated stereocenter at the 
oxazolone C5 position is the same in both reactions. 
 
Scheme 24.  
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3.2. 1,6-Additions to α’-oxy dienones 
After developing a robust method for the asymmetric 1,4-addition reactions, the 
investigation of the nucleophilic addition at more remote positions of polyunsaturated 
α’-oxy ketones was the next logical step. 
3.2.1. Precedents and objectives 
At the outset of this project there were only two precedents in the literature 
involving catalyst-controlled direct stereoselective 1,6-addition reactions of enolizable 
nucleophiles leading to the formation of a stereogenic center at Cα: On the one hand, 
Jørgensen and coworkers163 reported the regio- and stereoselective addition of cyclic β-
ketoesters and iminoesters to diverse unsubstituted diunsaturated electrophiles under 
phase-transfer conditions with excellent results (Scheme 25a). On the other hand, Ooi et 
al.164 performed the 1,6- and 1,8-addition of azlactones to polyunsaturated γ- and ζ-alkyl 
N-acylpyrroles respectively catalyzed by a triaminophosphorane catalyst with high 
levels of regio- and stereocontrol, and later extended the substrate scope to 
diunsaturated γ-aryl N-acylpyrroles (Scheme 25b).165 
 
Scheme 25.  
                                                 
163 L. Bernardi, J. López-Cantarero, B. Niess, K. A. Jørgensen, J. Am. Chem. Soc. 2007, 129, 5772–5778. 
164 a) D. Uraguchi, K. Yoshioka, Y. Ueki, T. Ooi, J. Am. Chem. Soc. 2012, 134, 19370–19373. b) D. 
Uraguchi, K. Yoshioka, T. Ooi, Nature Commun. DOI: 10.1038/ncomms14793. 
165 For further information on conjugate 1,6-addition reactions see: a) A. G. Csákÿ, G. Herrán, M. C. 
Murcia, Chem. Soc. Rev. 2010, 39, 4080–4102. b) E. M. P. Silve, A. M. S. Silva, 2012, 44, 3109–3128. 
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Moreover, while the project was ongoing Feng and coworkers reported the 
scandium-catalyzed asymmetric 1,6-addition of 3-substituted oxindoles to dienyl 
ketones in excellen selectivity (Scheme 26). 
 
Scheme 26.  
Taking into account the scarcity of methods, the viability of the asymmetric 1,6-
conjugate addition of enolizable carbonyl compounds to α’-oxy dienones was attempted 
(Scheme 27). 
 
Scheme 27.  
The realization of this objective possessed several challenges to overcome: i) the 
control of the face selectivity at sites remote from the coordination point, ii) the 
diminished reactivity of α’-oxy dienones as compared to the parent unsubstituted α’-oxy 
enones and iii) the control of the 1,4 vs 1,6 addition. 
The goal was to identify the factors that govern the different reactivity and 
selectivity aspects of this transformation. 
 
3.2.2. Oxazolones as nucleophiles 
The suitability of a catalytic 1,6-addition process involving our dienones was 
first evaluated by using oxazolone 17E and α’-oxy dienones 16 and 16’ in the presence 
of several Brønsted base catalysts (Table 8). In a first run the reaction was carried out 
under the conditions developed for the Michael reaction of oxazolones with β-aryl α’-
hydroxy enones. Under these conditions (C7 10 mol%, 70 ºC) a 2:1 mixture of the 1,6- 
and 1,4-addition products was obtained in low stereoselectivity (Table 8, entry 1). In 
Brønsted base-catalyzed α-functionalization of carbonyl compounds 
 
109 
 
light of this result, we decided to change the tertiary amine by a stronger basic 
functionality. The idea was that a stronger base would increase the amount of enolate 
present in the reaction media, thus accelerating the reaction and making feasible its 
performance under kinetic control, hopefully favouring the addition at the least 
sterically-hindered position (δ). 
For that goal, a set of novel guanidine catalysts (C14-C18) and phosphanimine 
C19 were synthesised. The reactions at 0 ºC with guanidine catalysts C14-C18, 
afforded the 1,6-addition adduct exclusively. However, enantioselectivity remained 
suboptimal in all the cases. For example guanidine C14, similar to the ones developed 
by Ishikawa,166 afforded the desired product in an almost racemic manner (Table 8, 
entry 2). Moreover, the use of catalysts C15-C17, including variations in the relative 
disposition of the stereogenic centers did not lead to substantial improvement of the 
enantioselection (entries 3, 5 and 7, respectively). The silylated dienone 16’ was also 
tested in the reaction with catalysts C15-C17 (entries 4, 6 and 8, respectively), but 
reaction times became longer and similar ee values to the ones obtained with dienone 16 
were observed. When chiral guanidine C18, similar to the one described by Wang and 
Qu,167 was tested in the reaction (Table 8, entry 9), similar results were obtained. 
Finally, phosphanimine catalyst C19 was also employed in the reaction (Table 8, entry 
10), but low conversion rates were observed. 
  
                                                 
166 T. Ishikawa, Y. Araki, T. Kumamoto, H. Seki, K. Fukuda, T. Isobe, Chem. Commun. 2001, 245–246. 
167 L. Zou, B. Wang, H. Mu, H. Zhang, Y. Song, J. Qu, Org. Lett. 2013, 15, 3106–3109. 
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Table 8. Catalyst screening for the reaction of oxazolone 17E with α’-oxy dienones[a] 
 
 
Entry cat Enone R t (h) Yield (%)[b] 29:29’[c] ee (%)[d] 
1 C7 28 H 48[e] 68 2:1 15 
2 C14 28 H 24 76 >20:1 13 
3 C15 28 H 24 74 >20:1 –22 
4 C15 28’ SiMe3 72 56 >20:1 –35 
5 C16 28 H 24 72 >20:1 –27 
6 C16 28’ SiMe3 72 45 >20:1 –36 
7 C17 28 H 24 79 >20:1 40 
8 C17 28’ SiMe3 72 73 >20:1 45 
9 C18 28 H 24 78 >20:1 -40 
10 C19 28 H 72 <25 n.d. n.d. 
[a] Reactions conducted on a 0.15 mmol scale in 0.45 mL of CH2Cl2 (17E/dienone/cat molar ratio 
= 1:2:0.1). [b] Yield of combined isomers after chromatography. [c] Determined by 1H NMR 
spectroscopy. [d] ee of compound 29, determined by chiral HPLC. [e] Reaction carried out at 70 oC 
using 1,2-DCE as the solvent. 
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While this study was ongoing, Misaki and Sugimura168 reported a similar work 
where they performed the conjugate 1,6-addition of oxazolones to simple dienones. The 
corresponding adducts were obtained in variable yield and excellent enantioselectivity 
as a mixture of E/Z isomers (Scheme 28). 
 
Scheme 28.  
 
3.2.3. α-Cyanoacetates as nucleophiles 
At this point, we decided to switch from oxazolones to α-cyanoacetates as 
nucleophiles, and the reaction of cyanoacetate 30 with α’-oxy dienone 16 was taken as a 
model to perform the catalyst screening (Table 9). Also some new catalysts C20-C25 
were synthesised. To begin with, guanidine catalysts bearing the squaramide (C16), 
thiourea (C20) and ureidopeptide (C21) motifs were employed in the reaction, and 
although the 1,6-addition adduct was formed exclusively, enantioselectivity near zero 
was obtained. When catalyst C18 was used for the reaction, some stereoselectivity was 
observed and therefore different catalysts bearing the same chiral guanidine structure 
were synthesised and tested. First, catalyst C22, with a different relative configuration, 
rendered the adduct in lower ee. On the other hand, catalyst C23, not bearing additional 
H-bonding groups, turned out to be an inefficient catalyst for the reaction. Finally, 
catalysts C24 and C25, with additional basic functionalities, rendered the desired 
product in good yield, but very low enantioselectivity. 
  
                                                 
168 a) A. Morita, T. Misaki, T. Sugimura, Chem Lett. 2014, 43, 1826–1828. b) A. Morita, T. Misaki, T. 
Sugimura, Tetrahedron Lett. 2015, 56, 264–267. 
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Table 9. Catalyst screening for the reaction of cyanoacetate 30 with α’-hydroxy dienone 16[a] 
 
At this point, seeing the difficulties we were encountering in our quest for a 
catalyst that could effectively control the enantioselectivity of the 1,6-addition reaction, 
we decided to provisionally put the project aside to focus on other goals. 
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3.3. Regio-, diastereo- and enantioselective functionalization of 
unactivated cyclic ketones 
3.3.1. Precedents and objectives 
Despite the great synthetic interest of chiral ketones, the direct asymmetric α-
functionalization of enolizable ketones remains challenging. This situation aggravates in 
the case of non-symmetrical unactivated ketones with two sites for deprotonation, in 
which the procedures for the catalytic asymmetric α-carbofunctionalization are mostly 
limited to the use of either chiral auxiliaries or preformed enolates and equivalents. For 
instance, to the best of our knowledge, the direct catalytic stereoselective α-arylation169 
of these ketones is yet to be achieved, and only scarce examples of allylation170 and 
alkylation171 reactions have been reported so far. 
Successful strategies for the α-alkylation involving the use of primary amine 
catalysts have been independently reported by the groups of Carter172 and Kotsuki,173 
but they require a high catalyst loading and harsh reaction conditions (Scheme 29). 
Furthermore, the substituent at Cα is limited to the methyl, ethyl, n-propyl and benzyl 
groups, affording the adducts of the latter two in low yield (<35%). 
                                                 
169 For reviews on the arylation of carbonyl compounds see: a) C. C. C. Johansson, T. J. Colacot, Angew. 
Chem. Int. Ed. 2010, 49, 676–707. b) F. Bellina, R. Rossi, Chem. Rev. 2010, 110, 1082–1146. 
170 For a metal-catalyzed example of this reaction see: a) W. Chen, M. Chen, J. F. Hartwig, J. Am. Chem. 
Soc. 2014, 136, 15825–15828. For reviews on the allylation of carbonyl compounds see: b) S. Oliver, P. 
A. Evans, Synthesis 2013, 45, 3179–3198. c) J. C. Hethcox, S. E. Shockley, B. M. Stolz, ACS Catal. 
2016, 6, 6207–6213. 
171 For a recent review on the direct asymmetric alkylation of ketones see: R. Cano, A. Zakarian, G. P. 
McGlacken, Angew. Chem. Int. Ed. 2017, 56, 9278–9290. 
172 a) J. Y. Kang, R. G. Carter, Org. Lett. 2012, 14, 3178–3181. b) J. Y. Kang, R. C. Johnston, K. M. 
Snyder, P. H.-Y. Cheong, R. G. Carter, J. Org. Chem. 2016, 81, 3629–3637. 
173 R. Horinouchi, K. Kamei, R. Watanabe, N. Hieda, N. Tatsumi, K. Nakano, Y. Ichikawa, H. Kotsuki, 
Eur. J. Org. Chem. 2015, 4457–4463. 
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Scheme 29.  
On the other hand, Toste174 and List175 have independently demonstrated the 
utility of chiral phosphoric acids as Brønsted acid catalysts for the regioselective 
asymmetric α-carbofunctionalization of cyclic ketones with allenamides, allylic alcohols 
and α’-branched α,β-unsaturated ketones (Scheme 30). 
 
Scheme 30.  
At the outset of this project, the only direct Brønsted base-catalyzed example in 
the literature for the regio- and stereoselective functionalization of ketones with two 
                                                 
174 a) X. Yang, F. D. Toste, Chem. Sci. 2016, 7, 2653–2656. For examples of heterofunctionalization 
reactions see: b) X. Yang, R. J. Phipps, F. D. Toste, J. Am. Chem. Soc. 2014, 136, 5225–5228. c) X. 
Yang, F. D. Toste, J. Am. Chem. Soc. 2015, 137, 3205–3208. 
175 a) I. Felker, G. Pupo, P. Kraft, B. List, Angew. Chem. Int. Ed. 2015, 54, 1960–1964. b) G. Pupo, R. 
Properzi, B. List, Angew. Chem. Int. Ed. 2016, 55, 6099–6102. For an example of amination reaction see: 
c) G. A. Shevchenko, G. Pupo, B. List, Synlett 2015, 26, 1413–1416. 
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distinct sites for deprotonation was the one reported by Wang,176 where the Michael 
reaction of α-aryl substituted cyclopentanones with nitroalkenes was catalyzed by a 
chiral thiourea-sulfonamide catalyst (Scheme 31). The corresponding α-alkylation 
adducts were obtained exclusively and in excellent yield, diastereo- and 
enantioselectivity. However, α-phenyl cyclohexanone behaved sluggishly. 
 
Scheme 31.  
We decided to explore alternative strategies to provide a methodology for the α-
functionalization of either cyclic or acyclic α-substituted ketones. The major handicaps 
in developing direct regio- and enantioselective C-C bond forming reactions at Cα 
position of α-branched ketones under proton transfer conditions stem from: i) the 
relatively high pKa value of the ketone substrate and ii) the steric constraints imposed 
by the carbonyl α-substituent, which difficult proton abstraction and decreases 
nucleophilicity. We envisioned that an alkenyl group installed at the α-position of the 
carbonyl function, that is an α-alkenyl cycloalkanone, would not only provide synthetic 
versatility to the resulting adducts, but, most importantly, also charge delocalization 
during enolization. As a result, a weak base catalyst might suffice to trigger the reaction 
while securing regioselective α- vs α’-enolization (Scheme 32). 
 
Scheme 32.  
                                                 
176 X.-Q. Dong, H.-L. Teng, M.-C. Tong, H. Huang, H.-Y. Tao, C.-J. Wang, Chem Commun. 2010, 46, 
6840–6842. 
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However, in that design the Brønsted base should also be effective in controlling 
both the α- vs γ-reactivity of the transiently formed vinylogous enolate and the reaction 
stereoselectivity during generation of the quaternary stereogenic center. 
Recently, I. Iriarte, O. Olaizola and Dr. Vera from this laboratory177 have 
addressed this latter problem in acyclic systems and found that conjugate additions of 
β,γ-unsaturated ketones to nitroalkenes catalyzed by bifunctional Brønsted bases 
provided only the α-addition adducts (Scheme 33). 
 
Scheme 33.  
 
3.3.2. α-Functionalization of α-alkenyl cycloalkanones 
On this basis, our study was initiated with the reaction of α-alkenyl 
cycloalkanones with vinyl sulphones under similar conditions, addressing the double 
α/α’/γ regioselectivity problem. We elected to use vinyl sulphones as acceptors because, 
upon double bond hydrogenation and desulfonylation, products from a formal α-
alkylation of α-alkyl cycloalkanones would result in a concise, simple way (Scheme 
34). Such products are otherwise difficult to achieve.178 
                                                 
177 I. Iriarte, O. Olaizola, S. Vera, I. Gamboa, M. Oiarbide, C. Palomo, Angew. Chem. Int. Ed. 2017, 56, 
8860–8864. 
178 For an approach involving protection of α’-position, α-alkylation and α’-deprotection see: a) T. 
Hamada, A. Chieffi, J. Ahman, S. L. Buchwald, J. Am. Chem. Soc. 2002, 124, 1261–1268. b) T. Kano, Y. 
Hayashi, K. Maruoka, J. Am. Chem. Soc. 2013, 135, 7134–7137. 
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Scheme 34.  
3.3.2.1. Catalyst screening 
Initially the reaction between 2-styrylcyclohexanone (34A) and 1,1-
bis(phenylsulfonyl)ethylene (35) was taken as a model to find the optimal catalyst for 
the α-alkylation reaction of cyclic α-alkenylketones (Table 10). In a first run, the 
reaction catalyzed by thiourea C9 afforded exclusively the desired α-addition product 
35A in good yield, but in an almost racemic manner. Urea catalysts C26179 and C27180 
afforded the adduct in better, but still low enantioselectivity. On the other hand, 
(DHQD)2PYR (C11) and squaramide catalysts C7
154a and C12154b rendered the addition 
product in high yield and moderate ee values (60–73% ee). When using the less basic 
amine C10156 as the catalyst low conversions were observed, even at room temperature. 
Moreover, the new squaramide catalysts bearing an amide group as an additional H-
bond donor functionality (C13 and C28181) led to no improvement as compared to C7. 
However, using a more sterically demanding catalyst such as C29182 the desired adduct 
was obtained in excellent yield and enantioselectivity (96% ee). Furthermore, catalyst 
C30, synthesised from hydrogenated quinine, afforded adduct 35A in even higher 
enantioselectivity (98% ee). Remarkably, no formation of α’- or γ-addition adducts was 
observed with any of the catalyst. 
  
                                                 
179 K. Greenaway, P. Dambruoso, A. Ferrali, A. J. Hazelwood, F. Sladojevich, D. J. Dixon, Synthesis 
2011, 12, 1880–1886. 
180 S. Diosdado, R. López, C. Palomo, Chem. Eur. J. 2014, 20, 6526–6531. 
181 I. Urruzuno, O. Mugica, M. Oiarbide, C. Palomo, Angew. Chem. Int. Ed. 2017, 56, 2059–2063. 
182 A. Odriozola, M. Oiarbide, C. Palomo, Chem. Eur. J. 2017, 23, 12758–12762. 
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Table 10. Catalyst screening for the reaction between 34A and 33[a] 
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3.3.2.2. Reaction scope 
Once the optimal catalyst for the reaction model was found, the reaction of 
cyclic α-alkenyl ketones 34 with bisulfone 33 was conducted following the next 
standard procedure: the donor ketone was dissolved in CH2Cl2 (0.5 M) and 1.5 
equivalents of 1,1-bis(phenylsulfonyl)ethylene (35) and 5 mol% of the catalyst C30 
were added. The reaction mixture was stirred at 0 ºC, and after verifying that the 
reaction finished (TLC monitoring, 14 h), the reaction mixture was submitted to flash 
column chromatography on silica gel eluting with hexane/EtOAc mixtures. 
As data in Table 11 show, the reaction tolerated well the different ring-sized 
cycloalkanones (34B–34D), affording the corresponding alkylation products 35B–35D 
in high yield and excellent enantioselectivity except for the cyclopentanone derivative 
35B, which was obtained in lower selectivity. It is noteworthy that in the case of 
adducts 35B and 35D switching the solvent to toluene resulted in an increase of 
stereoselectivity. Moreover, compound 35E, bearing substituents at the cyclohexanone 
ring and with a more electron-rich alkenylic group was also obtained with equally good 
results. However, product 35F, not having a styril group, was obtained in lower ee 
values. Curiously, when α-phenyl cyclohexanone (35G) was tested in the reaction for a 
comparison, no reaction was observed, probably due to the bigger steric hindrance 
present at the α-position as compared to the other substrates. In addition, the scalability 
of the reaction was demonstrated by performing the reaction at 3 mmol scale, obtaining 
adduct 35A with similar results. Importantly, in every case exclusively the α-addition 
product was formed. 
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Table 11. Reaction scope between α-alkenyl ketones and 33[a] 
 
In parallel to our work, O. Mugica from this laboratory found that vinyl 
sulphones  are suitable acceptors for the conjugate addition reaction with α-alkenyl α-
tetralones, and was able to obtain the addition products in high yield and almost perfect 
enantioselectivity by using “bulky” Brønsted base catalyst C30 (Scheme 35). 
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Scheme 35.  
3.3.2.3. Elaboration of adducts 
Once an efficient and highly selective procedure for the α-alkylation was 
obtained, some possibilities for the transformation of the adducts were briefly explored. 
First, the desulfonylation of adducts 35A and 35E was performed with 
magnesium in methanol after ketalization of the carbonyl to avoid its non-
stereoselective reduction (Scheme 36). The desired desulfonylated products 38 and 39 
were obtained in moderate yield. 
 
Scheme 36.  
Moreover, alkylation of product 36 was performed with methyl iodide and 
sodium hydride obtaining the methylated product 40 in high yield, and upon subsequent 
desulfonylation and deprotection α,α-disubstituted ketone 41 was obtained in moderate 
yield (Scheme 37). Unfortunately, preliminary attempts on benzylation and allylation of 
36 under the same reaction conditions were unsuccessful. 
 
Scheme 37.  
In another transformation, compound 38 was derivatized to afford known β-
ketoester 43,183 which served to determine the configuration of adduct 38 and its 
precursor 35A as R (Scheme 38). Configuration of remaining adducts was assumed 
based on a uniform reaction mechanism. 
                                                 
183 S. Pinheiro, A. Guingant, D. Desmaële, D. d’Angelo, Tetrahedron: Asymmetry 1992, 3, 1003–1006. 
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Scheme 38.  
On the other hand, the branched cycloalkanone 45 was synthesised in high yield 
from 38 via hydrolysis of the ketal and reduction of the double bond with H2/Pd 
(Scheme 39). The former is the adduct formally derived from the asymmetric alkylation 
of an α-alkyl cycloalkanone, which is difficult to achieve regio- and stereoselectivily. 
 
Scheme 39.  
Intermediate 44 was also used for the preparation of the β,γ-dihydroxy ketone 
derivative 42 (Scheme 40). In a first step ketone 44 was oxidized with osmium tetroxide 
and N-methylmorpholine N-oxide affording the hemiketal 46, and after conversion to 
the ketal the desired diol 42 was obtained in good yield and as a single isomer. 
 
Scheme 40.  
Additionally, a crystalline sample of adduct 46 was obtained by crystallization 
from a mixture of hexane/dichloromethane and thus the absolute configuration of 
compound 46 was established by a single crystal X-ray analysis. The configuration of 
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the molecule happened to be (1S, 6S, 7S, 8S), with both hydroxyl groups on the same 
side of the tetrahydrofurane ring (Figure 8). 
  
Figure 8.  
Finally, compound 39 was reduced with H2/Pd leading to the α,α-dialkyl ketal 
intermediate 47, which after subsequent oxidative scission and deprotection of the 
ketone afforded product 48 (Scheme 41). It is worth noting that 48 is the adduct 
formally derived from the asymmetric Michael reaction between an α-alkyl 
cycloalkanone and an enoate, a reaction for which no direct Brønsted base-catalyzed 
procedures have yet been reported. 
 
Scheme 41.  
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3.3.3. α-Alkylation of β-tetralone derivatives 
Given these results, we next explored the behaviour of β-tetralones in this type 
of reations. We hypothesised that the fused aromatic ring in β-tetralones might induce 
preferential enolization at Cα rather than Cα’ (Scheme 42), and that in the presence of a 
Brønsted base relatively high concentrations of the enolic form would be expected, thus 
eventually driving the catalytic process forward. Moreover, not only alkenyl, but also 
alkyl groups at this position might be equally tolerated. 
 
Scheme 42.  
The only previous asymmetric procedures for the α’- and α-functionalization of 
β-tetralone derivatives described by Seebach184 and d’Angelo185 respectively rely on the 
use of chiral amine auxiliaries, affording the corresponding adducts in good yield but 
variable diastereo- and enantioselectivity (Scheme 43). Most importantly, in these 
examples the regioselectivity of the reaction is strongly substrate-dependent. 
 
Scheme 43.  
In this context, the use of a chiral Brønsted base would not only enable the use 
of catalytic amounts of the chiral compound for the selective α-functionalization of β-
tetralones, but, compared to the previous procedures employing chiral amine auxiliaries, 
                                                 
184 a) S. J. Blarer, W. D. Seebach, Chem. Ber. 1982, 116, 3086–3096. 
185 a) T. Volpe, G. Revial, M. Pfau, J. d’Angelo, Tetrahedron Lett. 1987, 28, 2367–2370. b) J. d’Angelo, 
G. Revial, T. Volpe, M. Pfau, Tetrahedron Lett. 1988, 29, 4427–4430. 
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would also avoid the need for additional steps for the formation of the nucleophilic 
species and the recovery of the final carbonyl compound. 
Indeed, whilst O. Mugica from this laboratory demonstrated that β-tetralones can 
be selectively substituted at Cα in the presence of a Brønsted base catalyst employing 
vinyl sulphones as electrophiles,186 we have found that nitroolefins and 
azodicarboxylates are also suitable substrate acceptors for this reaction leading to 
attractive building-blocks of products of relatively greater complexity, as it has been 
shown in previous works (Scheme 44).187 
 
Scheme 44.  
3.3.3.1. Initial experiments and reaction scope 
Initially the reaction between β-tetralone 49B and nitrostyrene (32a) at 0 ºC was 
taken as a model in order to find the optimal Brønsted base catalyst to render the 
corresponding α,α-disubstituted β-tetralones. As the most representative experiments 
summarised in Table 12 show, all catalysts afforded the α-addition adduct exclusively in 
a completely diastereoselective manner. However, stereoselectivity happened to be 
                                                 
186 Results not published yet. 
187 For the synthesis of: Homoerythrina alkaloids: a) M. A. Le Dréau, D. Desmaele, F. Dumas, J. 
O’Angelo, J. Org. Chem. 1993, 58, 2933–2935. Morphan derivatives: b) G. Lim, J. W. Hooper, US 
Patent 4, 017,493; Apr. 12, 1997. Glucocorticoid receptors: c) B. P. Morgan, A. G. Swick, D. M. 
Hargrove, J. A. LaFlame, M. S. Moybihan, R. S. Carrol, K. A. Martin, G. Lee, D. Decosta, J. Bordner, J. 
Med. Chem. 2002, 45, 2417–2424. Stradiols: d) Y. Bouali, F. Nique, J.-G. Teutsch, P. Van de Velde, US 
Patent 6, 207,657BI, Mar 27, 2001. e) J. P. Larkin, C. Whrey, P. Boffelli, H. Lagraulet, G. Lamaitre, A. 
Nedelec, D. Prat, Org. Process Res. Dev. 2002, 6, 20–27. 
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highly catalyst-dependent. Catalysts bearing the squaramide H-bonding structure (C7, 
C12, C13, C28, C31-C33) exhibited a superior enantiocontrol when compared to 
catalysts with other functionalities such as urea (C26179), thiourea (C9155) and 
ureidopeptide (C35188), or catalysts not bearing this kind of H-bond donor moieties 
(C11 and C34), which all rendered adduct 51Ba in low ee (<50%). C7154a and C12154b 
afforded the adduct in similar enantioselectivity, while catalysts C13 and C31189 
provided slightly higher ee. Catalysts bearing a benzylic group instead of an arylic 
group at the amide functionality (C28181 and C32) rendered the product in improved 
enantioselectivity, although longer reaction times (16 h) were required. Furthermore, the 
use of N-methylated catalyst (C33) leaded to a significant loss of enantioselectivity, 
thus suggesting that the amide group is involved in some H-bond interaction during the 
reaction. 
Table 12. Catalyst screening for the reaction between 49B and 32a[a] 
 
                                                 
188 S. Diosdado, J. Etxabe, J. Izquierdo, A. Landa, A. Mielgo, I. Olaizaola, R. López, C. Palomo, Angew. 
Chem. Int. Ed. 2013, 52, 11846–11851. 
189 J. Etxabe, J. Izquierdo, A. Landa, M. Oiarbide, C. Palomo, Angew. Chem. Int. Ed. 2015, 54, 6883–
6886. 
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Continuation of Table 12
 
Next, to ensure that stereoselectivity was not substrate-dependent catalysts with 
the squaramide motif (C13, C28, C32 and C33) were tested in the reaction between β-
tetralone 49B and the more electron-rich nitroalkene 32b (Table 13). The results were 
similar to the ones above obtained. 
Table 13. Catalyst screening for the reaction between 49B and 32b[a]
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In light of the preliminary results, catalysts C13, C28 and C32 were chosen for 
the study of the effect of temperature in the reaction between β-tetralone 49B and 
nitrostyrene (32a) (Table 14). Lowering the temperature from 15 to 0 ºC improved the 
enantioselectivity obtained with catalyst C13, although reaction times became longer 
(entry 1 vs. 2). Further decrease in temperature to –20 ºC allowed to obtain adduct 51Ba 
in 90% ee (Table 14, entry 3). Conducting the reaction with catalyst C28 at –10 ºC 
instead of 15 ºC also improved the stereoselectivity (entry 4 vs. 5), and afforded 
comparable results to the ones obtained with catalysts C13 at –20 ºC (entry 3 vs. 5). An 
improvement in enantioselectivity was also observed with catalyst C32 when using it at 
0 ºC as compared to the same reaction at 15 ºC (entry 6 vs. 7). However, the low 
solubility of catalyst C32 made it behave sluggishly when decreasing the temperature 
bellow 0ºC, affording the product in similar yield and enantioselectivity, but after longer 
reaction times (72 h) (Table 14, entry 8). Thus, C28 was chosen as the optimal catalyst 
for the reaction of α-substituted β-tetralones with nitroalkenes (32). 
Table 14. Study of the effect of temperature in the reaction between 49B and 32a[a] 
 
Entry cat T (oC) t (h) Yield (%)[b] ee (%)[c] 
1 C13 15 6 85 76 
2 C13 0 16 84 86 
3 C13 –20 24 84 90 
4 C28 15 16 93 80 
5 C28 –10 24 82 90 
6 C32 15 16 84 85 
7 C32 0 24 86 89 
8 C32 –10 72[d] 80 90 
[a] Reactions conducted on a 0.30 mmol scale in 0.6 mL of CH2Cl2 (49B/32a/cat molar ratio = 
1:1.2:0.1). dr = >20:1 in all cases. [b] Yield after chromatography. [c] ee of major isomer, 
determined by chiral HPLC. [d] Low solubility of the catalyst. 
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With the optimized conditions in hand, the reaction of β-tetralone derivatives 
49B-49D with a set of nitroalkenes (32) was carried out following the next standard 
procedure: the donor was dissolved in CH2Cl2 (0.5 M) and 1.2 equivalents of the 
acceptor nitroalkene and 10 mol% of the catalyst C28 were added. The reaction mixture 
was stirred at –10 ºC, and after verifying that the reaction finished (TLC monitoring, 
16–64 h) the reaction mixture was submitted to flash column chromatography on silica 
gel eluting with hexane/EtOAc mixtures. 
As the results in Table 15 show, the reaction proceeds smoothly for the 
differently substituted aromatic nitroalkenes (32a-32d) affording the corresponding 
adducts (51Ba–51Bd) in high selectivity (90–92% ee). Furthermore, heteroaromatic 
(32h) and aliphatic (32i) nitroalkenes afforded the corresponding adducts (51Bh and 
51Bi) with similarly good yield and enantioselectivity. α-Subsituted tetralones bearing 
additional functionality (49C and 49D) were also successfully employed in the reaction 
with equally good yields and ee values (products 51Ce and 51Df). The reaction also 
tolerates β-tetralones bearing electron donating or withdrawing groups at the aromatic 
ring, which were equally efficient (adducts 51Fg, 51Ga and 51Hj). Importantly, in 
every case no traces of products from the reaction at the α’-carbon atom were found, 
and the adducts were obtained essentially as a sole diastereomer. It must be noted that 
for the formation of some adducts (51Ce, 51Fg and 51Ga) in high yield the use of the 
more active catalyst C13 was necessary. 
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Table 15. Michael reaction scope between α-substituted β-tetralones and nitroalkenes[a] 
 
In light of the good results obtained with α-substituted β-tetralones, the 
behaviour of the parent α-unsusbstituted β-tetralone 49A was investigated under similar 
reaction conditions. A selection of bifunctional Brønsted base catalysts bearing the 
squaramide functional unit (C7, C13 and C28) were tested in the reaction of 49A with 
nitrostyrene (32a) (Table 16). In all the cases the desired adduct 51Aa with a tertiary 
stereocenter at Cα was obtained in high yield, good diastereoselectivity and almost 
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perfect enantioselectivity. Importantly, no α,α-double addition or α’-addition adducts 
were observed in any of the cases. 
Table 16. Catalyst screening for the reaction between 35A and 34a[a] 
 
Next, the effect of temperature and the C7 loading in the reaction of 49A with 
nitrostyrene (32a) were examined (Table 17). Almost perfect enantioselectivity was 
obtained at 0, –20 and –40 ºC (Table 17, entries 1, 2 and 4, respectively), but higher 
temperatures (Table 17, entry 1) and prolonged reaction times (Table 17, entries 3 and 
4) were detrimental for the diastereomeric ratio, likely due to the tendency of the adduct 
to further deprotonate in the presence of the catalyst, resulting in epimerization. 
Furthermore, reactions with 5, 2 and 1 mol% C7 loadings afforded adduct 51Aa in 
equally good results (entries 5, 6 and 7, respectively). 
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Table 17. Study of the effect of temperature in the reaction between 49A and 32a catalyzed by C7[a] 
 
 
 
 
 
 
 
 
The diastereomeric ratio was determined by 1H NMR (300 MHz) analysis of the 
reaction crude (Figure 9) comparing the peak areas of the protons at Cα of adduct 51Aa 
(3.76 ppm for minor and 3.65 ppm for major). 
  
Figure 9.  
 
Entry C7 (mol%) T (oC) t (h) Yield (%)[b] dr (%)[c] ee (%)[d] 
1 10 15 1 74 1:1 99 
2 10 –20 2 85 4:1 99 
3 10 –20 8 81 1:1 99 
4 10 –40 16 75 2:1 99 
5 5 –20 4 82 4:1 99 
6 2 –20 8 83 4:1 99 
7 1 –20 16 82 4:1 98 
[a] Reactions conducted on a 0.30 mmol scale in 0.6 mL of CH2Cl2 (49A/32a molar 
ratio = 1:1.2). [b] Combined yield of isomers after chromatography. [c] Determined by 
1H NMR spectroscopy of an untreated reaction sample and confirmed by HPLC. [d] ee 
determined by chiral HPLC, same for both isomers. 
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Once the optimized conditions were found, the reaction of β-tetralone 49A with 
nitroalkenes (32) was carried out following the next standard procedure: the donor was 
dissolved in CH2Cl2 (0.5 M) and 1.2 equivalents of the acceptor nitroalkene and 2 mol% 
of the catalyst C7 were added. The reaction mixture was stirred at –20 ºC for the 
aromatic nitroalkenes, and at room temperature for the aliphatic ones. After verifying 
that the reaction finished (TLC monitoring, 8–24 h) the reaction mixture was submitted 
to flash column chromatography, isolating the corresponding adduct 51A as a mixture 
of diastereomers. 
As results in Table 18 show, the reaction was again found to be completely 
regioselective for all the nitroalkenes tested. Furthermore, the corresponding Michael 
addition products 51A were obtained from both aryl- (51Aa-51Ae) and alky-substituted 
(51Ai-51Aj) nitroalkenes in high yield and in excellent enantioselectivity. Furthermore, 
diastereoselectivity was good (4:1 or higher) with the only exception of the 2-furyl 
substituted nitroalkene 32h, which afforded a 1:1 diastereomeric mixture (entry 6). The 
reaction was also scaled up to a 2 mmol scale for adduct 51Aa obtaining equally good 
results (entry 10). 
Table 18. Michael reaction scope between β-tetralone 49A and nitroalkenes[a] 
 
Entry Product R T (oC) t (h) Yield (%)[b] dr (%)[c] ee (%)[d] 
1 51Aa Ph –20 8 83 4:1 99 
2 51Ab  4-MeOC6H4 –20 8 85 8:1 99 
3 51Ac  4-BrC6H4 –20 8 88 4:1 99 
4 51Ad  3-MeOC6H4 –20 8 80 4:1 99 
5 51Ae  2-ClC6H4 –20 8 84 >20:1 99 
6 51Ah  2-furyl –20 8 86 1:1 98 
7 51Ai  CH3(CH2)2 RT 16 81 5:1 99 
8 51Aj  Ph(CH2)2 RT 16 83 5:1 99 
9 51Ak  C6H11 RT 24 80 4:1 99 
10 51Aa Ph –20 8 83 4:1 98[e] 
[a] Reactions conducted on a 0.30 mmol scale in 0.6 mL of CH2Cl2 (49A/32/C7 molar ratio = 
1:1.2:0.02). [b] Combined yield of isomers after chromatography. [c] Determined by 1H NMR 
spectroscopy of an untreated reaction sample. [d] ee determined by chiral HPLC, same for 
both isomers. [e] Reaction conducted at a 2 mmol scale. 
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Control experiments were carried out to study the tendency of adducts 51A 
towards epimerization. Thus, when compound 51Aa (dr = 4:1) was exposed to 5 mol% 
of C7 at room temperature in dichloromethane for 3 h an equimolar mixture of 
diastereomers was obtained, as could be monitored by HPLC (Scheme 45). However, in 
the absence of C7, no epimerization was observed, even after 24 h at 80 ºC. 
 
Scheme 45.  
Later, the suitability of this method for the site- and stereoselective α-
functionalization of related ketone substrates was investigated. Indeed, the aromatic 
ring-fused cycloalkanone 53 with an oxygen heteroatom in the cycle was equally 
competent undergoing the regioselective Michael addition under described catalytic 
conditions (Scheme 46). The desired adduct 54 was obtained in high yield and excellent 
enantioselectivity as a 1:1 diastereomeric mixture. The diastereoselective formation of 
the product 54 was observed when lowering the reaction temperature to –60 ºC, but 
upon flash column chromatography on silica gel the 1:1 mixture was again obtained. 
 
Scheme 46.  
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Cycloalkanone 55, with a 7-membered ring, was also found suitable for the 
reaction although it needed to be conducted at room temperature and with a 10 mol% 
catalyst loading (Scheme 47). The corresponding adducts were obtained in good yield, 
good diastereoselectivity (4:1 or higher) and excellent enantioselectivity. Again, no 
double addition nor α’-addition products were observed. 
 
Scheme 47.  
 
3.3.3.2. Elaboration of adducts 
Once an efficient and highly regio- and stereoselective procedure for the 
Michael addition of β-tetralones to nitroalkenes was obtained, some possibilities for the 
transformation of the adducts into more complex polycyclic structures were explored. 
First, adducts 51Aa and 51Ae were reacted with nitroalkenes 32a and 32i, 
respectively, in the presence of 10 mol% C7, as shown in Scheme 48. As a result, the 
tricyclic systems 57/57’ and 58/58’ were obtained in moderate combined yield. 
Remarkably, with this procedure only two out of the possible 64 stereoisomers are 
obtained. Furthermore, no cyclization product derived from the minor isomer of 51A 
was observed in neither of the cases, and the isomeric composition of the isolated 
product was found to be independent of the initial mixture of 51A. These results suggest 
that formation of the tricycles through a Michael/Henry cascade reaction involves some 
kinetic resolution process. 
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Scheme 48.  
When 51Ae was treated with acrolein in the presence of C7 at room 
temperature, the Michael addition product 59 was isolated. Then, the aldol-reaction-
mediated cyclization to 60 was achieved employing 10 mol% pyrrolidine. Otherwise, 
direct transformation of 51Ae to the spirocyclic aldol 60 could also be achieved by 
treatment with acrolein in the presence of 10 mol% pyrrolidine. Both ways 60 was 
produced as essentially a single diastereomer. It should be noted that the course of the 
reaction is quite unexpected, taking into account that cycloalkanones under similar 
reaction conditions have been reported to afford substituted decalins instead.190 
 
Scheme 49.  
                                                 
190 S. Anwar, H.-J. Chang, K. Chen, Org. Lett. 2011, 13, 2200–2203. 
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Moreover, the reduction of adducts 51 afforded in very good yield hexahydro-
benzo[e]indoles, heterocyclic cores present in many biologically active compounds 
(Scheme 50).191 For instance, reduction of the adduct 51Ae with H2/Pd provided amine 
61 in a highly selective manner. On the other hand, adduct 51Ba was also reduced with 
either Zn/H+ or H2/Pd, providing imine 62 and imine N-oxide 63, respectively. 
 
Scheme 50.  
 
3.3.3.3. Determination of the absolute configuration 
The absolute configuration of compounds 57, 60 and 63 was established by a 
single crystal X-ray analysis and for the remaining compounds derived from β-
tetralones and related cyclic ketones was assumed based on a uniform reaction 
mechanism. The ORTEP diagrams of the molecules are shown in Figure 10. 
                                                 
191 C. H. Lin, S. R. Haadsma-Svensson, G. Phillips, R. B. McCall, M. F. Piercey, M. W. Smith, K. 
Svensson, A. Carlsson, C. G. Chidester, P. F. Von Voigtlander, J. Med. Chem. 1993, 36, 2208–2218. 
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Figure 10.  
Knowing the configuration of the Cβ, the absolute configuration of 61 was 
established by a NOESY analysis of its amide derivative 64 (Scheme 51). Irradiation at 
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3.80 ppm (H2) (Figure 11) revealed the proximity of H1 (NOESY >2%), indicating that 
both protons are on the same side of the pyrrolidine ring. On the other hand, only a 
small signal from H3 was detected (<0.5%), thus indicating that H2 and H3 are on 
opposite sides of the pyrrolidine ring. Therefore, the configuration of the molecule was 
assigned as (1R, 2S, 3S). 
 
Scheme 51.  
  
Figure 11.  
On the other hand, the configuration of 57’ was established by a NOESY 
analysis, and for product 58’ was assumed based on a uniform reaction mechanism. 
Irradiation at 3.82 ppm (H5) (Figure 12) revealed the proximity of H3 and H4 (NOESY 
>1.5%), indicating that both protons are on the same side of the ring. On the other hand, 
H1, H2 and H6, gave almost no signal (<0.30%), thus suggesting that these protons are 
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on the other side. Therefore, the configuration of the molecule was deduced to be (1S, 
2S, 3R, 4R, 5S, 6S). 
 
Figure 12.  
 
3.3.4. α-Amination of β-tetralone derivatives 
Given these results, we decided to further extend the regioselective 
functionalizaiton of β-tetralones. Thus, we explored the behaviour of β-tetralones in the 
amination reaction using azodicarboxylates as acceptors under similar reaction 
conditions. 
3.3.4.1. Catalyst screening 
Initially the reaction between β-tetralone 49B and di-tert-butyl azodicarboxylate 
(50) was taken as a model to find the optimum Brønsted base catalyst for the reaction to 
afford α-amino β-tetralones in a stereoselective manner (Table 19). We began by 
comparing catalysts C7, C9 and C26 in order to determine the most suited H-bond 
donor group for the reaction. In a first run, reaction with squaramide catalyst C7154a 
afforded the desired adduct 52B in complete regioselectivity and good yield, but low 
stereoselectivity. Unexpectedly, using the parent thiourea C9155 no addition product was 
2 
4 
1 
3 
6 
5 
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observed even after 24 h. The use of urea C26179 in the reaction allowed to shorten the 
reaction times, but low enantioselectivity was obtained. On the other hand, when 
ureidopeptide C27180 was employed the reaction finished in only 10 h and in excellent 
stereoselectivity. Finally, no reaction was observed when quinine (C34) was used as the 
catalyst. 
Table 19. Catalyst screening for the reaction between 49B and 50[a] 
 
 
3.3.4.2. Reaction scope 
The study of the generality of the method was addressed by carrying out the 
reaction of β-tetralones 49B-49E and related ketone substrates 65 and 66 with 50. As 
standard reaction conditions, the ketone was dissolved in CH2Cl2 (0.5 M) and 2.0 
equivalents of 50 and 5 mol% of the catalyst C27 were added. The reaction mixture was 
stirred at 0 ºC, and after verifying that the reaction finished (TLC monitoring, 10 h), the 
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mixture was submitted to flash column chromatography on silica gel eluting with 
hexane/EtOAc mixtures. 
As the results in Table 20 show, the reaction proceeded in good yield and 
excellent enantioselectivity with a variety of α-substituted β-tetralones (adducts 52B-
52E). Furthermore, the aromatic ring-fused cycloalkanone 67 with an oxygen 
heteroatom in the cycle was equally competent undergoing the amination reaction, 
although lower temperatures were needed in order to obtain good stereocontrol due to 
the higher reactivity of the nucleophile as compared to β-tetralones. On the other hand, 
reaction with the 7-membered ring cycloalkanone 66 did not happen, even after 24 h at 
room temperature. Importantly, no addition at the α’-carbon was observed in any of the 
cases. 
Table 20. α-Amination reaction of β-tetralones and related ketone substrates[a] 
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3.4. Conclusions 
In summary, the highly stereoselective generation of tetrasubstituted carbon 
stereocenters at Cα of several enolizable carbonyl compounds has been realized via 
bifunctional Brønsted base-catalyzed Michael reaction. 
 On the one hand the addition of oxazolones with differently substituted α’-oxy 
enones as key enoate surrogates has been preformed and it was demonstrated that the 
resulting α’-oxy ketone adducts can be smoothly converted into the corresponding 
carboxylic acid through simple oxidative cleavage of the ketol unit. 
In addition, a set of novel catalysts were developed for the 1,6-addition reaction 
of oxazolones and cyanoacetates to α’-oxy dienones, obtaining the desired adducts in 
good yield and virtually perfect regioselectivity using chiral guanidines as catalysts. 
Unfortunately, low enantioselectivity was obtained in all cases. 
On the other hand, the asymmetric Brønsted base-catalyzed regio-, diastereo- 
and enantioselective functionalization of cyclic unactivated ketones (not bearing a 
strongly EWG at α-carbon) has been studied. In this context, the α-functionalization of 
cyclic α-alkenyl ketones was achieved in a highly diastereo- and enantioselective 
manner and with complete regioselectivity, leading to the formation of quaternary 
carbon stereocenters at Cα. Furthermore, some possibilities for the transformation of 
these adducts were explored. 
Moreover, the method was successfully extended to the α-functionalization of β-
tetralone derivatives. Once again the reaction proceeded with complete regioselectivity, 
obtaining exclusively the α-substitution adducts in high diastereo- and 
enantioselectivity, and leading to the formation of either a tri- or tetrasubstituted 
stereogenic carbon atom. In addition, the synthetic utility of the method was 
demonstrated by easy transformation of adducts into diverse polycyclic compounds 
featuring up to six contiguous stereogenic centers. 
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Synthesis of arogenate by dearomatising cyclisation of a L-
tyrosine derivative 
4.1. Arogenate: Origin, structure and interest 
Arogenate [L-(8S)-β-(carboxy-4-hydroxy-2,5-cyclohexadien-1-yl)alanine]2– is a 
precursor in the biosynthesis of aromatic amino acids (AAA) in some 
microorganisms192 and plants.193 Although it is an immediate precursor of L-
phenylalanine and L-tyrosine in the shikimate pathway, organisms can alternatively 
obtain these amino acids through the phenylpyruvate route, as shown in Scheme 1.194 
Unlike in plants, pathways for the synthesis of AAA are inexistent in animals, 
and therefore enzymes involved in their biosynthesis are usual targets for the 
development of safe herbicides. Indeed, depending on the exact plant species, either one 
or both arogenate and phenylpyruvate routes are used to produce AAA, and thus this 
metabolic diversity might provide a source for discriminative herbicides through the 
selective inhibition of one of the pathways. In this context, herbicides structurally 
related to arogenate could inhibit either arogenate dehydrogenase (ADH) or arogenate 
dehydratase (ADT) (Scheme 1). 
                                                 
192 Selected examples: S. L. Stenmark, D. L. Pierson, G. I. Glover, R. A. Jensen, Nature (London) 1974, 
247, 290–292. b) S. L. Stenmark, D. L. Pierson, G. I. Glover, R. A. Jensen, Nature (London) 1974, 254, 
667–671. c) A. M. Fazel, R. A. Jensen, J. Bacteriol. 1979, 138, 805–815. d) R. Borde, D. Birnbaum, 
Biochem. Physiol. Pflanzen. 1978, 173, 44–49. 
193 Selected examples: N. Patel, S. Stenmark-Cox, R. A. Jensen, J. Biol. Chem. 1978, 253, 2972–2978. b) 
E. Jung, L. O. Zamir, R. A Jensen, Proc. Natl. Acad. Sci. USA 1986, 83, 7231–7245. 
194 H. Maeda, N. Dudareva, Annu. Rev. Plant Biol. 2012, 63, 73–105. 
Chapter 4 
150 
 
 
Scheme 1.  
Arogenate presents a chirality axis located in the future aromatic ring in addition 
to the stereocenter at Cα of natural α-amino acids, making it a small but rather complex 
molecule. Furthermore, the free acid (arogenic acid; see Scheme 1) is highly unstable 
and it is quantitatively transformed into L-phenylalanine,195 and arogenate salts are 
stable at pH 7.5 in the solid state, but decompose when exposed to heat or to a strong 
base.196 
 
  
                                                 
195 L. O. Zamir, R. A. Jensen, B. H. Arison, A. W. Douglas, G. Albers-Schönberg, J. R. Bowen, J. Am. 
Chem. Soc. 1980, 102, 4499–4504. 
196 M. J. Crossley, R. C. Reid, J. Chem. Soc., Chem. Commun. 1994, 2237–2238. 
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4.2. Previous approaches towards the synthesis of arogenate 
In light of the precarious stability of arogenate along with its difficult isolation 
from natural sources,195 a total synthesis seems to be a more appropriate alternative for 
the obtainment of arogenate and its structural analogues. Surprisingly, however, 
arogenate has received little synthetic attention, with only two published syntheses. 
In 1981 Danishefsky and coworkers197 described the first total synthesis of 
arogenate starting from a glutamic acid derivative in 8 steps, via a key Diels-Alder 
reaction (Scheme 2). However, the yield of the final step was not reported. 
 
Scheme 2.  
On the other hand, Crossley and Reid196 performed its synthesis in 7 steps in an 
overall 2.8% yield from methyl 2,5-diene-1-carboxylate through a key Michael addition 
and resolution (Scheme 3). 
                                                 
197 S. Danishefsky, J. Morris, L. A. Clizbe, J. Am. Chem. Soc. 1981, 103, 1602–1604. 
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Scheme 3.  
In both approaches, the diastereoselective reduction of a cyclohexadienone 
spyrolactam intermediate is the key step for the formation of the chirality axis of the 
cyclohexadiene ring present in arogenate, and in both cases a mixture of diastereomers 
is formed. 
Surprisingly, neither of these syntheses employ the obvious starting material to 
arogenate: tyrosine itself. 
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4.3. Group precedents and objectives 
Previous work in the Clayden group in the context of another project involving a 
development of Seebach’s self-regeneration of stereocenters198 explored the coupling of 
tyrosine-derived carbamoyl chloride 71 with N-methylaniline to form the corresponding 
urea. However, the alternative spirocyclic imidazolidinone 72 was obtained in high 
yield instead (Scheme 4). The intramolecular nucleophilic dearomatizing 
spirocyclisation reaction seemingly proceeds through the formation of a carbamoyl 
iodide intermediate, as low yield was obtained in the absence of the iodine salt. The 
spirocyclisation of the diastereomeric isomer of 71 was also attempted but no reaction 
was observed, most probably because the steric hindrance of the tert-butyl group 
avoided the approach of the phenol ring to the carbamoyl group.  
 
 
Scheme 4.  
Compound 72 is structurally closely related to the spirocyclic lactam 
intermediates described in the previously reported synthetic methods (see Scheme 2 and 
Scheme 3), and therefore it was thought that the dearomatising spirocyclisation reaction 
may open a pathway for the synthesis of arogenate and related compounds from the 
natural amino acid L-tyrosine, inverting the biological path for AAA metabolism 
(Scheme 5). 
                                                 
198 For a review see: D. Seebach, A. R. Sting, M. Hoffmann, Angew. Chem. Int. Ed. Engl. 1996, 35, 
2708–2748. 
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Scheme 5.  
The Luche reduction of compound 72 was performed before this stay, affording 
a 3:1 diastereomeric mixture of alcohol 73 in moderate yield (Scheme 6). Unfortunately, 
attempts to hydrolyse the three C–N bonds in the product under acid conditions without 
compromising the integrity of the fragile cyclohexadienone to afford arogenate were 
unsuccessful. 
 
Scheme 6.  
In light of this result, alternative synthetic pathways were proposed involving 
alternative heterocyclic structures, namely oxazolidinone and hydantoin, that may make 
feasible the use of milder hydrolysis conditions leading to arogenate (Figure 1). 
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Figure 1.  
A preparatory work on the formation of the oxazolidinone structure from L-
tyrosine was carried out in the Clayden group by L. Eagling (Scheme 7). O-tert-Butyl-
L-tyrosine was condensed with benzaldehyde forming the imine, which upon reaction 
with benzoyl chloride afforded the N-benzoyl substituted oxazolidinone in low yield. 
 
Scheme 7.  
On the other hand, in a preliminary work with the hydantoin structure, L. 
Eagling achieved the synthesis of hydantoin 75, which possessed the carbamoyl 
chloride moiety, from L-tyrosine methyl ester (Scheme 8). O-TBS L-tyrosine methyl 
ester was reacted with tert-butyl isocyanate to form the corresponding urea, and it was 
then treated with potassium tert-butoxyde to form hydantoin 74 in moderate yield. 
Finally, reaction with triphosgene afforded the N-substituted hydantoin 75 in low yield. 
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Scheme 8.  
At the outset of this doctoral stay, the development of a reproducible method for 
the synthesis of modifiable spirocyclic compounds that could subsequently be reduced 
and hydrolysed leading to arogenate was a priority, as it was essential for the posterior 
preparation of arogenate-based potential herbicides (Figure 2). 
 
Figure 2.  
With this aim, the series of possible synthetic routes described below were 
proposed. 
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4.4. Synthetic plan 
The synthesis of arogenate through oxazolidinone intermediates was taken as the 
first alternative, following the preliminary work carried out in the Clayden group (see 
Scheme 7). However, at the outset two main challenges of this synthetic route were 
patent: i) the formation and isolation of an N-carbamoyl oxazolidinone (Scheme 9, step 
1); and ii) the yet unrealised dearomatising spirocyclisation of this oxazolidinone 
intermediate (Scheme 9, step 2). 
 
Scheme 9.  
On the other hand, further exploration on the hydrolysis of spirocyclic 
imidazolidinone 73 was taken as a second option, this time under basic conditions given 
the low stability of arogenate at low pH (Scheme 10). 
 
Scheme 10.  
In addition, the importance of the cyclic imidazolidinone structure for the 
stabilization of the carbamoyl moiety and the spirocyclisation reaction was also 
investigated by comparison with the parent acyclic ester and amide (Figure 3). 
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Figure 3.  
Finally, the suitability of the hydantoin structure for the spirocyclisation reaction 
was addressed. The main challenge here was finding a suitable protecting group for the 
phenol functionality that would ideally be automatically cleaved during the 
spirocyclisation step, or alternatively in a previous step without affecting the integrity of 
the carbamoyl chloride moiety (Scheme 11). 
 
Scheme 11.  
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4.5. Results and discussion 
4.5.1. Oxazolidinone route 
In a first try, O-unprotected L-tyrosine was tested following the preliminary 
experiments on the oxazolidinone route in an attempt to avoid an additional 
deprotection step prior to the spirocyclisation. With that aim, l-tyrosine was condensed 
with benzaldehyde affording imine 76 in excellent yield. Unfortunately, when imine 76 
was submitted to the reaction conditions previously used for the preparation of 
oxazolidinones, a complex mixture of unknown compounds was obtained (Scheme 12). 
In a first instance it was assumed to be due to the participation of the unprotected 
phenol group in the reaction. 
 
Scheme 12.  
Next, imine 77 was prepared in good yield from the commercially available O-
methyl L-tyrosine for its reaction with a number of active carbonyl compounds to afford 
the corresponding N-carbonyl oxazolidinones (Scheme 13). In a first run, the imine was 
reacted with phosgene, but instead of the expected N-carbamoyl chloride substituted 
oxazolidinone, NCA (N-carboxyanhydride) 78 was isolated as the major product in low 
yield. In a second run, 4-nitrophenyl chloroformate was used instead of phosgene, but a 
complex product mixture was obtained, and no formation of the desired oxazolidinone 
product was observed. At this point, the reaction was repeated with benzoyl chloride in 
order to ensure the reproducibility of the reaction performed in the preliminary work 
(see Scheme 7), affording the oxazolidinone 79 in good yield. On the other hand, when 
1,1’-carbonyldiimidazole (DCI) was used instead of a an acyl chloride, no reaction was 
observed, even after 24 h at room temperature. Finally, in the reaction with N,N’-
disuccinimidyl carbonate (DSC), the unstable compound 80 was isolated as the major 
product in low yield. This result suggested that the reaction was not proceeding as 
expected because in most cases the addition to the electrophile occurred through the 
oxygen atom at the carboxylic salt instead of the nitrogen of the imine, therefore 
rendering impossible the formation of the oxazolidinone. 
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Scheme 13.  
In light of these results, the oxazolidinone route was discarded as a viable option 
for the synthesis of arogenate. 
 
4.5.2. Imidazolidinone route 
As stated in the group precedents of section 4.3, the spirocyclisation reaction 
using imidazolidinone 71 had previously been performed in the Clayden group and only 
the final hydrolysis step was lacking. Therefore, polycyclic compound 73 was 
synthesised following the previously established procedure from a small amount of O-
benzyl imidazolidinone 81 provided by L. Eagling (Scheme 14). Deprotection of 81 
with H2/Pd in THF afforded the desired unprotected alcohol 71 without observing 
reduction of the acyl choride, and it was subsequently cyclised to afford dienone 72 in 
high yield. The posterior Luche reduction afforded the corresponding alcohol as a 3:1 
mixture of diastereomers 73:73’ in good overall yield. 
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Scheme 14.  
The major isomer 73 was then submitted to hydrolysis. In order to avoid acid 
reaction conditions, which would compromise the integrity of arogenate, a set of basic 
hydrolysis conditions were tested for the cleavage of the C–N bonds (Scheme 15). In a 
first attempt, hydrolysis with sodium hydroxide and sodium carbonate in ethanol at 70 
ºC afforded a complex product mixture, in which no traces of arogenate were found by 
1H NMR. In a second run, reaction with triton B (benzyltrimethylammonium hydroxide) 
and sodium hydroxide in a water and THF mixture afforded similar results. 
Triethylamine was also tested as a base for hydrolysis, but no reaction occurred. 
Similarly, no change was observed in the reaction mixture when 73 was treated with 
lithium hydroxide or sodium hydroxide at room temperature. The treatment with 
sodium methoxide in methanol did not lead to any transformation either. On the other 
hand, when oxazolidinone 73 was treated with barium hydroxide in a dioxane / water 
mixture at 90 ºC, peaks matching the ones expected for arogenate were observed by 1H 
NMR. 
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Scheme 15.  
An initial attempt for the purification of arogenate was performed employing 
Sephadex A-25 ion exchange resin (chlorine form), but no separation of the reaction 
products was achieved. In a second trial arogenate (70) was purified by reverse phase 
column chromatography eluting with TFA / MeCN mixtures, obtaining traces of the 
desired compound. The chemical shifts observed in the 1H NMR (400 MHz) spectra 
(Figure 4) were consistent with the data found in the literature,199 thus confirming the 
formation of arogenate (70) and the configuration of intermediate 73. 
                                                 
199 S. Danishefsky, J. Morris, L. A. Clizbe, J. Am. Chem. Soc. 1981, 103, 1602-1604. 
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Figure 4.  
Interestingly, a posterior thorough study by L. Eagling in the Clayden group 
revealed that spiro-arogenate (69),200 which is the product from the penultimate step in 
Danishefsky’s synthesis of arogenate (see Scheme 2 in page 151), was the main product 
of this reaction, therefore further supporting the validity of this route for the synthesis of 
arogenate (Scheme 16). 
 
Scheme 16. Last setp of Danishefsky’s synthesis of arogenate 
The study of the imidazoline route is still ongoing in the Clayden group. 
  
                                                 
200 L. O. Zamir, R. Tiberio, E. Jung, R. Jensen, J. Biol. Chem. 1983, 258, 6486–6491. 
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4.5.3. Acyclic route 
As no investigation on the use of acyclic molecules for the spirocyclisation 
reaction had been performed, we set out to synthesise the ester and amide analogues of 
imidazolidinone 71 to determine whether the cyclic structure offered any real 
advantages for the synthesis of arogenate (Figure 5). 
 
Figure 5.  
We started by attempting to prepare the ester (Scheme 17), and in a first step the 
commercially available O-benzyl-L-tyrosine methyl ester was submitted to reductive 
amination with trimethylacetaldehyde, affording amine 82 in moderate yield. However, 
when the insertion of the N-carbamoyl chloride functionality was attempted employing 
the reaction conditions previously used for imidazolidinone 71, NCA 83 was obtained 
instead of the desired acyclic ester. 
 
Scheme 17.  
Next, the preparation of the amide was addressed. The readily available Boc-O-
benzyl-L-tyrosine hydroxysuccinimide ester was reacted with dimethylamine affording 
amide 84, and subsequently decarboxylated affording the unprotected amine 85 
quantitatively. The reductive amination with trimethylacetaldehyde afforded compound 
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86 in moderate yield, which was submitted to the same N-funtionalization conditions 
used for imidazolidinone 71. Unfortunately, although untreated 1H NMR aliquots of the 
reaction looked promising, only NCA 83 was isolated upon purification by silica gel 
column chromatography.  
 
Scheme 18.  
In light of these results, we could conclude that the rigidity of the cyclic 
structure of imidazolidinone provides the essential stability that mantains the carbamoyl 
chloride functionality intact under isolation or mild reaction conditions. 
 
4.5.4. Hydantoin route 
As stated in the group precedents of Section 0, hydantoin 75 had previously been 
synthesised in the Clayden group. Therefore, it was prepared following the previously 
established procedure from a small amount of O-TBS hydantoin 74 provided by L. 
Eagling in moderate yield. The dearomatising cyclisation reaction was then attempted 
with the O-TBS protected compound 75, but no reaction occurred, as shown in Scheme 
19. 
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Scheme 19.  
In consequence, the desilylation of 75 was addressed, as it was expected that the 
free alcohol would be able to undergo the intramolecular spirocyclisation reaction. 
Unfortunately, the carbamoyl moiety exhibited a higher reactivity than the TBS group, 
and therefore the selective deprotection of the alcohol could not be performed (Scheme 
20). Indeed, when 75 was treated with TBAF (tetrabutylammonium fluoride), the N-
unsubstituted hydantoin 87 was obtained in moderate yield. In a second run, HCl in 
Et2O was employed, but no reaction was observed. On the other hand, when HCl in 
MeOH was used, the product resulting from the nucleophilic addition of methanol to the 
carbamoyl group (88) was obtained. Despite having a worse leaving group than its 
precursor, as the phenol group was now unprotected, the spirocyclisation of compound 
88 was attempted in toluene at 100 ºC, but no reaction was observed even after 24 h. 
 
Scheme 20.  
In order to allow the deprotection of the phenol group without compromising the 
integrity of the carbamoyl moiety, the use of an O-benzyl substituted intermediate was 
besought based on the previous work with imidazolidinones (see Scheme 14). Thus, 
compound 91 was synthesised in three steps starting from the commercially available 
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O-benzyl-L-tyrosine methyl ester (Scheme 21). First, urea 89 was formed reacting the 
starting amine hydrochloride with tert-butyl isocyanate, and it was then reacted with 
potassium tert-butoxyde to form hydantoin 90 in moderate yield. Reaction with 
triphosgene afforded the N-substituted hydantoin 91 in low yield. As expected, the 
deportection of the alcohol with H2/Pd in THF proceeded smoothly affording hydantoin 
92 as the major product in moderate yield. 
 
Scheme 21.  
The dearomatising cyclisation of 92 was not attempted within the stay in the 
Clayden group. 
 
4.6. Conclusions 
In summary, oxazolidinones, imidazolidinones and hydantoins have been 
studied as intermediates for the synthesis of arogenate via an intramolecular 
dearomatising cyclisation reaction starting from the natural amino acid L-tyrosine. 
During the investigation, it was shown that the oxazolidinone route was not suitable for 
the formation of the necessary N-carbonyl substituted intermediates, and important 
advances were made in the hydantoin route. Furthermore, the importance of the cyclic 
structure of intermediates for the stabilization of the carbamoyl chloride functionality 
was demonstrated, and the total synthesis of arogenate was achieved for the first time 
employing imidazolidinone intermediates. 
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Experimental section 
5.1. Material and techniques 
5.1.1. Reagents and solvents 
Reagents were purchased from different commercial suppliers (Aldrich, Acros, 
Alfa Aesar, Fluka, TCI, Merck, Fluorochem, etc.), stored as specified by the 
manufacturer and used without previous purification unless otherwise stated. 
Triethylamine, DBU, DIPA and DIPEA were purified by distillation. Liquid 
aldehydes were purified by distillation before usage and stored in the fridge at –30 ºC 
under nitrogen. 
When anhydrous solvents were required, they were dried following established 
procedures.201 Dichloromethane was dried over CaH2, and diethyl ether and 
tetrahydrofuran were dried by filtration through activated alumina (powder ≈ 150 mesh, 
pore size 58 Å, basic, Sigma aldrich) columns. 
 
5.1.2. General experimental 
All non-aqueous reactions were performed under inhert atmosphere using oven-
dried glassware and were magnetically stirred. Yields refer to chromatographically 
purified and spectroscopically pure compounds, unless otherwise stated. 
Heat requiring reactions were performed using a hotplate with a sand bath and a 
condenser. Reactions requiring low temperatures were performed using cooling bath 
circulators Huber T100E and acetone or isopropanol baths. 
Organic layers washed with aqueous phases were dried over MgSO4 or Na2SO4 
and filtered through cotton. 
Organic solvents were evaporated under reduced pressure using rotavapors 
Büchi R-110, R-200 and R-210, the latter equipped with a Büchi V-700 vacuum pump 
and a Büchi V-850 vacuum controller, appropriate for the evaporation of solvents when 
products were volatile compounds. For the complete removal of solvents vacuum pump 
Telstar Top-3 (~0.5 mmHg) was employed. 
                                                 
201 Armarego, W. L. F.; Perrin, D. D. Purification of laboratory Chemicals 3rd Edition Butterworth-
Heinemann, Oxford 1988. 
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5.1.3. Chromatography 
Reactions and flash chromatographic columns were monitored by thin layer 
chromatography (TLC) using Merck silica gel 60 F254 plates and visualized by 
fluorescence quenching under UV light, Fisher Bioblock lamp VL-4LC, λ = 254 and 
365 nm. In addition, TLC plates were stained with a dipping solution of potassium 
permanganate (1 g) in 100 ml of water (limited lifetime), followed by heating.  
Chromatographic purification was performed on Merck ROCC 60 silica gel 40-
63 μm as stationary phase and a suitable mixture of solvents (typically hexane/ethyl 
acetate, pentane/diethyl ether or dichloromethane/methanol) as eluent. 
 
5.1.4. Optical rotation 
Optical rotations were recorded using a Jasco P-2000 polarimeter; specific 
rotation (SR) ([α]D) are reported in 10-1 deg∙cm2∙g-1; concentrations (c) are quoted in 
g/100 mL; D refers to the D-line of sodium (589 nm); temperatures (T) are given in 
degree Celsius (°C). 
 
5.1.5. Melting points 
Melting points were determined in open capillaries in a Stuart SHP3 melting 
point apparatus and microscope and were uncorrected. 
 
5.1.6. NMR spectra 
NMR spectra were recorded using a Bruker Avance 300 (300 MHz for 1H, 75 
MHz for 13C) spectrometer, Bruker 400 spectrometer (400 MHz for 1H, 100 MHz for 
13C), Varian 400 MR (400 MHz for 1H, 100 MHz for 13C) or Bruker AV-500 
spectrometer (500 MHz for 1H, 125 MHz for 13C). Chemical shifts (δ) are quoted in 
parts per million referenced to the residual solvent peak, usually CDCl3, 
1H (δ = 7.26) 
and 13C (δ = 77.0). The multiplicity of each signal is designated using the following 
abbreviations: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; brs, broad singlet. 
Coupling constants (J) are reported in Hertz (Hz). 
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MestrReNova Mnova 8.1 program was used to process and edit the registered 
spectra. 
 
5.1.7. Mass spectra 
MS spectra were recorded on an ESI-ion trap Mass spectrometer (Agilent 1100 
series LC/MSD, SL model) on a UPLC-DAD-QTOF, Ultra High Performance Liquid 
Chromatography-Mass spectrometer, Waters UPLC ACQUITY, Waters PDA detector, 
Waters Sunapt G2 or on an Agilent Thermoquest LCT spectrometer. Mass spectrometry 
analyses were performed in the General Research Service (SGIker) of the University of 
the Basque Country (UPV/EHU) or in the Chemistry School in the University of 
Bristol. 
 
5.1.8. Infrared spectra 
Infrared spectra were recorded on a Bruker Alpha FT-IR spectrometer as a thin 
film. 
 
5.1.9. Determination of enantiomeric excesses 
Enantiomeric excesses were determined using analytical high performance 
liquid chromatography (HPLC) performed on either a Waters 600 (equipped with 
Photodiode Array Detector Waters 2996). The used columns were Chiralpack AD-H, 
AY-H, IA, IB and IC; and flow/solvent conditions are given for each compound.  
 
5.1.10. X-Ray diffraction analysis 
The X-ray diffraction analysis experiments were conducted in the General 
Research Service (SGIker) of the University of the Basque Country (UPV/EHU) using 
difractometers for monocrystals. 
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5.2. Preparation of catalysts 
Catalysts C11 [(DHQD)2PYR] and C34 (quinine) are commercially available 
and were purchased from commercial suppliers. The remaining catalysts were prepared 
as follows. 
 
 
5.2.1. Preparation of proline-based aminocatalysts C1-C6 
Known catalysts C1,202 C5203 and C6204 and the newly prepared catalysts C2-C4 
were prepared according to the following synthetic sequence: 
 
Preparation of (S)-1-(1-benzylpyrrolidin-2-yl)ethan-1-one 
 
                                                 
202 E. Gómez-Bengoa, S. Jiménez, I. Lapuerta, A. Mielgo, M. Oiarbide, I. Otazo, I. Velilla, S. Vera, C. 
Palomo, I. Velilla, Chem. Sci. 2012, 3, 2949–2957. 
203 E. Gómez-Bengoa, A. Landa, A. Lizarraga, A. Mielgo, M. Oiarbide, C. Palomo, I. Velilla, Chem. Sci. 
2011, 2, 353–357. 
204 M. Marigo, T. C. Wabnitz, D. Fielenbach, K. A. Jørgensen, Angewandte Chem. Int. Ed. 2005, 44, 
794–797. 
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1st step:205 Thionyl chloride (4.0 mL, 55 mmol, 1.1 equiv.) was added dropwise over 5 
min to a suspension of L-proline (5.76 g, 50 mmol, 1 equiv.) in methanol at 0 ºC, and 
the resulting solution was stirred at reflux for 1 h. Then, the solvent and excess thionly 
chloride were eliminated under reduced pressure, affording the crude product as a 
yellow oil, which was used in the next step without further purification. 
2nd step:206 Benzyl bromide (6.5 mL, 55 mmol, 1.1 equiv.) was added dropwise to a 
solution of the crude product previously obtained (8.28 g, 50 mmol, 1 equiv.) and 
DIPEA (26.1 mL, 150 mmol, 3 equiv.) in toluene (50 mL) at 0 ºC, and the resulting 
solution was stirred at reflux for 6 h. Then, the reaction mixture was cooled to 0 ºC and 
a saturated solution of NaHCO3 (40 mL) was added. The layers were separated and the 
aqueous phase was extracted with EtOAc (2 × 40 mL). The combined organic layers 
were dried over MgSO4 and the solvent was eliminated under reduced pressure to afford 
the crude (S)-1-(1-benzylpyrrolidin-2-yl)ethan-1-one as a brown oil, which was used in 
the next step without further purification. Yield: 95% (10.3 g, 47.5 mmol). All data 
were consistent with those previously reported.207 1H-NMR (300 MHz, CDCl3) δ 7.34, 
(m, 5H), 5.15 (m, 2H), 4.35 (m, 1H), 3.86-3.40 (m, 5H), 2.30 -1.80 (m, 4H). 
 
General procedure for the preparation of catalysts C1-C6 
 
1st step:208 A solution of the corresponding alkyl or aryl bromide magnesium bromide 
(3 equiv.) was added dropwise to a stirred solution of the crude ester (4.38 g, 20 mmol, 
1 equiv.) in dry THF (40 mL) at 0 ºC. The reaction mixture was let to stir at room 
temperature for 16 h before being cooled to 0 ºC to quench the reaction by adding a 
saturated solution of NH4Cl (30 mL). The resulting salts were filtered over a path of 
celite and rinsed with dichloromethane (3 × 20 mL). The combined organic phases were 
                                                 
205 P. N. Confalone, E. H. Huie, S. S. Ko, G. H. Cole, J. Org. Chem. 1988, 53, 482–487. 
206 Adapted from: K. Funabashi, M. Jachmann, M. Kanai, M. Shibasaki, Angew. Chem. Int. Ed. 2003, 42, 
5489–5492.  
207 D. Gray, C. Concellón, T. Gallagher, J. Org. Chem. 2004, 69, 4849–4851.  
208 Adapted from: K. Soai, H, Hachida, N. Yokota, J. Chem. Soc. Perkin. Trans I 1987, 1909–1914. 
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washed with brine and dried over MgSO4, and the solvent was eliminated under reduced 
pressure. The desired alcohol was purified by flash column chromatography on silica 
gel eluting with a 95:5 mixture of hexane/EtOAc. 
2nd step:202 The product resulting from the previous step and palladium on activated 
charcoal (10% wt.) (20% wt.) were stirred in EtOH (1 mL/mmol) under an hydrogen 
atmosphere. The resulting suspension was filtered over a pad of celite and the solvent 
was eliminated under reduced pressure affording the crude unprotected amine, which 
was used in the next step without further purification. 
3rd step:202 The crude product obtained in the previous step (10 mmol, 1 equiv.) was 
dissolved in dichloromethane (20 mL), and DMAP (2.43 g, 20 mmol, 2 equiv.) and the 
corresponding silyl chloride (17.5 mmol, 1.75 equiv.) were added at 0 ºC. The resulting 
solution was refluxed for 16 h, and after cooling to room temperature water (25 mL) 
was added. The layers were separated, the aqueous phase was extracted with 
dichloromethane (3 × 25 mL), and the combined organic phases were washed with a 
saturated solution of NaHCO3 (40 mL). The organic phase was then dried over MgSO4, 
and the solvent was eliminated under reduced pressure. Catalysts C1-C6 were purified 
by silica gel flash column chromatography eluting with CH2Cl2/MeOH mixtures. The 
pure product was then dissolved in dichloromethane (20 mL), washed with a saturated 
solution of NaHCO3 (20 mL) and the organic phase was dried over MgSO4. The solvent 
was eliminated under reduced pressure to afford the corresponding pure and basified 
catalyst. 
(S)-2-(2,6-Dimethyl-4-((triphenylsilyl)oxy)heptan-4-yl)pyrrolidine (C1)202 
C1 was prepared starting from L-proline according to the general 
procedure described above using iBuMgBr (2 M solution in Et2O, 30 
mL, 60 mmol) in the Grignard reaction and Ph3SiCl (5.18 g, 17.5 
mmol) in the silylation step. White solid. m. p.: 112–115 ºC. Yield 
after 5 steps: 61%. All data were consistent with those previously reported. [α]D25 = 
+20.3º (c = 1.00, CH2Cl2). 1H-NMR (300 MHz, CDCl3) δ 7.74-7.67 (m, 6H), 7.45-7.33 
(m, 9H), 3.24 (t, J = 7.4 Hz, 1H), 2.74 (dt, J1 = 6.4 Hz, J2 = 12.7 Hz, 1H), 2.69-2.60 (m, 
1H), 1.97-1.79 (m, 2H), 1.74 (dd, J1 = 5.6 Hz, J2 = 14.4 Hz, 2H), 1.59 (dd, J1 = 3.4 Hz, 
J2 = 10.9 Hz, 2H), 1.55-1.48 (m, 2H), 1.50 (bs, 1H), 1.33 (dd, J1 = 5.7 Hz, J2 = 14.2, 
2H), 0.97 (d, J = 6.6 Hz, 3H), 0.90 (d, J = 2.5 Hz, 3H), 0.88 (d, J = 2.5 Hz, 3H), 0.70 (d, 
J = 6.6 Hz, 3H). 13C-NMR (75 MHz, CDCl3) δ 137.4, 135.8, 129.3, 127.5, 84.2, 65.7, 
47.0, 44.8, 27.2, 26.3, 25.3, 25.1, 24.9, 23.8, 23.4. MS: calculated for C31H42NOSi (M + 
H+): 472.3035; found: 472.3039. 
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 (S)-2-(2,6-Dimethyl-4-((methyldiphenylsilyl)oxy)heptan-4-yl)pyrrolidine (C2) 
C2 was prepared starting from L-proline according to the general 
procedure described above using iBuMgBr (2 M solution in Et2O, 30 
mL, 60 mmol) in the Grignard reaction and MePh2SiCl (3.20 g, 17.5 
mmol) in the silylation step. Yellow oil. Yield after 5 steps: 54%. 
[α]D20 = +7.4º (c = 1.00, CH2Cl2). 1H-NMR (300 MHz, CDCl3) δ 7.61 – 7.53 (m, 4H), 
7.38 – 7.29 (m, 6H), 2.99 (t, J = 7.2 Hz, 1H), 2.79 – 2.71 (m, 1H), 2.65 – 2.55 (m, 1H), 
1.86 – 1.72 (m, 2H), 1.67 – 1.45 (m, 7H), 1.41 (dd, J = 14.1, 4.9 Hz, 1H), 0.92 (ddd, J = 
7.5, 6.6, 1.8 Hz, 12H), 0.76 (s, 3H). 13C-NMR (75 MHz, CDCl3) δ 139.7, 134.8, 129.5, 
127.9, 83.3, 66.7, 47.3, 47.0, 46.2, 27.1, 26.3, 25.7, 25.6, 25.5, 25.3, 24.4, 24.1, 1.3. 
MS: calculated for C31H42NOSi (M, H
+): C26H39NOSi (M + H
+), 410.2789; found, 
410.2868. 
(S)-2-(4-((Dimethyl(phenyl)silyl)oxy)-2,6-dimethylheptan-4-yl)pyrrolidine (C3) 
C3 was prepared starting from L-proline according to the general 
procedure described above using iBuMgBr (2 M solution in Et2O, 30 
mL, 60 mmol) in the Grignard reaction and Me2PhSiCl (2.12 g, 17.5 
mmol) in the silylation step. Yellow oil. Yield after 5 steps: 50%. 
[α]D20 = –5.2º (c = 1.00, CH2Cl2). 1H-NMR (300 MHz, CDCl3) δ 7.62 – 7.57 (m, 2H), 
7.37 – 7.32 (m, 3H), 2.94 (t, J = 7.2 Hz, 1H), 2.89 – 2.79 (m, 1H), 2.65 (dt, J = 10.5, 6.3 
Hz, 1H), 1.82 – 1.68 (m, 2H), 1.68 – 1.54 (m, 5H), 1.52 – 1.37 (m, 3H), 0.99 – 0.89 (m, 
12H), 0.44 (s, 3H), 0.43 (s, 3H). 13C-NMR (75 MHz, CDCl3) δ 140.7, 133.3, 128.9, 
127.6, 82.0, 66.4, 46.8, 46.4, 46.0, 26.5, 25.8, 25.2, 25.1, 24.9, 24.9, 24.0, 23.9, 2.1, 1.9. 
MS: calculated for C21H37NOSi (M + H
+), 348.2722; found, 348.2717. 
(S)-2-(2,6-Dimethyl-4-((trimethylsilyl)oxy)heptan-4-yl)pyrrolidine (C4) 
C4 was prepared starting from L-proline according to the general 
procedure described above using iBuMgBr (2 M solution in Et2O, 30 
mL, 60 mmol) in the Grignard reaction and Me3SiCl (3.20 mL, 17.5 
mmol) in the silylation step. Yellow oil. Yield after 5 steps: 65%. 
[α]D25 = –6.2º (c = 1.00, CH2Cl2). 1H-NMR (300 MHz, CDCl3) δ 3.55 – 3.31 (m, 2H), 
3.23 – 3.07 (m, 1H), 2.11 (tt, J = 14.1, 7.0 Hz, 6H), 2.00 – 1.89 (m, 3H), 1.82 (dd, J = 
14.0, 4.9 Hz, 1H), 1.46 – 1.24 (m, 12H), 0.54 (s, 9H). 13C-NMR (75 MHz, CDCl3) δ 
81.2, 66.5, 47.0, 46.2, 26.5, 26.0, 25.2, 25.1, 24.9, 24.9, 23.9, 3.2. MS: calculated for 
C21H37NOSi (M + H
+), C20H34NOSi (M, H+), 286.2566; found, 286.2548. 
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(S)-2-(Diphenyl((triphenylsilyl)oxy)methyl)pyrrolidine (C5)203 
C5 was prepared starting from L-proline according to the general 
procedure described above using PhMgBr (2 M solution in Et2O, 30 mL, 
60 mmol) in the Grignard reaction and Ph3SiCl (5.18 g, 17.5 mmol) in 
the silylation step. White solid. m. p.: 147–150 ºC. Yield after 5 steps: 75%. All data 
were consistent with those previously reported. [α]D25 = –24.4º (c = 1.00, CH2Cl2). 1H-
NMR (300 MHz, CDCl3) δ 7.47-7.41 (m, 8H), 7.39–7.22 (m, 11H), 7.20–7.08 (m, 6H), 
3.98 (t, J = 7.6 Hz, 1H), 2.74–2.66 (m, 1H), 2.63–2.49 (m, 1H), 1.88–1.68 (m, 1H), 
1.60–1.38 (m, 3H), 1.30 (t, J = 10.6 Hz, 1H). 13C-NMR (75 MHz, CDCl3) δ 146.3, 
145.1, 136.3, 135.1, 129.3, 129.1, 127.8, 127.4, 127.0, 126.7, 85.0, 65.3, 46.9, 28.0, 
25.0. 
(S)-2-(Diphenyl((trimethylsilyl)oxy)methyl)pyrrolidine (C6)204 
C6 was prepared starting from L-proline according to the general 
procedure described above using PhMgBr (2 M solution in Et2O, 30 mL, 
60 mmol) in the Grignard reaction and Me3SiCl (3.20 mL, 17.5 mmol) 
in the silylation step. Yellow oil. Yield after 5 steps: 78%. All data were consistent with 
those previously reported. [α]D25 = +20.3º (c = 1.00, CH2Cl2). 1H-NMR (300 MHz, 
CDCl3) δ 7.47 – 7.42 (m, 2H), 7.37 – 7.32 (m, 2H), 7.31 – 7.27 (m, 2H), 7.26 – 7.17 (m, 
4H), 4.04 (t, J = 7.4 Hz, 1H), 2.91 – 2.65 (m, 2H), 1.62 – 1.50 (m, 3H), 1.42 – 1.31 (m, 
1H), -0.10 (s, 9H). 
 
5.2.2. Preparation of squaramide-based Brønsted base catalysts 
Squaramide-based catalysts were prepared according to the following synthetic 
sequence: 
 
  
Experimental section 
 
183 
 
5.2.2.1. Preparation of catalysts C7 and C12 
 
Known catalysts C7209 and C12210 were synthesised as follows: 
Preparation of squaric ester monoamides 
 
To a solution of 3,4-dimethoxy-3-cyclobutane-1,2-dione (280 mg, 2.0 mmol) in 
MeOH (20 mL) was added the corresponding amine (2.0 mmol) and the reaction 
mixture was stirred at room temperature for 48 h. The formed precipitate was filtered 
and dried in vacuo to give the squaric ester monoamide. 
3-((3,5-bis(Trifluoromethyl)phenyl)amino)-4-methoxycyclobut-3-ene-1,2-dione211 
The title compound was prepared according to the general 
procedure described above using 3,5-
bis(trifluoromethyl)aniline (310 mg, 2.0 mmol) as the amine. 
Yield: 68% (463, 1.36 mmol). All spectroscopic data were 
identical to those reported in literature. 1H-NMR (300 MHz, DMSO-d6) δ 11.18 (s, 1H), 
8.04 (s, 2H), 7.78 (s, 1H), 4.41 (s, 3H).  
3-((3,5-bis(Trifluoromethyl)benzyl)amino)-4-methoxycyclobut-3-ene-1,2-dione212 
The title compound was prepared according to the general 
procedure described above using 3,5-
bis(trifluoromethyl)benzylamine (486 mg, 2.0 mmol) as the 
amine. Yield: 62% (438, 1.24 mmol). All spectroscopic data 
were identical to those reported in literature. 1H-NMR (300 
                                                 
209 W. Yang, D. M. Du, Org. Lett. 2010, 12, 5450–5453. 
210 J. P. Malerich, K. Hagihara, V. H. Rawal. J. Am. Chem. Soc. 2008, 130, 14416–14417. 
211 Yang, W.; Du, D. M. Org. Lett. 2010, 12, 5450–5453. 
212 J. P. Malerich, K. Hagihara, V. H. Rawal. J. Am. Chem. Soc. 2008, 130, 14416–14417. 
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MHz, DMSO-d6) δ 8.94 (br s, 1H), 7.09 (s, 2H), 7.94 (s, 1H), 4.78 (br s, 2H), 4.26 (s, 
3H). 
 
Preparation of 9-amino-(9-deoxy)epiquinine213 
 
1st step:214 A mixture of quinine (16.2 g, 50 mmol, 1 equiv.) and triethylamine (25.1 
mL, 180 mmol, 3.6 equiv.) in dry THF (250 mL) was cooled to 0 ºC and then 
methanesulfonyl chloride (7.0 mL, 90 mmol, 1.8 equiv.) was added dropwise. The 
mixture was stirred overnight at room temperature. The reaction was quenched with 
water (40 mL) and then THF was removed under vacuum. The residue was dissolved in 
dichloromethane (40 mL) and washed with water (30 mL) and a saturated solution of 
NaHCO3 (30 mL). The organic layer was dried over MgSO4, filtered and concentred 
under vacuum to afford the crude product in 96% yield, which was used in the next step 
without further purification. 
2nd step:215 The crude product (19.3 g, 48 mmol, 1 equiv.) was dissolved in DMF (150 
mL). The solution was cooled to 0 ºC and NaN3 (6.2 g, 96 mmol, 2 equiv.) was added in 
portions. The mixture was stirred at 70 ºC for 16 h and after this time the reaction was 
quenched with water (80 mL) and then ethyl acetate (150 mL) was added. The organic 
layer was separated and washed with brine (10 × 60 mL), dried over MgSO4, filtered 
and evaporated under reduced pressure to obtain the crude product in quantitative yield, 
which was used in the next step without further purification. 
                                                 
213 Adapted from: H. Brunner, J. Büegler, B. Nuber, Tetrahedron: Asymmetry, 1995, 6, 1699–1702. 
214 Adapted from: M. Zielinska-Blajet, M. Kucharska, J. Skarzewski, Synthesis, 2006, 7, 4383–4387. 
215 Adapted from: U. Sudermeier, C. Döbler, G. M. Mehltretter, W. Baumann, M. Beller, Chirality, 2003, 
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3rd step:215 The crude product  was dissolved in THF (250 mL) and PPh3 (12.6 g, 48 
mmol, 1 equiv.) was added. The reaction mixture was heated to 40 ºC and stirred until 
the gas evolution ceased (~5 h). Then H2O (8 mL) was added and the mixture was 
stirred overnight at 40 ºC. The solvent was removed under vacuum and the residue was 
dissolved in CH2Cl2 (150 mL). HCl 6M (250 mL) was added and the aqueous phase 
was separated and washed with dichloromethane (2 × 100 mL). Then the aqueous layer 
was cooled to 0 ºC and basified until pH > 10 with NaOH 40%. The aqueous phase was 
then extracted with CH2Cl2 (3 × 150 mL), dried over MgSO4 and concentrated under 
reduced pressure to afford 9-amino-(9-deoxy)epiquinine  as a yellow viscous oil. Yield: 
56% (8.7 g, 26.9 mmol). All data were consistent with those previously reported. 1H 
NMR (300 MHz, CDCl3), δ 8.75 (d, J = 4.6 Hz, 1H), 7.36–8.05 (m, 4H), 5.79 (m, 1H), 
4.97 (m, 2H), 4.57 (d, J = 10.4 Hz, 1H), 3.97 (s, 3H), 3.02–3.34 (m, 3H), 2.77 (m, 2H), 
2.27 (m, 1H), 2.08 (s, 2H), 1.26–1.63 (m, 4H), 0.80 (m, 1H). 
 
Coupling with squaric ester monoamide 
 
To a suspension of the corresponding squaric ester monoamide prepared above 
(1.0 mmol, 1 equiv.) in CH2Cl2 (5 mL) was added 9-amino-(9-deoxy)epiquinine (323 
mg, 1.0 mmol, 1 equiv.) and the reaction mixture was stirred for 48 h at room 
temperature, the solvent evaporated, and the product submitted to purification by silica 
gel column chromatography (eluting hexane/EtOAc 50:50 → 0:100). 
3-((3,5-bis(Trifluoromethyl)phenyl)amino)-4-(((S)-(6-methoxyquinolin-4-
yl)((1S,2S,4S,5R)-5-vinylquinuclidin-2-yl)methyl)amino)cyclobut-3-ene-1,2-dione 
(C7)209 
The title compound was prepared according to the 
general procedure described above from 3-((3,5-
bis(trifluoromethyl)phenyl)amino)-4-methoxycyclobut-
3-ene-1,2-dione (339 mg, 1.0 mmol). Yellow solid. m. p. 
223–225 ºC. Yield: 70% (441 mg, 0.70 mmol). All 
spectroscopic data were identical to those reported in 
literature. 1H-NMR (300 MHz, DMSO-d6) δ 9.88 (br s, 1H), 8.80 (d, J = 4.5 Hz, 1H), 
8.36 (br s, 1H), 8.04 – 7.86 (m, 3H), 7.76 (d, J = 10.0 Hz, 1H), 7.67 (d, J = 4.5 Hz, 1H), 
7.58 (s, 1H), 7.47 (d, J = 6.8 Hz, 1H), 6.19 – 5.73 (m, 2H), 5.13 – 4.92 (m, 2H), 3.95 (s, 
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3H), 3.52-3.42 (m, 1H), 3.30- 3.25 (m, 1H) 2.77 – 2.58 (m, 2H), 2.35 – 2.20 (m, 1H), 
1.60 – 1.47 (m, 4H), 0.66 (m, 1H)..  
3-((3,5-bis(Trifluoromethyl)benzyl)amino)-4-(((S)-(6-methoxyquinolin-4-
yl)((1S,2S,4S,5R)-5-vinylquinuclidin-2-yl)methyl)amino)cyclobut-3-ene-1,2-dione 
(C12)210 
The title compound was prepared according to the 
general procedure described above from 3-((3,5-
bis(Trifluoromethyl)benzyl)amino)-4-
methoxycyclobut-3-ene-1,2-dione (353 mg, 1.0 mmol, 
1 equiv.). Yield: 64% (413, 0.64 mmol). All 
spectroscopic data were identical to those reported in 
literature. 1H-NMR (500 MHz, DMSO-d6) δ 8.90 (d, J = 4.5 Hz, 1H), 8.39 (d, J = 8.3 
Hz, 1H), 7.93-8.07 (m, 5H), 7.77 (t, J = 7.5 Hz, 1H), 7.74 (br s, 1H), 7.66 (t, J = 7.7 
Hz, 1H), 7.62 (d, J = 4.4 Hz, 1H), 6.06 (brs, 1H), 5.79 (ddd, J = 17.1, 10.5, 6.5 Hz, 
1H), 5.12 (d, J = 17.2 Hz, 1H), 5.03 (d, J = 10.5 Hz, 1H), 4.82 (m, 2H), 3.27 (q, J = 
9.4 Hz, 1H), 3.07 (dd, J = 13.9, 7.1 Hz, 1H), 2.89 (t, J = 12.2 Hz, 1H), 2.81 (m, 1H), 
2.74 (dd, J = 14.4, 10.5 Hz, 1H), 2.17 (q, J = 8.0 Hz, 1H), 1.40-1.55 (m, 3H), 0.83-
0.99 (m, 2H). 
 
5.2.2.2. Preparation of catalyst C8 
Known catalyst C8216 was prepared according to the following synthetic 
sequence: 
 
1st step:217 Na2CO3 (2.12 g, 20 mmol, 2 equiv.) and Boc2O (3.3 g, 15 mmol, 1.5 equiv.) 
were added to a solution of L-tert-leucine (1.31 g, 10 mmol, 1 equiv.) in water (20 mL) 
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and THF (5 mL) at 0 ºC. After stirring for 12 h at room temperature HCl (10 %) was 
added until pH 2 and the mixture was extracted with EtOAc (3 x 30 mL). The aqueous 
phases were combined, washed with brine (50 mL) and dried over MgSO4. After 
removing the solvent under reduced pressure, the resulting residue was redissolved in 
dry DMF (20 mL) and DIPEA (2.58 g, 20 mmol, 2 equiv.) and HBTU (5.7 g, 15 mmol, 
1.5 equiv.) were added. After stirring for 1 h piperidine (0.94 g, 11 mmol, 1.1 equiv.) 
was added and the mixture was stirred for further 16 h. The reaction was quenched 
adding HCl 1 M (20 mL) and the mixture was extracted with EtOAc (2 x 20 mL). The 
organic phases were combined and washed with HCl 1 M and brine (20 mL) and dried 
over MgSO4. The solvent was then removed under reduced pressure and the resulting 
residue was purified by flash column chromatography on silica gel (eluting with 
hexane/EtOAc 8:/15) to afford tert-butyl (S)-(3,3-dimethyl-1-oxo-1-(piperidin-1-
yl)butan-2-yl)carbamate as a white solid. Yield: 82% (2.5 g, 8.3 mmol). All 
spectroscopic data were identical to those reported in the literature. 1H NMR (300 MHz, 
CDCl3) δ 0.98 (s, 9H), 1.43 (s, 9H), 1.52 – 1.62 (m, 6H), 3.46 – 3.69 (m, 4 H), 4.54 (d, J 
= 9.7 Hz, 1H), 5.38 (d, J = 9.6 Hz, 1H). 
2nd step:217 The previously obtained amide (2.5 g, 8 mmol, 1 equiv.) was dissolved in a 
mixture of CH2Cl2 (8 mL) and trifluoroacetic acid (2 mL) and stirred at 40 ºC until no 
more starting material was observed by TLC (eluting with hexane/EtOAc 70:30). The 
solvent was then removed under reduced pressure and the residue was redissolved in 
CH2Cl2 (10 mL). The solution was washed with NaOH (40 %), dried over MgSO4 and 
the solvent was removed under reduced pressure to afford the aminoamide as a yellow 
oil. The aminoamide was then dissolved in dry diethyl ether (10 mL) and was added 
dropwise over a suspension of lithium aluminiumhydride (879 mg, 24 mmol, 3 equiv.) 
in diethyl ether (40 mL) at 0 ºC under nitrogen atmosphere. The mixture was stirred at 
the same temperature for some minutes and afterwards it was stirred at room 
temperature for 16 h. The reaction was quenched by the addition of water (5 mL) and 
NaOH 15 % (1.2 mL) at 0 ºC. The resulting mixture was filtered and the filtrate was 
extracted with diethyl ether (2 x 10 mL). The combined organic layers were dried over 
MgSO4 and the solvent was eliminated under reduced pressure. The residue was 
purified by flash column chromatography on silica gel (eluting with hexane/EtOAc 1:1) 
to afford (S)-3,3-dimethyl-1-(piperidin-1-yl)butan-2-amine as yellow oil. Yield: 92% 
(1.16 g, 6.8 mmol). All spectroscopic data were identical to those reported in the 
literature. 1H NMR (500 MHz, CDCl3) δ 2.66 (dd, J = 11.0, 2.5 Hz, 1H), 2.52 (d, J = 
12.3 Hz, 4H), 2.28 (dd, J = 12.3, 2.8 Hz, 3H), 2.13 (dd, J = 12.1, 11.2 Hz, 1H), 1.61-
1.53 (m, 4H), 1.44 – 1.42 (m, 2H), 0.90 (s, 9H). 
                                                                                                                                               
217 Y. Gao, Q. Ren, L. Wang, J. Wang, Chem. Eur. J. 2010, 16, 13068–13071. 
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3rd step:216 To a solution of the diamine (780 mg, 4.6 mmol, 1 equiv.) in methanol (30 
mL) the squaric ester monoamide obtained above (1.56 g, 4.6 mmol, 1 equiv.) was 
added and the mixture was stirred until complete disappearance of the starting amide as 
monitored by TLC (16 h). The formed white precipitate was filtered and washed with 
CH2Cl2 to afford essentially pure C8 as a white solid. m. p. 246–248 ºC. Yield: 59% 
(1.29 g, 2.6 mmol). All spectroscopic data were identical to those reported in the 
literature. 1H NMR (300 MHz, CDCl3) δ 10.09 (s, 1H), 8.08 (s, 2H), 7.64 (s, 1H), 4.07 – 
3.93 (m, 1H), 2.49 – 2.04 (m, 5H), 1.51 – 1.22 (m, 6H), 0.93 (s, 9H). 
 
5.2.2.3. Preparation of catalyst C10 
Known catalyst C10218 was prepared according to the following synthetic 
sequence: 
 
1st step:219 Glutaraldehyde (50 wt% in H2O, 1.90 mL, 10.4 mmol, 1.04 equiv.) was 
added dropwise into a mixture of diamine (1.140 g, 10 mmol, 1 equiv.) and 
NaBH(OAc)3 (8.500 g, 40 mmol, 4 equiv.) in 1,2-dichloroethane (60 mL) at room 
temperature. The resulting mixture was stirred at room temperature for 3h, and 
quenched with NaOH 6 M (30 mL). The organic layer was separated and the aqueous 
layer was extracted with CH2Cl2 (3 x 30 mL). The combined organic layers were 
concentrated. The residue was then redissolved in 50 mL CH2Cl2, washed with brine 
(20 mL), dried over MgSO4, filtered, and concentrated to give the product as a yellow 
liquid. Yield: 89% (1.622 g, 8.9 mmol). All spectroscopic data were identical to those 
reported in the literature. 1H NMR (300 MHz, CDCl3) δ 2.87 – 2.68 (m, 1H), 2.67 – 
2.49 (m, 3H), 2.41 – 2.19 (m, 2H), 2.16 – 1.92 (m, 2H), 1.88 – 1.34 (m, 8H), 1.31 – 0.97 
(m, 4H). 
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2nd step:218 To a suspension of the squaric ester monoamide described above in section 
5.2.2.1 (339 mg, 1.0 mmol, 1 equiv.) in 5 mL of CH2Cl2 was added 2-(piperidin-1-
yl)cyclohexanamine (379 mg, 1.0 mmol, 1 equiv.) and the reaction mixture was stirred 
for 48 h at room temperature. After solvent evaporation the desired product was 
obtained by silica gel column chromatography (eluting with CH2Cl2/MeOH, 98:2). 
White solid. m. p. 134–136 °C. Yield: 71% (347 mg, 0.71 mmol). All spectroscopic 
data were identical to those reported in the literature. 1H NMR (300 MHz, CDCl3) δ 
7.88 (s, 2H), 7.43 (s, 1H), 4.00 – 3.80 (m, 1H), 2.66 – 2.49 (m, 2H), 2.39 – 2.14 (m, 
3H), 1.93 – 1.59 (m, 4H), 1.48 – 0.98 (m, 10H). 
 
5.2.2.4. Preparation of catalysts C13, C28 and C31-C33 
Amide group-bearing squaramide-based catalysts C13, C28 and C31-C33 were 
prepared according to the following synthetic sequence. Catalyst C31220 was previously 
described in in our group and the rest were synthesised for the first time: 
 
                                                 
220 J. Etxabe, J. Izquierdo, A. Landa, M. Oiarbide, C. Palomo, Angew. Chem. Int. Ed. 2015, 54, 6883–
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1st step: Method A:221 1-Methylimidazole (1.0 mL, 1.25 mmol, 2.5 equiv.) was added to 
a slurry of the corresponding 3-nitrobenzoic acid (5 mmol, 1 equiv.) in CH2CL2 (25 
mL) at 0 °C, and the mixture was stirred for 10 min. MsCl (0.58 mL, 7.5 mmol, 1.5 
equiv.) in CH2Cl2 (1 mL) was added to the mixture under –5 °C. After the resulting 
mixture was stirred under that temperature for 20 min and then 3,5-
bis(trifluoromethyl)aniline (0.78 mL, 5 mmol, 1 equiv.) was added. The mixture was 
stirred at room temperature for 2 h. H2O (50 mL) was then added and a solid 
precipitated, which was solved in EtOAc (50 mL). The organic layer was washed with 
brine (3 × 25 mL) and dried over anhydrous MgSO4. The solvent was evaporated under 
reduced pressure and the crude was crushed with diethyl ether to afford the desired 
amide as a white solid in quantitative yield. 
Method B: Oxalyl chloride (0.47 mL, 5.5 mmol, 1.1 equiv.) was added to a suspension 
of the corresponding 3-nitrobenzoic acid (5 mmol, 1 equiv.) in dichloromethane (5 mL) 
at 0 ºC under nitrogen atmosphere. DMF (1 drop) was then added and the mixture was 
allowed to stir at room temperature for 2 h, observing the complete dissolution of the 
solid. The resulting crude was concentrated under reduced pressure and slowly added to 
a solution of the corresponding benzylamine (5 mmol, 1 equiv.) and triethylamine (2.1 
mL, 15 mmol, 3 equiv.) in dichloromethane (15 mL) at 0 ºC under nitrogen atmosphere. 
The reaction mixture was stirred at room temperature overnight and EtOAc (30 mL) 
was added. The organic phase was washed with aqueous HCl (1 M) (2 × 30 mL) and 
brine (30 mL), dried over MgSO4 and the solvent was eliminated under reduced 
pressure affording the desired amide as a white solid in quantitative yield. 
2nd step: To a solution of the previous benzamide (5 mmol) in EtOAc (15 mL) under 
inert atmosphere, Pd/C was added (230 mg, Pd 10% in activated carbon, 10% in 
weight). The reaction mixture was stirred under H2 atmosphere (1 atm) at room 
temperature for 20 h. After that the mixture was filtered over celite and the filtrate was 
concentrated under reduced pressure to afford the hydrogenated product quantitatively, 
which was used for the preparation of the corresponding squaric ester monoamide 
without further purification. 
3rd step: To a solution of 3,4-dimethoxy-3-cyclobutane-1,2-dione (280 mg, 2.0 mmol) 
in MeOH (20 mL) was added the corresponding amine (2.0 mmol) and the reaction 
mixture was stirred at room temperature for 48 h. The formed precipitate was filtered 
and dried in vacuo to give the squaric ester monoamide. 
4th step: To a suspension of the corresponding squaric ester monoamide prepared above 
(1.0 mmol) in CH2Cl2 (5 mL) was added 9-amino-(9-deoxy)epiquinine (323 mg, 1.0 
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mmol) and the reaction mixture was stirred for 48 h at room temperature, the solvent 
evaporated, and the product submitted to purification by silica gel column 
chromatography (eluting hexane/EtOAc 50:50 → 0:100), affording the catalysts 
corresponding catalyst. 
 N-(3,5-bis(Trifluoromethyl)phenyl)-3-((2-(((S)-(6-methoxyquinolin-4-
yl)((1S,2S,4S,5R)-5-vinylquinuclidin-2-yl)methyl)amino)-3,4-dioxocyclobut-1-en-1-
yl)amino)-5-(trifluoromethyl)benzamide (C13) 
The title compound was prepared according to the 
general procedure described above starting from 3-nitro-
5-(trifluoromethyl)benzoic acid (1.2 g, 5 mmol, 1 
equiv.) and 3,5-bis(trifluoromethyl)aniline (1.1 g, 5 
mmol, 1 equiv.). Yellow solid. Yield of 4th step: 68% 
(555 mg, 0.68 mmol). 1H-NMR (300 MHz, DMSO-d6) 
δ 10.13 (s, 1H), 9.24 (s, 1H), 8.13 (d, J = 4.6 Hz, 1H), 
7.81 (s, 2H), 7.55 (s, 1H), 7.31 (d, J = 9.2 Hz, 1H), 7.21 
– 6.67 (m, 8H), 5.48 – 5.16 (m, 2H), 4.46 – 4.19 (m, 2H), 3.29 (s, 3H), 2.89 – 2.58 (m, 
3H), 2.15 – 1.90 (m, 2H), 1.61 (s, 1H), 1.08 – 0.65 (m, 4H), -0.02 (s, 1H). 13C-NMR 
(75 MHz, DMSO-d6) δ 184.6, 180.1, 168.5, 164.4, 163.0, 157.9, 147.8, 144.3, 143.1, 
142.1, 140.7, 140.3, 136.0, 131.5, 130.9, 130.5, 127.5, 125.1, 121.2, 120.0, 118.0, 
117.5, 116.8, 114.3, 101.5, 58.9, 55.7, 27.3, 26.0. MS: calculated for C40H42NO4F9 (M 
+ H+): 472.3035; found: 472.3039. 
N-(3,5-bis(trifluoromethyl)benzyl)-3-((2-(((S)-(6-methoxyquinolin-4-
yl)((1S,2S,4S,5R)-5-vinylquinuclidin-2-yl)methyl)amino)-3,4-dioxocyclobut-1-en-1-
yl)amino)-5-(trifluoromethyl)benzamide (C28) 
The title compound was prepared according to the 
general procedure described above starting from 3-nitro-
5-(trifluoromethyl)benzoic acid (1.2 g, 5 mmol, 1 
equiv.) and 3,5-bis(trifluoromethyl)benzylamine (1.2 g, 
5 mmol, 1 equiv.). Yellow solid. Yield of 4th step: 84% 
(698 mg, 0.84 mmol). 1H-NMR (300 MHz, DMSO-d6) 
δ 10.16 (s, 1H), 9.38 (t, J = 5.9 Hz, 1H), 8.80 (d, J = 4.5 
Hz, 1H), 8.30 (s, 1H), 8.11 (s, 1H), 8.02 (s, 2H), 8.01–
7.94 (m, 2H), 7.92 (t, J = 1.8 Hz, 1H), 7.84 (s, 1H), 7.75 
(d, J = 2.7 Hz, 1H), 7.66 (d, J = 4.6 Hz, 1H), 7.44 (dd, J = 9.2, 2.5 Hz, 1H), 5.97 (ddd, 
J = 17.6, 10.2, 7.7 Hz, 2H), 5.15–4.89 (m, 2H), 4.66 (d, J = 5.8 Hz, 2H), 3.95 (s, 3H), 
3.33–3.08 (m, 3H), 2.81–2.55 (m, 2H), 2.34–2.18 (m, 1H), 1.69–1.40 (m, 4H), 0.77–
0.59 (m, 1H). 13C-NMR (75 MHz, DMSO-d6) δ 184.6, 180.0, 168.4, 164.8, 163.1, 
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157.9, 147.8, 144.3, 143.1, 142.8, 142.1, 140.1, 136.0, 131.5 (q), 130.5 (q), 130.2, 
128.3, 128.3, 127.4, 125.5, 125.2, 121.9, 121.6, 120.9, 120.8, 120.8, 120.7, 117.3, 
117.3, 117.1, 114.4, 101.5, 58.9, 55.7, 42.2, 27.3, 26.0. MS: calculated for 
C41H35N5O4F9 (M + H
+): 832.2545; found: 832.2559. 
N-(3,5-bis(Trifluoromethyl)phenyl)-3-((2-(((S)-(6-methoxyquinolin-4-
yl)((1S,2S,4S,5R)-5-vinylquinuclidin-2-yl)methyl)amino)-3,4-dioxocyclobut-1-en-1-
yl)amino)benzamide (C31) 
The title compound was prepared according to the general 
procedure described above starting from 3-nitrobenzoic 
acid (840 mg, 5 mmol, 1 equiv.) and 3,5-
bis(trifluoromethyl)aniline (1.1 g, 5 mmol, 1 equiv.). 
White solid. Yield of 4th step: 68% (510 mg, 0.68 mmol). 
All spectroscopic data were identical to those reported in 
literature. 1H-NMR (300 MHz, DMSO-d6) δ 10.94 (s, 1H), 
10.16 (s, 1H), 8.80 (d, J = 4.5 Hz, 1H), 8.47 (d, J = 1.8 
Hz, 2H), 8.27 (s, 1H), 8.17 (s, 1H), 7.97 (t, J = 4.5 Hz, 3H), 7.84 (s, 1H), 7.76 (s, 1H), 
7.67 (d, J = 4.6 Hz, 1H), 7.45 (dd, J = 9.2, 2.4 Hz, 1H), 6.22–5.82 (m, 2H), 5.30–4.81 
(m, 2H), 3.96 (s, 3H), 3.56–3.06 (m, 4H), 2.85–2.55 (m, 2H), 2.28 (q, J = 8.0, 7.2 Hz, 
1H), 1.84–1.34 (m, 4H), 0.68 (s, 1H).  
N-(3,5-bis(Trifluoromethyl)benzyl)-3-((2-(((1S)-(6-methoxyquinolin-4-yl)(5-
vinylquinuclidin-2-yl)methyl)amino)-3,4-dioxocyclobut-1-en-1-
yl)amino)benzamide (C32) 
The title compound was prepared according to the general 
procedure described above starting from 3-nitrobenzoic acid 
(840 mg, 5 mmol, 1 equiv.) and 3,5-
bis(trifluoromethyl)benzylamine (1.2 g, 5 mmol, 1 equiv.). 
Yellow solid. Yield of 4th step: 90% (686 mg, 0.90 mmol). 
1H-NMR (300 MHz, DMSO-d6) δ 9.98 (s, 1H), 9.14 (s, 1H), 
8.79 (d, J = 4.5 Hz, 1H), 8.39 (s, 1H), 8.04–7.95 (m, 3H), 
7.77 (d, J = 9.0 Hz, 2H), 7.71–7.63 (m, 2H), 7.54–7.36 (m, 
3H), 6.13–5.86 (m, 2H), 5.09–4.86 (m, 2H), 4.71–4.56 (m, 
2H), 3.95 (s, 3H), 3.46 (dd, J = 18.2, 9.3 Hz, 1H), 3.19 (dd, J = 13.4, 10.1 Hz, 1H), 
2.82–2.58 (m, 2H), 2.27 (t, J = 9.1 Hz, 1H), 1.52 (t, J = 20.0 Hz, 4H). 13C-NMR (75 
MHz, DMSO-d6) δ 184.2, 179.8, 168.1, 166.2, 163.6, 157.8, 147.8, 144.3, 143.2, 142.1, 
139.0, 135.1, 131.5, 130.4, 129.9, 129.4, 128.1, 127.4, 125.1, 121.9, 121.1, 120.6, 
117.4, 114.3, 101.5, 55.7, 55.6, 42.0, 30.7, 27.3, 26.0. MS: calculated for C40H36N5O4F6 
(M + H+): 764.2671; found: 764.2676. 
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N-(3,5-bis(Trifluoromethyl)benzyl)-3-((2-(((S)-(6-methoxyquinolin-4-
yl)((1S,2S,4S,5R)-5-vinylquinuclidin-2-yl)methyl)amino)-3,4-dioxocyclobut-1-en-1-
yl)amino)-N-methylbenzamide (C33) 
The title compound was prepared according to the general 
procedure described above starting from 3-nitrobenzoic acid 
(840 mg, 5 mmol, 1 equiv.) and 3,5-
bis(trifluoromethyl)benzylmethylamine222 (1.3 g, 5 mmol, 1 
equiv.). Yellow solid. Yield of 4th step: 90% (700 mg, 0.90 
mmol). 1H-NMR (300 MHz, CDCl3) δ 8.56 (d, J = 4.1 Hz, 
1H), 7.94 (d, J = 9.2 Hz, 1H), 7.80 (s, 1H), 7.75 (d, J = 16.0 
Hz, 2H), 7.54–7.28 (m, 4H), 6.98 (s, 2H), 6.89–6.73 (m, 
1H), 6.22 (s, 1H), 5.87–5.69 (m, 1H), 5.04–4.87 (m, 2H), 
4.85–4.54 (m, 2H), 3.95 (s, 3H), 3.63–3.34 (m, 2H), 3.17 (t, J = 11.4 Hz, 1H), 2.87 (s, 
3H), 2.81–2.63 (m, 2H), 2.35–2.19 (m, 1H), 1.75–1.42 (m, 4H), 0.78–0.64 (m, 1H). 
13C-NMR (75 MHz, CDCl3) δ 183.7, 181.3, 171.5, 168.7, 163.3, 158.7, 147.2, 144.5, 
143.4, 141.0, 139.3, 138.5, 136.0, 132.2, 131.8, 131.3, 129.4, 127.9, 127.0, 124.8, 
122.6, 121.7, 121.2, 120.4, 118.7, 117.4, 114.7, 101.1, 77.2, 59.7, 55.9, 50.4, 40.7, 39.3, 
37.4, 27.4, 26.1. MS: calculated for C40H36N5O4F6 (M + H
+): 764.2671; found: 
764.2676. 
 
5.2.2.5. Preparation of catalysts C14-C17 
New catalysts C14-C17 were synthesised as follows: 
Preparation of the imidazolium chlorides 
Known imidazolium salt intermediates were prepared according to a previously 
reported synthetic sequence:223 
 
                                                 
222 Prepared following the procedure previously described: A. Arasappan et al., PCI Int. Appl. 2011, 
2011103441. 
223 T. Ma, X. Fu, C. W. Kee, L. Zong, Y. Pan, K. Huang, C. Tan, J. Am. Chem. Soc. 2011, 133, 2828–
2831. 
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1st step: Triphosgene (2.93 g, 10 mmol, 1 equiv.) was slowly added to a solution of the 
corresponding 1,2-iphenylethylenediamine (6.36 g, 30 mmol, 1 equiv.) and 
triethylamine (12.3 mL, 90 mmol, 3 equiv.) in CH2Cl2 (75 mL) at 0 ºC. The reaction 
was then stirred for 5 h at room temperature and quenched adding H2O (60 mL). The 
aqueous phase was extracted with CH2Cl2 (2 x 100 mL), and the combined organic 
phases were washed with brine, dried over MgSO4 and the solvent was evaporated 
under reduced pressure to afford the desired intermediate as a yellow solid 
quantitatively, which was subsequently used without further purification. All 
spectroscopic data were identical to those reported in the literature. 1H NMR (300 
MHz, CDCl3) δ 7.36 (d, J = 7.3 Hz, 5H), 7.31 – 7.25 (m, 5H), 5.03 (s, 2H), 4.59 (s, 2H). 
2nd step: The solid obtained in the previous step was dissolved in dry THF (45 mL) and 
it was slowly added to a suspension of NaH (2.2 g, 90 mmol, 3 equiv.) in THF (60 mL). 
The reaction mixture was stirred at room temperature for 30 min and iodomethane (6.9 
mL, 111 mmol, 3.7 equiv.) was added. After completion of the reaction (TLC 
monitoring) the resulting mixture was filtered through celite and the reaction crude was 
concentrated under reduced pressure and purified by flash column chromatography 
(hexane/EtOAc 60:40), affording the dimethylated intermediate as a white solid. Yield: 
66% (5.2g, 20 mmol). All spectroscopic data were identical to those reported in the 
literature. 1H NMR (300 MHz, CDCl3) δ 7.38 (dd, J = 5.0, 2.0 Hz, 6H), 7.18 (dt, J = 
6.1, 2.4 Hz, 4H), 4.12 (s, 2H), 2.74 (s, 6H). 
3rd step: To a solution of the previously obtained solid (5.2 g, 20 mmol, 1 equiv.) in 
toluene (130 mL) oxalyl chloride (16.8 mL, 200 mmol, 10 equiv.) was added and the 
reaction mixture was refluxed for 16 h. The solvent was eliminated under reduced 
pressure with big care to avoid contact of the compound with air and the resulting white 
solid was stored under Ar in a desiccator until it was submitted to the next step. 1H 
NMR (300 MHz, CDCl3) δ 7.61 – 7.54 (m, 4H), 7.47 – 7.41 (m, 6H), 5.30 (s, 2H), 3.21 
(s, 6H). 
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Preparation of Boc-protected diamines 
Previously known Boc-protected diamine intermediates were prepared according 
to the following synthetic sequence: 
 
1st step:224 The corresponding amino acid (50 mmol, 1 equiv.) was added to a 
suspension of NaBH4 (4.78 g, 125 mmol, 2.5 equiv.) in THF (120 mL), and the 
resulting mixture was cooled to 0 ºC before I2 (12.7 g, 50 mmol, 1 equiv.) in THF (30 
mL) was added over a 30 min period. Then, the reaction mixture was allowed to warm 
to room temperature, and after the evolution of gas ceased it was refluxed for 16 h. The 
reaction was quenched by slow addition of MeOH at 0 ºC, and the solvent was removed 
under reduced pressure. The solid residue was dissolved in KOH (20%; 100 mL), 
stirring at room temperature for 4 h and the resulting solution was extracted with 
CH2Cl2 (5 x 50 mL), the combined organic layers were dried over MgSO4 and the 
solvent was evaporated under reduced pressure to afford the corresponding 
aminoalcohol as a colourless oil, which was used in the next step without further 
purification. Yield: Cuantitative. 
2nd step:225 To a solution of the previously obtained aminoalcohol (30 mmol, 1 equiv.) 
and triethylamine (4.2 mL, 30 mmol, 1 equiv.) in THF (90 mL) Boc2O (6.54 g, 30 
mmol, 1 equiv.) was added at 0 ºC, and the resulting mixture was allowed to stir at room 
temperature for 2 h. The solvent was removed under vacuum and the solid residue was 
redissolved in EtOAc (75 mL), washed with H2O (2 x 75 mL) and brine (75 mL). The 
organic phase was then dried over MgSO4 and the solvent was evaporated under 
reduced pressure to afford the corresponding N-boc aminoalcohol, which was 
subsequently used without further purification. Yield: Cuantitative. 
3rd step:226 A solution of phthalic anhydride (3.35 g, 22.8 mmol, 1.5 equiv.), 
triphenylphosphine (11.9 g, 45 mmol, 3 equiv.) and the alcohol above obtained (15 
mmol, 1 equiv.) in dry THF (150 mL) was cooled to 0 ºC and diethylazodicarboxylate 
(DEAD; 5.95 mL, 37.5 mmol, 2.5 equiv.) was slowly added. The resulting mixture was 
                                                 
224 M. Nakamura, T. Hatakeyama, K. Hara, E. Nakamura, J. Am. Chem. Soc. 2003, 125, 6362–6363. 
225 C. Ebner, A. Pfaltz, Tetrahedron. 2011, 67, 10287–10290. 
226 C. A. Busacca, D. Grossbach, E. Spinelli, Tetrahedron: Asymmetry 2000, 11, 1907–1910. 
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let to warm to room temperature and it was stirred at the same temperature for 3 h. The 
solvent was removed under reduced pressure and the product was purified by flash 
column chromatography (eluting with hexane/EtOAc 80:20), affording the 
corresponding phthalimide as a white solid. Yield: 80–90%. 
4th step:226 Hydrazine monohydrate (2.43 mL, 50 mmol, 5 equiv.) was added to a 
solution of the previously obtained solid (10 mmol, 1 equiv.) in EtOH (85 mL) and the 
mixture was refluxed for 45 min, observing the formation of a white solid. After cooling 
to room temperature, the mixture was filtered through a pad of celite and the filtrate was 
washed with Et2O (150 mL). The liquid phase was then washed with H2O (100 mL), 
dried over MgSO4 and the solvent was evaporated under reduced pressure affording the 
Boc-protected diamine as a white solid, which was used in the next step without further 
purification. Yield: 80–85%. 
tert-Butyl (S)-(1-amino-3,3-dimethylbutan-2-yl)carbamate227 
Prepared starting from L-tert-leucine (1.8 g, 8.5 mmol). 1H NMR (300 
MHz, CDCl3) δ 4.40 (d, J = 10.3 Hz, 1H), 3.33 (td, J = 10.3, 3.1 Hz, 1H), 
2.95 (dd, J = 13.3, 3.1 Hz, 1H), 2.39 (dd, J = 13.3, 10.3 Hz, 1H), 1.45 (s, 
9H), 1.06 (bs, 2H), 0.90 (s, 9H). 
tert-Butyl (R)-(1-amino-3-methylbutan-2-yl)carbamate226 
Prepared starting from D-valine (1.6 g, 8.0 mmol).1H NMR (300 MHz, 
CDCl3) δ 4.54 (s, 0H), 3.39 (s, 0H), 2.83 (dd, J = 13.2, 4.3 Hz, 1H), 2.65 
(dd, J = 13.2, 7.8 Hz, 1H), 1.78 (dq, J = 13.4, 6.7 Hz, 1H), 1.48 (s, 6H), 
0.96 (d, J = 6.8 Hz, 3H), 0.93 (d, J = 6.8 Hz, 3H). 
tert-Butyl (S)-(1-amino-3-phenylpropan-2-yl)carbamate228 
Prepared starting from L-phenylalanine (2.1 g, 8.4 mmol).1H NMR 
(300 MHz, CDCl3) δ 7.34 – 7.09 (m, 5H), 4.66 (bs, 1H), 3.86 – 3.72 (m, 
1H), 2.83 – 2.56 (m, 4H), 1.41 (s, 9H), 1.17 (bs, 2H). 
 
  
                                                 
227 H. Cho et al., PCI Int. Appl. 2002, 2002014324. 
228 G. Kokotos, V. Constantinou-Kokotou, J. Chem. Res. 1992, 12, 391. 
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Preparation of catalysts C14-C17 
 
1st step: A solution of the above prepared amine (1 mmol, 1 equiv.) in CH2Cl2 (2 mL) 
was added to a solution of the previously obtained imidazolium salt (1.5 mmol, 1.5 
equiv.) in CH2Cl2 (5 mL) and TEA (1.25 mL, 9 mmol, 9 equiv.) was added to the 
resulting solution. The reaction mixture was stirred at room temperature for 5 h making 
sure that the reaction media remained basic, and then the reaction was quenched by 
adding HCL 3 M. The aqueous phase was extracted with CH2Cl2 (3 x 10 mL) and the 
combined organic layer was dried over MgSO4 and the solvent was evaporated under 
reduced pressure to afford the crude product, which was subsequently purified by flash 
column chromatography (CH2Cl2/MeOH 90:10) affording the pure product as a viscous 
oil. Yield: 60–70%. 
2nd step: The guanidine above obtained (0.6 mmol) was dissolved in TFA and the 
resulting solution was stirred at room temperature for 2 h. The solvent was then 
removed under reduced pressure and the residue was redissolved in CH2Cl2 (5 mL). The 
solution was washed with NaOH 2 M (5 mL) and dried over MgSO4, and the solvent 
was evaporated under reduced pressure to afford the crude product, which was used in 
the next step without further purification. Yield: Cuantitative. 
3rd step: To a suspension of the squaric ester monoamide prepared above (Section 
5.2.2.1, 170 mg, 0.5 mmol, 1 equiv.) in CH2Cl2 (5 mL) was added the previously 
obtained amine (0.5 mmol, 1 equiv.) and the reaction mixture was stirred for 48 h at 
room temperature, the solvent evaporated, and the product submitted to purification by 
silica gel column chromatography (eluting CH2Cl2/MeOH 95:5). 
Chapter 5 
198 
 
3-((3,5-bis(Trifluoromethyl)phenyl)amino)-4-(((S)-1-(((4S,5S)-1,3-dimethyl-4,5-
diphenylimidazolidin-2-ylidene)amino)-3,3-dimethylbutan-2-yl)amino)cyclobut-3-
ene 1,2-dione (C14) 
The title compound was prepared from tert-
butyl (S)-(1-amino-3,3-dimethylbutan-2-
yl)carbamate (182 mg, 0.5 mmol) and the S,S-
imidazolium salt. Yellow solid. m. p. = 137–141 
ºC. Yield: 15%, (50 mg, 0.075 mmol). [α]D23= 
+30.7º (c = 0.5, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 8.07 (s, 2H), 7.49 – 7.08 (m, 
11H), 4.39 (d, J = 15.7 Hz, 1H), 4.17 (t, J = 24.9 Hz, 2H), 4.05 – 3.70 (m, 1H), 3.05 – 
2.70 (m, 6H), 1.10 (s, 9H). 13C NMR (75 MHz, CDCl3) δ 185.4, 180.1, 169.5, 165.1, 
160.7, 141.1, 135.4, 135.0, 132.2, 129.7, 129.5, 126.8, 125.0, 121.3, 118.2, 115.3, 77.2, 
75.9, 73.1, 63.8, 42.9, 36.1, 26.4. MS: calculated for C35H36N5O2F6 (M + H
+), 
672.2773; found, 672.2775. 
3-((3,5-bis(Trifluoromethyl)phenyl)amino)-4-(((S)-1-(((4R,5R)-1,3-dimethyl-4,5-
diphenylimidazolidin-2-ylidene)amino)-3,3-dimethylbutan-2-yl)amino)cyclobut-3-
ene-1,2-dione (C15) 
The title compound was prepared from tert-
butyl (S)-(1-amino-3,3-dimethylbutan-2-
yl)carbamate (182 mg, 0.5 mmol) and the R,R-
imidazolium salt. Yellow solid. m. p. = 162–165 
ºC. Yield: 70%, (235 mg, 0.35 mmol). [α]D24= –
25.0º (c = 1, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 8.17 (s, 2H), 7.46 – 7.26 (m, 7H), 
7.11 (dd, J = 22.0, 7.9 Hz, 4H), 4.34 (s, 1H), 4.30 – 4.18 (m, 1H), 4.08 – 3.97 (m, 1H), 
3.96 – 3.82 (m, 1H), 3.00 (s, 6H), 2.85 (s, 1H), 2.72 – 2.63 (m, 1H), 1.12 (s, 9H). 13C 
NMR (75 MHz, CDCl3) δ 186.1, 180.8, 170.2, 165.7, 161.4, 141.8, 136.1, 135.7, 132.9, 
130.4, 130.2, 127.5, 125.6, 122.0, 118.9, 115.9, 77.9, 76.6, 73.8, 64.5, 43.6, 36.8, 27.1. 
MS: calculated for C35H36N5O2F6 (M + H
+), 672.2773; found, 672.2775. 
3-((3,5-bis(trifluoromethyl)phenyl)amino)-4-(((S)-1-(((4R,5R)-1,3-dimethyl-4,5-
diphenylimidazolidin-2-ylidene)amino)-3-phenylpropan-2-yl)amino)cyclobut-3-
ene-1,2-dione (C16) 
The title compound was prepared from tert-
Butyl (S)-(1-amino-3-phenylpropan-2-
yl)carbamate (202 mg, 0.5 mmol) and the R,R-
imidazolium salt. Yellow solid. m. p. = 140–145 
ºC. Yield: 84%, (296 mg, 0.42 mmol). [α]D24= 
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9.2º (c = 1, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 8.19 (s, 1H), 7.48 – 7.08 (m, 15H), 
6.81 (s, 2H), 4.68 (bs, 1H), 4.48 (bs, 1H), 4.34 – 4.19 (m, 1H), 4.05 (bs, 1H), 3.90 – 
3.78 (m, 1H), 3.36 – 3.06 (m, 1H), 2.86 (s,3H), 2.58 (s, 3H), 1.38 – 1.19 (m, 2H), 0.96 – 
0.78 (m, 1H). 13C NMR (75 MHz, CDCl3) δ 184.4, 180.9, 169.8, 165.2, 165.0, 164.3, 
159.3, 158.9, 141.7, 137.3, 136.6, 135.2, 134.8, 132.1, 129.4, 128.6, 127.1, 126.9, 
126.6, 124.9, 121.3, 118.7, 118.4, 115.0, 76.4, 73.9, 57.5, 56.8, 40.4, 33.2, 29.4. MS: 
calculated for C38H34N5O2F6 (M, H
+), 706.2617; found, 706.2632. 
3-((3,5-bis(Trifluoromethyl)phenyl)amino)-4-(((R)-1-(((4S,5S)-1,3-dimethyl-4,5-
diphenylimidazolidin-2-ylidene)amino)-3-methylbutan-2-yl)amino)cyclobut-3-ene-
1,2-dione (C17) 
The title compound was prepared from tert-
butyl tert-Butyl (R)-(1-amino-3-methylbutan-2-
yl)carbamate (175 mg, 0.5 mmol) and the S,S-
imidazolium salt. Yellow solid. m. p. = 150–154 
ºC. Yield: 60%, (197 mg, 0.30 mmol).  [α]D23= 
+31.5º (c = 0.5, CH2Cl2). 1H NMR (300 MHz, CH2Cl2) δ 8.17 (s, 1H), 7.38 – 7.23 (m, 
7H), 7.09 (d, J = 5.6 Hz, 4H), 4.39 (s, 2H), 4.19 – 3.96 (m, 3H), 3.04 (s, 6H), 2.30 – 
2.11 (m, 1H), 1.10 (d, J = 6.7 Hz, 3H), 1.04 (d, J = 6.7 Hz, 3H). 13C NMR (75 MHz, 
CDCl3) δ 185.1, 180.48 , 169.7, 165.0, 160.0, 141.4, 135.4, 129.5, 129.4, 126.7, 125.0, 
121.3, 118.3, 114.9, 74.1, 60.9, 45.1, 34.7, 31.1, 29.6, 18.9, 18.5. MS: calculated for 
C34H34N5O2F6 (M + H
+), 658.2617; found, 658.2625. 
 
5.2.2.6. Preparation of catalysts C18 and C22 
New catalysts C18 and C22 were synthesised as follows: 
Preparation of the thiourea intermediate 
The known thiourea intermediate was prepared following a previously described 
synthetic sequence:229 
                                                 
229 L. Zou, X. Bao, Y. Ma, Y. Song, J. Qu, B. Wang, Chem. Commun. 2014, 50, 5760–5762. 
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1st step: A solution of diethyl(2R,3R)-2,3-O-isopropildentartrate (14.8 g, 60 mmol, 1 
equiv.) in THF (15 mL) was slowly added to phenylmagnesium bromide (3 M in THF; 
100 mL, 300 mmol, 5 equiv.) at 0 ºC, and the reaction mixture was refluxed for 1.5 h. 
After cooling, a saturated solution of NH4Cl (400 mL) was added, and the organic phase 
was separated. The aqueous phase was then extracted with EtOAc (1 x 150 mL) and the 
combined organic layers were washed with brine and dried over MgSO4, and the 
solvent was evaporated under reduced pressure to afford the crude product, which was 
purified by recrystallization from CH2Cl2/hexane, affording the diol as a white solid. All 
spectroscopic data were identical to those reported in the literature. Yield: 95% (27 g, 
57 mmol). 1H NMR (300 MHz, CDCl3) δ 7.55 (m, 4H), 7.35 (m, 16H), 4.61 (s, 2H), 
3.95 (s, 2H), 1.05 (s, 6H). 
2nd step: To a solution of the diol (4.7 g, 10 mmol, 1 equiv.) in CH2Cl2 (60 mL) at room 
temperature thionyl chloride was added (1.8 g, 30 mmol, 3 equiv.) and the mixture was 
warmed to reflux and TEA (4.2 g, 42 mmol, 4.2 equiv.) in CH2Cl2 (60 mL) was added 
during a 3 h period. The reaction mixture was stirred until complete consumption of the 
starting material was observed by TLC, and the solvent was eliminated under reduced 
pressure. The residue was dissolved in DMF (50 mL) and to this solution sodium azide 
(2.6 g, 40 mmol, 4 equiv.) was added and the reaction mixture was stirred at 80 ºC for 
72 h. After cooling to room temperature, H2O (150 mL) was added and the aqueous 
solution was extracted with Et2O (3 x 100 mL). The combined organic layer was 
washed with water (3 x 100 mL) dried over MgSO4, and the solvent was evaporated 
under reduced pressure to afford the crude product, which was purified by flash column 
chromatography (eluting hexane /acetate 80:20) to afford the diazide as a yellow solid. 
All spectroscopic data were identical to those reported in the literature. Yield: 84% (3.9 
g, 8.4 mmol). 1H NMR (300 MHz, CDCl3) δ 7.39 (m, 20H), 4.64 (s, 2H), 1.07 (s, 6H). 
3rd step: To a solution of the above obtained diazide (3.6 g, 7 mmol, 1 equiv.) in dry 
THF (40 mL) at 0 ºC was added dropwise a suspension of LiAlH4 (1,6 g, 42 mmol, 6 
equiv.) in dry THF (40 mL) and the reaction mixture was stirred at the same 
temperature for further 4 h. Then, NaOH 1M (5 mL) was added dropwise, the mixture 
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was diluted with Et2O (200 mL) and Na2SO4·10 H2O (20 g) was added. The mixture 
was stirred for 2 h at room temperature before being filtered, and the filtrate was dried 
over MgSO4 and the solvent evaporated under reduced pressure to afford the crude 
product. The product was purified by flash column chromatography (eluting 
CH2Cl2/MeOH 80:20) to afford the diamine as a white solid. All spectroscopic data 
were identical to those reported in the literature. Yield: 53% (1.72 g, 3.7 mmol). 1H 
NMR (300 MHz, CDCl3) δ 7.56 (m, 4H), 7.35 (m, 6H), 7.19 (m, 10 H), 4.28 (s, 2H), 
2.32 (brs, 4H), 1.12 (s, 6H). 
4th step: To a solution of the diamine obtained above (1.4 g, 3.0 mmol 1 equiv.) in 
pyridine (5 mL) was added carbon disulphide (361 µL, 6.0 mmol, 2 equiv.) and the 
resulting mixture was stirred at 60 ºC for 7 h. Then CH2Cl2 (20 mL) and H2O (10 mL) 
were added and the pH was adjusted to 2 adding HCl 1 M dropwise. The layers were 
separated and the aqueous phase was extracted with CH2Cl2 (3 x 50 mL) and the 
combined organic layers were washed with NaOH 1 M (1 x 50 mL) and brine (1 x 50 
mL), subsequently. The organich phase was dried over MgSO4 and the solvent 
evaporated under reduced pressure to afford the crude product, which was crushed with 
a hexane/CH2Cl2 mixture and filtered, affording the pure thiourea as a white solid. All 
spectroscopic data were identical to those reported in the literature. Yield: 81% (1.2 g, 
2.4 mmol). 1H NMR (300 MHz, CDCl3) δ 7.62 (m, 4H), 7.42 (m, 6H), 7.28 (m, 6H), 
7.15 (m, 4H), 6.85 (s, 2H), 4.59 (s, 2H), 1.20 (s, 6H). 
 
Preparation of catalysts C18 and C22 
 
1st step:229 The thiourea intermediate above prepared (250 mg, 0.50 mmol, 1 equiv.) 
was added to a suspension of K2CO3 (1.0 g, 7.5 mmol, 15 equiv.) and CuCl (1.0 g, 1.05 
mmol, 2.1 equiv.) in dry THF (5 mL) and the resulting mixture was stirred for 10 min at 
room temperature before adding the corresponding N-phthaloyl-1,2-
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diphenylethylenediamine230 (171 mg, 0.5 mmol, 1 equiv.). The reaction mixture was 
then stirred at 40 ºC for 72 h and a saturated solution of NH4Cl (2 mL) was added. Then 
HCl 1 M was added dropwise until pH 5 was reached, the mixture was extracted with 
CH2Cl2 (3 x 20 mL), and the combined organic phase was washed with brine (1 x 10 
mL), dried over MgSO4 and the solvent evaporated under reduced pressure to afford the 
crude product, which was purified by flash column chromatography (eluting 
CH2Cl2/MeOH 95:5) to afford the guanidine intermediate as a yellow solid. Yield: 60–
70%. 
2nd step: Hydrazine monohydrate (0.38 mL, 3.0 mmol, 10 equiv.)  was added to a 
solution of the previously obtained solid (245 mg, 0.3 mmol, 1 equiv.) in EtOH (1 mL) 
and the mixture was refluxed for 45 min, observing the formation of a white solid. After 
cooling to room temperature, the mixture was filtered through a pad of celite and the 
filtrate was washed with Et2O (15 mL). The liquid phase was then washed with H2O (10 
mL), dried over MgSO4 and the solvent was evaporated under reduced pressure 
affording the crude amine, which was crushed in MeOH and filtered to afford the pure 
intermediate. Yield: 75–85%. 
3rd step: To a suspension of the squaric ester monoamide prepared above (Section 
5.2.2.1, 68 mg, 0.5 mmol, 1 equiv.) in CH2Cl2 (5 mL) was added the previously 
obtained amine (0.5 mmol, 1 equiv.) and the reaction mixture was stirred for 48 h at 
room temperature, the solvent evaporated, and the product submitted to purification by 
silica gel column chromatography (eluting hexane/EtOAc 50:50). 
3-((3,5-bis(Trifluoromethyl)phenyl)amino)-4-(((1R,2R)-2-(((3aR,8aR)-2,2-dimethyl-
4,4,8,8-tetraphenylhexahydro-6H-[1,3]dioxolo[4,5-e][1,3]diazepin-6-
ylidene)amino)-1,2-diphenylethyl)amino)cyclobut-3-ene-1,2-dione (C18) 
The title compound was prepared according 
to the general procedure above described. 
Yellow solid. m. p. = 178–182 ºC. Yield after 
3 steps: 12%, (47 mg, 0.070 mmol). [α]D24= 
+38.8º (c = 1.00, CH2Cl2). 1H NMR (300 
MHz, CDCl3) δ 8.06 (s, 1H), 7.87 (d, J = 7.2 Hz, 2H), 7.66 – 7.48 (m, 9H), 7.45 – 7.23 
(m, 16H), 7.16 (d, J = 3.2 Hz, 7H), 6.98 (s, 2H), 4.69 (s, 1H), 4.56 (d, J = 8.0 Hz, 1H), 
4.23 (s, 1H), 4.02 (d, J = 8.0 Hz, 1H), 1.24 (s, 3H), 0.74 (s, 3H). 13C NMR (75 MHz, 
CDCl3) δ 201.2, 188.4, 176.1, 157.9, 149.2, 141.7, 129.8, 129.6, 129.0, 128.8, 128.4, 
128.1, 127.3, 126.7, 126.3, 117.6, 113.8, 108.3, 83.9, 81.0, 68.2, 66.1, 62.2, 27.2, 26.6. 
                                                 
230 Prepared following the procedure previously described: M. Kaik, J. Gawronski, Chem. Commun. 
2003, 14, 1559–1563. 
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MS: calculated for C46H45N4O2 (M – squaric ester monoamide), 685.3537; found, 
685.3533. 
3-((3,5-bis(Trifluoromethyl)phenyl)amino)-4-(((1S,2S)-2-(((3aR,8aR)-2,2-dimethyl-
4,4,8,8-tetraphenylhexahydro-6H-[1,3]dioxolo[4,5-e][1,3]diazepin-6-
ylidene)amino)-1,2-diphenylethyl)amino)cyclobut-3-ene-1,2-dione (C22) 
 The title compound was prepared 
according to the general procedure above 
described. Yellow solid. m. p. = 187–192 
ºC. Yield after 3 steps: 18%, (60 mg, 
0.090 mmol). [α]D24= +9.7º (c = 1.00, 
CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 
10.61 (s, 1H), 8.87 (s, 1H), 7.99 (s, 1H), 7.74 (d, J = 7.0 Hz, 2H), 7.64 – 7.50 (m, 8H), 
7.46 – 7.09 (m, 22H), 6.56 (d, J = 5.6 Hz, 2H), 4.69 (d, J = 8.0 Hz, 2H), 4.54 – 4.38 (m, 
1H), 3.95 (d, J = 7.9 Hz, 1H), 1.25 (s, 3H), 1.22 (s, 3H). ). 13C NMR (75 MHz, CDCl3) 
δ 202.5, 189.7, 177.4, 159.2, 150.5, 143.0, 131.1, 131.0, 130.3, 130.1, 129.7, 129.4, 
128.6, 128.0, 127.6, 118.9, 115.1, 109.6, 85.3, 82.45, 69.5, 67.4, 63.5, 28.6, 27.9. MS: 
calculated for C46H45N4O2 (M – squaric ester monoamide), 685.3537; found, 685.3533. 
 
5.2.2.7. Preparation of catalyst C19 
New catalyst C19 was prepared according to the following synthetic sequence: 
 
1st step:231 To a solution of the N-Boc diamine above prepared (Section 5.2.2.5; 324 
mg, 1.5 mmol, 1 equiv.), K2CO3 (351 mg, 2.6 mmol, 1.7 equiv.) and CuSO4·5H2O (3.9 
                                                 
231 M. G. Núñez, A. J. M. Farley, D. J. Dixon, J. Am. Chem. Soc. 2013, 135, 16348–16351. 
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mg, 1 mol %) in MeOH (9 mL) at 0 ºC 1H-Imidazole-1-sulfonyl azide hydrochloride232 
(372 mg, 1.8 mmol, 1.2 equiv.) was added carefully in small portions and the reaction 
mixture was allowed to stir at room temperature overnight. The resulting mixture was 
concentrated under reduced pressure without heating and was diluted with H2O (25 mL) 
and Et2O (25 mL). The aqueous phase was extracted with Et2O (2 x 20 mL) and the 
combined organic layer was washed with brine (50 mL), dried over MgSO4 and 
concentrated under reduced pressure. The crude compound was purified by silica gel 
column chromatography (eluting hexane/EtOAc 90:10). White solid. All spectroscopic 
data were identical to those reported in the literature. Yield: 82%, (300 mg, 1.23 mmol). 
1H NMR (300 MHz, CDCl3) δ 4.53 (d, J = 8.5 Hz, 1H), 3.71 – 3.54 (m, 1H), 3.47 (dd, J 
= 12.6, 3.5 Hz, 1H), 3.22 (dd, J = 12.4, 8.2 Hz, 1H), 1.46 (s, 9H), 0.93 (s, 9H). 
2nd step:232 To a solution of the azide above prepared (242 mg, 1.0 mmol, 1 equiv.) in 
Et2O (2.5 mL) was added triphenylphosphine (262 mg, 1.0 mmol, 1 equiv.) and the 
resulting solution was stirred until the complete disappearance of the azide was 
observed (TLC monitoring). The solvent was eliminated under reduced pressure 
affording the desired product as a white foam, which was subsequently used without 
further purification. Yield: Cuantitative. 1H NMR (300 MHz, CDCl3) δ 7.75 – 7.61 (m, 
6H), 7.57 – 7.39 (m, 9H), 4.82 (s, 1H), 3.44 – 3.22 (m, 2H), 3.12 – 2.89 (m, 1H), 1.43 
(s, 9H), 0.82 (s, 9H). 
3rd step:232 The compound obtained in the previous step (238 mg, 0.5 mmol, 1 equiv.) 
was dissolved in a mixture of CH2Cl2 and TFA (1:1, 5 mL) and the resulting solution 
was stirred at room temperature for 10 min. Then the solvent was eliminated under 
reduced pressure, and the residue was redissolved in CH2Cl2 (5 mL) and washed with 
NaOH 2 M (5 mL). The organic layer was dried over MgSO4 and concentrated under 
reduced pressure affording the crude product as a yellow solid, which was used in the 
next step without further purification. 
4th step: To a suspension of the squaric ester monoamide prepared above (Section 
5.2.2.1, 200 mg, 1.5 mmol, 3 equiv.) in MeOH (5 mL) was added the previously 
obtained crude amine (0.5 mmol, 1 equiv.) and the reaction mixture was stirred for 48 h 
at room temperature, the solvent evaporated, and the product submitted to purification 
by silica gel column chromatography (eluting CH2Cl2/MeOH 90:10). White solid. Yield 
after 2 steps: 32%, (110 mg, 0.16 mmol). [α]D24= –25.0º (c = 1.00, CH2Cl2). 1H NMR 
(300 MHz, CDCl3) δ 11.04 (s, 1H), 8.78 (s, 1H), 8.15 (s, 2H), 7.83 – 7.71 (m, 9H), 7.71 
– 7.62 (m, 6H), 7.43 (s, 1H), 3.95 – 3.79 (m, 1H), 3.57 – 3.39 (m, 1H), 3.21 – 3.08 (m, 
1H), 0.84 (s, 9H). 13C NMR (75 MHz, CDCl3) δ 184.6, 180.4, 170.5, 164.1, 141.0, 
                                                 
232 T. Wang, D. Y. W. Ng, Y. Wu, J. Thomas, T. TamTran, T. Weil, Chem. Commun. 2014, 50, 1116–
1118. 
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135.2, 133.5, 133.4, 132.1, 131.9, 130.2, 130.0, 128.6, 128.4, 65.1, 42.6, 34.4, 26.0. 
MS: calculated for C36H33N3O2F6P (M + H
+), 684.2215; found, 684.2232. 
 
5.2.2.8. Preparation of catalysts C29 and C30 
Catalyst C29,233 previously described in our group, and new catalyst C30 were 
synthesised as follows: 
Preparation of the squaric ester monoamide 
The squaric ester monoamide required for the preparation of catalysts C29 and 
C30 was prepared according to the synthetic sequence previously reported by our 
group:233 
 
1st step: To a solution 5-aminoisophthalic acid (1.81 g, 10 mmol, 1.0 equiv.) in MeOH 
(20 mL) was added concentrated H2SO4 (4.32 mL, 80 mmol, 8 equiv.). The reaction 
mixture was stirred for 24 h at 90 °C. After allowing the mixture to reach room 
temperature, the solvent was removed under reduced pressure. Then, water (10 mL) and 
NaOH 2 M was added until pH 7 and the mixture was extracted with ethyl acetate (3 × 
30 mL). The combined organic phases were dried over MgSO4, filtered and 
concentrated under reduced pressure. The product was obtained as white solid and used 
                                                 
233 A. Odriozola, M. Oiarbide, C. Palomo, Chem. Eur. J. 2017, 23, 12758–12762. 
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without further purification. Yield: 68% (1.54 g, 6.84 mmol). 1H-NMR (300 MHz, 
CDCl3) δ 8.05 (t, J = 1.5 Hz, 1H), 7.52 (d, J = 1.5 Hz, 2H), 3.92 (s, 6H). 
2nd step: To a solution of the crude dimethyl 3-aminophtalate (1.54 g, 6.84 mmol, 1 
equiv.) and Et3N (1.0 mL, 6.84 mmol, 1 equiv.) in CH2Cl2 (33 mL) was added dropwise 
at 0 °C acetyl chloride (0.54 mL, 7.52 mmol, 1.1 equiv.). After stirring for 7 h at room 
temperature, the reaction mixture was filtered and the solid was washed with cool 
CH2Cl2 (2 × 10 mL) to provide the title compound as white solid which was used in the 
next step without further purification. Yield: 90% (1.55 g, 6.16 mmol). 1H-NMR (300 
MHz, DMSO-d6) δ 10.39 (s, 1H), 8.46 (d, J = 1.4 Hz, 2H), 8.21 – 8.10 (m, 1H), 3.89 (s, 
6H), 2.08 (s, 3H). 
3rd step: A solution of the acetamide ester product obtained above (520 mg, 2.0 mmol, 
1 equiv.) in THF (5 mL) was added dropwise at 0 °C to a solution of 3,5-
bis(trifluoromethyl)phenyl magnesium bromide (3.2 mL, 0.5M in THF, 8 equiv.) and 
the mixture was stirred at 90 °C 16 h. The reaction was cooled to room temperature, 
quenched with a saturated solution of NH4Cl and solvent evaporated under reduced 
pressure. The resulting residue was extracted with CH2Cl2 (3 × 5 mL), and the 
combined organic layers were dried over MgSO4 and concentrated under reduced 
pressure. The crude material was purified by flash column chromatography on silica gel 
(eluting with hexane/EtOAc 7:3) to give the title compound as a brown solid. Yield: 
79% (1.03 g, 1.57 mmol). 1H-NMR (300 MHz, CDCl3) δ 7.86 – 7.78 (m, 4H), 7.64 (d, 
J = 1.7 Hz, 8H), 7.44 (d, J = 1.7 Hz, 2H), 7.34 (s, 1H), 2.03 (s, 3H). 
4th step: To a solution of the amide obtained above (522 mg, 0.5 mmol, 1 equiv.) in 
MeOH (4.0 mL) and water (0.5 mL) was added NaOH (400 mg, 10 mmol, 20 equiv.) 
and the mixture was heated at 85 °C for 3 d. The reaction mixture was neutralized by 
slow addition of HCl 1M until pH 7, and then it was extracted with CH2Cl2 (3 × 10 
mL). The combined organic layers were dried over MgSO4, filtered and the solvent was 
evaporated under reduced pressure to give the primary amine as a brown solid, which 
was used in the next step without further purification. Yield: 85% (431 mg, 0.43 mmol). 
1H-NMR (300 MHz, CDCl3) δ 7.88 – 7.78 (m, 4H), 7.68 (d, J = 1.7 Hz, 8H), 6.52 (d, J 
= 1.6 Hz, 2H), 6.08 (t, J = 1.7 Hz, 1H). 
5th step: To a solution of 3,4-dimethoxy-3-cyclobutane-1,2-dione (60 mg, 2.43 mmol) 
in MeOH (20 mL) was added the above obtained amine (430 mg, 0.43 mmol)  and the 
reaction mixture was stirred at room temperature for 48 h. The formed precipitate was 
filtered and dried in vacuo to give the squaric ester monoamide. 1H-NMR (300 MHz, 
MeOH-d4) δ 8.02 – 7.89 (m, 4H), 7.76 (d, J = 1.8 Hz, 8H), 7.49 (t, J = 2.4 Hz, 2H), 6.68 
(s, 1H), 4.27 (s, 3H). Yield: 81% (387 mg, 0.35 mmol). 
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Preparation of 9-amino-10,11-dihydro-(9-deoxy)epiquinine234 
 
9-amino-(9-deoxy)epiquinine (647 mg, 2 mmol) and palladium on activated charcoal 
(10% wt.) (130 mg, 20% wt.) were stirred in EtOH (1 mL/mmol) under an hydrogen 
atmosphere (1 atm). The resulting suspension was filtered over a pad of celite and the 
solvent was eliminated under reduced pressure affording the crude amine, which was 
used in the next step without further purification. Yield: Cuantitative. 1H-NMR (300 
MHz, CDCl3) δ 8.75 (d, J = 4.5 Hz, 1H), 8.04 (d, J = 9.2 Hz, 1H), 7.75 – 7.61 (m, 1H), 
7.53 – 7.45 (m, 1H), 7.39 (dd, J = 9.2, 2.7 Hz, 1H), 4.60 (d, J = 10.3 Hz, 1H), 3.97 (s, 
3H), 3.32 – 3.17 (m, 2H), 3.13 – 2.97 (m, 1H), 2.79 (ddd, J = 14.7, 10.2, 5.4 Hz, 1H), 
2.53 (ddd, J = 13.7, 4.6, 2.5 Hz, 1H), 1.62 – 1.48 (m, 2H), 1.38 – 1.27 (m, 2H), 1.27 – 
1.23 (m, 2H), 0.83 (t, J = 7.3 Hz, 3H). 
 
Preparation of catalysts C29 and C30 
Catalysts C29 and C30 were prepared from the squaric ester monoamide 
intermediate above synthesised according to the synthetic sequence previously 
described in our group:233 
 
                                                 
234 S. Diosdado, J. Etxabe, J. Izquierdo, A. Landa, A. Mielgo, I. Olaizaola, R. López, C. Palomo, Angew. 
Chem. Int. Ed. 2013, 52, 11846–11851. 
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1st step: To a solution of the squaric ester monoamide prepared above (218 mg, 0.20 
mmol) in CH2Cl2 (1 mL) was added the corresponding amine (0.20 mmol) and the 
reaction mixture was stirred for 48 h at room temperature. The solvent was evaporated, 
and the crude product was subsequently used without further purification. 
2nd step: To a suspension of the previously prepared diol-squaramide (0.20 mmol, 1 
equiv.) and DMAP (80 mg, 0.60 mmol, 3 equiv.) in CH2Cl2 (0.8 mL) was added 
dropwise chlorotrimethylsilane (80 μL, 0.60 mmol, 3 equiv.) and the reaction mixture 
was stirred for 14 h at room temperature. Then, additional CH2Cl2 (4 mL) was added 
and the mixture was washed with water (2 × 4 mL) and HCl 1 M (2 × 4 mL). The 
organic layer was dried over MgSO4 and the solvent was evaporated. The resulting 
residue was subjected to purification by flash column chromatography on silica gel 
(CH2Cl2/MeOH 98:2) affording the pure catalyst. 
3-((3,5-bis(bis(3,5-bis(Trifluoromethyl)phenyl)((trimethylsilyl)oxy)methyl)phenyl) 
amino)-4-(((1S)-(6-methoxyquinolin-4-yl)(5-vinylquinuclidin-2-
yl)methyl)amino)cyclobut-3-ene-1,2-dione (C29)233 
The title compound was prepared according to the 
general procedure described above using 9-amino-(9-
deoxy)epiquinine (65 mg, 0.2 mmol, 1 equiv.). Yellow 
solid. m. p. = 160–168 ºC. Yield of after 2 steps: 47% 
(145 mg, 0.094 mmol). 1H-NMR (300 MHz, CDCl3) δ 
8.47 (d, J = 4.6 Hz, 1H), 7.82 (d, J = 7.8 Hz, 13H), 
7.71 (s, 1H), 7.65 – 7.37 (m, 2H), 7.40 – 7.24 (m, 1H), 
7.24 – 7.12 (m, 1H), 7.12 – 7.03 (m, 1H), 6.14 (s, 1H), 
5.85 – 5.61 (m, 1H), 5.11 – 4.92 (m, 2H), 3.95 (s, 3H), 3.43 – 3.03 (m, 3H), 2.43 – 2.27 
(m, 1H), 1.79 – 1.58 (m, 3H), 1.49 (t, J = 12.0 Hz, 1H), 1.37 – 1.21 (m, 1H), 0.78 (td, J 
= 17.3, 13.8, 6.5 Hz, 1H), -0.28 (s, 18H). 13C-NMR (75 MHz, CDCl3) δ 185.1, 180.5, 
168.1, 164.9, 159.7, 148.2, 147.4, 147.0, 145.1, 140.8, 140.6, 132.7, 129.4, 129.0, 
128.7, 125.4, 124.0, 122.7, 121.8, 118.2, 118.1, 115.9, 101.6, 84.0, 60.7, 59.4, 56.7, 
56.3, 41.3, 39.2, 31.6, 30.4, 27.6, 26.5, 1.7. MS: calculated for C70H59N4O5F24Si2 (M + 
H+): 1547.3641; found: 1747.3595. 
3-((3,5-bis(bis(3,5-bis(Trifluoromethyl)phenyl)((trimethylsilyl)oxy)methyl)phenyl) 
amino)-4-(((S)-((1S,2S,4S,5R)-5-ethylquinuclidin-2-yl)(6-methoxyquinolin-4-
yl)methyl)amino)cyclobut-3-ene-1,2-dione (C30) 
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The title compound was prepared according to the 
general procedure described above using 9-amino-(9-
deoxy)epiquinine (65 mg, 0.2 mmol, 1 equiv.). Yellow 
solid. m. p. = 155–160 ºC. Yield of after 2 steps: 65% 
(202 mg, 0.13 mmol). 1H-NMR (300 MHz, DMSO-d6) 
δ 8.73 (d, J = 4.6 Hz, 1H), 8.21 (s, 1H), 7.96 (d, J = 3.9 
Hz, 4H), 7.93 (s, 1H), 7.89 (d, J = 4.9 Hz, 8H), 7.72 – 
7.63 (m, 1H), 7.59 – 7.54 (m, 1H), 7.46 (s, 2H), 7.36 
(dd, J = 9.2, 2.5 Hz, 1H), 6.85 (s, 1H), 5.96 (s, 1H), 3.88 (s, 3H), 3.53 – 3.45 (m, 1H), 
3.27 – 3.06 (m, 2H), 2.62 – 2.53 (m, 1H), 2.39 (d, J = 13.4 Hz, 1H), 1.61 – 1.17 (m, 
8H), 0.90 – 0.75 (m, 3H), 0.62 (s, 1H), -0.33 (s, 18H). 13C-NMR (75 MHz, DMSO-d6) 
δ 183.9, 179.2, 168.1, 162.9, 157.8, 147.5, 145.4, 144.3, 140.1, 131.4, 130.9, 130.5, 
130.1, 127.8, 124.6, 121.9, 121.0, 120.3, 117.2, 101.1, 82.9, 78.4, 72.0, 70.0, 60.3, 55.4, 
36.7, 26.8, 25.8, 24.9, 11.8, 0.6. MS: calculated for C70H61N4O5F24Si2 (M + H
+): 
1549.3797; found: 1749.3822. 
 
5.2.3. Preparation of thiourea- and urea-based Brønsted base catalysts C9, C20 
and C26 
Known thiourea/urea-based catalysts C9235 and C26236 and new thiourea-based 
catalyst C26 were prepared according to the following synthetic procedure:237  
 
To a solution of the corresponding amine (5 mmol, 1 equiv.) in THF (7.5 mL) at 
0 ºC, a solution of bis(trifluomethyl)phenyl isothiocyanate  (1.5 g, 5.5 mmol, 1.1 equiv.) 
or bis(trifluomethyl)phenyl isocyanate (0.6 mL, 5.5 mmol, 1.1 equiv.) in THF (2.5 mL) 
was added dropwise. The reaction mixture was stirred overnight at room temperature 
and then concentrated under reduced pressure. The residue was purified by flash column 
                                                 
235 B. Vakulya, S. Varga, A. Csámpai, T. Soós, Org. Lett. 2005, 7, 1967–1969. 
236 K. Greenaway, P. Dambruoso, A. Ferrali, A. J. Hazelwood, F. Sladojevich, D. J. Dixon, Synthesis 
2011, 12, 1880–1886. 
237 Adapted from: B. Vakulya, S. Varga, A. Csámpai, T. Soós, Org. Lett. 2005, 7, 1967–1969. 
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chromatography on silica gel (eluting with hexane/ ethyl acetate  80:20 → 0:100)  to 
afford compounds C9, C20 and C26. 
1-(3,5-bis(trifluoromethyl)phenyl)-3-((S)-(6-methoxyquinolin-4-yl)((1S,2S,4S,5R)-
5-vinylquinuclidin-2-yl)methyl)thiourea (C9)235 
C9 was prepared from bis(trifluomethyl)phenyl 
isothiocyanate  (1.5 g mL, 5.5 mmol) using 9-amino-(9-
deoxy)epiquinine (1.6 g, 5 mmol, 1 equiv.) as the amine, 
according to the general procedure described above. White 
solid. m. p.: 123–125 ºC. Yield: 88% (2.6 g, 4.4 mmol). 
All data were consistent with those previously reported. 
1H-NMR (300 MHz, MeOH-d4) δ 8.68 (d, J = 4.7 Hz, 1H), 8.11 (brs, 2H), 8.07 (d, J = 
2.6 Hz, 1H), 7.95 (d, J = 9.3 Hz, 1H), 7.59 (br s, 1H), 7.55 (d, J = 4.7 Hz, 1H), 7.44 (dd, 
J = 9.3, 2.6 Hz, 1H), 6.32 (d, J = 11.0 Hz, 1H), 5.84 (ddd, J = 17.2, 10.5, 6.2 Hz, 1H), 
5.02 (dt, J = 10.5, 1.5 Hz, 1H,), 4.98 (dt, J = 17.2, 1.5 Hz, 1H), 4.03 (s, 3H), 3.56–3.53 
(m, 1H), 3.39–3.37 (m, 1H), 3.29 (dd, J = 13.6, 9.9 Hz, 1H), 2.82 (ddd, J = 15.6, 13.8, 
4.9 Hz, 1H), 2.79 (ddd, J = 13.6, 4.7, 2.3 Hz, 1H), 2.38–2.35 (m, 1H), 1.71–1.68 (m, 
2H), 1.64–1.61 (m, 1H), 1.45 (ddd, J = 13.3, 10.4, 2.7 Hz, 1H), 0.89 (dd, J = 13.3, 10.4 
Hz, 1H). 
1-(3,5-bis(Trifluoromethyl)phenyl)-3-((S)-1-(((4R,5R)-1,3-dimethyl-4,5-
diphenylimidazolidin-2-ylidene)amino)-3-phenylpropan-2-yl)thiourea (C20) 
C20 was prepared from bis(trifluomethyl)phenyl 
isothiocyanate  (50 µL, 0.27 mmol, 1.1 equiv.) 
using the corresponding amine above prepared 
(section 5.2.2.5, 92 mg, 0.23 mmol, 1 equiv.) as the 
amine, according to the general procedure described 
above. White solid. Yield: 25% (39 mg, 0.06 mmol). [αD23= +2.5º (c = 1.00, CH2Cl2). 
1H-NMR (300 MHz, MeOH-d4) δ 8.17 (s, 1H), 7.73 (s, 1H), 7.50 – 7.30 (m, 10H), 7.24 
– 7.17 (m, 5H), 7.05 (s, 1H), 4.80 – 4.66 (m, 1H), 4.49 (dd, J = 12.0, 6.2 Hz, 1H), 4.17 
(s, 2H), 4.13 – 4.05 (m, 1H), 3.02 (dd, J = 13.0, 4.8 Hz, 1H), 2.88 (dd, J = 13.7, 8.5 Hz, 
1H), 2.72 (s, 1H), 2.60 (s, 6H). 13C NMR (75 MHz, CDCl3) δ 178.7, 177.8, 157.4, 
151.2, 139.8, 137.6, 135.1, 129.3, 129.0, 128.7, 127.6, 127.2, 124.3, 122.0, 119.6, 
112.9, 73.2, 57.2, 52.9, 41.4, 34.1. MS: calculated for C35H34N5SF6 (M + H
+): 
670.2439; found: 670.2439. 
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1-(3,5-bis(trifluoromethyl)phenyl)-3-((S)-(6-methoxyquinolin-4-yl)((1S,2S,4S,5R)-
5-vinylquinuclidin-2-yl)methyl)urea (C26)236 
C26 was prepared from bis(trifluomethyl)phenyl 
isocyanate (0.6 mL, 5.5 mmol) using 9-amino-(9-
deoxy)epiquinine (1.6 g, 5 mmol, 1 equiv.) as the amine, 
according to the general procedure described above. White 
solid. m. p.: 132–135 ºC. Yield: 82% (2.4 g, 4.1 mmol). 
All data were consistent with those previously reported. 
1H-NMR (300 MHz, MeOH-d4) δ 8.58 (d, J = 4.5 Hz, 1H), 7.84–7.90 (m, 3H), 7.66 (d, 
J = 2.5 Hz, 1H), 7.51 (d, J = 4.5 Hz, 1H), 7.36 (d, J = 1.5 Hz, 1H), 7.34 (d, J = 2.5 Hz, 
1H), 5.83–5.89 (m, 1H), 5.65 (bs, 1H), 5.18 (d, J = 17.5 Hz, 1H), 5.09 (d, J = 10.5 Hz, 
1H), 3.91 (s, 3H), 3.47–3.52 (m, 1H), 3.35–3.41 (m, 1H), 3.03–3.15 (m, 4H), 2.41–2.43 
(m, 1H), 1.40–1.73 (m, 3H), 1.17–1.25 (m, 3H). 
 
5.2.4. Ureidopeptide-like Brønsted base catalysts C21, C27 and C35 
New catalyst C21 and known catalysts C27238 and C35234 were prepared 
according to the synthetic sequence previously reported by our group:234 
 
1st step:239 To a stirred solution of the aryl alcohol (10 mmol, 1 equiv.) in 
dichloromethane (50 mL) at 0 ºC was added pyridine (0.92 mL, 11.5 mmol, 1.15 equiv.) 
followed by triphosgene (1.2 g, 4 mmol, 0.4 equiv.) or p-nitropheylchloroformate (2.2 
g, 11 mmol, 1.1 equiv.). The resulting mixture was stirred at room temperature 
overnight, and then it was partially evaporated at reduced pressure and diluted with 
hexane (50 mL). The solids were removed by filtration and the filtrate was evaporated 
to afford the corresponding chloroformate in quantitative yield, which was used for the 
next step without further purification. 
                                                 
238 S. Diosdado, R. López, C. Palomo, Chem. Eur. J. 2014, 20, 6526–6531. 
239 Adapted from: L. Fang, F. Yang, Org. Lett. 2010, 12, 3124–3127. 
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2nd step:240 To a stirred solution of the L-tert-leucine (1.3 g, 10 mmol, 1 equiv.) in 10% 
aqueous Na2CO3 (26 mL), and dioxane (10 mL) was slowly added at 0 ºC a solution of 
the previous chloroformate (1.4 mL, 10 mmol, 1 equiv.) in dioxane (30 mL). The 
mixture was stirred at the same temperature for 1 h and then allowed to warm to room 
temperature. The solution was subsequently stirred overnight, poured into H2O (100 
mL) and extracted with Et2O (3 × 50 mL). The aqueous layer was cooled in an ice bath 
and acidified with concentrated HCl, followed by extraction with EtOAc (3 × 50 mL). 
The combined extracts were dried over MgSO4, filtered off and the solvent evaporated 
under reduced pressure to afford the corresponding L-tert-leucine derivative in 
quantitative yield, which was used for the next step without further purification. 
3rd step:241 The previously obtained acid (5.0 mmol, 1 equiv.) was dissolved in THF (20 
mL), and isobutyl chloroformate (0.65 mL, 5 mmol1 equiv.) and N-methylmorpholine 
(0.6 mL, 5 mmol1 equiv.) were added. Then, the mixture was stirred at–20 ºC for 20 
min and a suspension of NaN3 (0.48 g, 7.5 mmol, 1.5 equiv.,) in H2O (5 mL) was added. 
After 30 min at the same temperature, the organic layer was separated, diluted with 
CH2Cl2 (30 mL), and washed with water (15 mL). The organic phase was dried over 
MgSO4, and concentrated under reduced pressure to give a yellow oil which was 
redissolved in dry CH2Cl2 (10 mL). The resulting solution was heated at 40 ºC under 
nitrogen until completion (reaction monitored by IR analysis until disappearance of the 
isocyanate band, 1–2 h). Then, the corresponding amine was added (3.5 mmol, 0.7 
equiv.) and the reaction mixture was stirred overnight at room temperature. The solvent 
was evaporated and the residue was purified by flash column chromatography on silica 
gel (eluting with dichloromethane/MeOH 90:10) to afford the corresponding catalyst. 
Naphthalen-2-ylmethyl ((S)-1-(3-((S)-(6-methoxyquinolin-4-yl)((1S,2S,4S,5R)-5-
vinylquinuclidin-2-yl)methyl)ureido)-2,2-dimethylpropyl)carbamate (C21)  
C21 was prepared from benzyl alcohol (1.0 
g, 10 mmol) according to the general 
procedure using triphosgene (1.2 g, 4.0 
mmol, 0.4 equiv.) in the first step and the 
corresponding amine above prepared (section 
5.2.2.5, 140 mg, 3.5 mmol, 1 equiv.) as the amine. Yield: 30% (70 mg, 0.11 mmol). 
[αD23= –8.9º (c = 1.00, CH2Cl2).1H-NMR (300 MHz, CDCl3) δ 7.43 – 7.10 (m, 20H), 
6.89 (s, 1H), 5.37 (bs, 1H), 4.95 (d, J = 12.2 Hz, 1H), 4.76 – 4.64 (m, 1H), 4.38 – 4.20 
                                                 
240 Adapted from: b) J. D. Bain, D. A. Wacker, E. E. Kuo, A. R. Chamberlin, Tetrahedron 1991, 47, 
2389–2400. 
241 Adapted from: Suresh Babu, V. V.; Patil, B. S.; Venkataramanarao, R.  J. Org. Chem. 2006, 71, 7697– 
7705. 
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(m, 3H), 3.51 (d, J = 6.7 Hz, 2H), 3.15 (dd, J = 13.3, 5.0 Hz, 1H), 2.86 (s, 1H), 2.65 (s, 
6H), 0.98 (s, 9H). 13C NMR (75 MHz, CDCl3) δ 159.7, 158.4, 155.7, 138.5, 136.4, 
135.8, 129.2, 128.5, 128.2, 127.7, 127.4, 126.4, 77.2, 74.0, 66.1, 51.4, 47.1, 40.1, 36.0, 
33.6, 25.5. MS: calculated for C40H49N6O3 (M + H
+): 661.3866; found: 661.3865. 
Benzyl ((S)-1-(3-((S)-(6-methoxyquinolin-4-yl)((1S,2S,4S,5R)-5-vinylquinuclidin-2-
yl)methyl)ureido)-2,2-dimethylpropyl)carbamate (C27)238 
C27 was prepared from benzyl alcohol (1.0 g, 10 
mmol) according to the general procedure using 
triphosgene (1.2 g, 4 mmol, 0.4 equiv.) in the first 
step and 9-amino-(9-deoxy)epiquinine (1.12 g, 3.5 
mmol, 1 equiv.) as the amine. Yield: 72% (1.48 g, 
2.5 mmol). All data were consistent with those 
previously reported. 1H-NMR (300 MHz, CDCl3) δ 8.62 (d, J = 4.3, 1H), 8.01 (d, J = 
9.2, 1H), 7.74 (d, J = 2.6, 1H), 7.39 (d, J = 2.7, 1H), 7.37–7.34 (m, 5H), 7.22 (d, J = 4.4, 
1H), 6.48–6.35 (bs, 1H), 5.84–5.73 (m, 1H), 5.32–5.29 (m, 1H), 5.20 (d, J = 9.4, 1H), 
5.08–5.05 (m, 2H), 5.04–4.95 (m, 3H), 3.97 (s, 3H), 3.30–3.23 (m, 2H), 3.12–2.99 (m, 
1H), 2.80–2.70 (m, 2H), 2.34–2.27 (s, 1H), 1.68–1.64 (m, 2H), 1.62–1.56 (m, 1H), 
1.45–1.38 (m, 1H), 0.82 (s, 10H). 
Naphthalen-2-ylmethyl ((S)-1-(3-((S)-(6-methoxyquinolin-4-yl)((1S,2S,4S,5R)-5-
vinylquinuclidin-2-yl)methyl)ureido)-2,2-dimethylpropyl)carbamate (C35)234 
C35 was prepared from 2-nafthalenemethanol 
(1.6 g, 10 mmol) according to the general 
procedure using p-nitropheylchloroformate 
(2.2 g, 11 mmol, 1.1 equiv.) in the first step 
and 9-amino-(9-deoxy)epiquinine (1.12 g, 3.5 
mmol, 1 equiv.) as the amine. Yield: 86% (1.9 
g, 3.0 mmol). All data were consistent with those previously reported. 1H-NMR (300 
MHz, CDCl3) δ 8.58 (d, J = 4.3 Hz, 1H), 7.99 (d, J = 9.2 Hz, 1H), 7.87–7.67 (m, 5H), 
7.35 (dd, J = 9.2, 2.7 Hz, 4H), 7.24 (d, J = 4.6 Hz, 1H), 6.42–6.24 (bs, 1H), 5.85–5.66 
(m, 1H), 5.33–5.22 (bs, 1H), 5.12–4.85 (m, 4H), 3.95 (s, 3H), 3.33–2.98 (m, 3H), 2.87–
2.57 (m, 2H), 2.35–2.22 (m, 1H), 1.94–1.78 (m, 1H), 1.69–1.30 (m, 4H), 0.86 (s, 9H). 
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5.2.5. Preparation of catalysts C23-C25 
New catalysts C23-C25 were synthesised according to a previously described 
synthetic procedure:242 
 
The thiourea intermediate above prepared (Section 5.2.2.6, 250 mg, 0.50 mmol, 
1 equiv.) was added to a suspension of K2CO3 (1.0 g, 7.5 mmol, 15 equiv.) and CuCl 
(1.0 g, 1.05 mmol, 2.1 equiv.) in THF (5 mL) and the resulting mixture was stirred for 
10 min at room temperature before adding the corresponding amine (0.50 mmol, 1 
equiv.). The reaction mixture was then stirred at 40 ºC for 72 h and a saturated solution 
of NH4Cl (2 mL) was added. Then HCl 1 M was added dropwise until pH 5 was 
reached, the mixture was extracted with CH2Cl2 (3 x 20 mL), and the combined organic 
phase was washed with brine (1 x 10 mL), dried over MgSO4 and the solvent 
evaporated under reduced pressure to afford the crude product, which was purified by 
flash column chromatography (eluting CH2Cl2/MeOH 95:5) to afford the pure catalyst. 
(3aR,8aR)-N-(3,5-di-tert-Butylphenyl)-2,2-dimethyl-4,4,8,8-tetraphenylhexahydro-
6H-[1,3]dioxolo[4,5-e][1,3]diazepin-6-imine (C23) 
The title compound was prepared following the general 
procedure above desctibed using 3,5-di-tert-butylaniline (103 
mg, 0.50 mmol, 1 equiv.) as the amine. Yellow solid. Yield: 
64% (214 mg, 0.32 mmol). [αD23= +53.9º (c = 1.00, 
CH2Cl2). 1H-NMR (300 MHz, CDCl3) δ 7.95 (d, J = 5.7 Hz, 
2H), 7.55 (s, 2H), 7.49 – 7.32 (m, 8H), 7.28 (s, 5H), 7.15 (s, 3H), 7.03 (d, J = 9.1 Hz, 
3H), 6.85 (s, 2H), 4.75 (d, J = 14.1 Hz, 2H), 1.34 (s, 3H), 1.24 (s, 18H), 1.19 (s, 3H). 
13C NMR (75 MHz, CDCl3) δ 152.1, 145.3, 144.9, 141.8, 141.2, 129.0, 128.3, 127.7, 
127.6, 127.4, 127.0, 117.3, 116.8, 110.2, 81.2, 80.0, 66.2, 65.6, 34.7, 31.3, 27.0, 26.6. 
MS: calculated for C46H52N3O2 (M + H
+), 678.4060; found, 678.4056. 
(3aR,8aR)-N-((S)-(6-methoxyquinolin-4-yl)((1S,2S,4S,5R)-5-vinylquinuclidin-2-
yl)methyl)-2,2-dimethyl-4,4,8,8-tetraphenylhexahydro-6H-[1,3]dioxolo[4,5-
e][1,3]diazepin-6-imine (C24) 
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The title compound was prepared following the general 
procedure above desctibed using 9-amino-(9-
deoxy)epiquinine (194 g, 0.50 mmol, 1 equiv.)  as the 
amine. Yellow solid. Yield: 64% (254 mg, 0.32 mmol). 
[αD23= +95.5º (c = 1.00, CH2Cl2). 1H-NMR (300 MHz, 
CDCl3) δ 7.96 (d, J = 9.2 Hz, 1H), 7.73 – 7.29 (m, 16H), 
7.21 (s, 6H), 7.02 – 6.83 (m, 2H), 6.59 (s, 2H), 5.81 – 5.58 
(m, 1H), 5.02 – 4.86 (m, 2H), 4.78 (s, 1H), 4.17 (s, 1H), 3.51 (s, 3H), 3.09 (s, 1H), 2.66 
(d, J = 39.9 Hz, 2H), 2.22 (s, 2H), 1.58 (s, 6H), 1.32 – 1.17 (m, 2H), 1.11 – 0.49 (m, 
6H). 13C NMR (75 MHz, CDCl3) δ 157.1, 147.3, 144.4, 141.2, 131.9, 131.8, 131.1, 
129.5, 128.4, 128.2, 127.3, 127.0, 121.5, 114.2, 111.1, 55.5, 55.0, 40.3, 39.4, 27.9, 27.3, 
26.5, 25.2. MS: calculated for C52H54N5O3 (M + H
+), 796.4227; found, 796.4223. 
(3aR,3a'R,8aR,8a'R)-N,N'-((1R,2R)-1,2-Diphenylethane-1,2-diyl)bis(2,2-dimethyl-
4,4,8,8-tetraphenylhexahydro-6H-[1,3]dioxolo[4,5-e][1,3]diazepin-6-imine) (C25) 
The title compound was prepared following the 
general procedure above desctibed using 1,2-
diphenylethylenediamine (53 g, 0.25 mmol, 0.5 
equiv.) as the amine. Yellow solid. Yield: 60% 
(173 mg, 0.15 mmol). [αD23= +135.5º (c = 1.00, 
CH2Cl2). 1H-NMR (300 MHz, CDCl3) δ 7.69 – 7.63 (m, 8H), 7.46 – 7.39 (m, 12H), 
7.31 – 7.25 (m, 12H), 7.22 – 7.15 (m, 8H), 6.81 (s, 2H), 6.65 (s, 2H), 5.23 (s, 3H), 4.60 
(s, 3H), 1.30 (s, 1H). 13C NMR (75 MHz, CDCl3) δ 159.9, 144.2, 140.5, 128.7, 128.3, 
127.7, 127.5, 127.4, 127.2, 109.6, 78.8, 65.6, 26.6. MS: calculated for C78H73N6O4 (M + 
H+), 1157.5688; found, 1157.5705. 
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5.2.6. Representative NMR spectra 
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5.3. Experimental section of Chapter 2 
5.3.1. Synthesis of propargylic aldehydes 1 
Phenyl propynal (1a) and octynal (1b) are commercially available and were 
purchased from commercial suppliers. New propargylic aldehydes 1c and 1d were 
synthesised as described bellow:242 
 
To a round bottomed flask filled with Et2O (50 mL) and cooled to –60 ºC were 
successively added dropwise nBuLi (50 mmol, 20 mL, 2.5 M in hexane) and the 
corresponding alkyne (50 mmol). The reaction mixture was stirred at that temperature 
for 30 min after which DMF (4.3 mL, 62.5 mmol) was added slowly. The resulting 
mixture was removed from the bath, warmed slowly to room temperature and stirred at 
this temperature for 20 min. Then, the reaction mixture was poured into a cold solution 
of water (25 mL) and concentrated HCl (4 mL) and a solution of saturated NaHCO3 was 
added dropwise until pH 6-7. The organic layer was separated and the aqueous phase 
extracted with Et2O (3 × 20 mL). The combined organic layers were dried over MgSO4, 
and the solvent was eliminated under reduced pressure. The crude product was purified 
by flash column chromatography on silica gel to afford the corresponding pure ynone 1. 
5-Methylhex-2-ynal (1c) 
The compound was prepared according to the general procedure, 
starting from 4-methylpent-1-yne (1.4 mL, 10 mmol). Black oil. Yield: 
63% (700 mg, 7.0 mmol). 1H-NMR (500 MHz, CDCl3) δ 9.23 (s, 1H), 
2.35 (dd, J = 6.5, 0.7 Hz, 2H), 2.04 – 1.89 (m, 1H), 1.07 (s, 3H), 1.05 (s, 3H). 
3-(Thiophen-3-yl)propiolaldehyde (1d) 
Prepared according to the general procedure, starting from 3-
ethynylthiophenone (0.98 mL, 10 mmol). Black oil. Yield: 45% (610 
mg, 4.5 mmol). 1H-NMR (300 MHz, CDCl3) δ 9.40 (s, 1H), 7.82 (d, J 
= 1.7 Hz, 1H), 7.40 – 7.32 (m, 1H), 7.26 (d, J = 5.0 Hz, 1H). 
                                                 
242 L. Bradsma, Preparative acetylenic chemistry (Studies in Organic Chemistry 34); Elsevier, 
Amsterdam, 1988, 97–112.  
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5.3.2. Synthesis of propargylic ketoesters 2243 
Known ketoester 2a and new ketoesters 2b-2d were synthesised according to the 
following synthetic procedure: 
 
To a mixture of copper (I) iodide (100 mg, 0.5 mmol, 5 mol%) and triethylamine 
(2.8 mL, 20 mmol, 2 equiv.) in THF (50 mL) the corresponding alkyne (10 mmol, 1 
equiv.) and methyl oxalyl chloride (1.8 mL, 20 mmol, 2 equiv.) were successively 
added and the mixture was allowed to stir at room temperature for 16 h. The reaction 
was quenched by addition of a saturated solution of NaHCO3 (50 mL) and the aqueous 
phase was extracted with diethyl ether (3 × 40 mL). The organic phases were combined, 
dried over MgSO4, and the solvent was eliminated under reduced pressure. The crude 
material was purified by flash column chromatography on silica gel (eluting with 
hexane/EtOAc 95:5) obtaining the pure desired product. 
Methyl 2-oxo-4-phenylbut-3-ynoate (2a)244 
 The compound was prepared according to the general procedure, 
starting from phenylacetylene (1.1 mL, 10 mmol). Yellow solid. 
Yield: 61% (990 mg, 6.1 mmol). All data were consistent with those 
previously reported. 1H-NMR (300 MHz, CDCl3) δ 7.72 – 7.64 (m, 2H), 7.56 – 7.51 
(m, 1H), 7.45 – 7.40 (m, 2H), 3.97 (s, 3H). 
Methyl 4-(4-fluorophenyl)-2-oxobut-3-ynoate (2b) 
 The compound was prepared according to the general 
procedure, starting from 1-ethynyl-1-fluorobenzene (1.2 mL, 
10 mmol). Yellow solid. Yield: 50% (1.0 g, 5.0 mmol). 1H-
NMR (300 MHz, CDCl3) δ 7.74 – 7.65 (m, 2H), 7.18 – 7.08 
(m, 2H), 3.96 (s, 3H). 
                                                 
243 Adapted from: W. Yao, L. Pan, Y. Zhang, G. Wang, X. Wang, C. Ma, Angew. Chem. Int. Ed. 2010, 
49, 9210–9214.  
244 M. Ueda, Y. Ikeda, A. Sato, Y. Ito, M. Kakiuchi, H. Shono, T. Miyoshi, T. Naito, O. Miyata, 
Tetrahedron, 2011, 67, 4612–4615.  
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Methyl 4-(3-chlorophenyl)-2-oxobut-3-ynoate (2c) 
 The compound was prepared according to the general 
procedure, starting from 3-chloro-1-ethynylbenzene (1.4 g, 10 
mmol). Brown solid. Yield: 22% (500 mg, 2.2 mmol). 1H-
NMR (300 MHz, CDCl3) δ 7.66 (t, J = 1.8 Hz, 1H), 7.56 (dt, J 
= 7.6, 1.3 Hz, 1H), 7.50 (ddd, J = 8.1, 2.1, 1.1 Hz, 1H), 7.37 (t, J = 7.9 Hz, 1H), 3.97 (s, 
3H). 
Methyl 4-(3-methylphenyl)-2-oxobut-3-ynoate (2d) 
 The compound was prepared according to the general 
procedure, starting from 1-ethynyl-3-methylbenzene (1.2 g, 
10 mmol). Brown solid. Yield: 58% (1.2 mg, 5.8 mmol). 1H-
NMR (300 MHz, CDCl3) δ 7.49 (dd, J = 6.4, 1.4 Hz, 2H), 
7.32 (dd, J = 6.2, 1.1 Hz, 2H), 3.96 (s, 3H), 2.38 (s, 3H). 
 
5.3.3. Cross-aldol reaction of α,β-ynals 
5.3.3.1. General procedure 
 
To a solution of the amine catalyst C1 (47 mg, 0.1 mmol, 20 mol%) in THF (0.5 
mL) at –60 ºC were successively added 4-pentenal (3B, 74 µL, 0.75 mmol, 1.5 equiv.), 
benzoic acid (12 mg, 0.1 mmol, 20 mol%) and the corresponding ynal 1 (0.5 mmol, 1 
equiv.). The resulting solution was stirred at –60 ºC for 24–48 h until the reaction 
stopped (1H NMR monitoring), and to the mixture MeOH (4.5 mL), trimethyl 
orthoformate (0.16 mL, 1.5 mmol, 3 equiv.) and pTSA (20 mg, 0.1 mmol, 20 mol%) 
were successively added at –60 ºC. The mixture was allowed to reach 0 ºC and, after 2 h 
stirring, the reaction was quenched with saturated NaHCO3 (5 mL) and extracted with 
ethyl acetate (2 × 4 mL). The combined organic layers were washed with brine, dried 
over MgSO4 and concentrated. The crude product was purified by flash column 
chromatography on silica gel (eluting with hexane/EtOAc 90:10), thus allowing in each 
case separation of anti (major) and syn (minor) aldol diastereomers. 
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Racemic reactions were conducted following the procedure for the asymmetric 
version, but using (±)1C (20 mol%) as the catalyst. 
 
5.3.3.2. Characterization data for compounds 5B 
 (3S,4R)-4-(Dimethoxymethyl)-1-phenylhept-6-en-1-yn-3-ol (5Ba) 
The compound was obtained following the general procedure 
using ynal 1a (61 µL, 0.5 mmol). Yellow oil. The adduct was 
obtained in a 1:8 syn/anti ratio. Yield: 72% (93 mg, 0.36 mmol). 
[α]D24 = –8.2º (c = 1.05, 94% ee, CH2Cl2). 1H-NMR (300 MHz, 
CDCl3) δ 7.51 – 7.31 (m, 5H), 5.94 (ddt, J = 17.2, 10.1, 7.2 Hz, 1H), 5.27 – 5.07 (m, 
2H), 4.80 (d, J = 5.9 Hz, 1H), 4.64 (d, J = 4.9 Hz, 1H), 3.50 (s, 3H), 3.49 (s, 3H), 2.55 – 
2.37 (m, 2H), 2.20 (ddd, J = 10.7, 7.4, 5.7 Hz, 1H). 13C-NMR (75 MHz, CDCl3) δ 
136.5, 130.0, 128.9, 125.3, 117.2, 106.7, 88.5, 81.0, 63.2, 56.1, 55.0, 46.3, 30.4. MS: 
calculated for C16H20O3 (M + H
+), 261.1446; found, 261.1440. The enantiomeric purity 
of the major isomer was determined by chiral HPLC analysis of the crude reaction 
mixture (Daicel Chiralpak AD-H, hexane/isopropanol, 95:5; flux = 1 mL/min; retention 
times: 19.8 min (minor), 22.0 min (major)). 
 (4R,5S)-4-(Dimethoxymethyl)dodec-1-en-6-yn-5-ol (5Bb) 
The compound was obtained following the general procedure 
using ynal 1b (0.71 mL, 5.0 mmol). Yellow oil. The adduct was 
obtained in a 1:20 syn/anti ratio. Yield: 50% (640 mg, 2.5 mmol). 
[α]D24 = +13.4º (c = 1.00, 99% ee, CH2Cl2). 1H-NMR (300 MHz, 
CDCl3) δ 6.04 – 5.66 (m, 1H), 5.30 – 4.99 (m, 2H), 4.56 (d, J = 5.1 Hz, 2H), 3.47 (s, 
3H), 3.45 (s, 3H) 2.38 (dd, J = 13.7, 7.1 Hz, 2H), 2.27 (td, J = 7.0, 2.0 Hz, 2H), 2.09 – 
2.02 (m, 1H), 1.55 (dd, J = 14.0, 7.0 Hz, 2H), 1.46 – 1.35 (m, 4H), 0.93 (t, J = 7.1 Hz, 
3H). 13C-NMR (75 MHz, CDCl3) δ 137.1, 117.1, 107.0, 86.9, 80.1, 63.1, 56.1, 55.0, 
46.7, 31.4, 30.6, 28.7, 22.5, 19.1, 14.3. MS: calculated for C14H23O2 (M – OMe–), 
223.1704; found, 223.1696. The enantiomeric purity of the major isomer was 
determined by chiral HPLC analysis of the corresponding O-benzoylate derivative 
(Daicel Chiralpak IC, hexane/isopropanol, 99:1; flux = 1 mL/min; retention times: 5.9 
min (major), 8.2 min (minor)). 
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(4R,5S)-4-(dimethoxymethyl)-9-methyldec-1-en-6-yn-5-ol (5Bc) 
The compound was obtained following the general procedure 
using ynal 1c (0.71 mL, 5.0 mmol). Yellow oil. The adduct was 
obtained in a 1:20 syn/anti ratio. Yield: 50% (640 mg, 2.5 
mmol). [α]D24 = +14.3º (c = 1.00, 99% ee, CH2Cl2). 1H-NMR 
(300 MHz, CDCl3) δ 6.04 – 5.66 (m, 1H), 5.30 – 4.99 (m, 2H), 4.56 (d, J = 5.1 Hz, 2H), 
3.47 (s, 3H), 3.45 (s, 3H) 2.38 (dd, J = 13.7, 7.1 Hz, 2H), 2.27 (td, J = 7.0, 2.0 Hz, 2H), 
2.09 – 2.02 (m, 1H), 1.55 (dd, J = 14.0, 7.0 Hz, 2H), 1.46 – 1.35 (m, 4H), 0.93 (t, J = 
7.1 Hz, 3H). 13C-NMR (75 MHz, CDCl3) δ 137.1, 117.1, 107.0, 86.9, 80.1, 63.1, 56.1, 
55.0, 46.7, 31.4, 30.6, 28.7, 22.5, 19.1, 14.3. MS: calculated for C13H21O2 (M – OMe–), 
209.1547; found, 209.1523. The enantiomeric purity of the major isomer was 
determined by chiral HPLC analysis of the corresponding O-benzoylate derivative 
(Daicel Chiralpak IC, hexane/isopropanol, 98:2; flux = 0.75 mL/min; retention times: 
6.5 min (major), 7.5 min (minor)). 
(3S,4R)-4-(dimethoxymethyl)-1-(thiophen-3-yl)hept-6-en-1-yn-3-ol (5Bd) 
The compound was obtained following the general procedure 
using ynal 1d (52 mg, 0.5 mmol). Yellow oil. The adduct was 
obtained in a 1:9 syn/anti ratio. Yield: 72% (96 mg, 0.36 
mmol). [α]D24 = +21.6º (c = 1.00, 99% ee, CH2Cl2). 1H-NMR 
(300 MHz, CDCl3) δ 7.44 (s, 1H), 7.26 (s, 1H), 7.11 (d, J = 3.9 Hz, 1H), 6.03 – 5.74 (m, 
1H), 5.16 (d, J = 16.0 Hz, 1H), 5.08 (d, J = 9.6 Hz, 1H), 4.74 (s, 1H), 4.58 (d, J = 4.7 
Hz, 1H), 3.46 (s, 3H), 3.45 (s, 3H), 2.48 – 2.33 (m, 2H), 2.15 – 1.12 (m, 1H). 13C-NMR 
(75 MHz, CDCl3) δ 136.5, 131.6, 128.3, 128.2, 122.4, 117.0, 106.7, 88.9, 85.7, 63.0, 
55.9, 54.8, 46.3, 30.3. MS: calculated for C13H15O2S(M, – OMe–), 235.0798; found, 
235.0784. The enantiomeric purity of the major isomer was determined by chiral HPLC 
analysis of the crude reaction mixture (Daicel Chiralpak AD-H, hexane/isopropanol, 
95:5; flux = 1 mL/min; retention times: 25.8 min (minor), 26.7 min (major)). 
 
5.3.3.3. Benzoylation of adducts for ee determination by HPLC 
 
The ee of adducts 5Bb and 5Bc was determined on their benzoylated derivative, 
prepared as follow. To a solution of alcohol 5B (0.15 mmol) in CH2Cl2 (0.5 mL) at 0 ºC 
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were successively added DMAP (55 mg, 0.45 mmol, 3 equiv.) and benzoyl chloride (32 
mg, 0.23 mmol, 1.5 equiv.). The resulting mixture was stirred at 0 ºC for 3 h, diluted 
with CH2Cl2 (10 mL) and the organic solution was washed with a saturated solution of 
NH4Cl (2 × 5 mL) and a saturated solution of NaHCO3 (2 × 5 mL). The organic layer 
was dried over MgSO4 and concentrated. The crude material was purified by flash 
column chromatography on silica gel (eluting with hexane/EtOAc 95:5) to afford the 
pure benzoylated product. 
(4R,5S)-4-(Dimethoxymethyl)dodec-1-en-6-yn-5-yl benzoate (5’Bb) 
The product was prepared as described above starting from 
adduct 5Bb (38 mg, 0.15 mmol, 1 equiv.). Yellow oil. Yield: 
95% (51 mg, 0.14 mmol). 1H-NMR (300 MHz, CDCl3) δ 8.10 
– 8.03 (m, 2H), 7.60 – 7.53 (m, 1H), 7.47 – 7.41 (m, 2H), 6.07 
– 5.92 (m, 1H), 5.84 (dd, J = 4.3, 2.1 Hz, 1H), 5.15 – 4.95 (m, 3H), 4.43 (d, J = 7.2 Hz, 
1H), 3.41 (s, 3H), 3.37 (s, 4H), 2.56 – 2.41 (m, 3H), 2.34 – 2.28 (m, 1H), 2.23 (ddd, J = 
7.1, 4.5, 2.1 Hz, 3H), 1.55 – 1.48 (m, 2H), 1.40 – 1.31 (m, 4H), 0.92 – 0.86 (m, 3H). 
(4R,5S)-4-(Dimethoxymethyl)-9-methyldec-1-en-6-yn-5-yl benzoate (5’Bc) 
The product was prepared as described above starting from 
adduct 5Bc (36 mg, 0.15 mmol, 1 equiv.). Yellow oil. Yield: 
95% (51 mg, 0.14 mmol). 1H-NMR (300 MHz, CDCl3) δ 
8.16 – 7.94 (m, 2H), 7.61 – 7.52 (m, 1H), 7.47 – 7.42 (m, 
2H), 6.10 – 5.90 (m, 1H), 5.86 (dt, J = 4.2, 2.0 Hz, 1H), 5.15 – 4.90 (m, 2H), 4.44 (d, J 
= 7.3 Hz, 1H), 3.41 (s, 3H), 3.36 (s, 3H), 2.59 – 2.39 (m, 2H), 2.37 – 2.27 (m, 1H), 2.14 
(dd, J = 6.5, 2.0 Hz, 2H), 1.91 – 1.72 (m, 1H), 0.98 (d, J = 6.6 Hz, 6H). 
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5.3.4. Cross-aldol reaction of α,β-ynones 
5.3.4.1. General procedure 
 
To a solution of the amine catalyst C1 (47 mg, 0.1 mmol, 20 mol%), benzoic 
acid (12 mg, 0.1 mmol, 20 mol%) and the corresponding ynone 2 (0.5 mmol, 1 equiv.) 
in THF (0.5 mL) at –40 ºC the corresponding aldehyde 3 (0.75 mmol, 1.5 equiv.) was 
added. The resulting solution was stirred at –40 ºC for 48 h until the reaction stopped 
(1H NMR monitoring), and to the mixture MeOH (4.5 mL), trimethyl orthoformate 
(0.16 mL, 1.5 mmol, 3 equiv.) and pTSA (20 mg, 0.1 mmol, 20 mol%) were 
successively added at –60 ºC. The mixture was allowed to reach 0 ºC and, after 2 h 
stirring, the reaction was quenched with saturated NaHCO3 (5 mL) and extracted with 
ethyl acetate (2 × 4 mL). The combined organic layers were washed with brine, dried 
over MgSO4 and concentrated. The crude product was purified by flash column 
chromatography on silica gel (eluting with hexane/THF 92:8), thus allowing in each 
case separation of syn (major) and anti (minor) aldol diastereomers. 
Racemic reactions were conducted following the procedure for the asymmetric 
version, but using (±)1C (20 mol%) as the catalyst. 
 
5.3.4.2. Characterization data for compounds 9 
Methyl (R)-2-((R)-1,1-dimethoxy-3-phenylpropan-2-yl)-2-hydroxy-4-phenylbut-3-
ynoate (9Aa) 
The compound was obtained following the general procedure from 
aldehyde 3A (97 µL, 0.75 mmol) and ynone 2a (94 mg, 0.5 mmol). 
White solid. The adduct was obtained in a 5:1 syn/anti ratio. m. p.: 
123–127ºC. Yield: 83% (153 mg, 0.42 mmol). [α]D25 = –69.5º (c = 
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1.00, 95% ee, CH2Cl2). 1H-NMR (500 MHz, CDCl3) δ 7.41 – 7.38 (m, 2H), 7.36 – 7.27 
(m, 6H), 7.22 – 7.13 (m, 2H), 4.33 (d, J = 6.2 Hz, 1H), 3.81 (s, 3H), 3.52 (s, 1H), 3.41 
(dd, J = 7.4, 6.1 Hz, 1H), 3.34 (s, 3H), 3.10 (s, 3H), 2.93 (dd, J = 14.4, 7.9 Hz, 1H), 2.89 
– 2.81 (m, 1H). 13C-NMR (125 MHz, CDCl3) δ 172.6, 140.8, 132.0, 131.9, 129.2, 
129.2, 129.1, 128.7, 128.6, 128.5, 128.2, 128.2, 125.9, 106.2, 87.7, 85.9, 73.6, 56.7, 
53.5, 53.2, 50.1, 33.3. MS: calculated for C20H17O3 (M – (OMe)2–), 305.1178; found, 
305.1189. The enantiomeric purity of the major isomer was determined by chiral HPLC 
analysis of the crude reaction mixture (Daicel Chiralpak IA, hexane/isopropanol, 95:5; 
flux = 0.5 mL/min; retention times: 20.2 min (major), 27.5 min (minor)). 
Methyl (2R,3R)-3-(dimethoxymethyl)-2-hydroxy-2-(phenylethynyl)hex-5-enoate 
(9Ba) 
The compound was obtained following the general procedure from 
aldehyde 3B (74 µL, 0.75 mmol) and ynone 2a (94 mg, 0.5 mmol). 
Colourless oil. The adduct was obtained in a 6:1 syn/anti ratio. 
Yield: 74% (117 mg, 0.37 mmol). [α]D25 = –83.0º (c = 1.00, 94% 
ee, CH2Cl2). 1H-NMR (300 MHz, CDCl3) δ 7.50 – 7.40 (m, 2H), 7.37 – 7.22 (m, 3H), 
6.05 (td, J = 10.1, 5.0 Hz, 1H), 5.17 – 4.96 (m, 2H), 4.42 (d, J = 7.0 Hz, 1H), 4.04 (s, 
1H), 3.83 (s, 3H), 3.36 (s, 3H), 3.35 (s, 3H), 2.77 – 2.66 (m, 1H), 2.62 – 2.50 (m, 2H). 
13C-NMR (75 MHz, CDCl3) δ 173.1, 137.5, 132.3, 129.1, 128.7, 122.5, 116.4, 106.3, 
87.8, 86.1, 73.7, 57.4, 54.2, 53.8, 48.6, 32.2. MS: calculated for C16H15O3 (M – (OMe)2–
), 255.1021; found, 255.1039. The enantiomeric purity of the major isomer was 
determined by chiral HPLC analysis of the crude reaction mixture (Daicel Chiralpak IC, 
hexane/isopropanol, 98:2; flux = 1 mL/min; retention times: 11.6 min (major), 13.1 min 
(minor)). 
Methyl (2R,3R)-3-(dimethoxymethyl)-2-((4-fluorophenyl)ethynyl)-2-hydroxyhex-5-
enoate (9Bb) 
The compound was obtained following the general 
procedure from aldehyde 3B (74 µL, 0.75 mmol) and ynone 
2b (102 mg, 0.5 mmol). Colourless oil. The adduct was 
obtained in a 8:1 syn/anti ratio. Yield: 77% (129 mg, 0.39 
mmol). [α]D21 = –80.9º (c = 1.00, 93% ee, CH2Cl2). 1H-NMR (300 MHz, CDCl3) δ 7.41 
(dd, J = 8.9, 5.4 Hz, 2H), 6.99 (t, J = 8.7 Hz, 2H), 6.15 – 5.90 (m, 1H), 5.15 – 4.99 (m, 
2H), 4.39 (d, J = 6.9 Hz, 1H), 4.04 (s, 1H), 3.82 (s, 3H), 3.35 (s, 3H), 3.34 (s, 3H), 2.76 
– 2.64 (m, 1H), 2.62 – 2.44 (m, 2H). 13C-NMR (75 MHz, CDCl3) δ172.6, 164.4, 161.1, 
137.0, 133.8, 133.7, 115.9, 115.7, 115.4, 105.8, 87.1, 84.6, 73.2, 56.9, 53.8, 53.3, 48.1, 
31.7. MS: calculated for C16H14FO3 (M – (OMe)2–), 273.0927; found, 273.0916. The 
enantiomeric purity of the major isomer was determined by chiral HPLC analysis of the 
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crude reaction mixture (Daicel Chiralpak IC, hexane/isopropanol, 95:5; flux = 1 
mL/min; retention times: 7.3 min (major), 8.0 min (minor)). 
Methyl (2R,3R)-2-((3-chlorophenyl)ethynyl)-3-(dimethoxymethyl)-2-hydroxyhex-5-
enoate (9Bc) 
The compound was obtained following the general 
procedure from aldehyde 3B (74 µL, 0.75 mmol) and ynone 
2c (111 mg, 0.5 mmol). Colourless oil. The adduct was 
obtained in a 5:1 syn/anti ratio. Yield: 65% (115 mg, 0.33 
mmol). [α]D21 = –18.3º (c = 1.00, 94% ee, CH2Cl2). 1H-NMR (300 MHz, CDCl3) δ 7.42 
(t, J = 1.8 Hz, 1H), 7.34 – 7.28 (m, 2H), 7.25 – 7.20 (m, 1H), 6.02 (td, J = 10.1, 5.0 Hz, 
1H), 5.16 – 4.97 (m, 2H), 4.40 (d, J = 6.9 Hz, 1H), 4.05 (s, 1H), 3.84 (s, 3H), 3.37 (s, 
3H), 3.35 (s, 3H), 2.74 – 2.65 (m, 1H), 2.62 – 2.48 (m, 2H). 13C-NMR (75 MHz, 
CDCl3) δ 172.5, 136.9, 134.1, 131.7, 130.0, 129.5, 129.0, 125.5, 116.1, 105.8, 88.6, 
84.2, 73.2, 57.0, 53.8, 53.4, 48.1, 31.8. MS: calculated for C18H21ClO5 (M – (OMe)2–), 
261.0318; found, 261.0763. The enantiomeric purity of the major isomer was 
determined by chiral HPLC analysis of the crude reaction mixture (Daicel Chiralpak IA, 
hexane/isopropanol, 98:2; flux = 1 mL/min; retention times: 9.5 min (major), 11.5 min 
(minor)). 
Methyl (2R,3R)-3-(dimethoxymethyl)-2-hydroxy-2-(m-tolylethynyl)hex-5-enoate 
(9Bd) 
The compound was obtained following the general 
procedure from aldehyde 3B (74 µL, 0.75 mmol) and ynone 
2d (101 mg, 0.5 mmol). Colourless oil. The adduct was 
obtained in a 13:1 syn/anti ratio. Yield: 72% (120 mg, 0.36 
mmol). [α]D21 = –83.0º (c = 1.00, 80% ee, CH2Cl2). 1H-NMR (300 MHz, CDCl3) δ 7.32 
– 7.08 (m, 5H), 6.06 (ddd, J = 17.1, 10.1, 7.0 Hz, 1H), 5.19 – 4.95 (m, 2H), 4.41 (d, J = 
7.0 Hz, 1H), 4.02 (s, 1H), 3.83 (s, 3H), 3.36 (s, 3H), 3.35 (s, 3H), 2.81 – 2.66 (m, 1H), 
2.67 – 2.45 (m, 2H), 2.31 (s, 3H). 13C-NMR (75 MHz, CDCl3) δ 173.1 , 138.3 , 137.5 , 
132.8 , 130.0 , 129.3 , 128.5 , 125.9 , 122.2 , 116.3 , 106.3 , 87.4 , 86.3, 73.6 , 57.3 , 
54.1 , 53.7 , 48.5 , 32.2 , 30.7 , 21.5. MS: calculated for C18H21ClO5 (M – (OMe)2–), 
261.0318; found, 261.0763. The enantiomeric purity of the major isomer was 
determined by chiral HPLC analysis of the crude reaction mixture (Daicel Chiralpak IA, 
hexane/isopropanol, 95:5; flux = 1 mL/min; retention times: 6.7 min (major), 8.0 min 
(minor)). 
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Methyl (2R,3R)-3-(dimethoxymethyl)-2-hydroxy-2-(phenylethynyl)hexaneate (9Ca) 
The compound was obtained following the general procedure from 
aldehyde 3C (74 µL, 0.75 mmol) and ynone 2a (94 mg, 0.5 mmol). 
Colourless oil. The adduct was obtained in a 8:1 syn/anti ratio. 
Yield: 65% (120 mg, 0.36 mmol). [α]D21 = –21.0º (c = 1.00, 93% 
ee, CH2Cl2). 1H-NMR (300 MHz, CDCl3) δ 7.45 – 7.40 (m, 2H), 7.34 – 7.27 (m, 3H), 
4.39 (d, J = 7.4 Hz, 1H), 4.01 (d, J = 0.4 Hz, 1H), 3.83 (s, 3H), 3.37 (s, 3H), 3.36 (s, 
3H), 2.45 (dt, J = 7.3, 4.8 Hz, 1H), 1.89 (ddd, J = 11.9, 8.4, 3.5 Hz, 1H), 1.73 – 1.50 (m, 
3H), 0.96 (t, J = 7.2 Hz, 3H). 13C-NMR (75 MHz, CDCl3) δ 173.4, 132.2, 129.0, 128.6, 
125.9, 122.6, 107.0, 88.1, 85.5, 73.9, 58.7 – 57.4, 54.3, 53.7, 48.5, 30.7, 30.0, 22.1, 
15.0. MS: calculated for C17H21O4 (M – OMe–), 289.1434; found, 289.1427. The 
enantiomeric purity of the major isomer was determined by chiral HPLC analysis of the 
crude reaction mixture (Daicel Chiralpak IA+IC, hexane/isopropanol, 95:5; flux = 0.5 
mL/min; retention times: 29.7 min (major), 34.6 min (minor)). 
Methyl (2R,3R)-3-(dimethoxymethyl)-2-hydroxy-4-methyl-2-
(phenylethynyl)pentanoate (9Da) 
The compound was obtained following the general procedure from 
aldehyde 3D (74 µL, 0.75 mmol) and ynone 2a (94 mg, 0.5 mmol). 
Colourless oil. The adduct was obtained in a 5:1 syn/anti ratio. 
Yield: 70% (112 mg, 0.35 mmol). [α]D22 = –33.4º (c = 1.00, 95% 
ee, CH2Cl2). 1H-NMR (300 MHz, CDCl3) δ 7.46 – 7.40 (m, 2H), 7.33 – 7.26 (m, 3H), 
4.52 (d, J = 8.1 Hz, 1H), 3.98 (d, J = 0.7 Hz, 1H), 3.83 (s, 3H), 3.36 (s, 3H), 3.35 (s, 
3H), 2.68 – 2.56 (m, 1H), 2.47 – 2.40 (m, 1H), 1.16 (dd, J = 7.1, 3.2 Hz, 6H). 13C-NMR 
(75 MHz, CDCl3) δ 173.3, 131.7, 129.0, 128.6, 128.2, 128.2, 105.2, 88.1, 85.7, 74.2, 
57.1, 53.3, 53.2, 51.6, 27.7, 23.2, 19.1. MS: calculated for C16H17O3 (M – (OMe)2–), 
257.11782; found, 257.1216. The enantiomeric purity of the major isomer was 
determined by chiral HPLC analysis of the crude reaction mixture (Daicel Chiralpak IA, 
hexane/isopropanol, 95:5; flux = 1 mL/min; retention times: 9.2 min (major), 11.2 min 
(minor)). 
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5.3.5. Elaboration of adducts 5 and 9 
5.3.5.1. Silylation of adducts 
General procedure for the silylation of adducts 5 
 
To a solution of alcohol 5 (0.5 mmol) in CH2Cl2 (2 mL) at –10 ºC were 
successively added DIPEA (194 mg, 1.5 mmol, 3 equiv.) and triisopropylsilyl 
trifluoromethanesulfonate (184 mg, 0.6 mmol, 1.2 equiv.). The resulting mixture was 
stirred at –10 ºC for 1 h, diluted with CH2Cl2 (15 mL), and the organic solution was 
washed with a saturated solution of NH4Cl (2 × 10 mL) and saturated NHCO3 (2 × 10 
mL). The organic layer was dried over MgSO4 and concentrated. The crude product was 
purified by flash column chromatography on silica gel (eluting with hexane/EtOAc 
95:5) to afford the pure silyl ether compound as a yellow oil. 
(((3R,4R)-4-(Dimethoxymethyl)-1-phenylhept-6-en-1-yn-3-yl)oxy)triisopropylsilane 
(6a) 
The compound was prepared as described above from adduct 5a 
(130 mg, 0.5 mmol). Yield: 72% (150 mg, 0.36 mmol). 1H-NMR 
(300 MHz, CDCl3) δ 7.45 – 7.42 (m, 2H), 7.35 – 7.33 (m, 3H), 
6.24 – 5.97 (m, 1H), 5.16 – 5.04 (m, 1H), 5.04 – 4.96 (m, 1H), 
4.94 (d, J = 4.8 Hz, 1H), 4.47 (d, J = 7.5 Hz, 1H), 3.43 (s, 3H), 3.40 (s, 3H), 2.57 (dt, J 
= 15.7, 7.0 Hz, 1H), 2.39 (dt, J = 14.5, 7.8 Hz, 1H), 2.19 (dt, J = 13.0, 5.5 Hz, 1H), 1.23 
– 1.11 (m, 21H). 
(((4R,5R)-4-(dimethoxymethyl)-9-methyldec-1-en-6-yn-5-yl)oxy)triisopropylsilane 
(6c) 
The compound was prepared as described above from adduct 5c 
(120 mg, 0.5 mmol). Yield: 68% (135 mg, 0.34 mmol). 1H-
NMR (300 MHz, CDCl3) δ 6.14 – 6.00 (m, 1H), 5.05 (dd, J = 
17.1, 2.3 Hz, 1H), 4.99 – 4.87 (m, 1H), 4.38 (d, J = 7.7 Hz, 1H), 
3.39 (s, 3H), 3.35 (s, 3H), 2.68 – 2.43 (m, 1H), 2.36 – 2.21 (m, 1H), 2.14 (d, J = 2.0 Hz, 
1H), 2.12 (d, J = 2.0 Hz, 1H), 2.10 – 2.04 (m, 1H), 3.15 – 3.10 (m, 21H), 1.01 (d, J = 
6.6 Hz, 6H). 
Experimental section 
 
247 
 
(((3R,4R)-4-(Dimethoxymethyl)-1-(thiophen-3-yl)hept-6-en-1-yn-3-
yl)oxy)triisopropylsilane (6d) 
The compound was prepared as described above from adduct 5d 
(133 mg, 0.5 mmol). Yield: 70% (144 mg, 0.35 mmol). 1H-
NMR (300 MHz, CDCl3) δ 7.45 – 7.42 (m, 2H), 7.35 – 7.33 (m, 
3H), 6.24 – 5.97 (m, 1H), 5.16 – 5.04 (m, 1H), 5.04 – 4.96 (m, 
1H), 4.94 (d, J = 4.8 Hz, 1H), 4.47 (d, J = 7.5 Hz, 1H), 3.43 (s, 3H), 3.40 (s, 3H), 2.57 
(dt, J = 15.7, 7.0 Hz, 1H), 2.39 (dt, J = 14.5, 7.8 Hz, 1H), 2.19 (dt, J = 13.0, 5.5 Hz, 
1H), 1.23 – 1.11 (m, 21H). 
 
Silylation of adduct 9Aa 
 
To a solution of tertiary alcohol 9Aa (159 mg, 0.5 mmol, 1 equiv.) in CH2Cl2 (2 
mL) at –10 ºC were successively added DMAP (6.1 mg, 0.05 mmol, 10 mol%), TEA 
(0.2 mL, 1.5 mmol, 3 equiv.) and trimethylchlorosilane (134 µL, 1 mmol, 2 equiv.). The 
resulting mixture was stirred at room temperature for 1 h, diluted with CH2Cl2 (15 mL), 
and the organic solution was washed with a saturated solution of NH4Cl (2 × 10 mL) 
and saturated NaHCO3 (2 × 10 mL). The organic layer was dried over MgSO4 and 
concentrated. The crude product was purified by flash column chromatography on silica 
gel (eluting with hexane/EtOAc 95:5) to afford the pure silyl ether compound as a 
yellow oil. Yield: Cuantitative (195 mg, 0.5 mmol). 1H-NMR (300 MHz, CDCl3) δ 7.48 
– 7.44 (m, 2H), 7.39 – 7.33 (m, 3H), 6.09 (ddd, J = 13.9, 10.1, 7.2 Hz, 1H), 5.17 – 4.95 
(m, 2H), 4.38 (d, J = 8.0 Hz, 1H), 3.79 (s, 3H), 3.37 (s, 3H), 3.36 (s, 3H), 2.73 – 2.55 
(m, 2H), 2.53 – 2.42 (m, 1H), 0.30 (s, 9H). 
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5.3.5.2. Intramolecular Pauson-Khand reaction 
Intramolecular Pauson-Khand reaction of compounds 6 
 
[Co2(CO)8] (341 mg, 1 mmol, 2 equiv.) was added to a solution of the 
corresponding sylilated propargylic alcohol 6 (0.5 mmol, 1 equiv.) in CH2Cl2 (2 mL) at 
room temperature and was stirred for 30 min. Then trimethylamine N-oxide (TMANO) 
(226 mg, 3 mmol, 6 equiv.) was added at –10 ºC and the mixture was allowed to warm 
to room temperature until the initially formed Co complex disappeared (16 h), at which 
time usually a purple precipitate had formed. The mixture was passed through a small 
plug of silica gel and the filtrate was concentrated in vacuo. The residue was purified by 
flash column chromatography on silica gel eluting with hexane/EtOAc 95:5, affording 
the desired bicyclic compound as a yellow oil. 
(4S,5R,6aR)-5-(dimethoxymethyl)-3-phenyl-4-((triisopropylsilyl)oxy)-4,5,6,6a-
tetrahydropentalen-2(1H)-one (7a) 
The compound was obtained following the general procedure from 
silylated propargylic alcohol 6a (208 mg, 0.5 mmol). Yellow oil. 
The adduct was obtained in a >20:1 dr. Yield: 65% (144 mg, 0.33 
mmol). 1H-NMR (300 MHz, CDCl3) δ 7.41 – 7.29 (m, 5H), 5.06 
(s, 1H), 4.09 (d, J = 6.4 Hz, 1H), 3.35 (s, 3H), 3.34 (s, 3H), 2.85 (dd, J = 18.3, 6.6 Hz, 
1H), 2.70 (dd, J = 14.4, 6.5 Hz, 1H), 2.40 (dt, J = 12.9, 9.1 Hz, 1H), 2.24 (dd, J = 18.4, 
2.7 Hz, 1H), 1.23 – 1.16 (m, 1H), 0.97 – 0.89 (m, 21H). 13C-NMR (75 MHz, CDCl3) δ 
209.2, 180.2, 134.2, 131.4, 128.4, 128.2, 127.9, 106.2, 69.6, 54.9, 53.8, 53.2, 42.7, 39.0, 
30.1, 17.8, 17.8, 12.2. MS: calculated for C26H40O4Si (M + H
+), 445.2774; found: 
445.2726. 
(4S,5R,6aR)-5-(dimethoxymethyl)-3-isobutyl-4-((triisopropylsilyl)oxy)-4,5,6,6a-
tetrahydropentalen-2(1H)-one (7c) 
The compound was obtained following the general procedure from 
silylated propargylic alcohol 6c (127 mg, 0.32 mmol). Yellow oil. 
The adduct was obtained in a >20:1 dr. Yield: 64% (87 mg, 0.32 
mmol). 1H-NMR (300 MHz, CDCl3) δ 4.82 (s, 1H), 4.01 (d, J = 
7.4 Hz, 1H), 3.34 (s, 3H), 3.29 (s, 3H), 2.67 (dd, J = 18.3, 6.4 Hz, 
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2H), 2.36 – 2.27 (m, 1H), 2.26 – 2.18 (m, 1H), 2.11 – 2.01 (m, 1H), 1.97 (d, J = 13.1 
Hz, 1H), 1.91 – 1.81 (m, 1H), 1.09 – 1.02 (m, 21H), 1.00 – 0.92 (m, 2H), 0.88 (d, J = 
6.5 Hz, 3H), 0.80 (d, J = 6.5 Hz, 3H). 13C-NMR (75 MHz, CDCl3) δ 211.5, 179.2, 
134.7, 105.9, 69.8, 54.5, 53.7, 52.9, 42.4, 39.4, 33.1, 30.8, 27.1, 22.9, 22.4, 18.0, 18.0, 
12.5. MS: calculated for C24H44O4Si (M + H
+), 425.3087; found: 425.3053. 
(4S,5R,6aR)-5-(dimethoxymethyl)-3-(thiophen-3-yl)-4-((triisopropylsilyl)oxy)-
4,5,6,6a-tetrahydropentalen-2(1H)-one (7d) 
The compound was obtained following the general procedure from 
silylated propargylic alcohol 6d (76 mg, 0.18 mmol). Yellow oil. 
The adduct was obtained in a >20:1 dr. Yield: 65% (52 mg, 0.33 
mmol). 1H-NMR (300 MHz, CDCl3), 7.70 – 7.65 (m, 1H), 7.35 – 
7.28 (m, 2H), 5.16 (s, 1H), 4.04 (d, J = 6.5 Hz, 1H), 3.33 (s, 3H), 
3.32 (s, 3H), 2.83 (dd, J = 18.3, 6.6 Hz, 1H), 2.70 (dd, J = 14.8, 6.6 Hz, 1H), 2.46 – 2.33 
(m, 1H), 2.21 (dd, J = 18.3, 2.7 Hz, 1H), 1.23 – 1.10 (m, 1H), 1.03 – 0.90 (m, 21H). 
13C-NMR (75 MHz, CDCl3) δ 209.2, 178.5, 127.0, 125.2, 124.3, 106.2, 70.1, 54.9, 
53.8, 53.2, 42.8, 39.0, 30.1, 17.9, 17.8, 12.3. MS: calculated for C24H38O4SSi (M + H
+), 
452.338; found: 451.2318. 
 
Intramolecular Pauson-Khand reaction of compound 11 
 
The intramolecular Pauson-Khand reaction of compound 11 (195 mg, 0.5 mmol) 
was conducted following the procedure described above for secondary silylated 
propargylic alcohols 6, obtaining the bicyclic product as a 1.5:1 mixture of 
diastereomers. Combined yield: 53% (97 mg, 0.27 mmol). Data of major isomer: 1H-
NMR (300 MHz, CDCl3) 7.37 (ddd, J = 8.7, 7.8, 6.1 Hz, 3H), 7.26 – 7.16 (m, 2H), 4.54 
(d, J = 8.5 Hz, 1H), 3.54 – 3.43 (m, 1H), 3.30 (s, 3H), 3.30 (s, 3H), 3.07 – 2.89 (m, 2H), 
2.86 (s, 3H), 2.36 (dd, J = 18.0, 3.7 Hz, 1H), 2.16 (ddd, J = 13.4, 11.4, 9.3 Hz, 1H), 1.72 
(ddd, J = 13.7, 10.2, 5.3 Hz, 1H), 0.32 (s, 9H). 13C-NMR (75 MHz, CDCl3) δ 208.5, 
177.5, 171.1, 135.1, 130.3, 129.2, 128.2, 128.0, 104.8, 80.9, 55.5, 53.4, 52.0, 51.2, 44.7, 
39.8, 29.0, 2.5. MS: calculated for C24H44O4Si (M + H
+), 419.1890; found, 419.1869. 
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5.3.5.3. Hydrolysis of the acetal 7a 
 
To a solution of the acetal 7a (355 mg, 0.80 mmol) in CH2Cl2 (40 mL) 7.4 wt% 
FeCl3 on SiO2 (80 mg) was added, and the resulting suspension was stirred vigorously 
for 1 h. Then aqueous NaHCO3 (1 mL) was added, and the organic phase was washed 
with brine, dried over MgSO4 and concentrated. Flash column chromatography on silica 
gel (hexane/EtOAc 95:5) of the residue afforded the pure aldehyde 8 (yellow oil; 65%, 
206 mg, 0.52 mmol) along with unreacted starting material 7a (15%, 54 mg, 0.12 
mmol). Effective yield of isolated 8 based on recovered starting material: 80%. 1H-
NMR (300 MHz, CDCl3) 9.74 (d, J = 1.1 Hz, 1H), 7.44 – 7.30 (m, 5H), 5.42 (s, 1H), 
3.45 (ddd, J = 16.2, 9.4, 2.8 Hz, 1H), 3.39 – 3.30 (m, 1H), 2.90 (dd, J = 18.4, 6.6 Hz, 
1H), 2.60 (dt, J = 12.8, 9.1 Hz, 1H), 2.30 (dd, J = 18.4, 2.8 Hz, 1H), 1.51 (ddd, J = 12.9, 
9.8, 7.5 Hz, 1H), 1.07 – 0.84 (m, 21H). 13C-NMR (75 MHz, CDCl3) δ 208.3, 199.6, 
177.2, 135.7, 130.7, 128.6, 128.4, 128.3, 68.0, 62.9, 42.6, 39.3, 29.3, 18.0, 17.9, 12.3. 
MS: calculated for C24H35O3Si (M + H
+), 399.2355; found, 399.2328. 
 
5.3.5.4. Reduction of adducts 9Ba and 9Ca 
 
To a solution of 9Ba or 9Ca (0.2 mmol) in EtOH (0.8 mL) Pd 10% wt. on 
activated carbon (20 wt%) was added. The mixture was allowed to stir under hydrogen 
atmosphere (1 atm) for 16 h. The mixture was then filtered over celite (2 cm) and the 
solvent was eliminated under reduced pressure yielding the desired product 10 as 
colourless oil. Yield: 76% (49 mg, 0.15 mmol). 1H-NMR (300 MHz, CDCl3) 7.31 – 
7.24 (m, 2H), 7.23 – 7.14 (m, 3H), 4.28 (d, J = 5.8 Hz, 1H), 3.75 (s, 3H), 3.73 (d, J = 
0.8 Hz, 1H), 3.35 (s, 3H), 3.35 (s, 3H), 2.76 (td, J = 12.8, 4.6 Hz, 1H), 2.35 – 2.20 (m, 
1H), 2.15 – 2.01 (m, 2H), 1.99 – 1.85 (m, 1H), 1.60 – 1.43 (m, 3H), 1.41 – 1.25 (m, 
1H), 0.89 (t, J = 6.9 Hz, 3H). 13C-NMR (75 MHz, CDCl3) δ 176.9, 141.82,128.43 
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128.4, 125.9, 78.3, 56.7, 54.63, 52.2, 47.6, 39.4, 29.7, 27.4, 22.2, 14.6. MS: calculated 
for C17H25O4Si (M – OMe–), 293.1753; found, 293.1768. 
 
5.3.6. ORTEP diagram of compound 9Aa 
CCDC-930356 contains the supplementary crystallographic data for the 
structural analysis of 9Aa. These data can be obtained free of charge from The 
Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. 
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5.3.7. Representative NMR spectra 
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5.3.8. HPLC chromatograms 
Chiralpack AD-H, 0.5 mL/min, hexane/isopropanol 95:5, λ = 240 nm 
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Chiralpack IC, 1 mL/min, hexane/isopropanol 99:1, λ = 230 nm 
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Chiralpack IC, 0.75 mL/min, hexane/isopropanol 98:2, λ = 230 nm 
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Chiralpack AD-H, 0.5 mL/min, hexane/isopropanol 95:5, λ = 210 nm 
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Chiralpack IA, 0.5 mL/min, hexane/isopropanol 95:5, λ = 240 nm 
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Chiralpack IC, 1 mL/min, hexane/isopropanol 98:2, λ = 240 nm 
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Chiralpack IC, 1 mL/min, hexane/isopropanol 95:5, λ = 240 nm 
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Chiralpack IA, 1 mL/min, hexane/isopropanol 98:2, λ = 240 nm 
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Chiralpack IA, 1 mL/min, hexane/isopropanol 95:5, λ = 240 nm 
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Chiralpack IA+IC, 0.5 mL/min, hexane/isopropanol 95:5, λ = 240 nm 
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Chiralpack IA, 1 mL/min, hexane/isopropanol 95:5, λ = 240 nm 
 
 
 
 
 
 
  
Experimental section 
 
287 
 
5.4. Experimental section of Chapter 3 
5.4.1. General procedures for the synthesis of α’-oxy enones 
5.4.1.1. Preparation of α’-oxy enones 13 
Preparation of α’-hydroxy enone 13a 
Known enone 13a was prepared according to either of the following previously 
described procedures: 
 
Method A:245 To a solution of methoxypropadiene (3.50 g, 50 mmol) in dry Et2O (100 
mL) at –40 °C, nBuLi (2.5 M in hexanes, 22 mL, 55 mmol) was added under nitrogen 
and the reaction mixture was stirred at –40 °C for 10 min. Then, acetone (4.04 mL, 55 
mmol) in dry Et2O (55 mL) was added within 5 min. The reaction mixture was stirred at 
the same temperature for 0.5 h and quenched with H2O (100 mL). The resulting mixture 
was allowed to warm to room temperature and extracted with Et2O (3 x 100 mL). The 
combined organic extracts were dried over Na2SO4 and concentrated under reduced 
pressure to afford 2-methyl-3-methoxy-3,4-pentadien-2-ol as a yellow liquid, which was 
added dropwise to 5% aq H2SO4 (110 mL) at 0 °C and the mixture was stirred for 1.5 h. 
After this time, the reaction was allowed to warm to room temperature and the solution 
was saturated with solid NaCl. The mixture was extracted with Et2O (5 x 60 mL) and 
the combined extracts were washed with brine and dried over Na2SO4. The solvent was 
removed to give a yellow oil which upon distillation afforded the enone as a colorless 
liquid. Yield: 88% (4.42 g, 38.7 mmol). All data were consistent with those previously 
reported. b.p. = 45 ºC (13 mmHg). 1H NMR (CDCl3) δ 6.73 (dd, J = 9.5, 16.8 Hz, 1H), 
6.50 (dd, J = 2.2, 16.8 Hz, 1H), 5.82 (dd, J = 2.2, 10.3 Hz, 1H), 1.38 (s, 6H). 13C NMR 
(CDCl3) δ 202.3, 131.1, 128.8, 75.4, 26.1. 
                                                 
245 C. Palomo, M. Oiarbide, J. M. García, A. González, E. Arceo, J. Am. Chem. Soc. 2003, 125, 13942–
13943. 
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Method B:246 Commercially available 3-hydroxy-3-methyl-2-butanone (1 equiv., 5.3 
mL, 50 mmol) and paraformaldehyde (2 equiv., 3 g, 100 mmol) were added to a 
solution of iPr2NH (2 equiv., 14.0 mL, 100 mmol) and TFA (2.5 equiv., 9.6 mL, 125 
mmol) in THF (250 mL). The mixture was refluxed and paraformaldehyde (2 equiv., 3 
g, 100 mmol) was added every 2 h three times. The mixture was stirred at reflux 
overnight and then was cooled to room temperature. CH2Cl2 (100 mL) was added and 
the mixture was washed with 1N HCl (75 mL), 1N NaOH (75 mL) and brine (75 mL), 
and the organic layer was dried over MgSO4. The solvent was removed under reduced 
pressure (230 mbar/ bath 40 ºC). The residue was purified by flash column 
chromatography on silica gel (eluent: diethyl ether) to afford 4-hydroxy-4-methylpent-
1-en-3-one as colorless oil. Yield: 89% (5.0 g, 44.5 mmol). 
 
Preparation of α’-trimethylsilyloxy enone 13b247 
 
3-(Trimethylsilyl)-2-oxazolidinone (TMSO) (3.4 mL, 22.5 mmol, 1.5 equiv.) 
and 3 drops of trifluoromethanesulfonic acid were added to enone 13a (1.68 g, 15 
mmol, 1.5 equiv.). The reaction mixture was stirred at room temperature for 2 h, diluted 
with pentane (20 mL) and subsequently washed with water (20 mL) and NaHCO3 sat. 
(20 mL). The organic phase was then dried over with MgSO4 and concentred under 
reduced pressure to afford the title compound 13b as a colorless oil. Yield: 93% (2.6 g, 
14.0 mmol). 1H NMR (300 MHz, CDCl3) δ 7.03 (dd, J = 17.3, 10.4 Hz, 1H), 6.38 (dd, J 
= 17.3, 2.1 Hz, 1H), 5.72 (dd, J = 10.4, 2.1 Hz, 1H), 1.37 (s, 6H), 0.14 (s, 9H). 13C 
NMR (75 MHz, CDCl3) δ 202.8, 130.7, 129.2, 79.3, 27.2, 2.3. 
 
Preparation of α’-triethylsilyloxy enone 13c 
The title compound 13c was prepared according to the following synthetic 
sequence: 
                                                 
246 Adapted from: A. Bugarin, K. D. Jones, B. T. Connell, Chem. Commun. 2010, 46, 1715–1717. 
247 Adapted from: J. M. Aizpurua, C. Palomo, A. L. Palomo, Can. J. Chem. 1984, 62, 336–340. 
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1st step:248 Methyl 2-hydroxyisobutyrate (6.9 mL, 60 mmol, 1.2 equiv.) was added 
under a nitrogen atmosphere to a solution of dimethyl amino pyridine (1.22 g, 10 mmol, 
0.2 equiv.), triethylamine (10 mL, 50 mmol, 1 equiv.) and triethylchlorosilane (6.7 mL, 
50 mmol, 1 equiv.) in 50 mL of CH2Cl2. The reaction mixture was stirred at room 
temperature for 24 hours. After filtering over celite to remove the salt, the filtrate was 
diluted with diethyl ether (150 mL) and the resulting solution was washed with brine (1 
x 50 mL) and water (1 x 50 mL). The solvent was removed under reduced pressure to 
give the corresponding triethylsilyl ether, which was used as such without further 
purification. Dimethyl methyl phosphonate (13.8 mL, 130 mmol, 2.5 equiv.) in dry THF 
(40 mL) was added dropwise to a cold solution of nBuLi (1.6 M in hexanes, 79 mL, 130 
mmol, 2.5 equiv.) in dry THF (80 mL) at –78 °C under a nitrogen atmosphere. After 30 
min of stirring at the same temperature, a solution of the crude triethylsilyl ether (16 g, 
50 mmol, 1 equiv.) in dry THF (100 mL) was added dropwise at –78 °C. The mixture 
was stirred at the same temperature (–78 °C) for 3 h and then quenched at this 
temperature with a saturated NH4Cl solution (200 mL). The reaction mixture was 
allowed to reach room temperature, it was extracted with diethyl ether (3 x 250 mL) and 
dried over MgSO4. The solvent was then evaporated under reduced pressure to get 
phosphonic acid dimethyl ester, which was used for the next step without further 
purification. Yield: 99%, (16.0 g, 49.5 mmol). 1H NMR (300 MHz, CDCl3) δ 3.79 (d, J 
= 11.2 Hz, 6H), 3.39 (d, J = 20.7 Hz, 2H), 1.36 (s, 6H), 1.05 – 0.86 (m, 9H), 0.74 – 0.56 
(m, 6H). 
2nd step: Dried LiCl (1.17 g, 27 mmol, 1 equiv.) and Et3N (3.8 mL, 27 mmol, 1 equiv.) 
were added successively to a solution of (3-methyl-2-oxo-3-
triethylsilyloxybutyl)phosphonic acid dimethyl ester (8.7 g, 27 mmol) in dry MeCN (67 
mL). The resulting milky suspension was stirred for 15 min at room temperature and the 
formaldehyde (37% in water; 5.4 mL, 54 mmol, 2 equiv.) was added dropwise. The 
mixture was stirred for 40 h, diluted with water and extracted with Et2O. The organic 
layer was dried over MgSO4 and concentrated in vacuo. to afford the crude product that 
was purified by flash silica gel chromatography (hexane/EtOAc, 95:5). 1H NMR (300 
MHz, CDCl3) δ 7.07 (dd, J = 17.3, 10.4 Hz, 1H), 6.37 (dd, J = 17.4, 2.1 Hz, 1H), 5.71 
(dd, J = 10.4, 2.1 Hz, 1H), 1.36 (s, 6H), 1.06 – 0.85 (m, 9H), 0.71 – 0.53 (m, 6H). 
                                                 
248 Adapted from: a) P. Sampson, V. Roussis, G. J. Drtina, F. L. Koerwitz, D. F. Wiemer, J. Org. Chem. 
1986, 51, 2525–2529. b) D. G. McCarthy, C. C. Collins, J. P. O’Driscoll, S. E. Lawrence, J. Chem. Soc., 
Perkin Trans. 1 1999, 3667–3675. 
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5.4.1.2. Preparation of β-substituted α’-hydroxy enones 14 
Preparation of β-aryl substituted α’-hydroxy enones 14a-14d 
Enones 14a-14d were synthesised following the procedure previously described 
in our group:249 
 
3-Hydroxy-3-methyl-2-butanone (5.0 g, 30 mmol, 1 equiv.) was dissolved in a 
mixture of MeOH (90 mL) and H2O (30 mL). Freshly distilled aldehyde (60 mmol, 2 
equiv.) was then added followed by LiOH·H2O (5.0 g, 120 mmol, 4 equiv.). The 
reaction mixtue was stirred at reflux for 3 h, and after removal of MeOH under reduced 
pressure, the aqueous residue was diluted with H2O (30 mL) and extracted with CH2Cl2 
(3 x 50 mL). The CH2Cl2 extracts were combined, dried over MgSO4 and concentrated, 
and the crude product was purified by column chromatography (silca gel, 
hexane/EtOAc 90:10). 
(E)-4-hydroxy-4-methyl-1-(p-tolyl)pent-1-en-3-one (14a) 
The title compound 14a was prepared using 4-
methylbenzaldehyde (3.4 mL, 60 mmol, 2 equiv.) according to 
the general procedure. Yellow oil. Yield: 75% (4.4 g, 23 mmol). 
1H-NMR (300 MHz, CDCl3) δ 7.84 (d, J = 15.6 Hz, 1H), 7.50 (dd, J = 7.3, 1.1 Hz, 2H), 
7.29 – 7.16 (m, 2H), 6.99 (d, J = 15.7 Hz, 1H), 2.39 (s, 3H), 1.46 (s, 7H). 13C NMR (75 
MHz, CDCl3), δ 202.3, 145.2, 141.2, 131.4, 129.4, 128.8, 128.4, 126.7, 117.3, 75.3, 
26.2, 21.2. 
(E)-1-(4-bromophenyl)-4-hydroxy-4-methylpent-1-en-3-one (14b) 
The title compound 14c was prepared using 4-
methylromobenzaldehyde (10 g, 60 mmol, 2 equiv.) according 
to the general procedure. Yellow oil. Yield: 85% (6.5 g, 25.5 
mmol). 1H-NMR (300 MHz, CDCl3) δ 7.66 (d, J = 15.8 Hz, 1H), 7.52 – 7.31 (m, 4H), 
7.09 (d, J = 15.7 Hz, 1H), 4.11 (s, 1H), 1.41 (s, 7H). 13C NMR (75 MHz, CDCl3), δ 
202.1, 143.4, 132.9, 131.8, 129.6, 124.8, 119.0, 75.5, 26.1. 
                                                 
249 a) C. Palomo, M. Oiarbide, R. Halder, M. Kelso, E. Gómez-Bengoa, J. M. García, J. Am. Chem. Soc. 
2004, 126, 9188–9189. b) C. Palomo, M. Oiarbide, B. G. Kardak, J. M. García, A. Linden, J. Am. Chem. 
Soc. 2005, 127, 4154–4155. 
Experimental section 
 
291 
 
(E)-4-hydroxy-1-(3-methoxyphenyl)-4-methylpent-1-en-3-one (14c) 
The title compound 14d was prepared using 3-
methoxybenzaldehyde (6.6 mL, 60 mmol, 2 equiv.) according 
to the general procedure. Yellow oil. Yield: 75% (4.6 g, 24 
mmol). 1H-NMR (300 MHz, CDCl3) δ 7.75 (d, J = 15.7 Hz, 1H), 7.27 (t, J = 7.9 Hz, 
1H), 7.15 (dt, J = 7.8, 1.3 Hz, 1H), 7.08 – 7.01 (m, 2H), 6.92 (ddd, J = 8.1, 2.6, 1.0 Hz, 
1H), 4.04 (s, 1H), 3.79 (s, 3H), 1.43 (s, 7H). 13C NMR (75 MHz, CDCl3), δ 202.3, 
159.7, 145.1, 135.5, 129.8, 121.0, 118.6, 116.4, 113.5, 75.5, 55.1, 26.3. 
(E)-4-hydroxy-4-methyl-1-phenylpent-1-en-3-one (14d)250 
The title compound 14b was prepared using benzaldehyde (6.1 
mL, 60 mmol, 2 equiv.) according to the general procedure. 
Yellow oil. All data were consistent with those previously 
reported. Yield: 95% (5.4 g, 28 mmol). 1H-NMR (300 MHz, CDCl3) δ 7.83 (d, J =15.7 
Hz, 1H), 7.58 (m, 2H), 7.40 (m, 3H), 7.02 (d, J =15.4 Hz, 1H), 4.00 (s, 1H), 1.45 (s, 
6H). 13C NMR (75 MHz, CDCl3), δ 7.83 (d, J =15.7 Hz, 1H), 7.58 (m, 2H), 7.40 (m, 
3H), 7.02 (d, J =15.4 Hz, 1H), 4.00 (s, 1H), 1.45 (s, 6H). 
 
Preparation of (E)-2-hydroxy-2-methylhept-4-en-3-one (14e) 
Known compound 14e251 was prepared according to the following synthetic 
sequence: 
 
1st step:252 Methyl 2-hydroxyisobutyrate (6.9 mL, 60 mmol, 1.2 equiv.) was added 
under a nitrogen atmosphere to a solution of dimethyl amino pyridine (1.22 g, 10 mmol, 
0.2 equiv.), triethylamine (10 mL, 50 mmol, 1 equiv.) and trimethylchlorosilane (6.3 
mL, 50 mmol, 1 equiv.) in 50 mL of CH2Cl2. The reaction mixture was stirred at room 
temperature for 24 hours. After filtering over celite to remove the salt, the filtrate was 
diluted with diethyl ether (150 mL) and the resulting solution was washed with brine (1 
                                                 
250 C. Palomo, M. Oiarbide, J. M. García, A. González, E. Arceo, J. Am. Chem. Soc. 2003, 125, 13942–
13943. 
251 A. R. Katritzky, D. Feng, H. Lang, J. Org. Chem. 1997, 62, 706–714. 
252 Adapted from: a) P. Sampson, V. Roussis, G. J. Drtina, F. L. Koerwitz, D. F. Wiemer, J. Org. Chem. 
1986, 51, 2525–2529. b) D. G. McCarthy, C. C. Collins, J. P. O’Driscoll, S. E. Lawrence, J. Chem. Soc., 
Perkin Trans. 1 1999, 3667–3675. 
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x 50 mL) and water (1 x 50 mL). The solvent was removed under reduced pressure to 
give the trimethylsilyl ether, which was used as such without further purification. 
Dimethyl methyl phosphonate (13.8 mL, 130 mmol, 2.5 equiv.) in dry THF (40 mL) 
was added dropwise to a cold solution of nBuLi (1.6 M in hexanes, 79 mL, 130 mmol, 
2.5 equiv.) in dry THF (80 mL) at –78 °C under a nitrogen atmosphere. After 30 min of 
stirring at the same temperature, a solution of the crude triethylsilyl ether (16 g, 50 
mmol, 1 equiv.) in dry THF (100 mL) was added dropwise at –78 °C. The mixture was 
stirred at the same temperature (–78 °C) for 3 h and then quenched at this temperature 
with a saturated NH4Cl solution (200 mL). The reaction mixture was allowed to reach 
room temperature, it was extracted with diethyl ether (3 x 250 mL) and dried over 
MgSO4. The solvent was then evaporated under reduced pressure to get phosphonic acid 
dimethyl ester, which was used for the next step without further purification. Yield: 
99%, (14.6 g, 49.5 mmol).  
2nd step: Dried LiCl (1.17 g, 27 mmol, 1 equiv.) and Et3N (3.8 mL, 27 mmol, 1 equiv.) 
were added successively to a solution of (3-methyl-2-oxo-3-
trimethylsilyloxybutyl)phosphonic acid dimethyl ester (8.0 g, 27 mmol) in dry MeCN 
(67 mL). The resulting milky suspension was stirred for 15 min at room temperature 
and the propanal (3.9 mL, 54 mmol, 2 equiv.) was added dropwise. The mixture was 
stirred for 40 h, diluted with water and extracted with Et2O. The organic layer was dried 
over MgSO4 and concentrated in vacuo. The crude was dissolved in methanol (200 mL) 
and a solution of hydrofluoric acid (HF) (48% in water, 5 mL) was added. The resulting 
mixture was stirred for 0.5 h at room temperature and then was neutralized by addition 
of a saturated solution of NaHCO3. The mixture was extracted with CH2Cl2 (3 x 100 
mL) and the combined organic layers were dried over MgSO4 and evaporated to afford 
the crude desilylated product that was purified by flash silica gel chromatography 
(hexane/EtOAc, 98:2). Colourless oil. All spectroscopic data were consistent with those 
previously reported. Yield: 75% (3.2 mg, 20 mmol). 1H NMR (400 MHz, CDCl3) δ 
7.22 – 7.10 (m, 1H), 6.46 (d, J = 15.4 Hz, 1H), 4.09 (s, 1H), 2.30 –2.20 (m, 2H), 1.55 – 
1.43 (m, 2H), 1.40 (s, 6H), 0.97 (t, J = 7.4 Hz, 3H). 
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5.4.1.3. Preparation of α-methyl α’-oxy enones 15 
Preparation of α-methyl α’-hydroxy enone 15 
Known enone 15253 was prepared according to the following procedure: 
 
1st step: To a solution of methyl 2-hydroxy-2-methylpropanoate (1.77 g, 15 mmol, 1 
equiv.) and N,O-dimethylhydroxylamine hydrochloride (15 mmol, 1.5 equiv.) in dry 
THF (50 mL), iPrMgCl (2 M in THF; 60 mmol, 4 equiv.) was added at –20 ºC and the 
reaction mixture was stirred for 1.5 h at room temperature. The reaction was then 
quenched with a saturated solution of NH4Cl (30 mL) and extracted with CH2Cl2 (2 x 
30 mL). The combined organic phases were dried over MgSO4 and filtered and the 
solvent was evaporated under reduced pressure and crude material was purified by flash 
column chromatography (hexane/EtOAc, 80:20) to obtain the desired amide product as 
colourless oil. Yield: 90% (1.99 g, 13.5 mmol). All spectroscopic data were consistent 
with those previously reported.254 1H NMR (300 MHz, CDCl3) δ 4.29 (s, 1H), 3.73 (s, 
3H), 3.28 (s, 3H), 1.47 (s, 6H). 13C NMR (75 MHz, CDCl3) δ 177.2, 72.1, 61.0, 33.6, 
26.5. 
2nd step: To a solution of the starting amide (1.85 g, 10 mmol, 1 equiv.) in Et2O (20 
mL), isopropenyl magnesium bromide (0.5 M in THF; 60 mL, 3 equiv.) was added at –
20 ºC, and the resulting mixture was stirred at 0 ºC for 16 h. The reaction was quenched 
with a saturated solution of NH4Cl (50 mL) and extracted with Et2O (2 x 50 mL). The 
combined organic phases were dried over MgSO4, filtered and the solvent was 
evaporated under reduced pressure. The crude product was purified by flash column 
chromatography (pentane/Et2O 95:5) to obtain the desired product 15 as a colourless oil. 
Yield: 65% (833 mg, 6.5 mmol). All spectroscopic data were consistent with those 
previously reported. 1H NMR (300 MHz, CDCl3) δ 5.91 (s, 1H), 5.75 (s, 1H), 4.11 (s, 
1H), 1.86 (s, 3H), 1.42 (s, 6H). 13C NMR (75 MHz, CDCl3) δ 206.3, 140.3, 125.6, 72.0, 
28.3, 19.9. 
 
  
                                                 
253 A. Basheer, M. Mishima, I. Marek, Org. Lett. 2011, 13, 4076–4079. 
254 F. Miege, B. M. Trost, J. Am. Chem. Soc. 2014, 136, 3016–3019. 
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Preparation of α-methyl α’-trimethylsilyloxy enone 15 
 
3-(Trimethylsilyl)-2-oxazolidinone (TMSO) (1.1 mL, 7.5 mmol, 1.5 equiv.) and 
a drop of trifluoromethanesulfonic acid were added to enone 15 (640 mg, 5.0 mmol, 1 
equiv.). The reaction mixture was stirred at room temperature for 2 h, diluted with 
pentane (20 mL) and subsequently washed with water (20 mL) and NaHCO3 sat. (20 
mL). The organic phase was then dried over with MgSO4 and concentred under reduced 
pressure to afford the title compound 15’ as a yellow oil. Yield: 82% (820 mg, 4.1 
mmol). 1H NMR (300 MHz, CDCl3) δ 6.34 (s, 1H), 5.78 (s, 1H), 1.89 (s, 3H), 1.46 (s, 
6H), 0.10 (s, 9H). 
 
5.4.1.4. Preparation of α’-oxy dienones 16 
Preparation of α’-hydroxy dienone 16255 
 
3-Hydroxy-3-methyl-2-butanone (2.1 mL, 20 mmol, 1 equiv.) in THF (2.5 mL) 
was slowly added to a solution of n-butyllithium (1.6 M in Et2O; 32 mL, 50 mmol, 2.5 
equiv.) and diisopropylamine (7.7 mL, 50 mmol, 1.5 equiv.) in THF (25 mL) at –78 ºC 
and the resulting solution was stirred at the same temperature for 5 min. Next, acrolein 
(1.23 g, 22 mmol, 1.1 equiv.) in THF (2.5 mL) was added over a 10 min period and then 
p-toluenesulfonyl chloride (1.84 mL, 24 mmol, 1.2 equiv.) was added dropwise. The 
reaction mixture was allowed to warm to room temperature and was stirred until 
completion of the reaction (TLC monitoring). The solvent was eliminated under 
reduced pressure and the residue was redissolved in CH2Cl2 (80 mL). The organic phase 
was then washed with water (80 mL) and a saturated solution of NH4Cl (80 mL), dried 
over with MgSO4 and concentred under reduced pressure to afford the crude product, 
which was purified by column chromatography on silica gel (eluting hexane/EtOAc 
80:20). Yellow oil. Yield: 75% (2.1 g, 15 mmol). 1H NMR (300 MHz, CDCl3) δ 7.48 – 
                                                 
255 Adapted from: L. Bernardi, J. López-Cantero, B. Niess, K. A. Jørgensen, J. Am. Chem. Soc. 2007, 129, 
5772–5778. 
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7.36 (m, 1H), 6.59 – 6.42 (m, 2H), 5.79 – 5.59 (m, 2H), 3.94 (s, 1H), 1.39 (s, 6H). 13C 
NMR (75 MHz, CDCl3) δ 202.7, 145.4, 134.9, 128.0, 122.6, 75.4, 26.3. 
 
Preparation of α’-trimethylsilyloxy dienone 16’ 
 
3-(Trimethylsilyl)-2-oxazolidinone (TMSO) (1.1 mL, 7.5 mmol, 1.5 equiv.) and 
a drop of trifluoromethanesulfonic acid were added to dienone 16 (700 mg, 5.0 mmol, 1 
equiv.). The reaction mixture was stirred at room temperature for 2 h, diluted with 
pentane (20 mL) and subsequently washed with water (20 mL) and NaHCO3 sat. (20 
mL). The organic phase was then dried over with MgSO4 and concentred under reduced 
pressure to afford the title compound 16’ as a yellow oil. Yield: 88% (934 mg, 4.4 
mmol). 1H NMR (300 MHz, CDCl3) δ 7.29 (dd, J = 15.4, 11.0 Hz, 1H), 6.81 (d, J = 
15.4 Hz, 1H), 6.62 – 6.42 (m, 1H), 5.76 – 5.50 (m, 2H), 1.37 (s, 6H), 0.14 (s, 9H). 13C 
NMR (75 MHz, CDCl3) δ 203.2, 143.5, 135.6, 126.3, 124.6, 30.9, 27.2, 2.2. 
 
5.4.2. Preparation of 5H-oxazol-4-ones (oxazolones) 17 
Known oxazolones 17A-17D and new oxazolone 17E were prepared according 
to the synthetic sequence described by Misaki and Sugimura:256 
 
1st step:257 The corresponding amino acid (40 mmol, 1 equiv.) is solubilized in 48% 
HBr (40 mL) and 36 mL water. The reaction mixture was cooled to 0 °C and a solution 
of NaNO2 (4.4 g, 64 mmol, 1.6 equiv.) in 10 mL water was added dropwise. The 
mixture was stirred for 2.5 h at room temperature, then concentrated to remove acid 
                                                 
256 T. Misaki, G. Takimoto, T. Sugimura, J. Am. Chem. Soc. 2010, 132, 6286–6287. 
257 Z. P. Kortylewicz, R. E. Galardy, J. Med. Chem. 1990, 33, 263-273. 
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vapour, and extracted with Et2O (4 x 10 mL). The organic layers were washed with 
water, brine, dried over MgSO4, and concentrated under reduced pressure yielding the 
corresponding 2-bromo-carboxylic acid as colorless oil, which was used without further 
purification.  
2nd step:258 A solution of oxalyl chloride (1.0 mL, 12 mmol, 1.2 equiv.) in dry 
dichloromethane (6 mL) was added slowly to a stirred solution of the corresponding 
bromoacid (10 mmol, 1 eq.) in dichloromethane (0.5 mL/mmol) at 0 ºC, then 2 drops of 
DMF were added. Gas evolution was observed, and the system was allowed to stir at 
room temperature for 2 additional hours. Volatiles were removed under reduced 
pressure and the resulting crude material was added over 5 min to a suspension of 
benzamide (1.2 g, 10 mmol, 1.0 eq.) and pyridine (0.81 mL, 10 mmol, 1.0 eq.) in THF 
(12.5 mL) at 0 °C. The resulting suspension was stirred overnight at room temperature 
and diluted with EtOAc. The mixture was acidified to pH 2 with HCl 1 M and the 
phases were separated. The aqueous phase was extracted with EtOAc (3 x 20 mL) and 
the combined organic layers were washed with water (3 x 20 mL) and brine (20 mL), 
dried over MgSO4, and filtered. Volatiles were removed under reduced pressure. The 
imide product was purified by flash chromatography on silica gel (eluting with 
hexane/EtOAc 90:10). 
3rd step:256 A suspension of K2CO3 (2.0 g, 20 mmol, 2.0 equiv.) in methyl tert-
butylether (MTBE) (20 mL) was refluxed for 2 h to remove water using a Dean-Stark 
trap. The suspension was cooled to room temperature and the corresponding imide was 
added in one portion. The resulting mixture was refluxed overnight and cooled to room 
temperature. Inorganic salts were filtered through a celite pad with suction and the filter 
cake was washed with EtOAc. The combined organic layers were concentrated in vacuo 
and the crude material was purified by flash chromatography on silica gel (eluting with 
hexane/EtOAc 80:20). 
5-isobutyl-2-phenyloxazol-4(5H)-one (17A) 259 
The title compound 17A was prepared from 2-bromo-4-methylpentanoic 
acid (2.0 g, 10 mmol) according to the general procedure. White solid. 
All data were consistent with those previously reported. m. p. = 57–59 
ºC. Yield: 54% (1.2 g, 5.4 mmol). 1H-NMR (300 MHz, CDCl3) δ 8.26 – 
8.15 (m, 2H), 7.74 – 7.63 (m, 1H), 7.59 – 7.47 (m, 2H), 4.79 (dd, J = 10.0, 3.5 Hz, 1H), 
2.11 – 1.82 (m, 2H), 1.77 – 1.62 (m, 1H), 1.04 (d, J = 6.4 Hz, 6H). 13C NMR (75 MHz, 
                                                 
258 Adapted from: T. Misaki, G. Takimoto, T. Sugimura, J. Am. Chem. Soc. 2010, 132, 6286–6287. 
259 D. Zhao, L. Wang, D. Yang, Y. Zhang, R. Wang, Angew. Chem. Int. Ed. 2012, 51, 7523–7527. 
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CDCl3), δ 192.2, 186.3, 135.1, 130.0, 128.9, 125.9, 80.8, 40.2, 25.5, 22.8, 21.9. MS: 
calculated for C13H16NO2 (M + H
+), 218.1181; found, 218.1183. 
2-phenyl-5-propyloxazol-4(5H)-one (17B)260 
The title compound 17B was prepared from 2-bromopentanoic acid (1.8 
g, 10 mmol) according to the general procedure. White solid. All data 
were consistent with those previously reported. m. p. = 55–56 ºC. Yield: 
24% (480 mg, 2.4 mmol). 1H-NMR (300 MHz, CDCl3) δ 8.27 – 8.18 (m, 
2H), 7.76 – 7.65 (m, 1H), 7.60 – 7.47 (m, 2H), 4.79 (dd, J = 7.7, 4.5 Hz, 1H), 2.15 – 
2.00 (m, 1H), 1.93 – 1.78 (m, 1H), 1.56 (dq, J = 14.8, 7.5 Hz, 2H), 1.00 (t, J = 7.4 Hz, 
3H). 13C NMR (75 MHz, CDCl3), δ 192.3, 186.9, 135.5, 130.5, 129.4 126.3, 82.2, 33.6, 
18.5, 14.0. MS: calculated for C12H14NO2 (M + H
+), 204.1021; found, 204.1024. 
5-benzyl-2-phenyloxazol-4(5H)-one (17C)261 
The title compound 17C was prepared from 2-bromo-3-phenylpropanoic 
acid (2.3 g, 10 mmol) according to the general procedure. All data were 
consistent with those previously reported. White solid. m. p. = 97–98 ºC. 
Yield: 34% (850 mg, 3.4 mmol). 1H-NMR (300 MHz, CDCl3) δ 8.13 (dd, 
J = 5.2, 3.3 Hz, 2H), 7.70 – 7.62 (m, 1H), 7.49 (dd, J = 10.6, 4.8 Hz, 2H), 7.29 – 7.20 
(m, 5H), 4.98 (dd, J = 7.6, 4.0 Hz, 1H), 3.43 (dd, J = 14.8, 4.0 Hz, 1H), 3.12 (dd, J = 
14.8, 7.6 Hz, 1H). 13C NMR (75 MHz, CDCl3), δ 190.9, 186.4, 135.2, 134.6, 130.0, 
129.3, 128.9, 128.6, 127.3, 125.6, 81.9, 37.3. MS: calculated for C16H14NO2 (M + H
+), 
252.1025; found, 252.1024. 
5-methyl-2-phenyloxazol-4(5H)-one (17D)256 
The title compound 17D was prepared from 2-bromopropanoic acid (1.5 
g, 10 mmol) according to the general procedure. White solid. All data 
were consistent with those previously reported. m. p. = 68–70 ºC. Yield: 
62% (1.1 g, 6.2 mmol). 1H-NMR (300 MHz, CDCl3) δ 8.15 – 7.99 (m, 
2H), 7.64 – 7.46 (m, 1H), 7.46 – 7.35 (m, 2H), 4.72 (q, 1H), 1.49 (d, J = 7.1 Hz, 3H). 
13C NMR (75 MHz, CDCl3), δ 192.0, 185.8, 134.8, 129.6, 128.5, 125.4, 77.6, 16.0. 
MS: calculated for C10H10NO2 (M + H
+), 176.0712; found, 176.0717. 
  
                                                 
260 H. Huang, K. Zhu, W. Wu, Z. Jin, J. Ye, Chem. Commun. 2012, 48, 461–463. 
261 B. M. Trost, K. Dogra, M. Franzini, J. Am. Chem. Soc. 2004, 126, 1944–1945. 
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5-pentyl-2-phenyloxazol-4(5H)-one (17E) 
The title compound 17E was prepared from 2-bromopropanoic acid (1.5 
g, 10 mmol) according to the general procedure. White solid. m. p. = 69–
70 ºC. Yield: 44% (1.1 g, 4.4 mmol). 1H-NMR (300 MHz, CDCl3) δ 8.23 
(dd, J = 8.4, 1.3 Hz, 2H), 7.76 – 7.63 (m, 1H), 7.54 (t, J = 7.7 Hz, 2H), 
4.78 (dd, J = 7.6, 4.5 Hz, 1H), 2.19 – 2.00 (m, 1H), 1.86 (td, J = 14.8, 7.6 Hz, 1H), 1.51 
(dt, J = 15.7, 6.9 Hz, 2H), 1.33 (ddd, J = 11.2, 8.1, 4.5 Hz, 6H), 0.87 (t, J = 6.7 Hz, 3H). 
13C NMR (75 MHz, CDCl3), δ 8.23 (dd, J = 8.4, 1.3 Hz, 2H), 7.76 – 7.63 (m, 1H), 7.54 
(t, J = 7.7 Hz, 2H), 4.78 (dd, J = 7.6, 4.5 Hz, 1H), 2.19 – 2.00 (m, 1H), 1.86 (td, J = 
14.8, 7.6 Hz, 1H), 1.51 (dt, J = 15.7, 6.9 Hz, 2H), 1.33 (ddd, J = 11.2, 8.1, 4.5 Hz, 6H), 
0.87 (t, J = 6.7 Hz, 3H). MS: calculated for C15H20NO2 (M + H
+), 246.1494; found, 
246.1494. 
 
5.4.3. Preparation of α-cyanoacetate 30 
α-Cyanoacetate 30 was synthesised according to the procedure previously 
described in the literature:262 
 
A solution of 2-(p-tolyl)acetonitrile (1.3 g, 10 mmol, 1 equiv.) in THF (10 mL) 
was added dropwise to a solution of LDA (3.1 mL, 25 mmol, 2.5 equiv.) in THF (30 
mL) cooled to ‒78 ºC. The reaction mixture was allowed to stir at –78 ºC for 45 min. 
and then at room temperature for an additional 45 minutes. Then it was cooled to ‒78 
ºC and a solution of di-tert-butyl dicarbonate (2.62 g, 12 mmol, 1.2 equiv.) in THF (10 
mL) was added dropwise via syringe. After stirring at ‒78 ºC for 16 hours, the mixture 
was quenched with saturated ammonium chloride (20 mL) and extracted with Et2O (3 x 
50 mL). The organic layer was washed with 1 N HCl (30 mL), brine (30 mL) and dried 
over MgSO4. The solvent was removed under reduced pressure and the resulting crude 
oil was purified by silica gel flash chromatography (hexane/EtOAc 95:5) to yield the 
desired cyanoester 30 as a clear oil. The characterization data were coincident with the 
previously reported. Yield: 75% (1.7 g, 7.5 mmol). 1H NMR (300 MHz, CDCl3) δ 7.32 
(d, J = 8.2 Hz, 2H), 7.21 (d, J = 8.0 Hz, 2H), 4.56 (s, 1H), 2.36 (s, 3H), 1.44 (s, 9H). 13C 
NMR (75 MHz, CDCl3) δ 164.3, 139.1, 130.1, 127.8, 116.3, 84.5, 44.6, 27.8, 21.3. 
                                                 
262 S. Jautze, R. Peters, Angew. Chem. Int. Ed. 2008, 47, 9284–9288.  
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5.4.4. 1,4-addition of oxazolones to unsubstituted α’-silyloxy enone 13b 
5.4.4.1. General procedure 
 
To a mixture of the corresponding oxazolone 17 (1 equiv., 0.3 mmol) and the 
enone 13b (83.9 mg, 3.0 equiv., 0.9 mmol), in CH2Cl2 (0.9 mL) at room temperature the 
catalyst C8 (20 mol%) was added. The resulting suspension was stirred at the same 
temperature until consumption of the oxazolone (monitored by 1H-NMR). Then, 3 mL 
of methanol and 0.6 mL of aqueous HF 48% were added and the mixture was stirred for 
45 min. The reaction was treated at 0 ºC with saturated solution of NaHCO3 until pH 7. 
The product was extracted from the aqueous phase with CH2Cl2 (3 x 3 mL) and the 
combined organic phases were dried with MgSO4. Evaporation of the solvent under 
reduced pressure gave the title products 18, which were purified by flash column 
chromatography (eluting hexane/EtOAc 80:20).  
Racemic reactions were conducted following the procedure for the asymmetric 
version using enone 13a (3 equiv.) and TEA (20 mol%) as the catalyst. 
 
5.4.4.2. Characterization data for compounds 18 
(R)-5-(4-Hydroxy-4-methyl-3-oxopentyl)-5-isobutyl-2-phenyloxazol-4(5H)-one 
(18A) 
The title compound was obtained following the general 
procedure from oxazolone 17A (65 mg, 0.30 mmol). 
Colourless oil. Yield: 80% (79 mg, 0.24 mmol). [α]D22 = 
+10.7º (c = 1.00, 93% ee, CH2Cl2). 1H-NMR (300 MHz, 
CDCl3) δ 8.22 – 8.09 (m, 2H), 7.73 – 7.61 (m, 1H), 7.57 – 7.46 (m, 2H), 3.56 (s, 1H), 
2.57 – 2.47 (m, 1H), 2.38 – 2.23 (m, 1H), 2.22 – 2.08 (m, 1H), 2.04 – 1.84 (m, 2H), 1.82 
– 1.64 (m, 2H), 1.25 (s, 3H), 1.21 (s, 3H), 0.88 (dd, J = 10.0, 6.4 Hz, 6H). 13C-NMR 
(75 MHz, CDCl3) δ 212.7, 193.4, 185.6, 130.0, 129.0, 125.4, 90.2, 76.4, 60.3, 44.4, 
29.7, 29.0, 26.4, 23.9, 23.3, 14.1. MS: calculated for C19H26NO4 (M + H 
+), 332.1862; 
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found, 332.1866. The enantiomeric purity was determined by chiral HPLC analysis of 
the crude reaction mixture (Daicel Chiralpak IC, hexane/isopropanol, 85:15; flux = 1 
mL/min; retention times: 18.1 min (major), 22.4 min (minor)). 
(S)-5-(4-Hydroxy-4-methyl-3-oxopentyl)-2-phenyl-5-propyloxazol-4(5H)-one (18B) 
The title compound was obtained following the general 
procedure from oxazolone 17B (61 mg, 0.30 mmol). 
Colourless oil. Yield: 86% (52 mg, 0.26 mmol). [α]D22 = 
+58.4º (c = 1.00, 92% ee, CH2Cl2). 1H-NMR (300 MHz, 
CDCl3) δ 8.29 – 8.15 (m, 2H), 7.77 – 7.64 (m, 1H), 7.55 (t, J = 7.7 Hz, 2H), 3.62 (s, 
1H), 2.59 (t, J = 7.7 Hz, 2H), 2.40 – 2.13 (m, 2H), 1.93 (ddd, J = 10.0, 5.8, 4.0 Hz, 2H), 
1.40 – 1.15 (m, 8H), 0.90 (t, J = 7.3 Hz, 3H). 13C-NMR (75 MHz, CDCl3) δ 212.7, 
193.1, 185.7, 135.3, 130.0, 128.9, 125.3, 90.3, 76.3, 37.9 29.4, 29.1, 26.4, 16.2, 13.7. 
MS: calculated for C18H24NO4 (M + H 
+), 318.1705; found, 318.1697. The enantiomeric 
purity was determined by chiral HPLC analysis of the crude reaction mixture (Daicel 
Chiralpak IC, hexane/isopropanol, 90:10; flux = 1 mL/min; retention times: 36.3 min 
(major), 39.5 min (minor)). 
(R)-5-Benzyl-5-(4-hydroxy-4-methyl-3-oxopentyl)-2-phenyloxazol-4(5H)-one (18C) 
The title compound was obtained following the general 
procedure from oxazolone 17C (75 mg, 0.30 mmol). 
Colourless oil. Yield: 73% (80 mg, 0.22 mmol). [α]D22 = 
+44.6º (c = 1.00, 96% ee, CH2Cl2). 1H-NMR (300 MHz, 
CDCl3) δ 8.12 – 7.99 (m, 2H), 7.64 (t, J = 7.5 Hz, 1H), 7.46 (t, J = 7.7 Hz, 2H), 7.14 (d, 
J = 6.0 Hz, 5H), 3.61 (s, 1H), 3.20 (s, 2H), 2.60 (dd, J = 10.8, 5.3 Hz, 2H), 2.34 (dd, J = 
15.2, 7.5 Hz, 2H), 1.26 (s, 3H), 1.22 (s, 3H). 13C-NMR (75 MHz, CDCl3) δ 212.6, 
192.4, 185.4, 135.2, 132.8, 129.8, 128.8, 128.3, 127.4, 125.2, 90.1, 76.4, 42.2, 29.3, 
29.2, 26.4. MS: calculated for C22H24NO4 (M + H 
+), 366.1705; found, 366.1708. The 
enantiomeric purity was determined by chiral HPLC analysis of the crude reaction 
mixture (Daicel Chiralpak IC, hexane/isopropanol, 85:15; flux = 1 mL/min; retention 
times: 28.0 min (minor), 32.8 min (major)). 
(S)-5-(4-Hydroxy-4-methyl-3-oxopentyl)-5-methyl-2-phenyloxazol-4(5H)-one (18D) 
The title compound was obtained following the general 
procedure from oxazolone 17D (53 mg, 0.30 mmol). 
Colourless oil. Yield: 86% (52 mg, 0.26 mmol). [α]D22 = –
25.6º (c = 1.00, 92% ee, CH2Cl2). 1H-NMR (300 MHz, 
CDCl3) δ 8.30 – 8.14 (m, 2H), 7.77 – 7.66 (m, 1H), 7.55 (t, J = 7.7 Hz, 2H), 2.59 (t, J = 
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7.5 Hz, 2H), 2.46 – 2.13 (m, 3H), 1.62 (s, 4H), 1.32 (s, 3H), 1.28 (s, 4H). 13C-NMR (75 
MHz, CDCl3) δ 212.5, 193.4, 185.4, 135.4, 130.2, 129.1, 87.1, 30.4, 29.4, 26.6, 22.3. 
MS: calculated for C16H20NO4 (M + H 
+), 290.1392; found, 290.1381. The enantiomeric 
purity was determined by chiral HPLC analysis of the crude reaction mixture (Daicel 
Chiralpak IA, hexane/isopropanol, 98:2; flux = 1 mL/min; retention times: 89.1 min 
(major), 102.1 min (minor)). 
(S)-5-Hexyl-5-(4-hydroxy-4-methyl-3-oxopentyl)-2-phenyloxazol-4(5H)-one (18E) 
The title compound was obtained following the general 
procedure from oxazolone 17E (84 mg, 0.30 mmol). 
Colourless oil. Yield: 79% (61 mg, 0.21mmol). [α]D22 = +10.6º 
(c = 1.00, 97% ee, CH2Cl2). 1H-NMR (300 MHz, CDCl3) δ 
8.26 – 8.07 (m, 2H), 7.76 – 7.60 (m, 1H), 7.51 (t, J = 7.7 Hz, 2H), 2.55 (t, J = 7.7 Hz, 
2H), 2.41 – 2.09 (m, 2H), 1.89 (d, J = 3.9 Hz, 2H), 1.34 – 1.08 (m, 14H), 0.78 (t, J = 6.7 
Hz, 3H). 13C-NMR (75 MHz, CDCl3) δ 213.4, 193.8, 186.3, 135.9, 130.7, 129.6, 126.0, 
91.0, 77.0, 36.6, 31.9, 30.0, 29.8, 29.5 27.1, 23.3, 22.9, 14.5. MS: calculated for 
C21H30NO4 (M + H 
+), 360.2175; found, 360.2170. The enantiomeric purity was 
determined by chiral HPLC analysis of the crude reaction mixture (Daicel Chiralpak IC, 
hexane/isopropanol, 95:5; flux = 1 mL/min; retention times: 66.6 min (major), 72.7 min 
(minor)). 
 
5.4.5. 1,4-addition of oxazolones to β-substituted α’-hydroxy enones 14 
5.4.5.1. General procedure 
 
To a mixture of the corresponding oxazolone 17 (0.15 mmol, 1 equiv.) and the 
corresponding enone 14 (0.45 mmol, 3.0 equiv.), in 1,2-dichloroethane (0.45 mL) at 70 
ºC, catalyst C7 (9.5 mg, 10 mol%) was added. The resulting mixture was stirred at the 
same temperature until consumption of the starting oxazolone as monitored by 1H-
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NMR. The crude product was purified by flash column chromatography (eluting 
hexane/EtOAc 80:20). 
The same above procedure was followed except that reactions were run at 50 ºC 
and DBU was used as the catalyst instead of C7. 
 
5.4.5.2. Characterization data for compounds 19 
(S)-5-((R)-4-Hydroxy-4-methyl-3-oxo-1-(p-tolyl)pentyl)-5-isobutyl-2-phenyloxazol-
4(5H)-one (19Aa) 
The title compound was obtained following the general 
procedure from oxazolone 17A (33 mg, 0.15 mmol) and enone 
14a (92 mg, 0.45 mmol) in a 13:1 dr. Yellow oil. Yield: 67% 
(43 mg, 0.10 mmol). Data of major isomer: [α]D25 = –45.4º (c 
= 1.00, 99% ee, CH2Cl2). 1H-NMR (300 MHz, CDCl3) δ 8.18 
– 8.08 (m, 2H), 7.74 – 7.62 (m, 1H), 7.52 (dd, J = 8.3, 7.2 Hz, 
2H), 7.17 – 7.08 (m, 2H), 7.05 – 6.95 (m, 2H), 3.85 (dd, J = 10.8, 3.3 Hz, 1H), 3.45 – 
3.24 (m, 2H), 2.72 (dd, J = 17.5, 3.3 Hz, 1H), 2.21 (s, 3H), 1.80 (dd, J = 6.2, 4.2 Hz, 
2H), 1.64 – 1.52 (m, 1H), 1.23 (s, 3H), 1.04 (s, 3H), 0.86 (d, J = 6.6 Hz, 3H), 0.77 (d, J 
= 6.6 Hz, 3H). 13C-NMR (75 MHz, CDCl3) δ 211.1, 193.4, 185.7, 137.2, 135.2, 134.0, 
129.9, 129.0, 128.8, 125.4, 92.8, 76.3, 46.3, 43.6, 35.8, 26.0, 24.1, 23.8, 20.9. MS: 
calculated for C26H32NO4 (M + H 
+), 422.2331; found, 422.2314. The enantiomeric 
purity of the major isomer was determined by chiral HPLC analysis of the crude 
reaction mixture (Daicel Chiralpak IB, hexane/isopropanol, 98:2; flux = 1 mL/min; 
retention times: 18.8 min (minor), 18.8 min (major)). 
(S)-5-Hexyl-5-((R)-4-hydroxy-4-methyl-3-oxo-1-(p-tolyl)pentyl)-2-phenyloxazol-
4(5H)-one (19Ea) 
The title compound was obtained following the general 
procedure from oxazolone 17E (37 mg, 0.15 mmol) and enone 
14a (92 mg, 0.45 mmol) in a 13:1 dr. Yellow oil. Yield: 80% 
(55 mg, 0.12 mmol). Data of major isomer: [α]D25 = –53.6º (c 
= 1.00, 96% ee, CH2Cl2). 1H-NMR (300 MHz, CDCl3) δ 8.23 
– 8.13 (m, 2H), 7.78 – 7.63 (m, 1H), 7.60 – 7.48 (m, 2H), 7.16 
(d, J = 8.1 Hz, 2H), 7.04 (d, J = 7.9 Hz, 2H), 3.86 (dd, J = 10.8, 3.3 Hz, 1H), 3.27 (dd, J 
= 17.4, 10.8 Hz, 1H), 2.70 (dd, J = 17.4, 3.3 Hz, 1H), 2.24 (s, 3H), 1.21 (s, 3H), 1.13 
(m, 8H), 1.04 (s, 3H), 0.81 – 0.72 (m, 3H). 13C-NMR (75 MHz, CDCl3) δ 210.9, 193.2, 
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185.8, 137.3, 135.3, 134.3, 130.0, 129.1, 129.0, 128.8, 125.3, 93.2, 76.3, 45.8, 36.1, 
35.2, 31.3, 28.9, 26.0, 22.7, 22.3, 21.0, 13.8. MS: calculated for C28H36NO4 (M + H 
+), 
450.2666; found, 450.2626. The enantiomeric purity of the major isomer was 
determined by chiral HPLC analysis of the crude reaction mixture (Daicel Chiralpak IC, 
hexane/isopropanol, 80:20; flux = 1 mL/min; retention times: 9.5 min (minor), 11.2 min 
(major)). 
(S)-5-((R)-1-(4-Bromophenyl)-4-hydroxy-4-methyl-3-oxopentyl)-5-hexyl-2-
phenyloxazol-4(5H)-one (19Eb) 
The title compound was obtained following the general 
procedure from oxazolone 17E (37 mg, 0.15 mmol) and enone 
14b (115 mg, 0.45 mmol)  in a 12:1 dr. White soldi. m. p. = 
125-127 ºC. Yield: 78% (60 mg, 0.12 mmol). Data of major 
isomer: [α]D25 = –57.3º (c = 1.00, 96% ee, CH2Cl2). 1H-NMR 
(300 MHz, CDCl3) δ 8.10 (dd, J = 8.3, 1.3 Hz, 2H), 7.68 – 
7.59 (m, 1H), 7.46 (t, J = 7.7 Hz, 2H), 7.32 (d, J = 8.3 Hz, 1H), 7.16 (d, J = 8.4 Hz, 2H), 
3.82 (dd, J = 10.9, 3.1 Hz, 1H), 3.69 (s, 1H), 3.30 (dd, J = 18.0, 10.9 Hz, 1H), 2.76 (dd, 
J = 17.9, 3.1 Hz, 1H), 1.88 – 1.85 (m, 1H), 1.70 – 1.57 (m, 1H), 1.10 – 1.00 (m, 14H), 
0.75 – 0.65 (m, 3H). 13C-NMR (75 MHz, CDCl3) δ 210.9, 192.6, 185.7, 136.6, 135.3, 
131.2, 130.5, 129.8, 128.9, 124.8, 121.4, 92.6, 76.3, 45.3, 35.9, 34.9, 31.0, 28.6, 25.8, 
25.8, 22.4, 22.1, 13.6. MS: calculated for C27H33BrNO4 (M + H 
+), 514.1593; found, 
514.1594. The enantiomeric purity of the major isomer was determined by chiral HPLC 
analysis of the crude reaction mixture (Daicel Chiralpak IA, hexane/isopropanol, 90:10; 
flux = 1 mL/min; retention times: 14.2 min (minor), 19.7 min (major)). 
(S)-5-Hexyl-5-((R)-4-hydroxy-4-methyl-3-oxo-1-(p-tolyl)pentyl)-2-phenyloxazol-
4(5H)-one (19Ec) 
The title compound was obtained following the general 
procedure from oxazolone 17E (37 mg, 0.15 mmol) and enone 
14c (103 mg, 0.45 mmol)  in a 12:1 dr. Yellow oil. Yield: 
81% (57 mg, 0.12 mmol). Data of major isomer: [α]D25 = –
54.4º (c = 1.00, 96% ee, CH2Cl2). 1H-NMR (300 MHz, 
CDCl3) δ 8.18 (dd, J = 8.4, 1.4 Hz, 2H), 7.74 – 7.64 (m, 1H), 7.54 (dd, J = 8.4, 7.1 Hz, 
2H), 7.16 (t, J = 7.9 Hz, 1H), 6.91 – 6.80 (m, 2H), 6.72 (ddd, J = 8.3, 2.6, 0.9 Hz, 1H), 
3.86 (dd, J = 10.6, 3.3 Hz, 1H), 3.74 (s, 3H), 3.41 (s, 1H), 3.26 (dd, J = 17.5, 10.7 Hz, 
1H), 2.69 (dd, J = 17.4, 3.3 Hz, 1H), 1.94 – 1.80 (m, 1H), 1.79 – 1.64 (m, 1H), 1.20 (s, 
3H), 1.17 – 1.06 (m, 8H), 1.05 (s, 3H), 0.80 – 0.73 (m, 3H). 13C-NMR (75 MHz, 
CDCl3) δ 210.8, 193.0, 185.99, 159.3, 139.0, 135.3, 130.0, 129.3, 129.0, 125.3, 121.2, 
115.2, 112.7, 93.0, 76.3, 55.1.0, 46.2, 36.0, 35.1, 31.3, 28.9, 26.0, 22.7, 22.3, 13.8. MS: 
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calculated for C27H33NO4 (M + H 
+), 466.2593; found, 466.2577. The enantiomeric 
purity of the major isomer was determined by chiral HPLC analysis of the crude 
reaction mixture (Daicel Chiralpak IB, hexane/isopropanol, 95:5; flux = 1 mL/min; 
retention times: 11.9 min (minor), 14.0 min (major)). 
(S)-5-Hexyl-5-((R)-4-hydroxy-4-methyl-3-oxo-1-phenylpentyl)-2-phenyloxazol-
4(5H)-one (19Ed) 
The title compound was obtained following the general 
procedure from oxazolone 17E (37 mg, 0.15 mmol) and enone 
14d (79 mg, 0.45 mmol)  in a 12:1 dr. White soldi. m. p. = 
125-127 ºC. Yield: 73% (47 mg, 0.11 mmol). Data of major 
isomer: [α]D25 = –49.9º (c = 1.00, 96% ee, CH2Cl2). 1H-NMR 
(300 MHz, CDCl3) δ 8.22 – 8.10 (m, 2H), 7.74 – 7.65 (m, 1H), 7.58 – 7.48 (m, 2H), 
7.32 – 7.12 (m, 5H), 3.90 (dd, J = 10.7, 3.4 Hz, 1H), 3.39 (s, 1H), 3.30 (dd, J = 17.5, 
10.7 Hz, 1H), 2.74 (dd, J = 17.5, 3.3 Hz, 1H), 2.00 – 1.81 (m, 1H), 1.81 – 1.64 (m, 1H), 
1.21 (s, 3H), 1.18 – 1.07 (m, 8H), 1.03 (s, 3H), 0.82 – 0.71 (m, 3H). 13C-NMR (75 
MHz, CDCl3) δ 210.9, 193.0, 185.8, 137.4, 135, 123.0, 129.0, 128.4, 127.7, 125.3, 93.0, 
76.3, 46.2, 36.0, 35.2, 31.3, 28.9, 26.0, 22.7, 22.3, 13.8. MS: calculated for C27H34NO4 
(M + H +), 436.2488; found, 436.2275. The enantiomeric purity of the major isomer was 
determined by chiral HPLC analysis of the crude reaction mixture (Daicel Chiralpak IC, 
hexane/isopropanol, 90:10; flux = 1 mL/min; retention times: 18.7 min (minor), 20.5 
min (major)). 
 
5.4.6. 1,4-addition of oxazolones to α-substituted α’-hydroxy enone 15 
5.4.6.1. General procedure 
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To a mixture of the corresponding oxazolone 17 (0.30 mmol, 2 equiv.) and 
enone 15 (0.15 mmol, 1 equiv.), in 1,2-dichloroethane (0.45 mL) at 50 ºC, catalyst C13 
(12.3 mg, 10 mol%) was added. The resulting mixture was stirred at the same 
temperature until consumption of the starting oxazolone as monitored by 1H-NMR. The 
crude product was submitted to flash column chromatography (eluting hexane/EtOAc 
80:20), affording the desired adduct as a mixture of diastereomers. 
The same above procedure was followed except DBU was used as the catalyst 
instead of C13. 
 
5.4.6.2. Characterization data for compounds 22 
(5S)-5-(4-Hydroxy-2,4-dimethyl-3-oxopentyl)-2-phenyl-5-propyloxazol-4(5H)-one 
(22B) 
The title compound was obtained following the general 
procedure from oxazolone 17B (61 mg, 0.30 mmol) in a 1:1 
dr. Yellow oil. Yield: 69% (34 mg, 0.10 mmol). Data of major 
isomer: 1H-NMR (300 MHz, CDCl3) δ 8.19 (d, J = 8.4 Hz, 
2H), 7.82 – 7.64 (m, 1H), 7.59 – 7.48 (m, 2H), 3.53 (s, 1H), 3.21 – 3.06 (m, 1H), 2.31 
(dd, J = 15.0, 5.6 Hz, 1H), 2.04 (dd, J = 15.0, 6.7 Hz, 1H), 1.96 – 1.78 (m, 2H), 1.42 (s, 
3H), 1.36 (s, 3H), 1.26 – 1.20 (m, 2H), 1.09 (d, J = 6.8 Hz, 3H), 0.87 (t, J = 7.3 Hz, 3H). 
13C-NMR (75 MHz, CDCl3) δ 216.8, 193.1, 185.8, 135.4, 130.1, 129.0, 125.6, 90.8, 
76.9, 38.8, 38.3, 34.7, 26.7, 26.6, 19.5, 16.2, 13.8. Data of minor isomer: 1H-NMR (300 
MHz, CDCl3) δ 3.35 – 3.24 (m, 1H), 2.45 (dd, J = 14.8, 7.0 Hz, 1H), 2.00 – 1.95 (m, 
1H), 1.96 – 1.78 (m, 2H), 1.28 (s, 3H), 1.27 (s, 3H), 1.26 – 1.20 (m, 2H), 1.16 (d, J = 
6.9 Hz, 3H), 0.89 (t, J = 7.2 Hz, 3H). 13C-NMR (75 MHz, CDCl3) δ 216.5, 193.7, 
185.8, 135.4, 130.1, 129.0, 125.6, 90.4, 76.8, 39.0, 38.1, 34.2, 26.9, 26.6, 12.0, 16.2, 
13.8. MS: calculated for C19H26NO4 (M + H 
+), 332.1862; found, 332.1866. The 
enantiomeric purity of the major isomer was determined by chiral HPLC analysis of the 
crude reaction mixture (Daicel Chiralpak IB, hexane/isopropanol, 95:5; flux = 1 
mL/min; retention times: 17.5 min (major), 28.0 min (minor)). 
(5R)-5-Benzyl-5-(4-hydroxy-2,4-dimethyl-3-oxopentyl)-2-phenyloxazol-4(5H)-one 
(22C) 
The title compound was obtained following the general 
procedure from oxazolone 17C (75 mg, 0.30 mmol) in a 1.5:1 
dr. Yellow oil. Yield: 77% (44 mg, 0.12 mmol). Data of major 
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isomer: 1H-NMR (300 MHz, CDCl3) δ 8.05 (d, J = 8.4 Hz, 2H), 7.72 – 7.61 (m, 1H), 
7.60 – 7.42 (m, 2H), 7.21 – 7.04 (m, 5H), 3.46 (s, 1H), 3.22 (s, 2H), 3.30 – 3.09 (m, 
1H), 2.43 (dd, J = 15.0, 5.2 Hz, 1H), 2.13 (dd, J = 15.0, 7.0 Hz, 1H), 1.45 (s, 3H), 1.38 
(s, 3H), 1.09 (d, J = 6.8 Hz, 3H).. 13C-NMR (75 MHz, CDCl3) δ 216.7, 192.4, 185.5, 
135.3, 132.7, 129.9, 129.0, 128.4, 127.5, 125.4, 90.6, 76.9, 42.6, 38.5, 34.9, 29.7, 26.7, 
26.6, 19.3. Data of minor isomer: 1H-NMR (300 MHz, CDCl3) δ 8.05 (d, J = 8.4 Hz, 
2H), 7.72 – 7.61 (m, 1H), 7.60 – 7.42 (m, 2H), 7.21 – 7.04 (m, 5H), 3.39 – 3.26 (m, 
1H), 3.17 (s, 2H), 2.56 (dd, J = 14.8, 7.4 Hz, 1H), 2.07 (dd, J = 14.8, 4.7 Hz, 1H), 1.27 
(s, 3H), 1.25 (s, 3H), 1.18 (d, J = 6.9 Hz, 3H). 13C-NMR (75 MHz, CDCl3) δ 216.4, 
193.0, 185.5, 135.3, 132.8, 129.9, 128.9, 128.4, 127.5, 125.5, 90.2, 77.2, 42.5, 38.8, 
34.4, 29.7, 27.0, 26.7, 20.1. MS: calculated for C23H25NO4 (M + H 
+), 379.1784; found, 
379.1775. The enantiomeric purity of the major isomer was determined by chiral HPLC 
analysis of the crude reaction mixture (Daicel Chiralpak IA, hexane/isopropanol, 95:5; 
flux = 1 mL/min; retention times: 51.7 min (major), 112.0 min (minor)). 
(5S)-5-(4-Hydroxy-2,4-dimethyl-3-oxopentyl)-5-methyl-2-phenyloxazol-4(5H)-one 
(22D) 
The title compound was obtained following the general 
procedure from oxazolone 17D (53 mg, 0.30 mmol) in a 1:1 
dr. Yellow oil. Yield: 74% (34 mg, 0.11 mmol). Data of major 
isomer: 1H-NMR (300 MHz, CDCl3) δ 8.31 – 7.98 (m, 2H), 
7.70 (t, J = 7.4 Hz, 1H), 7.65 – 7.49 (m, 2H), 3.53 (s, 1H), 3.21 (dt, J = 13.1, 6.0 Hz, 
1H), 2.36 (dd, J = 15.0, 6.3 Hz, 1H), 2.02 (dd, J = 14.8, 6.1 Hz, 1H), 1.57 (s, 3H), 1.45 
(s, 3H), 1.39 (s, 3H), 1.13 (d, J = 6.8 Hz, 3H). 13C-NMR (75 MHz, CDCl3) δ 216.7, 
193.4, 185.3, 135.4, 130.1, 129.0, 127.8, 87.5, 75.1, 39.6, 34.8, 26.8, 26.7, 22.3, 19.6. 
Data of minor isomer: 1H-NMR (300 MHz, CDCl3) δ 8.26 – 8.14 (m, 2H), 7.70 (t, J = 
7.4 Hz, 1H), 7.64 – 7.50 (m, 2H), 3.49 (s, 1H), 3.30 (dt, J = 12.7, 6.3 Hz, 1H), 2.44 (dd, 
J = 14.8, 6.8 Hz, 1H), 1.97 (dd, J = 14.5, 5.5 Hz, 1H), 1.59 (s, 3H), 1.30 (s, 3H), 1.29 (s, 
3H), 1.18 (d, J = 6.9 Hz, 3H). 13C-NMR (75 MHz, CDCl3) δ 216.4, 193.4, 185.3, 132.8, 
130.1, 129.0, 128.8, 127.8, 87.5, 75.1, 39.8 34.5, 26.9, 26.7, 22.4, 19.7. MS: calculated 
for C17H22NO4 (M + H 
+), 304.1549; found, 304.1552. The enantiomeric purity of the 
major isomer was determined by chiral HPLC analysis of the crude reaction mixture 
(Daicel Chiralpak IA+AY-H, hexane/isopropanol, 80:20; flux = 0.5 mL/min; retention 
times: 33.2 min (major), 57.8 min (minor)). 
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(5S)-5-Hexyl-5-(4-hydroxy-2,4-dimethyl-3-oxopentyl)-2-phenyloxazol-4(5H)-one 
(22B) 
The title compound was obtained following the general 
procedure from oxazolone 17E (74 mg, 0.30 mmol) in a 1.5:1 
dr. Yellow oil. Yield: 67% (32 mg, 0.10 mmol). Data of major 
isomer: 1H-NMR (300 MHz, CDCl3) δ 8.27 – 8.14 (m, 2H), 
7.81 – 7.66 (m, 1H), 7.64 – 7.52 (m, 2H), 3.50 (s, 1H), 3.21 – 3.09 (m, 1H), 2.31 (dd, J 
= 15.0, 5.6 Hz, 1H), 2.12 – 1.84 (m, 3H), 1.44 (s, 3H), 1.38 (s, 3H), 1.26 – 1.19 (m, 8H), 
1.11 (d, J = 6.8 Hz, 3H), 0.83 (t, J = 6.2 Hz, 3H). 13C-NMR (75 MHz, CDCl3) δ 216.8, 
193.1, 185.8, 135.4, 130.1, 129.1, 125.6, 76.9, 38.9, 36.2, 34.7, 31.3, 28.9, 26.7, 26.6, 
22.6, 22.4, 19.5, 13.9. Data of minor isomer: 1H-NMR (300 MHz, CDCl3) δ 8.27 – 8.14 
(m, 2H), 7.81 – 7.66 (m, 1H), 7.64 – 7.52 (m, 2H), 3.46 (s, 1H), 3.35 – 3.23 (m, 1H), 
2.46 (dd, J = 14.8, 7.0 Hz, 1H), 2.12 – 1.84 (m, 3H), 1.30 (s, 3H), 1.28 (s, 3H), 1.26 – 
1.19 (m, 8H), 1.17 (d, J = 6.9 Hz, 3H), 0.83 (t, J = 6.2 Hz, 3H). 13C-NMR (75 MHz, 
CDCl3) δ 217.0, 194.2, 186.2, 135.8, 130.5, 129.5, 126.0, 90.9, 77.2, 39.5, 36.5, 34.6, 
31.8, 30.1, 27.3, 27.0, 23.1, 22.8, 20.4, 14.3. MS: calculated for C22H32NO4 (M + H 
+), 
374.2331; found, 374.2333. The enantiomeric purity of the major isomer was 
determined by chiral HPLC analysis of the crude reaction mixture (Daicel Chiralpak IA, 
hexane/isopropanol, 95:5; flux = 1 mL/min; retention times: 14.6 min (major), 24.8 min 
(minor)). 
 
5.4.7. Elaboration of adducts 18 and 19 
5.4.7.1. Transformation of adducts to carboxylic acids 23-26 
 
To a stirred solution of the ketol (0.8 mmol, 1 equiv.) in acetonitrile (10 mL) at 0 
ºC a solution of cerium ammonium nitrate (CAN) (3 equiv., 1.46 g, 2.7 mmol) in water 
(5 mL) was added dropwise and the mixture was stirred at the same temperature until 
starting material disappeared (TLC hexane/EtOAc 60:40). Water was then added (3 mL) 
and the mixture was extracted with CH2Cl2 (2 x 10 mL), after which the organic phases 
were combined, dried over MgSO4 and concentrated. The crude material was purified 
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by flash chromatography on silica gel (eluting with CH2Cl2/MeOH 95:5) obtaining the 
desired product. 
(R)-3-(5-benzyl-4-oxo-2-phenyl-4,5-dihydrooxazol-5-yl)propanoic acid (23) 
The title compound was obtained from adduct 18C according to 
the procedure above described. Yellow oil. Yield: 84% (217 mg, 
0.67 mmol). 1H-NMR (300 MHz, CDCl3) δ 8.12 – 8.02 (m, 2H), 
7.66 (t, J = 7.5 Hz, 1H), 7.48 (t, J = 7.7 Hz, 2H), 7.17 (s, 5H), 
3.22 (s, 2H), 2.41 – 2.29 (m, 4H). 13C-NMR (75 MHz, CDCl3) δ 192.6, 185.9, 177.2, 
135.6, 133.1, 130.2, 129.2, 128.7, 127.8, 90.3, 42.3, 30.6, 28.4. MS: calculated for 
C19H18NO4 (M + H 
+), 324.1236; found, 324.1227.  
(S)-3-(5-Hexyl-4-oxo-2-phenyl-4,5-dihydrooxazol-5-yl)propanoic acid (24) 
The title compound was obtained from adduct 18D according to 
the procedure above described. Yellow oil. Yield: 82% (208 mg, 
0.66 mmol). 1H-NMR (300 MHz, CDCl3) δ 8.22 – 8.15 (m, 2H), 
7.69 (t, J = 7.5 Hz, 1H), 7.52 (t, J = 7.7 Hz, 2H), 2.37 – 2.27 (m, 
2H), 1.96 – 1.84 (m, 2H), 1.34 – 1.14 (m, 10H), 0.81 (t, J = 6.6 Hz, 3H). 13C-NMR (75 
MHz, CDCl3) δ 193.0, 185.8, 176.9, 135.4, 130.1, 129.0, 127.4, 125.4, 90.2, 35.8, 31.3, 
30.6, 28.9, 28.0, 22.7, 22.4, 13.9. MS: calculated for C18H24NO4 (M + H 
+), 318.1705; 
found, 318.1691. The enantiomeric purity was determined by chiral HPLC analysis of 
the crude reaction mixture (Daicel Chiralpak IC, hexane:ethanol, 70:30; flux = 0.5 
mL/min; retention times: 16.8 min (major), 18.2 min (minor)). 
(R)-3-(4-Bromophenyl)-3-((S)-5-hexyl-4-oxo-2-phenyl-4,5-dihydrooxazol-5-
yl)propanoic acid (25) 
The title compound was obtained from adduct 19Eb according to 
the procedure above described. Yellow oil. Yield: 80% (301 mg, 
0.64 mmol). 1H-NMR (300 MHz, CDCl3) δ 8.23 – 8.15 (m, 2H), 
7.78 – 7.67 (m, 1H), 7.55 (t, J = 7.7 Hz, 2H), 7.41 (d, J = 8.1 Hz, 
2H), 7.17 (d, J = 8.1 Hz, 2H), 3.64 (dd, J = 11.2, 3.9 Hz, 1H), 
2.75 (dd, J = 16.2, 11.2 Hz, 1H), 2.61 (dd, J = 16.2, 3.9 Hz, 1H), 
1.81 (dt, J = 14.5, 6.7 Hz, 1H), 1.70 – 1.53 (m, 2H), 1.20 – 1.06 (m, 8H), 0.77 (t, J = 6.8 
Hz, 3H). 13C-NMR (75 MHz, CDCl3) δ 192.6 , 185.9, 175.1, 136.0, 135.6.0, 131.7, 
130.7, 130.0, 129.1, 125.0, 121.9, 92.4, 46.5, 34.9, 34.6, 31.3, 28.9, 22.6, 22.3, 13.9. 
MS: calculated for C24H27BrNO4 (M + H 
+), 472.1123; found, 472.1109. 
(R)-3-((S)-5-Hexyl-4-oxo-2-phenyl-4,5-dihydrooxazol-5-yl)-3-phenylpropanoic acid 
(26) 
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The title compound was obtained from adduct 19Eb according to 
the procedure above described. Yellow oil. Yield: 86% (275 mg, 
0.69 mmol). 1H-NMR (300 MHz, CDCl3) δ 9.26 (bs, 1H), 8.21 – 
8.13 (m, 2H), 7.69 (t, J = 7.5 Hz, 1H), 7.52 (t, J = 7.7 Hz, 2H), 
7.30 – 7.18 (m, 5H), 3.68 (dd, J = 11.2, 3.8 Hz, 1H), 2.79 (dd, J 
= 16.1, 11.2 Hz, 1H), 2.61 (dd, J = 16.1, 3.8 Hz, 1H), 1.91 – 1.76 (m, 1H), 1.72 – 1.55 
(m, 1H), 1.19 – 1.05 (m, 8H), 0.76 (t, J = 6.8 Hz, 3H). 13C-NMR (75 MHz, CDCl3) δ 
192.8, 185.8, 175.6, 136.7, 135.3, 129.9, 128.9, 128.3, 127.7, 125.1, 92.7, 47.0, 34.8, 
34.6, 31.2, 28.8, 22.5, 22.2, 13.7. MS: calculated for C25H27NO4 (M + H 
+), 394.2018; 
found, 394.2003. 
 
Elaboration of the carboxylic acids 25 and 26 to carboxylic esters 25’ and 26’ 
 
The corresponding carboxylic acid (0.25 mmol, 1 equiv.) was dissolved in 
MeOH (7.5 mL) and a solution of (trimethylsilyl)diazomethane in diethyl ether (2 M; 
0,38 mL, 0.75 mmol, 3 equiv.) was added dropwise, observing the coloration of the 
mixture. The reaction mixture was stirred for further 3 h and disappearance of the acid 
was checked by TLC (hexane/EtOAc 1:1). The reaction mixture was concentrated and 
the crude material was purified by flash column chromatography on silica gel (eluting 
with hexane/EtOAc 90:10) obtaining the desired product. 
(R)-3-(4-Bromophenyl)-3-((S)-5-hexyl-4-oxo-2-phenyl-4,5-dihydrooxazol-5-
yl)propanoic acid (25’) 
The title compound was obtained from compound 25 according 
to the procedure above described. Yellow oil. Yield: 87% (103 
mg, 0.22 mmol). 1H-NMR (300 MHz, CDCl3) δ 8.26 – 8.19 (m, 
2H), 7.80 – 7.71 (m, 1H), 7.59 (dd, J = 8.4, 7.2 Hz, 2H), 7.47 
(d, J = 8.4 Hz, 2H), 7.24 (d, J = 8.5 Hz, 2H), 3.73 (dd, J = 11.3, 
4.0 Hz, 1H), 3.50 (s, 3H), 2.79 (dd, J = 15.8, 11.3 Hz, 1H), 2.65 
(dd, J = 15.8, 4.1 Hz, 1H), 1.95 – 1.79 (m, 1H), 1.74 – 1.58 (m, 1H), 1.25 – 1.07 (m, 
8H), 0.81 (t, J = 6.8 Hz, 3H). 13C-NMR (75 MHz, CDCl3) δ 192.6, 185.9, 170.7, 136.2, 
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135.5, 131.6, 130.7, 130.0, 129.1, 125.2, 121.8, 92.3, 51.8, 46.8 , 35.0, 34.6, 31.3, 28.9, 
22.6, 22.3, 13.8. MS: calculated for C25H29BrNO4 (M + H 
+), 486.1280; found, 
486.1258. The enantiomeric purity was determined by chiral HPLC analysis of the 
crude reaction mixture (Daicel Chiralpak IC, hexane/isopropanol, 80:20; flux = 1 
mL/min; retention times: 14.2 min (minor), 15.8 min (major)). 
(R)-3-((S)-5-hexyl-4-oxo-2-phenyl-4,5-dihydrooxazol-5-yl)-3-phenylpropanoic acid 
(26’) 
The title compound was obtained from compound 26 according 
to the procedure above described. Yellow oil. Yield: 97% (99 
mg, 0.24 mmol). 1H-NMR (300 MHz, CDCl3) δ 8.26 – 8.12 (m, 
2H), 7.74 – 7.63 (m, 1H), 7.53 (dd, J = 8.4, 7.1 Hz, 2H), 7.34 – 
7.17 (m, 5H), 3.72 (dd, J = 11.2, 4.1 Hz, 1H), 3.42 (s, 3H), 2.79 
(dd, J = 15.6, 11.2 Hz, 1H), 2.62 (dd, J = 15.7, 4.1 Hz, 1H), 1.91 – 1.76 (m, 1H), 1.70 – 
1.55 (m, 1H), 1.21 – 1.04 (m, 8H), 0.75 (t, J = 6.6 Hz, 3H). 13C-NMR (75 MHz, CDCl3) 
δ 192.9, 185.8, 170.8, 137.0, 135.2, 129.9, 128.9, 128.3, 127.7, 125.2, 92.6, 51.5, 47.4, 
34.9, 34.7, 31.2, 28.8, 22.5, 22.2, 13.7. MS: calculated for C25H30NO4 (M + H 
+), 
408.2175; found, 408.2155. The enantiomeric purity was determined by chiral HPLC 
analysis of the crude reaction mixture (Daicel Chiralpak IC, hexane/isopropanol, 80:20; 
flux = 1 mL/min; retention times: 18.6 min (minor), 24.5 min (major)). 
 
5.4.7.2. Synthesis of γ-lactone 28 
Known γ-lactone 28 was prepared according to the following synthetic 
sequence: 
 
1st step:263 The acid 23 (0.6 mmol) was dissolved in a 2.5 M aqueous solution of NaOH 
(6 mL) and stirred at room temperature for 4 h. Then CH2Cl2 was added and the mixture 
                                                 
263 Adapted from: a) T. Misaki, G. Takimoto, T. Sugimura, J. Am. Chem. Soc. 2010, 132, 6286–6287. b) 
A. Paju, M. Laos, A. Jõgi, M. Päri, R. Jäälaid, T. Pehk, T. Kanger, M. Lopp, Tetrahedron Lett.. 2006, 47, 
4491–4493. 
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was acidified to pH 1 using a concentrated aqueous solution of HCl. The phases were 
separated and the aqueous layer was extracted with EtOAc (2 x 10 mL). The organic 
phases were united and the solvent was eliminated under reduced pressure. The crude 
was then redissolved in CH2Cl2 (12 mL) and a concentrated aqueous solution of HCl 
(0.12 mL) was added, letting the mixture to stir at room temperature overnight. The 
organic phase was washed with a saturated solution of NaHCO3 (3 x 10 mL), dried over 
MgSO4 and the solvent was eliminated under reduced pressure, obtaining (R)-2- benzyl-
5-oxotetrahydrofuran-2-carboxamide 27 as a white solid, which was used in the next 
step without further purification. Yield: 85% (112 mg, 0.51 mmol). m. p. = 165–168 ºC. 
1H NMR (300 MHz, CDCl3) δ 7.40 – 7.15 (m, 5H), 6.26 (s, 1H), 5.66 (s, 1H), 3.29 (d, J 
= 14.1 Hz, 1H), 3.09 (d, J = 14.1 Hz, 1H), 2.67 – 2.49 (m, 1H), 2.49 – 2.27 (m, 2H), 
2.18 – 1.97 (m, 1H). 13C NMR (75 MHz, CDCl3) δ 175.4, 174.2, 133.9, 130.4, 128.6, 
127.5, 87.7, 43.4, 29.9, 28.1. MS: calculated for C12H14NO3 (M, H
+), 220.0974; found, 
220.0981.  
2nd step:264 The above obtained adduct 28 (0.31 mmol) was dissolved in an aqueous 
concentrated HCl solution (2 mL) and heated at 85 ºC in a sealed tube for 24 h. The 
reaction mixture was extracted with CH2Cl2 (3 x 5 mL) and the combined organic 
phases were dried over MgSO4 and the solvent eliminated under reduced pressure 
obtaining a brown solid. The solid was triturated with Et2O obtaining the desired 
carboxylic acid 30 as a white solid. Yield: 62% (43 mg, 0.19 mmol). m. p. = 101–104 
ºC. [α]D26= –2.73° (c = 1.00, acetone) ([α]D20 Lit265 = –5.3° (c = 1.97, acetone). All 
spectroscopic data were identical to those reported in the literature. 1H NMR (300 
MHz, CDCl3) δ 7.35 – 7.24 (m, 5H), 3.40 (d, J = 14.4 Hz, 1H), 3.15 (d, J = 14.4 Hz, 
1H), 2.57 – 2.43 (m, 2H), 2.39 – 2.25 (m, 1H), 2.24 – 2.06 (m, 1H). 13C NMR (75 
MHz, CDCl3) δ 175.67, 175.49, 133.42, 130.57, 128.64, 127.62, 85.80, 42.14, 29.96, 
27.93. 
 
                                                 
264 S. Caille, S. Cui, T.-L. Hwang, X. Wang, M. M. Faul, J. Org. Chem. 2009, 74, 3833–3842. 
265 A. Paju, M. Laos, A. Jõgi, M. Päri, R. Jäälaid, T. Pehk, T. Kanger, M. Lopp, Tetrahedron Lett. 2006, 
47, 4491–4493. 
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5.4.8. 1,6-addition to α’-oxy dienones 
5.4.8.1. General procedure 
 
To a mixture of the corresponding nucleophile (0.15 mmol, 1 equiv.) and 
dienone 16 (42 mg, 0.30 mmol, 3.0 equiv.), in CH2Cl2 (0.45 mL) at 0 ºC, the selected 
catalyst (10 mol%) was added. The resulting mixture was stirred at the same 
temperature until consumption of the starting nucleophile as monitored by 1H-NMR. 
The crude product was purified by flash column chromatography (eluting 
hexane/EtOAc 80:20). 
For the racemic version of the reaction the same procedure was followed using 
DBU as the catalyst. 
 
5.4.8.2. Characterization data for compounds 29 and 31 
(E)-5-Hexyl-5-(6-hydroxy-6-methyl-5-oxohept-2-en-1-yl)-2-phenyloxazol-4(5H)-one 
(29) 
The title compound was obtained following the general 
procedure from oxazolone 17E (37 mg, 0.15 mmol) 
employing catalyst C17. Colourless oil. Yield: 79% (39 
mg, 0.12 mmol). [α]D23 = –3.9º (c = 0.80, 40% ee, 
CH2Cl2). 1H-NMR (300 MHz, CDCl3) δ 8.26 – 8.17 (m, 2H), 7.71 (t, J = 7.4 Hz, 1H), 
7.60 – 7.51 (m, 2H), 5.73 (dt, J = 13.9, 6.8 Hz, 1H), 5.40 (dt, J = 15.4, 7.2 Hz, 1H), 3.23 
– 3.14 (m, 2H), 2.71 – 2.63 (m, 2H), 1.99 – 1.88 (m, 2H), 1.37 – 1.18 (m, 14H), 0.84 (t, 
J = 6.6 Hz, 3H). 13C-NMR (75 MHz, CDCl3) δ 211.8, 193.1, 185.5, 145.4, 141.8, 
135.1, 130.0, 128.9, 127.8, 125.4, 124.2, 90.6, 76.2, 39.1, 35.5, 31.4, 29.0, 26.9, 26.2, 
25.3, 22.8, 22.4, 13.9. MS: calculated for C23H32NO4 (M + H 
+), 386.2331; found, 
386.2342. The enantiomeric purity of the major isomer was determined by chiral HPLC 
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analysis of the crude reaction mixture (Daicel Chiralpak IC, hexane/isopropanol, 95:5; 
flux = 1 mL/min; retention times: 34.7 min (major), 37.4 min (minor)). 
(E)-5-Hexyl-5-(6-hydroxy-6-methyl-5-oxohept-2-en-1-yl)-2-phenyloxazol-4(5H)-one 
(29’) 
The title compound was obtained as a byproduct following the 
general procedure from oxazolone 17E (37 mg, 0.15 mmol) but 
at 70 ºC in 1,2-dichloroethane and employing catalyst C7. 
Colourless oil. Yield: 23% (11 mg, 0.034 mmol). 1H-NMR 
(300 MHz, CDCl3) δ 8.26 – 8.20 (m, 2H), 7.77 – 7.68 (m, 1H), 7.61 – 7.52 (m, 2H), 
5.64 – 5.44 (m, 1H), 5.26 – 5.08 (m, 2H), 3.37 (td, J = 9.8, 3.1 Hz, 1H), 2.90 (dd, J = 
17.2, 10.2 Hz, 1H), 2.58 (dd, J = 17.2, 3.2 Hz, 1H), 2.01 – 1.88 (m, 2H), 1.33 (s, 3H), 
1.28 (s, 3H), 1.22 (dd, J = 13.3, 6.6 Hz, 8H), 0.82 (t, J = 7.1 Hz, 3H). MS: calculated 
for C23H32NO4 (M + H 
+), 386.2331; found, 386.2342.  
tert-Butyl (E)-2-cyano-8-hydroxy-8-methyl-7-oxo-2-(p-tolyl)non-4-enoate (31) 
The title compound was obtained following the general 
procedure from α-cyanoacetate 30 (69 mg, 0.15 mmol) 
employing catalyst C18. Colourless oil. Yield: 83% (46 
mg, 0.12 mmol). [α]D23 = +3.1º (c = 1.00, 30% ee, 
CH2Cl2). 1H-NMR (300 MHz, CDCl3) δ 7.50 – 7.38 (m, 2H), 7.01 – 6.88 (m, 2H), 5.81 
(dt, J = 13.8, 6.7 Hz, 1H), 5.52 (dt, J = 14.5, 7.1 Hz, 1H), 3.82 (s, 3H), 3.53 (s, 1H), 
3.31 (d, J = 6.7 Hz, 2H), 3.06 (dd, J = 14.0, 7.4 Hz, 1H), 2.77 (dd, J = 13.9, 6.9 Hz, 
1H), 1.42 (s, 9H), 1.36 (s, 3H), 1.35 (s, 3H). 13C-NMR (75 MHz, CDCl3) δ 211.8, 
165.9, 159.6, 128.2, 127.2, 126.9, 126.2, 118.4, 114.2, 84.2, 76.3, 55.2, 54.1, 40.6, 39.2, 
27.5, 26.5. MS: calculated for C22H29NO5Na (M + Na
+), 410.1943; found, 410.1938. 
The enantiomeric purity of the major isomer was determined by chiral HPLC analysis 
of the crude reaction mixture (Daicel Chiralpak IC, hexane/isopropanol, 95:5; flux = 1 
mL/min; retention times: 31.0 min (major), 35.8 min (minor)). 
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5.4.9. Preparation of α-alkenyl cycloalkanones 34 
Preparation of α-styryl cycloalkanones (34A-34E) 
Known cycloalkanones 34A and 34B and new cycloalkanones 34C-34E were 
synthesised following the procedure reported by Trofimov:266 
 
A solution of the corresponding cyclic ketone (8 mmol, 1 equiv.), the 
corresponding alkyne (8 mmol, 1 equiv.) and potassium tert-butoxyde (900 mg, 8 
mmol, 1 equiv.) in DMSO (20 mL) was stirred at 100 ºC for 30 min in a sealed tube 
under argon. Te reaction mixture was then cooled to room temperature, water (20 mL) 
was added and the mixture was neutralized with a saturated solution of NH4Cl. The 
resulting biphasic mixture was extracted with Et2O (4 x 20 mL) , the combined organic 
extract was washed with water (2 x 20 mL) and dried over MgSO4, and volatiles were 
removed under reduced pressure to obtain crude compound which was purified by silica 
gel flash column chromatography (hexane/CH2Cl2 1:1). 
(E)-2-Styrylcyclohexan-1-one (34A)266 
The title compound was obtained following the general procedure above 
described starting from cyclohexanone (0.83 mL, 8 mmol, 1 equiv.) and 
phenylacetylene (0.88 mL, 8 mmol, 1 equiv.) as a yellow solid. Yield: 
50% (800 mg, 4.0 mmol). All data were consistent with those previously reported. 1H 
NMR (300 MHz, CDCl3) δ 7.38 (d, J = 7.4 Hz, 2H), 7.30 (t, J = 7.5 Hz, 2H), 7.21 (t, J 
= 7.3 Hz, 1H), 6.52 – 6.31 (m, 2H), 3.26 – 3.15 (m, 1H), 2.55 – 2.44 (m, 1H), 2.44 – 
2.32 (m, 1H), 2.25 – 2.13 (m, 1H), 2.13 – 2.01 (m, 1H), 1.99 – 1.86 (m, 1H), 1.85 – 1.68 
(m, 3H). 
(E)-2-Styrylcyclopentan-1-one (34B)267 
The title compound was obtained following the general procedure above 
described starting from cyclopentanone (0.71 mL, 8 mmol, 1 equiv.) and 
phenylacetylene (0.88 mL, 8 mmol, 1 equiv.) as a yellow oil. Yield: 
62% (1.3 g, 6.9 mmol). All data were consistent with those previously reported. 1H 
NMR (300 MHz, CDCl3) δ 7.46 – 6.92 (m, 5H), 6.47 (d, J = 16.1 Hz, 1H), 6.24 (dd, J = 
                                                 
266 B. A. Trofimov, E. Y. Schmidt, N. V. Zorina, E. V. Ivanova, I. A. Ushakov, J. Org. Chem. 2012, 77, 
6880–6886. 
267 L.-L. Zhu, X.-X. Li, W. Zhou, X. Li, Z. Chen, J. Org. Chem. 2011, 76, 8814–8823. 
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16.1, 6.2 Hz, 1H), 3.02 – 2.87 (m, 1H), 2.45 – 2.02 (m, 5H), 1.97 – 1.80 (m, 2H). 13C 
NMR (75 MHz, CDCl3) δ 218.0, 136.9, 131.9, 128.4, 127.3, 126.2, 126.0, 52.4, 37.8, 
29.7, 20.7. 
(E)-2-Styrylcycloheptan-1-one (34C) 
The title compound was obtained following the general procedure 
above described starting from cycloheptanone (0.94 mL, 8 mmol, 1 
equiv.) and phenylacetylene (0.88 mL, 8 mmol, 1 equiv.) as a yellow 
oil. Yield: 67% (1.2 g, 5.4 mmol). 1H NMR (300 MHz, CDCl3) δ 7.42 – 7.32 (m, 2H), 
7.39 – 7.24 (m, 2H), 7.25 – 7.18 (m, 1H), 6.43 (d, J = 16.1 Hz, 1H), 6.32 (dd, J = 16.0, 
7.2 Hz, 1H), 3.35 (ddd, J = 11.0, 7.2, 4.0 Hz, 1H), 2.66 – 2.45 (m, 2H), 2.06 – 1.82 (m, 
4H), 1.77 – 1.57 (m, 2H), 1.54 – 1.38 (m, 2H). 13C NMR (75 MHz, CDCl3) δ 213.7, 
137.0, 130.8, 128.5, 128.4, 127.3, 126.2, 56.2, 42.4, 31.5, 29.7, 27.9, 24.8. MS: 
calculated for C15H19O (M + H
+), 215.1436; found, 215.1432. 
(E)-2-Styrylcyclooctan-1-one (34D) 
The title compound was obtained following the general procedure 
above described starting from cyclooctanone (1.0 g mL, 8 mmol, 1 
equiv.) and phenylacetylene (0.88 mL, 8 mmol, 1 equiv.) as a yellow 
oil. Yield: 74% (1.4 g, 5.9 mmol). 1H NMR (300 MHz, CDCl3) 7.39 – 
7.18 (m, 5H), 6.45 (d, J = 16.0 Hz, 1H), 6.27 (dd, J = 16.0, 7.7 Hz, 1H), 3.39 (ddd, J = 
11.2, 7.7, 3.7 Hz, 1H), 2.60 – 2.23 (m, 2H), 2.11 – 1.79 (m, 4H), 1.79 – 1.63 (m, 2H), 
1.60 – 1.37 (m, 4H). 13C NMR (75 MHz, CDCl3) δ 216.7, 136.9, 130.9, 128.4, 128.3, 
127.3, 126.1, 55.0, 40.7, 32.4, 26.9, 26.1, 25.8, 24.5. MS: calculated for C16H21O (M + 
H+), 229.1592; found, 229.1604. 
(E)-2-(4-Methoxystyryl)-4,4-dimethylcyclohexan-1-one (34E) 
The title compound was obtained following the general 
procedure above described starting from 4,4-
dimethylcyclohexanone (1.01g mL, 8 mmol, 1 equiv.) and 4-
ethynylanisole (1.04 mL, 8 mmol, 1 equiv.) as a yellow oil. 
Yield: 27% (490 mg, 1.9 mmol). 1H NMR (300 MHz, CDCl3) δ 7.33 (d, J = 8.8 Hz, 
1H), 6.86 (d, J = 8.8 Hz, 1H), 6.40 – 6.21 (m, 2H), 3.82 (s, 2H), 3.37 – 3.24 (m, 1H), 
2.64 – 2.46 (m, 1H), 2.41 – 2.30 (m, 1H), 1.95 – 1.64 (m, 3H), 1.29 (s, 3H), 1.08 (s, 
3H). 13C NMR (75 MHz, CDCl3) δ 211.9, 159.0, 130.6, 130.0, 127.4, 125.4, 113.6, 
55.3, 49.7, 47.2, 38.2, 31.4, 30.8, 24.6. MS: calculated for C17H23O2 (M + H
+), 
259.1698; found, 259.1711. 
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Preparation of 2-(2-methylprop-1-en-1-yl)cyclohexan-1-one (34F) 
Cycloalkanone 34F was prepared according to the synthetic procedure reported 
by Toste:268 
 
1st step: To a solution of CuI (380 mg, 2 mmol, 0.1 equiv.) in THF (20 mL) and 2-
methyl-1-propenylmagnesium bromide (0.5 M in THF; 52 mL, 26 mmol, 1.3 equiv.) 
was added at –78 ºC. After stirring for 30 min cyclohexene oxide (2.0 mL, 20 mmol, 1 
equiv.) was added, and the resulting mixture was further stirred for 2 h at –20 ºC. The 
reaction was quenched by adding a saturated solution of NH4Cl (50 mL) and the 
mixture was extracted with Et2O (3 x 50 mL). The combined organic extract was 
washed with brine (50 mL) and dried over MgSO4. Volatiles were removed under 
reduced pressure to obtain crude compound which was purified by silica gel flash 
column chromatography (hexane/EtOAc 80:20). Yield: 55% (1.7 g, 11 mmol). 1H 
NMR (300 MHz, CDCl3) δ 4.99 (d, J = 9.3 Hz, 0H), 3.81 (qd, J = 6.8, 3.5 Hz, 1H), 2.64 
– 2.45 (m, 1H), 2.02 – 1.82 (m, 1H), 1.82 – 1.49 (m, 6H), 1.37 – 1.20 (m, 1H). 
2nd step: DMSO (1.1 mL, 15 mmol, 3 equiv.) was added to a solution of (COCl)2 (0.64 
mL, 7.5 mmol, 1.5 equiv.) in CH2Cl2 (15 mL) at –78 ºC. After stirring for 30 min a 
solution of the alcohol obtained above (5 mmol, 1 equiv.) in CH2Cl2 (5 mL) was slowly 
added and the mixture stirred for further 2 h at the same temperature before slowly 
warming it to room temperature. The mixture was stirred for an additional hour and the 
reaction was quenched by adding a saturated solution of NH4Cl (10 mL) and the 
mixture was extracted with CH2Cl2 (3 x 20 mL). The combined organic extract was 
washed with brine (50 mL) and dried over MgSO4, and volatiles were removed under 
reduced pressure (400 bat at 35 oC) to obtain the crude compound, which was purified 
by silica gel flash column chromatography (hexane/Et2O 95:5). Yellow oil. All data 
were consistent with those previously reported. Yield: 40% (400 mg, 2.0 mmol). 1H 
NMR (300 MHz, CDCl3) δ 4.99 (d, J = 8.3 Hz, 1H), 3.14 – 2.78 (m, 1H), 2.40 – 1.96 
(m, 5H), 1.95 – 1.70 (m, 5H), 1.70 – 1.56 (m, 4H). 
 
                                                 
268 X. Yang, F. D. Toste, J. Am. Chem. Soc. 2015, 137, 3205–3208. 
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5.4.10. α-Functionalization of α-alkenyl cycloalkanones 
5.4.10.1. General procedure 
 
Catalyst C30 (11.5 mg, 5 mol%) was added over a solution of the corresponding 
α-alkenyl cycloalkanone 34 (0.15 mmol, 1 equiv.) and 1,1-bis(phenylsulfonyl)ethylene 
(33) (69 mg, 0.23 mmol, 1.5 equiv.) in CH2Cl2 at 0 ºC. The resulting solution was 
stirred until the reaction was completed (monitored by TLC hexane/EtOAc 80:20). 
Then the mixture was directly submitted to a flash column chromatography 
(hexane/EtOAc 85:15), affording the corresponding adducts as essentially pure 
compound. 
The racemic version of the reaction was performed following the asymmetric 
reaction procedure except the reaction was conducted at room temperature and TEA (20 
mol%) was used as the catalyst. 
 
5.4.10.2. Characterization data of compounds 35 
(R,E)-2-(2,2-bis(Phenylsulfonyl)ethyl)-2-styrylcyclohexan-1-one (35A) 
The adduct was obtained according to the general procedure 
described above using (E)-2-styrylcyclohexan-1-one (34A) (30 mg, 
0.15 mmol, 1 equiv.). White solid. m. p. = 92–93 ºC. Yield: 91% (69 
mg, 0.136 mmol). [α]D23= –95.8º (c = 1.00, 98% ee, CH2Cl2). 1H 
NMR (300 MHz, CDCl3) δ 8.02 – 7.85 (m, 2H), 7.71 – 7.61 (m, 3H), 7.57 – 7.45 (m, 
3H), 7.45 – 7.25 (m, 7H), 6.42 (d, J = 16.6 Hz, 1H), 6.12 (d, J = 16.6 Hz, 1H), 4.56 (t, J 
= 4.3 Hz, 1H), 3.18 (dd, J = 16.6, 4.0 Hz, 1H), 2.64 – 2.51 (m, 1H), 2.49 – 2.37 (m, 2H), 
2.26 (dd, J = 16.6, 4.6 Hz, 1H), 2.06 – 1.69 (m, 5H). 13C NMR (75 MHz, CDCl3) δ 
211.0, 138.3, 137.3, 136.1, 134.5, 134.1, 132.6, 130.3, 130.2, 129.5, 128.9, 128.8, 
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128.3, 126.6, 80.8, 54.4, 39.7, 36.1, 31.1, 27.0, 21.3. MS: calculated for C28H32NO5S2 
(M + NH4
+), 526.6855; found, 526.1727. The enantiomeric purity was determined by 
chiral HPLC analysis (Daicel Chiralpak IA, hexane/isopropanol, 70:30; flux = 1 
mL/min; retention times: 17.6 min (minor), 18.9 min (major)). 
(R,E)-2-(2,2-bis(Phenylsulfonyl)ethyl)-2-styrylcyclopentan-1-one (35B) 
 The adduct was obtained according to the general procedure 
described above using (E)-2-styrylcyclopentan-1-one (34B) (28 mg, 
0.15 mmol, 1 equiv.) in toluene instead of dichloromethane. White 
solid. m. p. = 154–156 ºC. Yield: 85% (62 mg, 0.128 mmol). [α]D23= 
–36.0º (c = 0.75, 80% ee, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 7.91 – 7.81 (m, 4H), 
7.59 (t, J = 7.4 Hz, 1H), 7.50 (t, J = 7.4 Hz, 1H), 7.45 – 7.37 (m, 4H), 7.35 – 7.25 (m, 
5H), 6.37 (d, J = 16.3 Hz, 1H), 5.93 (d, J = 16.3 Hz, 1H), 4.89 (t, J = 4.2 Hz, 1H), 2.91 
(dd, J = 16.4, 4.3 Hz, 1H), 2.49 – 2.25 (m, 4H), 2.23 – 1.87 (m, 3H). 13C NMR (75 
MHz, CDCl3) δ 218.0, 140.3, 138.3, 137.2, 136.2, 134.9, 134.5, 134.2, 131.5, 129.9, 
129.5, 128.9, 128.6, 128.0, 126.7, 79.5, 53.7, 37.9, 35.1, 31.4, 18.7. MS: calculated for 
C27H27O5S2 (M + H
+), 495.1300; found, 495.1299. The enantiomeric purity was 
determined by chiral HPLC analysis (Daicel Chiralpak IA, hexane/isopropanol, 70:30; 
flux = 1 mL/min; retention times: 15.0 min (major), 16.9 min (minor)). 
(R,E)-2-(2,2-bis(Phenylsulfonyl)ethyl)-2-styrylcycloheptan-1-one (35C) 
 The adduct was obtained according to the general procedure 
described above using (E)-2-styrylcycloheptan-1-one (34C) (32 mg, 
0.15 mmol, 1 equiv.). White foam. Yield: 86% (67 mg, 0.129 
mmol). [α]D23= –123.0º (c = 1.00, 96% ee, CH2Cl2). 1H NMR (300 
MHz, CDCl3) δ 7.86 (d, J = 8.2 Hz, 2H), 7.73 (d, J = 8.3 Hz, 2H), 7.55 (q, J = 7.3 Hz, 
2H), 7.51 – 7.16 (m, 9H), 6.51 (d, J = 16.5 Hz, 1H), 6.14 (d, J = 16.5 Hz, 1H), 4.63 (t, J 
= 4.0 Hz, 1H), 3.12 (dd, J = 16.6, 4.5 Hz, 1H), 2.72 – 2.61 (m, 1H), 2.61 – 2.50 (m, 1H), 
2.30 (dd, J = 16.5, 3.5 Hz, 1H), 2.20 – 1.99 (m, 2H), 1.68 (dp, J = 31.2, 11.0, 9.1 Hz, 
5H), 1.52 – 1.38 (m, 1H). 13C NMR (75 MHz, CDCl3) δ 212.9, 138.5, 137.1, 136.5, 
134.5, 134.0, 132.4, 130.5, 130.1, 129.5, 128.9, 128.8, 128.7, 128.0, 126.7, 80.5, 57.0, 
41.1, 32.6, 30.2, 29.9, 26.5, 24.4. MS: calculated for C29H31O5S2 (M + H
+), 523.1613; 
found, 523.1620. The enantiomeric purity was determined by chiral HPLC analysis 
(Daicel Chiralpak IC, hexane/isopropanol, 50:50; flux = 1 mL/min; retention times: 
33.4 min (minor), 49.5 min (major)). 
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(R,E)-2-(2,2-bis(Phenylsulfonyl)ethyl)-2-styrylcyclooctan-1-one (35D) 
 The adduct was obtained according to the general procedure 
described above using (E)-2-styrylcyclooctan-1-one (34D) (34 mg, 
0.15 mmol, 1 equiv.) in toluene instead of dichloromethane. White 
foam. Yield: 88% (69 mg, 0.132 mmol). [α]D23= –87.6º (c = 1.00, 
94% ee, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 7.88 (d, J = 7.3 Hz, 2H), 7.69 (d, J = 
7.3 Hz, 2H), 7.62 (t, J = 7.5 Hz, 1H), 7.54 (t, J = 7.5 Hz, 1H), 7.49 – 7.41 (m, 4H), 7.41 
– 7.26 (m, 5H), 6.63 (d, J = 16.6 Hz, 1H), 6.23 (d, J = 16.6 Hz, 1H), 3.19 (dd, J = 16.7, 
4.2 Hz, 1H), 2.85 – 2.68 (m, 1H), 2.46 – 2.26 (m, 4H), 2.25 – 2.14 (m, 1H), 1.87 – 1.62 
(m, 5H), 1.58 – 1.38 (m, 2H), 1.25 – 1.07 (m, 1H). 13C NMR (75 MHz, CDCl3) δ 214.9, 
138.4, 137.3, 136.4, 134.4, 134.0, 132.8, 130.1, 129.8, 129.5, 128.8, 128.8, 128.2, 
126.7, 81.3, 56.6, 38.0, 30.0, 29.4, 26.7, 26.2, 24.7, 24.2. MS: calculated for 
C30H33O5S2 (M + H
+), 137.1769; found, 137.1766. The enantiomeric purity was 
determined by chiral HPLC analysis (Daicel Chiralpak IC, hexane/isopropanol, 50:50; 
flux = 1 mL/min; retention times: 20.6 min (minor), 26.5 min (major)). 
(R,E)-2-(2,2-bis(Phenylsulfonyl)ethyl)-2-styrylcyclohexan-1-one (35E) 
 The adduct was obtained according to the general procedure 
described above using (E)-2-(4-methoxystyryl)-4,4-
dimethylcyclohexan-1-one (34E) (39 mg, 0.15 mmol, 1 equiv.). 
White solid. m. p. = 107 ºC.  Yield: 91% (69 mg, 0.136 mmol). 
[α]D23= +10.8º (c = 1.00, 92% ee, CH2Cl2). 1H NMR (300 
MHz, CDCl3) δ 7.86 – 7.72 (m, 4H), 7.66 – 7.51 (m, 2H), 7.49 
– 7.22 (m, 6H), 6.89 (d, J = 8.8 Hz, 2H), 6.13 (d, J = 16.7 Hz, 1H), 5.98 (d, J = 16.7 Hz, 
1H), 4.89 – 4.80 (m, 1H), 3.83 (s, 3H), 2.98 (d, J = 20.0 Hz, 1H), 2.74 – 2.54 (m, 1H), 
2.42 – 2.32 (m, 1H), 2.32 – 2.21 (m, 1H), 2.13 (d, J = 14.2 Hz, 1H), 1.75 (d, J = 14.2 
Hz, 1H), 1.68 (dd, J = 9.1, 4.6 Hz, 2H), 1.16 (s, 3H), 1.06 (s, 3H). 13C NMR (75 MHz, 
CDCl3) δ 212.0, 159.6, 138.3, 134.1, 134.1, 130.8, 130.3, 129.7, 129.7, 129.1, 128.8, 
128.8, 127.7, 114.2, 80.9, 55.3, 52.5, 51.0, 38.3, 36.3, 33.0, 32.1, 30.9, 27.3. MS: 
calculated for C31H35O6S2 (M + H
+), 567.1875; found, 567.1882. The enantiomeric 
purity was determined by chiral HPLC analysis (Daicel Chiralpak IA, 
hexane/isopropanol, 70:30; flux = 1 mL/min; retention times: 16.7 min (minor), 23.2 
min (major)). 
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(R,E)-2-(2,2-bis(Phenylsulfonyl)ethyl)-2-(2-methylprop-1-en-1-yl)cyclohexan-1-one 
(35F) 
 The adduct was obtained according to the general procedure 
described above using 2-(2-methylprop-1-en-1-yl)cyclohexan-1-
one (34F) (23 mg, 0.15 mmol, 1 equiv.). Colourless oil. Yield: 
84% (58 mg, 0.126 mmol). [α]D23= –36.1º (c = 1.00, 61% ee, 
CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 7.94 (d, J = 7.2 Hz, 1H), 7.85 (d, J = 7.2 Hz, 
1H), 7.69 – 7.58 (m, 1H), 7.56 – 7.47 (m, 3H), 5.00 (s, 0H), 4.96 (dd, J = 5.3, 3.2 Hz, 
1H), 2.81 (dd, J = 16.2, 5.3 Hz, 1H), 2.59 – 2.47 (m, 1H), 2.37 (dd, J = 16.2, 3.2 Hz, 
1H), 2.32 – 2.20 (m, 1H), 2.19 – 2.12 (m, 2H), 2.06 – 1.96 (m, 1H), 1.56 (s, 2H), 1.52 
(s, 2H). 13C NMR (75 MHz, CDCl3) δ 220.6, 138.7, 138.2, 137.6, 134.5, 134.1, 129.9, 
129.5, 129.0, 128.9, 124.9, 79.1, 51.7, 38.8, 37.4, 31.0, 27.1, 19.8, 18.7. MS: calculated 
for C24H29O5S2 (M + H
+), 461.6105; found, 461.6100. The enantiomeric purity was 
determined by chiral HPLC analysis (Daicel Chiralpak AD-H, hexane/isopropanol, 
70:30; flux = 1 mL/min; retention times: 9.3 min (minor), 10.4 min (major)). 
 
5.4.11. Elaboration of adducts 35 
5.4.11.1. Synthesis of 38 and 39 
Ketals 38 and 39 were prepared according to the following synthetic sequence: 
 
Step 1: Protection of the ketone moiety (36 and 37) 
The above obtained ketone 35 (0.25 mmol, 1 equiv.), etylenglycol (60 µL, 1.0 
mmol, 4 equiv.) and triethyl orthoformate (80 µL, 0.50 mmol, 2 equiv.) were dissolved 
in 1,2-DCE (0.6 mL) and camphorsulphonic acid (16 mg, 0.07 mmol, 0.28 equiv.) was 
added. The resulting solution was stirred at 70 ºC overnight before being directly 
submitted to silica gel flash column chromatography (hexane/EtOAc 80:20). 
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(R,E)-6-(2,2-bis(Phenylsulfonyl)ethyl)-6-styryl-1,4-dioxaspiro[4.5]decane (36) 
The ketal was obtained from adduct 35A (125 mg, 0.25 mmol, 1 
equiv.) following the procedure described above. White solid. m. p. 
= 67–69 ºC. Yield: 98% (135 mg, 0.244 mmol). [α]D23= –69.0º (c = 
1.00, 98% ee, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 8.05 – 7.99 
(m, 2H), 7.72 – 7.65 (m, 1H), 7.60 – 7.52 (m, 4H), 7.50 – 7.44 (m, 3H), 7.42 – 7.34 (m, 
2H), 7.29 (d, J = 7.2 Hz, 1H), 7.20 – 7.12 (m, 2H), 6.37 (d, J = 4.4 Hz, 3H), 4.43 (t, J = 
4.0 Hz, 2H), 4.04 – 3.80 (m, 4H), 2.79 (dd, J = 16.2, 4.0 Hz, 1H), 2.34 (dd, J = 16.2, 4.0 
Hz, 2H), 2.05 (d, J = 14.1 Hz, 2H), 1.82 – 1.43 (m, 7H). 13C NMR (75 MHz, CDCl3) δ 
138.9, 137.6, 137.3, 134.7, 134.1, 132.3, 131.2, 130.8, 129.6, 129.0, 128.9, 128.9, 
127.9, 126.8, 111.7, 81.4, 65.2, 65.1, 49.5, 32.5, 30.4, 27.9, 23.5, 21.0. MS: calculated 
for C30H36N2O5S2 (M + NH4
+), 570.7385; found, 570.1994. 
(R,E)-6-(2,2-bis(Phenylsulfonyl)ethyl)-6-(4-methoxystyryl)-8,8-dimethyl-1,4-
dioxaspiro[4.5]decane (37) 
The ketal was obtained from adduct 35E (283 mg, 0.5 mmol, 1 
equiv.) following the procedure described above. White solid. m. 
p. = 90–93 ºC. Yield: 90% (274 mg, 0.45 mmol). [α]D23= –45.9 (c 
= 1.00, 92% ee, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 7.85 (d, 
J = 7.4 Hz, 2H), 7.70 (d, J = 7.6 Hz, 2H), 7.61 – 7.45 (m, 2H), 
7.41 (t, J = 7.6 Hz, 4H), 7.29 (t, J = 7.9 Hz, 2H), 6.92 (d, J = 8.6 Hz, 2H), 6.63 (d, J = 
16.9 Hz, 1H), 6.22 (d, J = 16.9 Hz, 1H), 4.77 (t, J = 3.7 Hz, 1H), 4.15 – 3.85 (m, 4H), 
3.80 (s, 3H), 2.82 (dd, J = 16.3, 3.0 Hz, 1H), 2.19 (dd, J = 16.3, 4.9 Hz, 1H), 1.83 – 1.43 
(m, 5H), 1.29 – 1.18 (m, 1H), 0.97 (s, 3H), 0.91 (s, 3H). 13C NMR (75 MHz, CDCl3) δ 
159.0, 140.2, 138.4, 137.9, 134.7, 134.0, 133.7, 130.8, 130.2, 129.9, 129.6, 129.6, 
128.5, 128.4, 128.2, 127.5, 113.9, 111.7, 81.3, 64.1, 63.7, 55.1, 48.0, 45.7, 36.1, 33.9, 
30.8, 29.4, 28.2, 27.8. MS: calculated for C33H39O7S2 (M + H
+), 611.2137; found, 
611.2125. 
 
Step 2: Desulfonylation of ketals 36 and 37 to afford 38 and 39 
The above obtained ketal (0.25 mmol, 1 equiv.) was dissolved in MeOH (2 mL) 
and magnesium powder (61 mg, 2.5 mmol, 10 equiv.) was added. The resulting 
suspension was cooled to 0 ºC and a drop of trimethylsilylchloride and a drop of 1,2-
dibromoethane were added. The resulting mixture was warmed to room temperature 
observing the formation of hydrogen, and the reaction was followed by TLC 
(hexane/EtOAc 80:20). After completion of the reaction the mixture was filtered 
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through a pad of celite and washed with MeOH. The solvent was eliminated under 
reduced pressure and the residue was dissolved in dichloromethane (10 mL). The 
organic solution was washed with water (2 x 10 mL), dried over MgSO4, volatiles were 
removed under reduced pressure to obtain crude compound which was purified by silica 
gel flash column chromatography (hexane/EtOAc 95:5). 
(R,E)-6-Ethyl-6-styryl-1,4-dioxaspiro[4.5]decane (38) 
The product was obtained from 36 (138 mg, 0.25 mmol, 1 equiv.) 
following the procedure described above as a colourless oil. Yield: 56% 
(38 mg, 0.14 mmol). [α]D23= –16.2º (c = 0.80, 98% ee, CH2Cl2). 1H NMR 
(300 MHz, CDCl3) δ 7.39 (d, J = 7.1 Hz, 2H), 7.30 (t, J = 7.4 Hz, 2H), 
7.19 (t, J = 7.2 Hz, 1H), 6.34 (d, J = 16.7 Hz, 1H), 6.23 (d, J = 16.7 Hz, 1H), 4.03 – 
3.82 (m, 4H), 1.94 – 1.82 (m, 1H), 1.74 – 1.51 (m, 8H), 1.51 – 1.38 (m, 1H), 0.74 (t, J = 
7.5 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 138.9, 134.4, 130.3, 129.1, 128.8, 127.4, 
126.7, 126.1, 113.3, 65.9, 65.6, 49.0, 32.7, 29.8, 25.7, 24.2, 21.3, 8.4. MS: calculated 
for C18H25O2 (M + H
+), 273.3955; found, 273.1722. 
(S,E)-6-Ethyl-6-(4-methoxystyryl)-8,8-dimethyl-1,4-dioxaspiro[4.5]decane (39) 
The product was obtained from 37 (270 mg, 0.40 mmol, 1 equiv.) 
following the procedure described above. Colourless oil. Yield: 
53% (70 mg, 0.21 mmol). [α]D26= –13.7º (c = 0.50, 92% ee, 
CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 7.33 (d, J = 8.7 Hz, 2H), 
6.86 (d, J = 8.7 Hz, 2H), 6.40 (d, J = 16.7 Hz, 1H), 6.12 (d, J = 
16.7 Hz, 1H), 4.09 – 3.89 (m, 4H), 3.81 (s, 3H), 1.78 – 1.59 (m, 5H), 1.59 – 1.41 (m, 
3H), 1.04 (s, 3H), 1.01 (s, 3H), 0.82 (t, J = 7.5 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 
158.5, 132.8, 129.4, 128.5, 127.0, 113.8, 64.8, 64.7, 55.2, 47.8, 43.5, 36.4, 31.4, 30.6, 
30.5, 28.9, 27.5, 8.2. 
 
5.4.11.2. Synthesis of compound 41 
Ketone 41 was synthesised from ketal 36 according to the following synthetic 
sequence: 
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1st step: Sodium hydride (60% wt in oil) (9.5 mg) was added to a solution of the above 
obtained ketal 58 (116 mg, 0.20 mmol, 1 equiv.) in dry DMF (0.5 mL) at 0 ºC. The 
mixture was stirred at room temperature for 30 min and was recooled to 0 ºC to slowly 
add iodomethane (75 µL, 0.6 mmol, 3 equiv.). The resulting solution mas stirred 
overnight at 40 ºC. The reaction was quenched by adding a saturated solution of NH4Cl, 
and the resulting aqueous phase was extracted with EtOAc (3 x 3 mL). The combined 
organic layer was washed with brine (5 x 5 mL), dried over MgSO4, and volatiles were 
removed under reduced pressure to obtain crude compound which was purified by silica 
gel flash column chromatography (hexane/EtOAc 80:20) obtaining product 62 as a 
white foam. Yield: 86% (99 mg, 0.172 mmol). [α]D25= –59.3º (c = 1.00, 98% ee, 
CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 8.08 (d, J = 7.2 Hz, 2H), 7.91 (d, J = 7.3 Hz, 
2H), 7.75 – 7.45 (m, 6H), 7.25 (dt, J = 24.9, 7.6 Hz, 5H), 6.46 – 6.26 (m, 1H), 5.90 (d, J 
= 16.8 Hz, 1H), 3.99 – 3.72 (m, 4H), 2.34 – 2.20 (m, 1H), 1.96 (dt, J = 14.0, 6.7 Hz, 
1H), 1.88 (s, 3H), 1.69 – 1.48 (m, 8H). 13C NMR (75 MHz, CDCl3) δ 137.4, 136.8, 
136.1, 134.2, 132.3, 131.8, 131.5, 128.6, 128.4, 128.4, 127.2, 126.1, 112.3, 89.8, 64.8, 
49.2, 31.3, 31.1, 23.1, 20.9, 16.4. 
2nd step: The methylated adduct 40 (142 mg, 0.25 mmol) was submitted to the 
desulfonylation procedure described above (Section 5.4.11.1), and the resulting ketal 
was dissolved in a mixture of THF (0.5 mL) and aqueous HCl (6 M) (0.5 mL) and 
stirred at room temperature overnight. THF was eliminated under reduced pressure and 
the remaining aqueous phase was extracted with dichloromethane (3 x 2 mL). The 
combined organic layer was dried over MgSO4 and volatiles were removed under 
reduced pressure to obtain crude compound 41, which was purified by silica gel flash 
column chromatography (hexane/CH2Cl2 60:40). Yield: 41% (25 mg, 0.102 mmol). 
[α]D25= +48.0º (c = 0.30, 98% ee, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 7.44 – 7.18 
(m, 5H), 6.38 (d, J = 16.6 Hz, 1H), 6.28 (d, J = 16.6 Hz, 1H), 2.64 – 2.49 (m, 1H), 2.46 
– 2.32 (m, 1H), 2.18 – 2.08 (m, 1H), 2.01 – 1.89 (m, 1H), 1.90 – 1.73 (m, 4H), 1.70 – 
1.52 (m, 2H), 1.41 – 1.19 (m, 2H), 0.92 (t, J = 7.3 Hz, 3H). 13C NMR (75 MHz, CDCl3) 
δ 213.2, 137.1, 133.5, 130.3, 128.6, 127.5, 126.1, 54.6, 40.1, 39.6, 36.7, 27.3, 21.7, 
17.1, 14.8. MS: calculated for C17H23O (M + H
+), 243.1749; found, 243.1752. 
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5.4.11.3. Preparation of β-ketoester 43 
Known β-ketoester 43269 was synthesised according to the following synthetic 
sequence: 
 
1st step:270 Alkene 38 (68 mg, 0.25 mmol, 1 equiv.) was dissolved in a mixture of tert-
butanol (3 mL) and water (1 mL) and citric acid (72 mg, 0.75 mmol, 3 equiv.). To the 
resulting solution N-methylmorpholine N-oxide (136 mg, 0.75 mmol, 3 equiv.) and 
osmium tetraoxide (2.5 wt% in tBuOH) (0.6 mL, 0.05 mmol, 0.2 equiv.) were added and 
the reaction mixture was stirred at 55 ºC for 24 h. Part of the solvent was eliminated 
under reduced pressure and the aqueous phase was extracted with dichloromethane (3 x 
2 mL). The combined organic layers were dried over MgSO4 and volatiles were 
removed under reduced pressure to obtain the crude compound which was purified by 
silica gel flash column chromatography (hexane/EtOAc 85:15). The desired diol 42 was 
obtained as a mixture of two isomers at a 1:1 ratio. Yield: 52% (40 mg, 0.13 mmol). 
2nd step:271 The diol 42 obtained in the previous step (37 mg, 0.12 mmol, 1 equiv.) was 
dissolved in a 2:2:3 mixture of CH3CN, CCl4 and H2O (2 mL) and sodium 
metaperiodate (205 mg, 0.96 mmol, 8 equiv.) and ruthenium(III) chloride (0.6 mg, 2.5 
mol%) were added. The resulting mixture was vigorously stirred for 2.5 h before being 
diluted with dichloromethane (2 mL). The layers were separated and the aqueous phase 
was extracted with dichloromethane (3 x 2 mL). The combined organic layers were 
dried over MgSO4 and volatiles were removed under reduced pressure. The crude 
obtained was dissolved in dry DMF (1.6 mL) and potassium carbonate (66 mg, 0.48 
mmol, 4 equiv.) was added. The mixture was stirred for 30 min at room temperature 
before adding iodomethane (0.10 mL, 0.72 mmol, 6 equiv.) and letting to stir overnight. 
The mixture was poured over HCl (1 M) and diethylether and the aqueous layer was 
extracted with diethylether (5 x 2 mL). The combined organic layers were washed with 
brine (10 x 2 mL), dried over MgSO4 and volatiles were removed under reduced 
pressure. The reaction crude was then redissolved in methanol (3.6 mL) and aqueous 
                                                 
269 K. Umemura, H. Matsuyama, N. Watanabe, M. Kobayashi, N. Kamigata, J. Org. Chem. 1989, 59, 
2374–2383. 
270 Adapted from: J-J. Wu, Y. Shi, W-S. Tian, Tetrahedron Lett. 2017, 58, 923–925. 
271 a) S. H. Jacobo, C-T. Chang, G-J. Lee, J. A. Lawson, W. S. Powel, D. Pratico, G. A. FitzGerald, J. 
Rokach, J. Org. Chem. 2006, 71, 1370–1379. b) G. Song, X. Shen, S. Li, Y. Li, H. Si, J. Fan, J. Li, E. 
Gao, S. Liu, Eur. J. Med. Chem. 2016, 199, 109–121. 
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HCl (3 M) (0.7 mL) was added. The resulting solution was stirred at room temperature 
overnight and diluted with an aqueous solution of NaHCO3 (5%). The mixture was 
extracted with Et2O (3 x 5 mL) and the combined organic layers were washed with 
brine (10 x 2 mL), dried over MgSO4 and volatiles were removed under reduced 
pressure to obtain the crude ketoester 63, which was purified by silica gel flash column 
chromatography (hexane/EtOAc 97:3). All data were consistent with those previously 
reported. Yield: 45% (10 mg, 0.054 mmol). The absolute configuration of the molecule 
was determined by comparison of the [α] value.272 [α]D23= –91.3º (c= 0.08, 98% ee, 
EtOH), ([α]D20 Lit272 = –82.4° (c = 5.7, EtOH). 1H NMR (300 MHz, CDCl3) δ 3.73 (s, 
3H), 2.56 – 2.39 (m, 3H), 2.06 – 1.87 (m, 2H), 1.78 – 1.52 (m, 4H), 1.50 – 1.37 (m, 
1H), 0.84 (t, J = 7.5 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 208.0, 172.5, 61.3, 52.2, 
41.2, 35.5, 29.7, 27.6, 22.5, 8.8. MS: calculated for C10H17O3 (M + Na
+), 185.1178; 
found, 185.1183. 
 
5.4.11.4. Preparation of cycloalkanone 45 
α,α-Dialkyl cycloalkanone 45 was synthesised according to the following 
synthetic sequence: 
 
1st step: Ketal 38 obtained above (16 mg, 0.6 mmol, 1 equiv.) was dissolved in a 
mixture of THF (0.5 mL) and aqueous HCl (6 M) (0.5 mL) and stirred at room 
temperature overnight. THF was eliminated under reduced pressure and the remaining 
aqueous phase was extracted with CH2Cl2 (3 x 2 mL). The combined organic layer was 
dried over MgSO4 and volatiles were removed under reduced pressure to obtain the 
desired ketone 44 as an essentially pure liquid compound. Yield: 89% (12.2 mg, 0.053 
mmol). [α]D23= –30.3º (c = 0.50, 98% ee, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 7.40 
– 7.27 (m, 4H), 7.26 – 7.22 (m, 1H), 6.30 (d, J = 3.9 Hz, 2H), 2.62 – 2.47 (m, 1H), 2.42 
– 2.29 (m, 1H), 2.14 – 2.04 (m, 1H), 1.99 – 1.59 (m, 7H), 0.84 (t, J = 7.5 Hz, 3H). 13C 
                                                 
272 For the same isomer: a) [α]D20 = –9.0º (11% ee, EtOH), K. Umemura, H. Matsuyama, N. Watanabe, 
M. Kobayashi, N. Kamigata, J. Org. Chem. 1988, 54, 2374–2383. b) [α]D20 = –82.4º (c = 5.7, 94% ee, 
EtOH), S. Pinheiro, A. Guingant, D. Desmaële, J. d’Angelo, Tetrahedron: Asymmetry. 1992, 3, 1003–
1006. For the other isomer: [α]D20 = +13.6º (c = 0.43, 16% ee, EtOH), M. Kobayashi, K. Umemura, N. 
Watanabe, H. Matsuyama, Chem. Lett. 1985, 1067–1070. 
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NMR (75 MHz, CDCl3) δ 213.2, 137.1, 133.2, 130.6, 128.6, 127.5, 126.1, 54.8, 39.6, 
36.0, 30.3, 27.3, 21.6, 8.2. 
2nd step: The previously obtained desulfonylated product 44 (11 mg, 0.5 mmol, 1 
equiv.) and palladium on activated charcoal (10% wt.) (20% wt, 2.2 mg) were stirred 
under an hydrogen atmosphere at 30 bar overnight. The resulting suspension was 
filtered over a pad of celite and the solvent was eliminated under reduced pressure. The 
α,α-dialkyl cycloalkanone 45 was purified by silica gel flash column chromatography 
(hexane/EtOAc 95:5). Colourless oil. Yield: 81% (9.3 mg, 0.040 mmol). [α]D23= –19.6º 
(c = 0.25, 98% ee, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 7.31 – 7.24 (m, 2H), 7.23 – 
7.12 (m, 3H), 2.53 (td, J = 12.9, 5.1 Hz, 1H), 2.44 – 2.27 (m, 3H), 1.99 – 1.69 (m, 9H), 
1.65 – 1.51 (m, 1H), 0.82 (t, J = 7.5 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 215.3, 
142.7, 128.4, 128.3, 125.8, 51.7, 39.2, 36.4, 36.1, 30.0, 27.2, 27.0, 20.8, 7.8. MS: 
calculated for C16H23O (M + H
+), 231.1749; found, 231.1755. 
 
5.4.11.5. Synthesis of hemiketal 46 and diastereopure diol 42 
Compound 42 was prepared in a diastereopure manner according to the 
following synthetic sequence: 
 
1st step:270 Compound 44 (62 mg, 0.25 mmol, 1 equiv.) was dissolved in a mixture of 
tert-butanol (36 mL) and H2O (1 mL) and citric acid (72 mg, 0.75 mmol, 3 equiv.). To 
the resulting solution N-methylmorpholine N-oxide (136 mg, 0.75 mmol, 3 equiv.) and 
osmium tetraoxide (2.5 wt % in tBuOH) (1.2 mL, 0.1 mmol, 0.2 equiv.) were added and 
the reaction mixture was stirred at 55 ºC for 24 h. Part of the solvent was eliminated 
under reduced pressure and the aqueous phase was extracted with dichloromethane (3 x 
2 mL). The combined organic layer was dried over MgSO4 and volatiles were removed 
under reduced pressure to obtain the crude compound which was purified by silica gel 
flash column chromatography (hexane/EtOAc 85:15). The hemiketal 46 was obtained as 
a single diastereomer and its structure was confirmed by X-ray analysis.  Yield: 60% 
(38 mg, 0.150 mmol). [α]D26= –18.1º (c = 1.00, 98% ee, CH2Cl2). 1H NMR (300 MHz, 
CDCl3) δ 7.51 – 7.34 (m, 4H), 7.34 – 7.24 (m, 1H), 5.49 (d, J = 4.2 Hz, 1H), 3.99 (d, J 
= 2.5 Hz, 2H), 2.12 – 1.78 (m, 3H), 1.70 (d, J = 4.0 Hz, 1H), 1.66 – 1.17 (m, 8H), 0.96 
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(t, J = 7.4 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 138.2, 128.6, 127.7, 126.7, 107.7, 
83.3, 79.1, 51.9, 31.9, 27.2, 22.5, 20.6, 18.8, 8.9. MS: calculated for C16H21O2 (M – 
OH–), 245.1536; found, 245.1551. 
2nd step: Diol 42 was obtained following the acetalization procedure described above 
(Section 5.4.11.1) starting from the hemiketal 46 obtained in the previous step (25 mg, 
0.10 mmol). White foam. Yield: 96% (29 mg, 0.096 mmol). [α]D25= +20.1º (c = 0.50, 
98% ee, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 7.41 – 7.19 (m, 5H), 5.54 (d, J = 4.7 
Hz, 1H), 4.04 – 3.87 (m, 2H), 3.73 – 3.61 (m, 3H), 2.80 (d, J = 10.7 Hz, 1H), 2.35 – 
2.21 (m, 1H), 2.08 – 1.95 (m, 1H), 1.89 (d, J = 13.3 Hz, 2H), 1.74 – 1.67 (m, 1H), 1.62 
– 1.50 (m, 2H), 1.49 – 1.36 (m, 3H), 1.32 – 1.20 (m, 2H), 0.98 (t, J = 7.4 Hz, 3H). 13C 
NMR (75 MHz, CDCl3) δ 139.1, 128.0, 126.9, 126.4, 83.6, 79.0, 62.1, 61.7, 52.7, 28.7, 
27.9, 22.7, 20.6, 18.8, 8.7. MS: calculated for C18H27O5 (M + H
+), 307.1904; found, 
307.1917. 
 
5.4.11.6. Synthesis of cycloalkanone 48 
α,α-Dialkyl cycloalkanone 48 was synthesised according to the following 
synthetic sequence: 
 
1st step: The previously obtained desulfonylated compound 39 (70 mg, 0.20 mmol, 1 
equiv.) and palladium on activated charcoal (10% wt.) (20% wt, 14 mg) were stirred 
under an hydrogen atmosphere at 30 bar overnight. The resulting suspension was 
filtered over a pad of celite and the solvent was eliminated under reduced pressure. 
Product 47 was purified by silica gel flash column chromatography (hexane/EtOAc 
95:5). White foam. Yield: 75% (51 mg, 0.15 mmol). [α]D23= –18.0º (c = 0.50, 92% ee, 
CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 7.11 (d, J = 8.6 Hz, 2H), 6.82 (d, J = 8.6 Hz, 
2H), 4.03 – 3.89 (m, 4H), 3.79 (s, 3H), 2.60 – 2.47 (m, 2H), 1.98 – 1.73 (m, 2H), 1.71 – 
1.39 (m, 6H), 1.36 (s, 2H), 1.01 (s, 6H), 0.95 (t, J = 7.5 Hz, 3H). 13C NMR (75 MHz, 
CDCl3) δ 157.5, 136.0, 129.1, 113.7, 64.1, 55.2, 46.2, 43.6, 36.4, 35.8, 31.3, 30.6, 30.5, 
29.7, 27.8, 25.6, 8.8. 
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2nd step:273 The product above obtained (40 mg, 0.12 mmol, 1 equiv.) was dissolved in 
a 2:2:3 mixture of CH3CN, CCl4 and H2O (2 mL), and sodium metaperiodate (107 mg, 
1.2 mmol, 10 equiv.) and ruthenium(III) chloride (0.6 mg, 2.5 mol%) were added. The 
resulting mixture was vigorously stirred for 2.5 h before being diluted with 
dichloromethane (2 mL). The layers were separated and the aqueous phase was 
extracted with dichloromethane (3 x 2 mL). The combined organic layers were dried 
over MgSO4 and volatiles were removed under reduced pressure. The residue was then 
dissolved in a mixture of THF (0.5 mL) and aqueous HCl (6 M) (0.5 mL) and stirred at 
room temperature overnight. THF was eliminated under reduced pressure and the 
remaining aqueous phase was extracted with dichloromethane (3 x 2 mL). The 
combined organic layer was dried over MgSO4 and volatiles were removed under 
reduced pressure to afford the desired ketone 48. Yield: 56% (15.2 mg, 0.067 mmol). 
[α]D25= +8.2º (c = 1.00, 92% ee, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 2.49 – 2.32 
(m, 2H), 2.32 – 2.13 (m, 2H), 1.95 – 1.74 (m, 2H), 1.74 – 1.62 (m, 3H), 1.62 – 1.48 (m, 
3H), 1.09 (s, 3H), 1.05 (s, 3H), 0.78 (t, J = 7.5 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 
216.1, 179.4, 49.8, 47.6, 37.3, 35.7, 30.6, 30.6, 30.3, 30.0, 29.4, 28.9, 8.0. MS: 
calculated for C13H23O3 (M + H
+), 227.1647; found, 227.1658. 
 
5.4.12. General procedure for the synthesis of rac 1-substituted β-tetralones 49 
New β-tetralones 49B-H where synthesised following the procedure previously 
reported by McNally.274 49A was commercially available. 
 
 
                                                 
273 Adapted from: I. Comomer, R. C. Barcelos, T. J. Donohoe, Angew. Chem. Int. Ed. 2016, 55, 4748–
4752. 
274 M. A. Youngman, N. M. Willard, S. L. Dax, J. J. McNally, Synth. Commun. 2003, 33, 2215–2227. 
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Pyrrolidine (0.46 mL, 6 mL, 1.2 equiv.) was added to a solution of the 
corresponding β-tetralone (5 mmol, 1 equiv.) in MeOH under argon and the resulting 
mixture was stirred for 1 h at room temperature, observing the precipitation of the 
enamine. The solvent was evaporated and 1,2-dichloroethane (10 mL) was added and 
evaporated to eliminate the excess pyrrolidine. The residue was dissolved in acetonitrile 
(10 mL) and the corresponding bromide (6 mmol, 1.2 equiv.) was added. The resulting 
solution was stirred at room temperature for 5 h and the solvent was eliminated under 
reduced pressure. The obtained crude was dissolved in a mixure of dichloromethane (7 
mL), water (7 mL), methanol (15 mL) and acetic acid (1 mL) and the mixture was 
stirred at room temperature overnight. The layers were separated and the aqueous phase 
was extracted with dichloromethane (3 x 5 mL). The combined organic phases were 
washed with brine (20 mL), dried over MgSO4 and the solvent was eliminated under 
reduced pressure. The corresponding products were purified by flash column 
chromatography (hexane/EtOAc 90:10). 
1-Benzyltetralone (49B) 
The adduct was obtained following the general procedure. Yellow oil. 
Yield: 68% (803 mg, 3.4 mmol). The spectral data was coincidental 
with the one described in the literature. 1H NMR (300 MHz, CDCl3) δ 
7.22–7.08 (m, 6H), 6.99–6.86 (m, 3H), 3.74 (t, J = 6.4 Hz, 1H), 3.23 
(d, J = 2.8 Hz, 1H), 3.21 (d, J = 1.9 Hz, 1H), 2.90–2.75 (m, 1H), 2.69–2.39 (m, 3H). 
13C NMR (75 MHz, CDCl3) δ 212.2, 138.1, 136.9, 136.4, 129.4, 128.5, 128.1, 127.6, 
126.8, 126.6, 126.4, 55.0, 39.0, 38.3, 27.2. 
1-(3-Methylbut-2-en-1-yl)-tetralone (49C) 
The adduct was obtained following the general procedure. Yellow oil. 
Yield: 82% (879 mg, 4.1 mmol). 1H NMR (300 MHz, CDCl3) δ 7.24–
7.11 (m, 1H), 5.06 (m, 1H), 3.43 (t, J = 6.8 Hz, 1H), 3.15 (m, 1H), 
3.01 (m, 1H), 2.59 (m, 4H), 1.65 (s, 3H), 1.45 (s, 3H). 13C NMR (75 
MHz, CDCl3) δ 212.5, 137.2, 136.6, 134.3, 128.3, 127.8, 126.8, 126.7, 120.5, 53.8, 
37.9, 30.8, 27.9, 25.8, 17.7. MS: calculated for C15H19O (M + H
+), 215.1436; found, 
215.1433. 
2-(2-Oxo-1,2,3,4-tetrahydronaphthalen-1-yl)acetonitrile (49D) 
The adduct was obtained following the general procedure. Yellow oil. 
Yield: 43% (394 mg, 2.1 mmol). 1H NMR (300 MHz, CDCl3) δ 7.37–
7.24 (m, 1H), 3.85–3.80 (m, 0H), 3.15–2.98 (m, 1H), 2.80–2.70 (m, 
0H), 2.53 (ddd, J = 17.6, 8.7, 6.2 Hz, 1H). 13C NMR (75 MHz, 
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CDCl3) δ 207.7, 137.3, 133.1, 128.2, 128.0, 127.7, 125.8, 118.3, 48.9, 37.2, 27.9, 16.9. 
MS: calculated for C13H13O (M + H
+), 185.0966; found, 185.0958. 
1-(Prop-2-yn-1-yl)-tetralone (49E) 
The adduct was obtained following the general procedure. Yellow oil. 
Yield: 70% (645 mg, 3.5 mmol). 1H NMR (300 MHz, CDCl3) δ 7.39–
7.23 (m, 4H), 3.64 (m, 1H), 3.16–3.06 (m, 1H), 3.01–2.78 (m, 1H), 
2.73–2.50 (m, 1H). 13C NMR (75 MHz, CDCl3) δ 209.9, 137.3, 135.3, 
127.8, 127.2, 127.2, 127.1, 81.7, 70.4, 51.5, 37.8, 27.9, 19.4. MS: calculated for 
C13H13O (M + H
+), 185.0966; found, 185.0958. 
1-Benzyl-6-chlorotetralone (49F) 
The adduct was obtained following the general procedure. Yellow 
oil. Yield: 56% (758 mg, 2.8 mmol). 1H NMR (300 MHz, CDCl3) 
δ 7.20–7.15 (m, 3H), 7.15–7.10 (m, 2H), 6.87 (dd, J = 6.4, 3.1 Hz, 
2H), 6.82 (d, J = 7.9 Hz, 1H), 3.70 (t, J = 6.4 Hz, 1H), 3.22–3.16 
(m, 2H), 2.83–2.74 (m, 1H), 2.62–2.54 (m, 1H), 2.53–2.40 (m, 2H). 13C NMR (75 
MHz, CDCl3) δ 211.4, 138.6, 137.7, 134.9, 132.5, 130.0, 129.3, 128.2, 127.7, 126.7, 
126.6, 54.5, 39.2, 37.9, 27.0. MS: calculated for C17H19OCl (M + H
+), 271.0890; found, 
271.0895. 
6-Methoxy-1-(3-methylbut-2-en-1-yl)-tetralone (49G) 
The adduct was obtained following the general procedure. 
Yellow oil. Yield: 46% (561 mg, 2.3 mmol). 1H NMR (300 
MHz, CDCl3) δ 6.86–6.65 (m, 2H), 5.04 (t, J = 7.3 Hz, 1H), 
3.79 (s, 3H), 3.36 (t, J = 6.6 Hz, 1H), 3.17–3.02 (m, 1H), 3.02–
2.87 (m, 1H), 2.67–2.40 (m, 4H), 1.63 (s, 3H), 1.45 (s, 3H). 13C 
NMR (75 MHz, CDCl3) δ 212.5, 158.2, 137.7, 134.0, 129.1, 120.5, 113.1, 112.1, 55.2, 
52.9, 37.7, 30.8, 28.0, 25.6, 17.6. MS: calculated for C15H19O2 (M + H
+), 231.1385; 
found, 231.1372. 
1-Benzyl-7-methoxytetralone (49H) 
The adduct was obtained following the general procedure. 
Yellow oil. Yield: 60% (799 mg, 3.0 mmol). 1H NMR (300 
MHz, CDCl3) δ 7.25–7.10 (m, 4H), 7.05 (d, J = 8.3 Hz, 1H), 
6.92 (dd, J = 6.6, 2.9 Hz, 2H), 6.73 (dd, J = 8.3, 2.6 Hz, 1H), 
6.40 (d, J = 2.6 Hz, 1H), 3.66 (s, 3H), 3.29–3.08 (m, 2H), 2.87–2.73 (m, 1H), 2.69–2.35 
(m, 3H). 13C NMR (75 MHz, CDCl3) δ 212.2, 158.2, 138.1, 137.5, 129.4, 128.8, 128.6, 
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128.1, 126.4, 113.6, 112.7, 55.2, 39.1, 38.5, 26.4. MS (ESI, m/z): calculated for 
C18H19O2 (M + H
+), 167.1385; found, 167.1392. 
 
5.4.13. Preparation of chroman-3-ones 53 and 65 
8-Methoxychroman-3-one (53) 
The title compound was synthesised according to the following synthetic 
sequence as described in the literature:275 
 
1st step: o-Vanilin (1.5 mL, 10 mmol, 1 equiv.), acrylonitrile (3.28 mL, 50 mmol, 5 
equiv.) and DABCO (247 mg, 2.2 mmol, 0.22 equiv.) were stirred for 24 h at 90 °C and 
the course of the reaction was followed by TLC on silica (hex:CH2Cl2 70:30). After the 
aldehyde disappeared. the reaction mixture was cooled to room temperature and 
concentrated under reduced pressure. The crude mixture was dissolved in CH2Cl2 (30 
mL) and washed with a saturated solution of NaHCO3 and brine. The organic layers 
were dried with Na2SO4 and concentrated under reduced pressure, affording the crude 
nitrile, which was purified by column chromatography on silica gel (hexane/EtOAc 
80:20). Yield: 67% (1.0 g, 6.7 mmol). 1H NMR (300 MHz, CDCl3) δ 7.17 (t, J = 1.3 
Hz, 1H), 6.94 (d, J = 1.3 Hz, 1H), 6.92 (s, 1H), 6.74 (dd, J = 5.1, 4.0 Hz, 1H), 4.87 (d, J 
= 1.4 Hz, 2H), 3.88 (s, 3H). 
2nd step: An aqueous solution of NaOH (10%, 23 mL) was added to the 2H-
chromenecarbonitrile above obtained (1.0 g, 10 mmol, 1 equiv.). The reaction mixture 
was heated to 100 °C for 3 h. The course of the reaction was followed by TLC on silica 
(hex:CH2Cl2 1:1) and after completion, the reaction mixture was cooled to room 
temperature and an aqueous solution of HCl (3 N) was carefully added dropwise until 
pH 3 was reached. The product precipitated as a pale yellow solid, which was filtered, 
                                                 
275 D. Pressnitz, C. S. Fuchs, J. H. Sattler, T. Knaus, P. Macheroux, F. G. Mutti, W. Kroutil. ACS Catal. 
2013, 3, 555−559. 
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recrystallized from MeOH and dried over night over CaCl2 in a dessicator. Yield: 77% 
(1.4 g, 7.7 mmol). 
3rd step: The 2H-chromenecarboxylic acid obtained in the previous step (5 mmol, 1 
equiv.) was suspended in CH2Cl2 (11.5 mL). After addition of Et3N (0.9 mL, 6.5 mmol, 
1.3 equiv.), a homogeneous solution was obtained. Then, a solution of (PhO)2P(O)N3 
(1.19 mL, 5.5 mmol, 1.1 equiv.) in toluene (5 mL) was added dropwise to the reaction 
mixture over a period of 15 minutes. Afterwards, the solution was heated to 50 °C for 
1.5 h. Another aliquot of toluene (11.5 mL) was added and the solution was heated 
subsequently to 85 °C for 2.5 h. The quantitative formation of the isocyanate 
intermediate was followed by TLC on silica (hexane/CH2Cl2 20:80). Finally, the 
reaction mixture was cooled down and an aqueous solution of HCl (6 N, 50 mL) was 
added. The biphasic system was heated under reflux for 16 h. The course of the reaction 
was controlled by TLC on silica gel (hexane/CH2Cl2 20:80). Then, the layers were 
separated; the organic phase was washed with a saturated solution of NaHCO3 and 
brine, dried with Na2SO4 and concentrated under reduced pressure. The product was 
purified by column purification on silica gel (hexane/EtOAc 90:10). Pale yellow solid. 
m. p. = 81–82 ºC. Yield: 48% (430 mg, 2.4 mmol). 1H NMR (300 MHz, CDCl3) δ 7.02 
– 6.91 (m, 1H), 6.81 (d, J = 7.5 Hz, 1H), 6.68 (d, J = 8.3 Hz, 1H), 4.41 (s, 2H), 3.86 (s, 
3H), 3.56 (s, 2H). 13C NMR (75 MHz, CDCl3) δ 207.1, 149.1, 143.4, 123.2, 122.5, 
120.3, 110.7, 72.9, 55.8, 40.5. MS: calculated for C10H11O3 (M + H
+), 179.0708; found, 
179.0708. 
 
4-(2-Methylprop-1-en-1-yl)chroman-3-one (65) 
 
The same procedure employed for the synthesis of rac 1-substituted β-tetralones 
(Section 5.4.12) was used starting from the commercially available 5,7,8,9-tetrahydro-
6H-benzo[7]annulen-6-one (740 mg, 5 mmol), obtaining compound 65 as a yellow oil. 
Yield: 30% (360 mg, 1.5 mmol). 1H NMR (300 MHz, CDCl3) δ 7.30 – 7.17 (m, 4H), 
7.07 – 6.87 (m, 4H), 6.77 (d, J = 7.5 Hz, 1H), 4.51 (d, J = 17.8 Hz, 1H), 4.35 (d, J = 
17.8 Hz, 1H), 3.80 – 3.69 (m, 1H), 3.25 (dd, J = 13.5, 5.5 Hz, 1H), 3.09 (dd, J = 13.5, 
8.7 Hz, 1H).13C NMR (75 MHz, CDCl3) δ 209.1, 154.4, 137.4, 129.2, 129.1, 128.6, 
128.3, 126.6, 123.0, 117.6, 72.7, 52.6, 38.0. 
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5.4.14. Preparation of seven-membered cycloalkanones 55 and 66 
5,7,8,9-tetrahydro-6H-benzo[7]annulen-6-one (55) 
Known cycloalkanone 55276 was prepared according to the following synthetic 
sequence: 
 
1st step:277 Under argon atmosphere, potassium tert-butoxide (1.35 g, 12 mmol, 1.2 
equiv.) was added to a mixture of methyltripheylphosphonium bromide (4.29 g, 12 
mmol, 1.2 equiv.) in anhydrous Et2O. The resulting mixture was stirred at rt for 1 h and 
a solution of α-tetralone (1.3 mL, 10 mmol, 1 equiv.) in Et2O (5 mL) was slowly added. 
The resulting mixture was allowed to stir overnight, passed through a pad of celite and 
washed with Et2O. The solvent was eliminated under reduced pressure and the crude 
was diluted with hexane before passing it again trough a pad of celite. The alkene was 
purified by flash column chromatography (hexane/EtOAc 99:1). The spectroscopic data 
were identical to those reported in the literature. Yield: Cuantitative. 1H NMR (300 
MHz, CDCl3) δ 7.72 – 7.60 (m, 1H), 7.18 – 7.13 (m, 2H), 7.13 – 7.06 (m, 1H), 5.62 – 
5.27 (m, 1H), 4.95 (d, J = 1.3 Hz, 1H), 2.85 (t, J = 6.3 Hz, 2H), 2.61 – 2.46 (m, 2H), 
1.89 (p, J = 6.3 Hz, 2H). 
2nd step:276 Iodobenzene (1.3 mL, 11.5 mmol, 1.15 equiv.), meta-chloroperbenzoic acid 
(70%) (2.6 g, 11.5 mmol, 1.15 equiv.) and para-toluenesulfonic acid monohydrate (2.2 
g, 11.5 mmol, 1.15 equiv.) were stirred together in hexafluoroisopropanol 
(HFIP)/CH2Cl2 (1:6) (50 mL) for 30 min before the previously obtained alkene was 
added at 0 ºC. The reaction mixture was allowed to warm to rt and stirred for 1 h. The 
reaction was quenched with NaHCO3, the phases were separated and the aqueous phase 
was extracted with CH2Cl2 (20 mL). The combined organic layers were washed with 
brine (50 mL), dried over MgSO4 and the solvent was eliminated under reduced 
pressure. The desired ketone 55 was purified by flash column chromatography 
(hexane/EtOAc 92:8). Yellow oil. Yield: 90% (1.44 g, 9.0 mmol). The spectroscopic 
data were identical to those reported in the literature. 1H NMR (300 MHz, CDCl3) δ 
7.24–7.12 (m, 4H), 3.73 (s, 2H), 3.10–2.80 (m, 2H), 2.57 (t, J = 6.9 Hz, 2H), 2.00 (dt, J 
= 13.2, 6.6 Hz, 2H). 
                                                 
276 A. Ahmad, P. Scarassati, N. Jalalian, B. Olofsson, L. F. Silva Jr., Tetrahedron Lett. 2013, 54, 5818–
5820. 
277 D. H. T. Phan, K. G. M. Kou, V. M. Dong, J. Am. Chem. Soc. 2010, 132, 16354–16355. 
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5-benzyl-5,7,8,9-tetrahydro-6H-benzo[7]annulen-6-one (66) 
 
The same procedure employed for the synthesis of rac 1-substituted β-tetralones 
(Section 5.4.12) was used starting compound 55 (801 mg, 5 mmol), affording new 
product 66 as a yellow oil. Yield: 64% (803 mg, 3.2 mmol). 1H NMR (300 MHz, 
CDCl3) δ 7.31 – 7.06 (m, 8H), 7.02 (d, J = 6.3 Hz, 1H), 4.15 (dd, J = 7.9, 6.1 Hz, 1H), 
3.65 (dd, J = 13.4, 7.9 Hz, 1H), 3.08 – 2.93 (m, 2H), 2.79 (ddd, J = 14.1, 9.3, 4.0 Hz, 
1H), 2.67 – 2.53 (m, 1H), 2.53 – 2.43 (m, 1H), 2.15 – 2.00 (m, 1H), 1.98 – 1.80 (m, 
1H).13C NMR (75 MHz, CDCl3) δ 209.88 , 140.08 , 139.71 , 136.56 , 129.35 , 129.21 , 
128.15 , 127.85 , 127.27 , 126.88 , 126.05 , 58.67 , 43.70 , 35.02 , 32.72 , 27.88 . MS: 
calculated for C18H19O5 (M + H
+), 251.1436; found, 251.1436. 
 
5.4.15. α-Alkylation of β-tetralones and related ketones with nitroalkenes 
5.4.15.1. General procedure 
 
The selected catalyst (2 mol% for R2 = H; 10 mol% for R2 ≠ H) was added to a 
solution of the corresponding cycloalkanone 49, 53 or 55 (0.3 mmol, 1 equiv.) and 
nitroalkene 32 (0.36 mmol, 1,2 equiv.) in CH2Cl2 at the specified temperature. The 
resulting solution was stirred at the specified temperature until the reaction was 
completed (monitored by TLC hexane/EtOAc 80:20) and the mixture was directly 
submitted to a flash column chromatography (hexane/EtOAc 90:10), affording the 
corresponding α-alkylation adducts as essentially pure compound. 
The racemic version of the reaction was performed following the asymmetric 
reaction procedure except the reaction was conducted at room temperature and TEA (20 
mol%) was used as the catalyst. 
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5.4.15.2. Characterization data for compounds 51, 54 and 56 
(S)-1-((S)-2-Nitro-1-phenylethyl)-3,4-dihydronaphthalen-2(1H)-one (51Aa) 
The adduct was obtained as a 4:1 mixture of diastereomers by using 
β-tetralone 49A (40 µL, 0.3 mmol, 1 equiv.), nitrostyrene 32a (54 
mg, 0.36 mmol, 1.2 equiv.) and catalyst C7, and carrying out the 
reaction at –20 ºC. Foam. Yield: 83% (75 mg, 0.251 mmol). Major 
diastereomer (S,S): 1H NMR (300 MHz, CDCl3) δ 7.17 (dq, J = 22.2, 7.5 Hz, 6H), 6.84 
(d, J = 7.0 Hz, 1H), 6.71 (d, J = 6.9 Hz, 2H), 4.94 (dd, J = 13.4, 7.7 Hz, 1H), 4.72 (dd, 
J = 13.4, 7.7 Hz, 1H), 4.27 (q, J = 7.6 Hz, 1H), 3.65 (d, J = 6.3 Hz, 1H), 2.68–2.45 (m, 
2H), 2.45–2.27 (m, 1H), 2.14–1.99 (m, 1H). 13C NMR (75 MHz, CDCl3) δ 211.4, 
138.1, 135.8, 132.9, 129.6, 128.6, 128.2, 128.1, 127.6, 126.6, 77.2, 56.6, 46.3, 38.5, 
26.3. Minor diastereomer (R,S): 1H NMR (300 MHz, CDCl3) δ 7.17 (dq, J = 22.2, 7.5 
Hz, 6H), 7.03 (d, J = 7.6 Hz, 1H), 6.76 (d, J = 7.0 Hz, 2H), 5.30 (dd, J = 13.8, 7.3 Hz, 
1H), 5.03 (dd, J = 13.8, 8.0 Hz, 1H), 4.01–3.87 (m, 1H), 3.76 (d, J = 4.5 Hz, 1H), 2.68–
2.45 (m, 2H), 2.45–2.25 (m, 1H), 1.81–1.63 (m, 1H). 13C NMR (75 MHz, CDCl3) δ 
211.8, 137.3, 135.3, 132.9, 129.1, 128.6, 128.2, 127.9, 127.5, 127.3, 77.6, 54.8, 49.8, 
39.4, 26.1. MS: calculated for C18H18NO3 (M + H
+), 296.1287; found, 296.1284. The 
enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak IA, 
hexane/isopropanol, 95:5; flux = 1 mL/min; retention times of major diastereomer: 12.6 
min (major), 13.8 min (minor). Retention times of minor diastereomer: 10.4 min 
(minor), 23.3 min (major)). 
(S)-1-((S)-1-(4-Methoxyphenyl)-2-nitroethyl)-3,4-dihydronaphthalen-2(1H)-one 
(51Ab) 
The adduct was obtained as a 8:1 mixture of diastereomers by 
using β-tetralone 49A (40 µL, 0.3 mmol, 1 equiv.), p-
methoxynitrostyrene (32b) (65 mg, 0.36 mmol, 1.2 equiv.) and 
catalyst C7, and carrying out the reaction at –20 ºC. Foam. 
Yield: 85% (83 mg, 0.255 mmol). Major diastereomer (S,S): 1H 
NMR (300 MHz, CDCl3) δ 7.34–7.08 (m, 3H), 6.87 (d, J = 7.2 Hz, 1H), 6.71–6.57 (m, 
4H), 4.89 (dd, J = 13.2, 7.8 Hz, 1H), 4.66 (dd, J = 13.2, 7.8 Hz, 1H), 4.31–4.16 (m, 
1H), 3.74 (s, 3H), 2.65–2.45 (m, 2H), 2.42–2.22 (m, 1H), 2.14–1.97 (m, 1H). 13C NMR 
(75 MHz, CDCl3) δ 211.6, 159.3, 138.2, 133.0, 129.6, 129.3, 128.2, 127.6, 127.5, 126.6, 
113.9, 77.9, 56.5, 55.1, 45.8, 38.6, 26.3. Minor diastereomer (R,S): 1H NMR (300 MHz, 
CDCl3) δ 7.34–7.08 (m, 3H), 7.04 (d, J = 7.5 Hz, 1H), 6.71–6.57 (m, 4H), 5.32–5.21 
(m, 1H), 4.99 (dd, J = 13.6, 8.1 Hz, 1H), 3.93–3.84 (m, 1H), 3.74 (s, 3H), 2.65–2.45 (m, 
1H), 2.42–2.22 (m, 2H), 1.88–1.73 (m, 1H). 13C NMR (75 MHz, CDCl3) δ 211.6, 
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159.3, 138.2, 133.0, 129.6, 129.3, 128.2, 127.6, 127.5, 126.6, 113.9, 77.9, 56.5, 55.1, 
45.8, 38.6, 26.3. MS: calculated for C19H20NO4 (M + H
+), 348.1212; found, 348.1207. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak IA, 
hexane/isopropanol, 90:10; flux = 1 mL/min; retention times of major diastereomer: 
11.3 min (major), 12.6 min (minor). Retention times of minor diastereomer: 9.5 min 
(minor), 34.2 min (major)). 
(S)-1-((S)-1-(4-Bromophenyl)-2-nitroethyl)-3,4-dihydronaphthalen-2(1H)-one 
(51Ac) 
The adduct was obtained as a 4:1 mixture of diastereomers by 
using β-tetralone 49A (40 µL, 0.3 mmol, 1 equiv.), p-
bromonitrostyrene (32c) (82 mg, 0.36 mmol, 1.2 equiv.) and 
catalyst C7, and carrying out the reaction at –20 ºC. Foam. Yield: 
88% (99 mg, 0.264 mmol). Major diastereomer (S,S): 1H NMR 
(300 MHz, CDCl3) δ 7.35–7.11 (m, 5H), 6.84 (d, J = 6.8 Hz, 1H), 6.62 (dd, J = 15.2, 
8.4 Hz, 2H), 4.90 (dd, J = 13.4, 7.3 Hz, 1H), 4.70 (dd, J = 13.4, 8.2 Hz, 1H), 4.26 (q, J 
= 7.1 Hz, 1H), 3.64 (d, J = 6.3 Hz, 1H), 2.72–2.50 (m, 2H), 2.45–2.27 (m, 1H), 2.22–
2.08 (m, 1H). 13C NMR (75 MHz, CDCl3) δ 211.0, 138.0, 134.9, 132.6, 131.7, 129.9, 
129.5, 128.3, 127.9, 127.4, 122.3, 77.5, 56.3, 45.7, 38.5, 26.5. Minor diastereomer 
(R,S): 1H NMR (300 MHz, CDCl3) δ 7.35–7.11 (m, 5H), 7.06 (d, J = 7.5 Hz, 1H), 6.62 
(dd, J = 15.2, 8.4 Hz, 2H), 5.25 (dd, J = 13.8, 7.0 Hz, 1H), 5.03 (dd, J = 13.8, 8.3 Hz, 
1H), 3.97–3.87 (m, 1H), 3.76 (d, J = 4.5 Hz, 1H), 2.72–2.50 (m, 1H), 2.45–2.27 (m, 
2H), 1.92–1.78 (m, 1H). 13C NMR (75 MHz, CDCl3) δ 211.5, 137.1, 135.0, 134.4, 
131.7, 129.8, 129.0, 128.1, 127.7, 126.8, 122.3, 77.5, 54.6, 49.2, 39.5, 26.4. MS: 
calculated for C18H17NO3Br (M + H
+), 396.0211; found, 396.0217. The enantiomeric 
purity was determined by chiral HPLC analysis (Daicel Chiralpak IA, 
hexane/isopropanol, 90:10; flux = 1 mL/min; retention times of major diastereomer: 
14.9 min (minor), 17.9 min (major). Retention times of minor diastereomer: 9.0 min 
(minor), 31.0 min (major)). 
 
(S)-1-((S)-1-(3-Methoxyphenyl)-2-nitroethyl)-3,4-dihydronaphthalen-2(1H)-one 
(51Ad) 
The adduct was obtained as a 4:1 mixture of diastereomers by 
using β-tetralone 49A (40 µL, 0.3 mmol, 1 equiv.), m-
methoxynitrostyrene (32d) (65 mg, 0.36 mmol, 1.2 equiv.) and 
catalyst C7, and carrying out the reaction at –20 ºC. Foam. 
Yield: 80% (78 mg, 0.240 mmol). Major diastereomer (S,S): 1H NMR (300 MHz, 
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CDCl3) δ 7.39–7.34 (m, 1H), 7.32–7.05 (m, 3H), 6.91 (d, J = 6.9 Hz, 1H), 6.84–6.76 
(m, 1H), 6.38 (d, J = 7.6 Hz, 1H), 6.20 (dt, J = 4.2, 2.1 Hz, 1H), 4.96 (dd, J = 13.5, 7.9 
Hz, 1H), 4.74 (dd, J = 13.4, 7.5 Hz, 1H), 4.34–4.23 (m, 1H), 3.68 (d, J = 6.2 Hz, 1H), 
3.63 (s, 3H), 2.72–2.47 (m, 2H), 2.47–2.28 (m, 1H), 2.24–2.10 (m, 1H). 13C NMR (75 
MHz, CDCl3) δ 211.4, 159.5, 138.2, 137.2, 133.0, 129.6, 129.6, 128.1, 127.7, 127.3, 
120.6, 114.0, 113.5, 77.1, 56.5, 54.7, 46.4, 38.6, 26.3. Minor diastereomer (R,S): 1H 
NMR (300 MHz, CDCl3) δ 7.39–7.34 (m, 1H), 7.32–7.05 (m, 4H), 6.84–6.76 (m, 1H), 
6.45 (d, J = 7.7 Hz, 1H), 6.20 (dt, J = 4.2, 2.1 Hz, 1H), 5.32 (dd, J = 13.9, 7.4 Hz, 1H), 
5.05 (dd, J = 13.9, 7.9 Hz, 1H), 3.95 (td, J = 7.6, 4.5 Hz, 1H), 3.79 (d, J = 4.4 Hz, 1H), 
3.61 (s, 3H), 2.72–2.47 (m, 1H), 2.47–2.28 (m, 2H), 1.82 (ddd, J = 16.6, 11.2, 6.5 Hz, 
2H). 13C NMR (75 MHz, CDCl3) δ 211.8, 159.4, 137.4, 136.7, 135.4, 129.6, 129.1, 
127.9, 127.5, 126.6, 119.9, 114.2, 113.8, 77.5, 55.0, 55.0, 49.9, 39.5, 26.2. MS: 
calculated for C19H20NO4 (M + H
+), 348.1212; found, 348.1207. The enantiomeric 
purity was determined by chiral HPLC analysis (Daicel Chiralpak IA, 
hexane/isopropanol, 95:5; flux = 1 mL/min; retention times of major diastereomer: 14.0 
min (major), 15.2 min (minor). Retention times of minor diastereomer: 12.7 min 
(minor), 20.0 min (major)). 
(S)-1-((S)-1-(2-Chlorophenyl)-2-nitroethyl)-3,4-dihydronaphthalen-2(1H)-one 
(51Ae) 
The adduct was obtained as single isomer by using β-tetralone 49A 
(40 µL, 0.3 mmol, 1 equiv.), o-chloronitrostyrene (32e) (66 mg, 0.36 
mmol, 1.2 equiv.) and catalyst C7, and carrying out the reaction at –
20 ºC. Foam. Yield: 86% (85 mg, 0.258 mmol). [α]D23= –36.0º (c = 
2.00, 99% ee, dr = >20:1, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 
7.28–7.08 (m, 7H), 6.99–6.91 (m, 1H), 6.52 (d, J = 7.6 Hz, 1H), 5.05–4.86 (m, 2H), 
4.77–4.63 (m, 1H), 3.73 (d, J = 9.5 Hz, 1H), 3.32 (ddd, J = 16.8, 11.7, 5.5 Hz, 1H), 
2.98 (ddd, J = 15.8, 6.6, 2.9 Hz, 1H), 2.77 (ddd, J = 18.5, 5.5, 2.9 Hz, 1H), 2.49 (ddd, J 
= 18.5, 11.7, 6.7 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ 211.1, 137.4, 134.6, 133.1, 
130.0, 129.0, 128.9, 128.8, 127.9, 127.6, 127.0, 126.5, 76.4, 57.3, 40.5, 37.7, 27.1. MS: 
calculated for C18H16NO3ClNa (M + Na
+), 352.0716; found, 352.0721. The 
enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak IC, 
hexane/isopropanol, 90:10; flux = 1 mL/min; retention times: 17.5 min (major), 22.1 
min (minor)). 
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(S)-1-((S)-1-(Furan-2-yl)-2-nitroethyl)-3,4-dihydronaphthalen-2(1H)-one (51Ah) 
The adduct was obtained as a 1:1 mixture of diastereomers by using 
β-tetralone 49A (40 µL, 0.3 mmol, 1 equiv.), 2-(2-nitrovinyl)furan 
(32h) (50 mg, 0.36 mmol, 1.2 equiv.) and catalyst C7, and carrying 
out the reaction at –20 ºC. Foam. Yield: 84% (72 mg, 0.252 mmol). 
dr = 1:1. Diastereomer (S,S): 1H NMR (300 MHz, CDCl3) δ 7.37–7.07 (m, 4H), 6.84 (d, 
J = 7.5 Hz, 1H), 6.25–6.22 (m, 1H), 5.81 (d, J = 3.2 Hz, 1H), 5.07 (dd, J = 13.9, 6.6 
Hz, 1H), 4.91 (dd, J = 17.2, 7.5 Hz, 1H), 4.33 (q, J = 7.1 Hz, 1H), 3.80–3.72 (m, 1H), 
2.90–2.23 (m, 4H). 13C NMR (75 MHz, CDCl3) δ 210.5, 149.1, 142.3, 137.0, 134.7, 
128.8, 128.0, 127.5, 127.2, 110.9, 108.8, 76.2, 53.3, 42.8, 39.0, 26.6. Diastereomer 
(R,S): 1H NMR (300 MHz, CDCl3) δ 7.37–7.07 (m, 5H), 6.20 (dd, J = 3.2, 1.9 Hz, 1H), 
5.85 (d, J = 3.1 Hz, 1H), 4.86 (dd, J = 17.0, 7.5 Hz, 1H), 4.76 (dd, J = 13.7, 8.0 Hz, 
1H), 4.14 (ddd, J = 8.3, 6.8, 4.8 Hz, 1H), 3.80–3.72 (m, 1H), 2.90–2.23 (m, 4H). 13C 
NMR (75 MHz, CDCl3) δ 210.8, 149.3, 142.3, 137.4, 133.0, 129.0, 128.1, 127.7, 126.7, 
110.6, 108.7, 75.5, 55.2, 39.8, 38.3, 26.6. MS: calculated for C15H15NO4Na (M + Na
+), 
308.0899; found, 308.0896. The enantiomeric purity was determined by chiral HPLC 
analisys (Daicel Chiralpak IC, hexane/isopropanol, 90:10; flux = 1 mL/min; retention 
times of diastereomer A: 9.7 min (minor), 10.7 min (major). Retention times of 
diastereomer B: 13.9 min (minor), 14.3 min (major)). 
(S)-1-((R)-1-Nitropentan-2-yl)-3,4-dihydronaphthalen-2(1H)-one (51Ai) 
The adduct was obtained as a 5:1 mixture of diastereomers by using 
β-tetralone 49A (40 µL, 0.3 mmol, 1 equiv.), 1-nitropent-1-ene (32i) 
(41 mg, 0.36 mmol, 1.2 equiv.) and catalyst C7, and carrying out the 
reaction at room temperature. Foam. Yield: 81% (88 mg, 0.243 mmol). Major 
diastereomer (S,R): 1H NMR (300 MHz, CDCl3) δ 7.31–7.17 (m, 4H), 4.82 (dd, J = 
13.5, 7.8 Hz, 1H), 4.53–4.47 (m, 1H), 3.49 (d, J = 6.8 Hz, 1H), 3.32–3.10 (m, 1H), 
3.08–2.84 (m, 2H), 2.72–2.42 (m, 2H), 1.58–1.15 (m, 4H), 0.84 (t, J = 7.0 Hz, 3H). 13C 
NMR (75 MHz, CDCl3) δ 211.3, 137.4, 134.4, 128.6, 128.3, 127.5, 127.1, 76.8, 55.0, 
38.3, 38.1, 32.2, 27.7, 19.6, 13.8. Minor diastereomer (R,R): 1H NMR (300 MHz, 
CDCl3) δ 7.31–7.17 (m, 4H), 4.58–4.23 (m, 2H), 3.57 (d, J = 5.2 Hz, 1H), 3.32–3.10 
(m, 1H), 3.08–2.84 (m, 2H), 2.72–2.42 (m, 2H), 1.58–1.15 (m, 4H), 0.84 (t, J = 7.0 Hz, 
3H). 13C NMR (75 MHz, CDCl3) δ 211.3, 136.7, 135.5, 128.6, 128.3, 127.3, 127.2, 
77.5, 53.3, 41.4, 39.1, 30.5, 27.9, 20.1, 13.8. MS: calculated for C15H19NO3Na (M + 
H+), 284.1263; found, 284.1270. The enantiomeric purity was determined by chiral 
HPLC analysis (Daicel Chiralpak IC, hexane/isopropanol, 95:5; flux = 1 mL/min; 
retention times of major diastereomer: 21.9 min (major), 22.9 min (minor). Retention 
times of minor diastereomer: 12.7 min (minor), 14.1 min (major)). 
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(R)-1-((R)-1-Nitro-4-phenylbutan-2-yl)-3,4-dihydronaphthalen-2(1H)-one (51Aj) 
The adduct was obtained as a 5:1 mixture of diastereomers by using 
β-tetralone 49A (40 µL, 0.3 mmol, 1 equiv.), (4-nitrobut-3-en-1-
yl)benzene (32j) (62 mg, 0.36 mmol, 1.2 equiv.) and catalyst C7, 
and carrying out the reaction at room temperature. Foam. Yield: 
83% (81 mg, 0.249 mmol). Major diastereomer (S,R): 1H NMR (300 MHz, CDCl3) δ 
7.34–7.01 (m, 9H), 4.94–4.43 (m, 2H), 3.55 (d, J = 7.0 Hz, 1H), 3.24–3.05 (m, 1H), 
3.04–2.87 (m, 2H), 2.74–2.42 (m, 4H), 2.03–1.87 (m, 1H), 1.81–1.65 (m, 1H). 13C 
NMR (75 MHz, CDCl3) δ 210.6, 140.1, 136.9, 133.9, 128.2, 128.1, 127.9, 127.7, 127.2, 
126.8, 125.8, 76.4, 54.5, 37.6, 37.5, 32.4, 31.3, 27.3. Minor diastereomer (R,R): 1H 
NMR (300 MHz, CDCl3) δ 7.34–7.01 (m, 9H), 4.68–4.43 (m, 2H), 3.61 (d, J = 5.6 Hz, 
1H), 3.24–3.05 (m, 1H), 3.04–2.87 (m, 2H), 2.74–2.42 (m, 4H), 2.03–1.87 (m, 1H), 
1.81–1.65 (m, 1H). 13C NMR (75 MHz, CDCl3) δ 210.7, 139.2, 136.3, 133.7, 128.2, 
128.1, 127.9, 127.8, 127.0, 126.8, 125.8, 77.0, 53.2, 39.8, 38.4, 32.6, 29.6, 27.5. MS: 
calculated for C20H21NO3Na (M + Na
+), 346.1419; found, 346.1418. The enantiomeric 
purity was determined by chiral HPLC analysis (Daicel Chiralpak IC, 
hexane/isopropanol, 95:5; flux = 1 mL/min; retention times of major diastereomer: 30.1 
min (major), 34.5 min (minor). Retention times of minor diastereomer: 15.9 min 
(minor), 18.4 min (major)). 
 (S)-1-((R)-1-Cyclohexyl-2-nitroethyl)-3,4-dihydronaphthalen-2(1H)-one (51Ak) 
The adduct was obtained as a 4:1 mixture of diastereomers by using 
β-tetralone 49A (40 µL, 0.3 mmol, 1 equiv.), (2-
nitrovinyl)cyclohexane (32k) (41 mg, 0.36 mmol, 1.2 equiv.) and 
catalyst C7, and carrying out the reaction at room temperature. 
Foam. Yield: 80% (72 mg, 0.240 mmol). Major diastereomer (S,R): 1H NMR (300 
MHz, CDCl3) δ 7.40–7.00 (m, 4H), 4.73–4.26 (m, 2H), 3.55 (d, J = 8.4 Hz, 1H), 3.36 
(ddd, J = 16.1, 10.8, 5.6 Hz, 1H), 3.11–2.91 (m, 1H), 2.83–2.72 (m, 1H), 2.72–2.58 (m, 
1H), 2.59–2.36 (m, 1H), 1.85–1.44 (m, 6H), 1.35–0.77 (m, 5H). 13C NMR (75 MHz, 
CDCl3) δ 212.2, 137.5, 134.9, 129.0, 128.4, 127.6, 127.1, 74.7, 55.2, 42.5, 38.0, 37.7, 
31.8, 27.7, 27.5, 26.3, 26.2. Minor diastereomer (R,R): 1H NMR (300 MHz, CDCl3) δ 
7.40–7.00 (m, 4H), 4.73–4.26 (m, 2H), 3.55 (d, J = 8.4 Hz, 1H), 3.36 (m, 1H), 3.11–
2.91 (m, 1H), 2.83–2.72 (m, 1H), 2.72–2.58 (m, 1H), 2.59–2.36 (m, 1H), 1.85–1.44 (m, 
6H), 1.35–0.77 (m, 5H). 13C NMR (75 MHz, CDCl3) δ 211.3, 137.0, 135.1, 129.1, 
128.4, 127.7, 127.2, 75.5, 54.1, 44.9, 38.3, 38.0, 31.9, 28.6, 27.6, 26.5, 26.0. MS: 
calculated for C18H23NO3Na (M + Na
+), 324.1576; found, 324.1576. The enantiomeric 
purity was determined by chiral HPLC analysis (Daicel Chiralpak IC, 
hexane/isopropanol, 90:10; flux = 1 mL/min; retention times of major diastereomer: 
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30.7 min (major), 32.6 min (minor). Retention times of minor diastereomer: 15.1 min 
(minor), 15.9 min (major)). 
 (S)-1-Benzyl-1-((R)-2-nitro-1-phenylethyl)-3,4-dihydronaphthalen-2(1H)-one 
(51Ba) 
The adduct was obtained by using 1-benzyl-β-tetralone 49B (70 mg, 
0.3 mmol, 1 equiv.), nitrostyrene (32a) (54 mg, 0.36 mmol, 1.2 
equiv.) and catalyst C28 and carrying out the reaction at –10 ºC. 
Foam. Yield: 82% (95 mg, 0.261 mmol). Carrying out the reaction in 
the presence of 10 mol% catalyst C13 at –20 oC, compound 51Ba with essentially 
identical dr and ee was obtained in 80% isolated yield. [α]D23= –105.7º (c = 2,00, 92% 
ee, dr = >20:1, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 7.61 (d, J = 7.3 Hz, 1H), 7.54–
7.42 (m, 1H), 7.36–7.24 (m, 1H), 7.20–7.09 (m, 1H), 7.08–7.00 (m, 5H), 6.93 (d, J = 
7.5 Hz, 1H), 6.84–6.74 (m, 2H), 6.53 (d, J = 7.3 Hz, 2H), 5.10 (dd, J = 12.4, 4.2 Hz, 
1H), 4.85 (t, J = 12.0 Hz, 1H), 4.63 (dd, J = 11.7, 4.2 Hz, 1H), 3.60 (d, J = 12.5 Hz, 
1H), 3.35 (d, J = 12.6 Hz, 1H), 2.16–2.04 (m, 2H), 1.28–1.12 (m, 2H). 13C NMR (75 
MHz, CDCl3) δ 212.0, 139.9, 135.6, 135.2, 134.9, 130.3, 129.5, 128.7, 128.0, 128.0, 
127.8, 127.7, 127.6, 126.7, 126.4, 76.5, 60.4, 52.1, 43.3, 40.3, 26.1. MS: calculated for 
C25H23NO3Na (M + Na
+), 408.1576; found, 408.1587. The enantiomeric purity was 
determined by chiral HPLC analysis (Daicel Chiralpak IA, hexane/isopropanol, 95:5; 
flux = 1 mL/min; retention times: 11.8 min (minor), 14.7 min (major)). 
(S)-1-Benzyl-1-((R)-1-(4-methoxyphenyl)-2-nitroethyl)-3,4-dihydronaphthalen-
2(1H)-one (51Bb) 
The adduct was obtained by using 1-benzyl-β-tetralone 49B (70 
mg, 0.3 mmol, 1 equiv.), p-methoxynitrostyrene (32b) (65 mg, 
0.36 mmol, 1.2 equiv.) and catalyst C28, and carrying out the 
reaction at –10 ºC for 24 h. Foam. Yield: 79% (98 mg, 0.24 
mmol). [α]D23= –114.7º (c = 2.00, 91% ee, dr = >20:1, 
CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 7.59 (d, J = 7.5 Hz, 1H), 7.47 (t, J = 7.6 Hz, 
1H), 7.30 (t, J = 7.4 Hz, 1H), 7.09–7.00 (m, 3H), 6.95 (d, J = 7.6 Hz, 1H), 6.82–6.76 
(m, 2H), 6.58 (d, J = 9.0 Hz, 2H), 6.43 (d, J = 8.0 Hz, 2H), 5.06 (dd, J = 12.1, 4.1 Hz, 
1H), 4.78 (t, J = 12.0 Hz, 1H), 4.57 (dd, J = 11.9, 4.2 Hz, 1H), 3.70 (s, 3H), 3.57 (d, J = 
12.5 Hz, 1H), 3.33 (d, J = 12.6 Hz, 1H), 2.22–2.01 (m, 2H), 1.42–1.07 (m, 2H). 13C 
NMR (75 MHz, CDCl3) δ 212.2, 159.1, 139.9, 135.7, 135.0, 130.6, 130.3, 128.7, 128.0, 
127.7, 127.6, 127.0, 126.6, 126.4, 113.3, 76.8, 60.4, 55.1, 51.5, 43.3, 40.3, 26.2. MS: 
calculated for C26H25NO4Na (M + Na
+), 438.1681; found, 438.1687. The enantiomeric 
purity was determined by chiral HPLC analysis (Daicel Chiralpak IC, 
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hexane/isopropanol, 90:10; flux = 1 mL/min; retention times: 21.4 min (major), 29.3 
min (minor)). 
(S)-1-Benzyl-1-((R)-1-(4-bromophenyl)-2-nitroethyl)-3,4-dihydronaphthalen-
2(1H)-one (51Bc) 
The adduct was obtained by using 1-benzyl-β-tetralone 49B (70 
mg, 0.3 mmol, 1 equiv.), p-bromonitrostyrene (32c) (82 mg, 0.36 
mmol, 1.2 equiv.) and catalyst C28, and carrying out the reaction 
at –10 ºC for 24 h. Foam. Yield: 85% (118 mg, 0.26 mmol). 
[α]D23= –138.9º (c = 2.00, 91% ee, dr = >20:1, CH2Cl2). 1H 
NMR (300 MHz, CDCl3) δ 7.59 (d, J = 7.5 Hz, 1H), 7.48 (t, J = 7.2 Hz, 1H), 7.32 (t, J 
= 7.9 Hz, 1H), 7.19 (d, J = 8.7 Hz, 2H), 7.12–7.00 (m, 3H), 6.97 (d, J = 7.5 Hz, 1H), 
6.77 (d, J = 9.3 Hz, 2H), 6.40 (d, J = 8.0 Hz, 2H), 5.08 (dd, J = 12.3, 4.0 Hz, 1H), 4.79 
(t, J = 12.2 Hz, 1H), 4.60 (dd, J = 12.0, 4.0 Hz, 1H), 3.58 (d, J = 12.5 Hz, 1H), 3.30 (d, 
J = 12.5 Hz, 1H), 2.25–2.13 (m, 1H), 2.13–2.02 (m, 1H), 1.39–1.11 (m, 1H). 13C NMR 
(75 MHz, CDCl3) δ 211.9, 139.7, 135.3, 134.7, 134.3, 131.1, 130.2, 128.9, 128.1, 127.8, 
127.6, 126.8, 126.6, 122.1, 76.4, 60.1, 51.5, 43.5, 40.2, 26.3. MS: calculated for 
C25H22NO3BrNa (M + Na
+), 486.0681; found, 486.0682. The enantiomeric purity was 
determined by chiral HPLC analysis (Daicel Chiralpak IC, hexane/isopropanol, 90:10; 
flux = 1 mL/min; retention times: 12.5 min (major), 19.4 min (minor)). 
(S)-1-Benzyl-1-((R)-1-(3-methoxyphenyl)-2-nitroethyl)-3,4-dihydronaphthalen-
2(1H)-one (51Bd) 
The adduct was obtained by using 1-benzyl-β-tetralone 49B (70 
mg, 0.3 mmol, 1 equiv.), m-methoxynitrostyrene (32d) (66 mg, 
0.36 mmol, 1.2 equiv.) and catalyst C28 carrying out the 
reaction at –20 ºC. Foam. Yield: 80% (100 mg, 0.258 mmol). 
Carrying out the reaction in the presence of 10 mol% catalyst C13, compound 51Bd 
with essentially identical dr and ee was obtained in 86% isolated yield. [α]D23= –78.5º (c 
= 2.00, 91% ee, dr = >20:1, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 7.60 (d, J = 7.7 
Hz, 1H), 7.48 (t, J = 7.5 Hz, 1H), 7.30 (t, J = 7.5 Hz, 1H), 7.09–7.00 (m, 3H), 7.00–
6.92 (m, 2H), 6.79 (d, J = 7.0 Hz, 1H), 6.68 (d, J = 8.3 Hz, 1H), 6.18 (d, J = 7.4 Hz, 
1H), 5.98 (s, 1H), 5.10 (dd, J = 12.4, 4.2 Hz, 1H), 4.83 (t, J = 12.0 Hz, 1H), 4.61 (dd, J 
= 11.6, 4.2 Hz, 1H), 3.59 (d, J = 12.5 Hz, 1H), 3.53 (s, 3H), 3.34 (d, J = 12.5 Hz, 1H), 
2.26–2.00 (m, 2H), 1.37–1.09 (m, 2H). 13C NMR (75 MHz, CDCl3) δ 212.0, 158.91 , 
140.0, 136.7, 135.6, 135.1, 130.3, 129.0, 128.8, 128.0, 127.7, 127.6, 126.7, 126.4, 
122.2, 114.2, 76.5, 60.4, 54.9, 52.0, 43.3, 40.3, 26.2. MS: calculated for C26H26NO4 (M 
+ H+), 416.1862; found, 416.1870. The enantiomeric purity was determined by chiral 
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HPLC analysis (Daicel Chiralpak IA, hexane/isopropanol, 90:10; flux = 1 mL/min; 
retention times: 11.0 min (minor), 15.4 min (major)). 
(S)-1-Benzyl-1-((R)-1-(furan-2-yl)-2-nitroethyl)-3,4-dihydronaphthalen-2(1H)-one 
(51Bh) 
The adduct was obtained by using 1-benzyl-β-tetralone 49B (70 mg, 
0.3 mmol, 1 equiv.), 2-(2-nitrovinyl)furan (32h) (50 mg, 0.36 mmol, 
1.2 equiv.) and catalyst C28, and carrying out the reaction at –20 ºC. 
Foam. Yield: 60% (68 mg, 0.216 mmol). Carrying out the reaction in 
the presence of 10 mol% catalyst C13, compound 51Bh with essentially identical dr 
and ee was obtained in 72% isolated yield. [α]D23= –9.0º (c = 2.00, 90% ee, dr = >20:1, 
CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 7.54 (d, J = 7.8 Hz, 1H), 7.41 (t, J = 7.6 Hz, 
1H), 7.26 (t, J = 7.4 Hz, 1H), 7.20 (s, 1H), 7.03 (d, J = 24.3 Hz, 4H), 6.71 (dd, J = 7.8, 
1.6 Hz, 2H), 6.23 (dd, J = 3.3, 1.8 Hz, 1H), 6.01–5.93 (m, 1H), 4.89–4.74 (m, 2H), 4.65 
(dd, J = 10.0, 5.3 Hz, 1H), 3.48–3.31 (m, 2H), 2.27 (ddt, J = 16.4, 10.8, 5.2 Hz, 2H), 
2.11–1.96 (m, 1H), 1.66–1.52 (m, 1H). 13C NMR (75 MHz, CDCl3) δ 211.5, 149.7, 
142.3, 138.6, 135.6, 130.3, 128.6, 128.0, 127.5, 127.4, 126.7, 110.6, 109.7, 74.8, 59.3, 
46.4, 43.5, 40.5, 26.7. MS: calculated for C23H22NO4 (M + H
+), 376.1549; found, 
376.1555. The enantiomeric purity was determined by chiral HPLC analysis (Daicel 
Chiralpak IC, hexane/isopropanol, 90:10; flux = 1 mL/min; retention times: 17.0 min 
(major), 24.4 min (minor)). 
 (S)-1-Benzyl-1-((R)-1-nitropentan-2-yl)-3,4-dihydronaphthalen-2(1H)-one (51Bi) 
The adduct was obtained by using 1-benzyl-β-tetralone 49B (70 mg, 
0.3 mmol, 1 equiv.), 1-nitropent-1-ene (32i) (42 mg, 0.36 mmol, 1.2 
equiv.) and catalyst C28, and carrying out the reaction at room 
temperature for 48 h. Colourless oil. Yield: 72% (77 mg, 0.22 mmol). [α]D23= +53.7º (c 
= 2.00, 88% ee, dr = >20:1, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 7.55 (d, J = 7.3 
Hz, 1H), 7.39 (t, J = 8.3 Hz, 1H), 7.28–7.21 (m, 1H), 7.19–7.13 (m, 1H), 7.09–6.98 (m, 
3H), 6.62 (d, J = 7.7 Hz, 2H), 4.57 (dd, J = 13.0, 4.1 Hz, 1H), 4.19 (dd, J = 13.0, 8.3 
Hz, 1H), 3.48 (d, J = 12.6 Hz, 1H), 3.31 (dq, J = 8.1, 4.1 Hz, 1H), 3.13 (d, J = 12.6 Hz, 
1H), 2.87–2.72 (m, 1H), 2.40–2.23 (m, 2H), 1.88–1.64 (m, 2H), 1.34–1.10 (m, 3H), 
0.87 (t, J = 7.1 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ 212.1, 137.6, 136.9, 135.7, 
129.8, 129.0, 128.3, 127.4, 127.0, 126.9, 126.6, 126.1, 76.2, 58.8, 54.5, 45.9, 43.8, 40.1, 
32.2, 27.1, 20.9, 13.7. MS: calculated for C22H26NO3 (M + H
+), 352.1913; found, 
352.1928. The enantiomeric purity was determined by chiral HPLC analysis (Daicel 
Chiralpak IA, hexane/isopropanol, 98:2; flux = 1 mL/min; retention times: 9.4 min 
(minor), 12.1 min (major)). 
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(S)-1-((S)-1-(2-Chlorophenyl)-2-nitroethyl)-1-(3-methylbut-2-en-1-yl)-3,4-
dihydronaphthalen-2(1H)-one (51Ce) 
The adduct was obtained by using 1-(3-methylbut-2-en-1-yl)-β-
tetralone 49C (64 mg, 0.3 mmol, 1 equiv.), o-chloronitrostyrene 
(32e) (66 mg, 0.36 mmol, 1.2 equiv.) and catalyst C13, and 
carrying out the reaction at –20 ºC. Foam. Yield: 80% (95 mg, 
0.240 mmol). Carrying out the reaction in the presence of 10 
mol% catalyst C28, compound 51Ce with essentially identical dr and ee was obtained 
in 77% isolated yield. [α]D23= –59.7º (c = 2.00, 99% ee, dr = >20:1, CH2Cl2). 1H NMR 
(300 MHz, CDCl3) δ 7.35–7.26 (m, 4H), 7.23–7.09 (m, 3H), 6.90 (d, J = 7.5 Hz, 1H), 
4.99 (dd, J = 11.3, 4.0 Hz, 1H), 4.91–4.70 (m, 2H), 4.58 (t, J = 7.1 Hz, 1H), 2.94–2.73 
(m, 3H), 2.70–2.53 (m, 2H), 2.49–2.33 (m, 1H), 1.51 (s, 6H). 13C NMR (75 MHz, 
CDCl3) δ 211.8, 138.4, 137.0, 136.2, 135.4, 133.5, 130.0, 129.5, 129.0, 128.4, 127.4, 
127.0, 126.3, 117.8, 76.6, 57.5, 46.1, 40.5, 34.8, 27.7, 25.7, 18.0. MS: calculated for 
C23H25NO3Cl (M + H
+), 398.1523; found, 398.1536. The enantiomeric purity was 
determined by chiral HPLC analysis (Daicel Chiralpak IC, hexane/isopropanol, 90:10; 
flux = 1 mL/min; retention times: 19.1 min (major), 25.8 min (minor)). 
2-((S)-1-((R)-2-Nitro-1-(m-tolyl)ethyl)-2-oxo-1,2,3,4-tetrahydronaphthalen-1-
yl)acetonitrile (51Df) 
The adduct was obtained by using 1-cyanomethyl-β-tetralone 49D 
(56 mg, 0.3 mmol, 1 equiv.), o-chloronitrostyrene (32f) (58 mg, 
0.36 mmol, 1.2 equiv.) and catalyst C28, and carrying out the 
reaction at –10 ºC for 24 h. Foam. Yield: 78% (82 mg, 0.23 mmol). 
[α]D23= –31.5º (c = 2.00, 91% ee, dr= >20:1, CH2Cl2). 1H NMR 
(300 MHz, CDCl3) δ 7.41–7.28 (m, 2H), 7.23–7.17 (m, 1H), 7.10–6.97 (m, 3H), 6.49–
6.37 (m, 1H), 6.30 (s, 1H), 4.80–4.60 (m, 2H), 4.18 (dd, J = 9.1, 6.1 Hz, 1H), 3.19 (d, J 
= 16.0 Hz, 1H), 2.94 (d, J = 16.0 Hz, 1H), 2.85–2.73 (m, 1H), 2.72–2.56 (m, 2H), 2.16 
(s, 3H), 2.22–2.08 (m, 1H). 13C NMR (75 MHz, CDCl3) δ 209.9, 138.3, 138.2, 133.2, 
130.1, 129.4, 129.1, 128.6, 128.4, 127.3, 126.8, 126.2, 116.4, 75.4, 56.6, 50.0, 38.9, 
26.7, 24.2, 21.2. MS: calculated for C18H18NO3 (M + H
+), 371.1372; found, 371.1372. 
The enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak IA, 
hexane/isopropanol, 90:10; flux = 1 mL/min; retention times: 13.4 min (minor), 15.4 
min (major)). 
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 (S)-1-Benzyl-6-chloro-1-((R)-2-nitro-1-(p-tolyl)ethyl)-3,4-dihydronaphthalen-
2(1H)-one (51Fg) 
The adduct was obtained by using 1-benzyl-6-chloroβ-tetralone 
49F (81 mg, 0.3 mmol, 1 equiv.), p-bromonitrostyrene (32g) (58 
mg, 0.36 mmol, 1.2 equiv.) and catalyst C13, and carrying out 
the reaction at –20 ºC. Foam. Yield: 84% (109 mg, 0.252 
mmol). [α]D23= –162º (c = 2.00, 90% ee, dr = >20:1, CH2Cl2). 
1H NMR (300 MHz, CDCl3) δ 7.53 (d, J = 8.5 Hz, 1H), 7.45 (dd, J = 8.5, 2.2 Hz, 1H), 
7.20–6.99 (m, 4H), 6.96 (d, J = 2.1 Hz, 1H), 6.89 (d, J = 7.9 Hz, 2H), 6.77 (dd, J = 7.3, 
2.2 Hz, 2H), 6.44 (d, J = 7.8 Hz, 2H), 5.04 (dd, J = 12.2, 4.3 Hz, 1H), 4.77 (t, J = 11.9 
Hz, 1H), 4.56 (dd, J = 11.7, 4.3 Hz, 1H), 3.50 (d, J = 12.7 Hz, 1H), 3.35 (d, J = 12.7 
Hz, 1H), 2.23 (s, 3H), 2.14–2.01 (m, 2H), 1.30–1.10 (m, 2H). 13C NMR (75 MHz, 
CDCl3) δ 211.9, 142.4, 138.4, 136.0, 134.4, 134.0, 132.4, 130.9, 129.9, 129.8, 129.5, 
129.2, 128.7, 127.4, 127.2, 77.0, 60.9, 52.3, 43.8, 40.5, 26.6, 21.6. MS: calculated for 
C26H24NO3ClNa (M + Na
+), 456.1342; found, 456.1346. The enantiomeric purity was 
determined by chiral HPLC analysis (Daicel Chiralpak IC, hexane/isopropanol, 90:10; 
flux = 1 mL/min; retention times: 12.8 min (minor), 17.9 min (major)). 
(S)-6-Methoxy-1-(3-methylbut-2-en-1-yl)-1-((R)-2-nitro-1-phenylethyl)-3,4-
dihydronaphthalen-2(1H)-one (51Ga) 
The adduct was obtained by using 6-methoxy-1-cyanomethyl-
β-tetralone 49G (72 mg, 0.3 mmol, 1 equiv.), nitrostyrene 
(32a) (54 mg, 0.36 mmol, 1.2 equiv.) and catalyst C13, and 
carrying out the reaction at –20 ºC for 16 h. Foam. Yield: 79% 
(86 mg, 0.237 mmol). [α]D23= –81.9º (c = 2.00, 98% ee, dr = 
>20:1, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 7.19 (dd, J = 8.0, 4.2 Hz, 2H), 7.09 (t, J 
= 7.5 Hz, 2H), 6.93 (dd, J = 8.6, 2.6 Hz, 1H), 6.64–6.48 (m, 3H), 5.02 (dd, J = 12.6, 
4.5 Hz, 1H), 4.81–4.66 (m, 2H), 4.40 (dd, J = 11.4, 4.6 Hz, 1H), 3.89 (s, 3H), 3.00 (dd, 
J = 13.7, 9.2 Hz, 1H), 2.77 (dd, J = 13.5, 4.9 Hz, 1H), 2.47–2.30 (m, 2H), 2.18–2.02 
(m, 1H), 1.62 (s, 3H), 1.56 (s, 3H), 1.36–1.16 (m, 1H). 13C NMR (75 MHz, CDCl3) δ 
212.8, 158.6, 141.2, 135.5, 129.5, 128.3, 128.0, 127.8, 127.1, 117.9, 113.5, 112.3, 76.4, 
58.2, 55.3, 51.4, 40.4, 35.7, 26.5, 25.8, 18.0. MS: calculated for C24H28NO4 (M + H
+), 
394.2023; found, 394.2018. The enantiomeric purity was determined by chiral HPLC 
analysis (Daicel Chiralpak IC, hexane/isopropanol, 98:2; flux = 1 mL/min; retention 
times: 12.7 min (minor), 18.3 min (major)). 
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(S)-1-Benzyl-7-methoxy-1-((R)-1-nitro-4-phenylbutan-2-yl)-3,4-
dihydronaphthalen-2(1H)-one (51Hj) 
The adduct was obtained by using 1-benzyl-7-methoxy-β-
tetralone 49H (80 mg, 0.3 mmol, 1 equiv.), (4-nitrobut-3-en-1-
yl)benzene (32j) (64 mg, 0.36 mmol, 1.2 equiv.) and catalyst 
C28, and carrying out the reaction at 0 ºC. Foam. Yield: 81% 
(108 mg, 0.243 mmol). Carrying out the reaction in the presence of 10 mol% catalyst 
C13, compound 51Hj with essentially identical dr and ee was obtained in 81% isolated 
yield. [α]D23= +45.6º (c = 2.00, 89% ee, dr = >20:1, CH2Cl2). 1H NMR (300 MHz, 
CDCl3) δ 7.32–7.25 (m, 2H), 7.23–7.10 (m, 3H), 7.10–6.98 (m, 4H), 6.94 (d, J = 8.4 
Hz, 1H), 6.80 (dd, J = 8.4, 2.5 Hz, 1H), 6.63 (d, J = 6.7 Hz, 2H), 4.59 (dd, J = 12.8, 4.0 
Hz, 1H), 4.28 (dd, J = 12.8, 8.5 Hz, 1H), 3.88 (s, 3H), 3.42 (d, J = 11.7 Hz, 1H), 3.34–
3.23 (m, 1H), 2.95 (d, J = 12.7 Hz, 1H), 2.74–2.45 (m, 3H), 2.39–2.08 (m, 3H), 1.95–
1.78 (m, 1H), 1.67–1.50 (m, 1H). 13C NMR (75 MHz, CDCl3) δ 212.3, 158.5, 141.0, 
138.5, 135.9, 131.5, 130.2, 129.6, 128.5, 128.4, 127.9, 126.6, 126.2, 113.0, 112.9, 78.1, 
59.0, 55.4, 45.8, 44.0, 40.8, 34.4, 32.2, 26.7. MS: calculated for C28H30NO4 (M + H
+), 
444.2175; found, 444.2176. The enantiomeric purity was determined by chiral HPLC 
analysis (Daicel Chiralpak IC, hexane/isopropanol, 90:10; flux = 1 mL/min; retention 
times: 11.4 min (major), 18.7 min (minor)). 
(S)-8-Methoxy-4-((S)-2-nitro-1-phenylethyl)chroman-3-one (54) 
 The adduct was obtained by using 53 (54 mg, 0.3 mmol, 1 equiv.), 
nitrostyrene (32a) (56 mg, 0.36 mmol, 1.2 equiv.) and catalyst C7, 
and carrying out the reaction at –40 ºC. Foam. 1:1 mixture of 
diastereomers. Combined yield: 89% (88 mg, 0.267 mmol). 
Diastereomer (S,S): 1H NMR (300 MHz, CDCl3) δ 7.30–7.16 (m, 
5H), 6.88–6.77 (m, 2H), 6.21 (dd, J = 6.4, 2.7 Hz, 1H), 4.88 (dd, J = 
13.7, 7.1 Hz, 1H), 4.76 (dd, J = 13.7, 7.9 Hz, 1H), 4.44 (dd, J = 100.2, 18.2 Hz, 2H), 
4.11 (q, J = 7.8 Hz, 1H), 3.87 (s, 3H), 3.68 (d, J = 8.6 Hz, 1H). 13C NMR (75 MHz, 
CDCl3) δ 206.8, 149.4, 144.0, 135.5, 128.7, 128.3, 127.8, 123.1, 121.4, 111.7, 76.9, 
73.0, 56.0, 54.8, 45.5. Diastereomer (R,R): 1H NMR (300 MHz, CDCl3) δ 7.30–7.25 
(m, 3H), 7.11–6.89 (m, 3H), 6.74 (dd, J = 7.7, 1.3 Hz, 1H), 6.24–6.19 (m, 1H), 4.92–
4.72 (m, 2H), 4.44–4.15 (m, 2H), 4.16–4.03 (m, 1H), 3.88 (s, 3H), 3.80 (d, J = 7.1 Hz, 
1H). 13C NMR (75 MHz, CDCl3) δ 208.5, 149.5, 143.8, 135.1, 128.9, 128.5, 127.7, 
123.7, 120.9, 111.9, 77.1, 72.9, 56.0, 53.6, 47.2. MS: calculated for C18H17NO5Na (M + 
Na+), 250.1004; found, 250.0992. The enantiomeric purity was determined by chiral 
HPLC analysis (Daicel Chiralpak IC, hexane/isopropanol, 80:20; flux = 1 mL/min; 
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retention times of major diastereomer: 29.0 min (major), 35.5 min (minor). Retention 
times of minor diastereomer: 17.3 min (major), 26.1 min (minor)). 
(S)-5-((S)-2-Nitro-1-phenylethyl)-5,7,8,9-tetrahydro-6H-benzo[7]annulen-6-one 
(56a) 
 The adduct was obtained by using 55 (48 mg, 0.3 mmol, 1 equiv.), 
nitrostyrene (32a) (54 mg, 0.36 mmol, 1.2 equiv.) and 10 mol% 
catalyst C7, and carrying out the reaction at room temperature for 24 
h. Foam. 4:1 mixture of diastereomers. Combined yield: 82% (76 mg, 
0.25 mmol). Major diastereomer (S,S): 1H NMR (300 MHz, CDCl3) δ 
7.31–7.23 (m, 4H), 7.23–7.09 (m, 4H), 6.89–6.82 (m, 1H), 4.86 (dd, J = 12.8, 5.0 Hz, 
1H), 4.70 (dd, J = 12.9, 9.5 Hz, 1H), 4.39 (td, J = 9.3, 4.9 Hz, 1H), 4.28 (d, J = 9.3 Hz, 
1H), 2.81 (dt, J = 14.6, 5.0 Hz, 1H), 2.69–2.56 (m, 1H), 2.50–2.39 (m, 2H), 1.97–1.85 
(m, 2H). 13C NMR (75 MHz, CDCl3) δ 208.0, 141.0, 137.0, 133.7, 130.4, 129.1, 128.8, 
128.4, 128.3, 128.0, 127.6, 78.8, 61.1, 44.4, 43.2, 32.9, 28.2. Minor diastereomer (R,R): 
1H NMR (300 MHz, CDCl3) δ 7.31–7.23 (m, 4H), 7.23–7.09 (m, 4H), 7.06–6.99 (m, 
1H), 4.88–4.80 (m, 1H), 4.76–4.64 (m, 1H), 4.45–4.34 (m, 1H), 4.15 (d, J = 5.7 Hz, 
1H), 2.88–2.76 (m, 1H), 2.69–2.56 (m, 1H), 2.50–2.39 (m, 2H), 1.97–1.85 (m, 2H). 13C 
NMR (75 MHz, CDCl3) δ 209.4, 141.0, 136.2, 133.2, 129.9, 129.8, 128.7, 128.3, 128.2, 
127.7, 126.9, 78.5, 58.9, 42.3, 41.0, 31.4, 27.8. MS: calculated for C19H19NO3Na (M + 
Na+), 332.1263; found, 332.1265. The enantiomeric purity was determined by chiral 
HPLC analysis (Daicel Chiralpak IA, hexane/isopropanol, 95:5; flux = 1 mL/min; 
retention times of major diastereomer: 14.3 min (major), 23.2 min (minor). Retention 
times of minor diastereomer: 10.6 min (major), 10.8 min (minor)). 
(S)-5-((S)-1-(2-Chlorophenyl)-2-nitroethyl)-5,7,8,9-tetrahydro-6H-
benzo[7]annulen-6-one (56e) 
The general procedure was applied starting from 55 (48 mg, 0.3 
mmol, 1 equiv.), o-chloronitrostyrene (32e) (66 mg, 0.36 mmol, 1.2 
equiv.) and 10 mol% catalyst C7, and carrying out the reaction at 
room temperature for 32 h. Foam. Single diastereomer.Yield: 75% 
(77 mg, 0.23 mmol). [α]D23= –23.1º (c = 2.00, 99% ee, dr = >20:1, 
CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 7.39 (d, J = 7.9 Hz, 1H), 7.18–7.11 (m, 1H), 
7.11–6.94 (m, 5H), 6.81 (d, J = 7.6 Hz, 1H), 5.00–4.76 (m, 4H), 3.25 (ddd, J = 13.7, 
10.4, 2.8 Hz, 1H), 3.06–2.87 (m, 2H), 2.68 (ddd, J = 12.3, 5.2, 3.4 Hz, 1H), 2.33–2.18 
(m, 1H), 1.95–1.77 (m, 1H). 13C NMR (75 MHz, CDCl3) δ 208.1, 141.5, 134.3, 134.1, 
132.8, 130.2, 129.5, 128.9, 128.6, 127.6, 127.3, 127.2, 77.5, 54.7, 45.4, 38.7, 33.4, 28.7. 
MS: calculated for C19H18ClNO3Na (M + Na
+), 366.0873; found, 366.0869. The 
enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak IA, 
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hexane/isopropanol, 90:10; flux = 1 mL/min; retention times: 7.2 min (major), 8.4 min 
(minor)). 
 
5.4.16. Base-promoted epimerization of β-tetralone 51Aa 
 
Triethylamine (2.5 µL, 0.02 mmol, 20 mol%) was added over a solution of the 
51Aa/51Aa’ mixture previously obtained (dr = 3:1, 99% ee; 30 mg, 0.1 mmol, 1 equiv.) 
in CH2Cl2 (0.3 mL) and the mixture was stirred at room temperature for 2 h. The 
resulting product was purified by flash column chromatography (hexane/EtOAc 90:10). 
Yield: 95% (29 mg, 0.95 mmol). The enantiomeric and diastereomeric purity were 
determined by chiral HPLC analysis. 
Chromatograms before and after epimerization: 
 
 
 
 
 
 
Retention Time % Area 
10,360 0,09 
12,557 77,43 
13,777 0,07 
23,292 22,41 
Retention Time % Area 
10,635 0,08 
13,174 49,36 
14,200 0,30 
23,162 50,26 
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5.4.17. Elaboration of adducts 51 
5.4.17.1. Synthesis of tricyclic compounds 57/57’ and 58/58’ 
 
Nitrostyrene (60 mg, 0.4 mmol, 2 equiv.) was added to a solution of adduct 
51Aa (59 mg, 0.2 mmol, 1 equiv.) and catalyst C7 (12.6 mg, 0.02 mmol, 10 mol %) in 
dichloromethane (0.6 mL) and the resulting mixture was stirred for 48 h at room 
temperature. Then the mixture was directly submitted to a flash column 
chromatography (hexane/CH2Cl2 75:25) from which essentially pure compounds 57 and 
57’ were obtained separately as white solids. 
(4bS,5S,6R,7R,8S,8aR)-6,8-Dinitro-5,7-diphenyl-5,6,7,8,9,10-
hexahydrophenanthren-8a(4bH)-ol (57) 
The product was obtained following the general procedure from 
adduct 51Aa and nitrostyrene (32a). Major isomer. Diastereomeric 
ratio 3:1. Yield: 45% (40 mg, 0.09 mmol). Structure confirmed by x-
ray analysis. [α]D23= –38.3º (c = 0.30, 99% ee, acetone). 1H NMR 
(300 MHz, acetone-d6) δ 7.75 (d, J = 7.6 Hz, 1H), 7.46–7.28 (m, 
6H), 7.25–7.16 (m, 2H), 7.15–7.04 (m, 2H), 6.98 (d, J = 7.6 Hz, 1H), 6.86 (t, J = 7.6 
Hz, 1H), 6.75 (d, J = 7.8 Hz, 1H), 6.19 (d, J = 12.5 Hz, 1H), 5.56 (t, J = 4.8 Hz, 1H), 
4.73 (dd, J = 12.5, 4.7 Hz, 1H), 4.44 (dd, J = 12.3, 5.0 Hz, 1H), 4.14 (d, J = 12.3 Hz, 
1H), 4.06 (s, 1H), 3.25–3.10 (m, 1H), 3.10–2.99 (m, 1H), 2.99–2.87 (m, 1H), 1.80 (ddd, 
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J = 14.4, 10.3, 7.3 Hz, 1H). 13C NMR (75 MHz, acetone-d6) δ 140.4, 140.1, 137.6, 
137.1, 130.9, 130.3, 130.0, 129.6, 129.4, 128.8, 128.6, 128.1, 127.3, 126.7, 97.5, 92.5, 
74.9, 44.5, 43.4, 43.0, 36.7, 29.2, 27.6. MS: calculated for C25H26NO3 (M - H
+), 
443.1612; found, 443.1604. 
(4bS,5S,6R,7R,8S,8aS)-6,8-Dinitro-5,7-diphenyl-5,6,7,8,9,10-
hexahydrophenanthren-8a(4bH)-ol (57’) 
The product was obtained following the general procedure from 
adduct 51Aa and nitrostyrene (32a). Minor isomer. Diastereomeric 
ratio 3:1. Yield: 15% (39 mg, 0.061 mmol). Relative stereochemistry 
determined by NOESY. [α]D23= +111.1º (c = 0.60, 99% ee, acetone). 
1H NMR (300 MHz, Acetone-d6) δ 7.41–7.28 (m, 5H), 7.24–7.18 (m, 3H), 7.18–7.09 
(m, 2H), 7.04 (d, J = 7.6 Hz, 1H), 7.00–6.92 (m, 1H), 6.66 (dd, J = 6.0, 1.4 Hz, 2H), 
6.37 (d, J = 13.1 Hz, 1H), 5.27 (t, J = 4.8 Hz, 1H), 4.86 (s, 1H), 4.61 (dd, J = 13.1, 5.0 
Hz, 1H), 4.22 (d, J = 14.0 Hz, 1H), 3.82 (dd, J = 12.8, 4.5 Hz, 1H), 3.14–3.00 (m, 2H), 
2.96–2.83 (m, 1H), 2.04–1.94 (m, 1H). 13C NMR (75 MHz, acetone-d6) δ 137.6, 136.1, 
135.9, 135.3, 133.2, 129.9, 129.6, 129.3, 129.1, 128.8, 128.1, 127.2, 125.1, 95.3, 93.3, 
74.3, 50.9, 47.6, 46.0, 25.5, 24.1. MS: calculated for C25H26NO3 (M - H
+), 443.1612; 
found, 443.1604. 
 
The same procedure as above was followed starting from 51Ae (66 mg, 0.2 
mmol, 1 equiv.) and nitroalkene 32i (46 mg, 0.4 mmol, 2 equiv.). 
 
(4bS,5S,6R,7R,8S,8aR)-5-(2-Chlorophenyl)-6,8-dinitro-7-propyl-5,6,7,8,9,10-
hexahydrophenanthren-8a(4bH)-ol (58) 
The product was obtained following the general procedure from 
adduct 51Ae and 1-nitro-1-propene (32i). Diastereomeric ratio 2:1. 
Major isomer: Yield: 44% (40 mg, 0.088 mmol). [α]D23= –16.1º (c 
= 0.20, 99% ee, acetone). 1H NMR (300 MHz, CDCl3) δ 7.52 (d, J 
= 8.0 Hz, 1H), 7.27–7.05 (m, 4H), 7.01–6.88 (m, 2H), 6.48 (d, J = 
7.8 Hz, 1H), 5.50 (d, J = 12.1 Hz, 1H), 5.44 (t, J = 4.6 Hz, 1H), 4.54 (dd, J = 12.2, 4.8 
Hz, 1H), 3.86 (d, J = 12.1 Hz, 1H), 3.20–3.05 (m, 1H), 2.98–2.82 (m, 1H), 2.69–2.53 
(m, 2H), 1.75–1.56 (m, 2H), 1.42–1.25 (m, 4H), 0.92 (t, J = 7.1 Hz, 3H). 13C NMR (75 
Chapter 5 
350 
 
MHz, CDCl3) δ 138.2, 134.6, 134.5, 133.5, 130.3, 129.3, 128.0, 127.6, 127.2, 127.2, 
126.9, 126.4, 93.5, 88.6, 73.2, 41.6, 38.6, 37.4, 36.2, 30.2, 26.5, 19.7, 13.6. MS: 
calculated for C23H25N2O5ClNa (M + Na
+), 467.1350; found, 467.1357. 
 
5.4.17.2. Synthesis of spirocyclic compound 60 
(4S,5S)-5-(2-chlorophenyl)-4-nitro-5-((S)-2-oxo-1,2,3,4-tetrahydronaphthalen-1-
yl)pentanal (59) 
 
Catalyst C7 (13 mg, 0.02 mmol, 10 mol%) was added to a solution of acrolein 
(27 µL, 0.4 mmol, 2 equiv.) and the previously obtained nitroketone 51Ae (67 mg, 0.2 
mmol, 1 equiv.) in CH2Cl2 (0.4 mL) and the resulting solution was stirred at room 
temperature for 8 h. The product was purified by flash column chromatography 
(hexane/EtOAc 90:10) obtaining the addition compound as a sole diastereomer. Foam. 
Yield: 80% (62 mg, 0.16 mmol). 1H NMR (300 MHz, CDCl3) δ 9.64 (s, 1H), 7.18 (ddd, 
J = 40.5, 22.9, 9.2 Hz, 6H), 6.87 (d, J = 7.4 Hz, 1H), 6.48 (d, J = 7.7 Hz, 1H), 5.12 (dt, 
J = 13.3, 6.7 Hz, 1H), 4.85 (dd, J = 11.0, 5.8 Hz, 1H), 3.54 (d, J = 5.7 Hz, 1H), 2.69–
2.56 (m, 2H), 2.52–2.42 (m, 2H), 2.39–2.23 (m, 2H), 1.85 (q, J = 6.8 Hz, 2H). 
 
(1R,2S,3R,6R)-2-(2-Chlorophenyl)-6-hydroxy-3-nitro-3',4'-dihydro-2'H-
spiro[cyclohexane-1,1'-naphthalen]-2'-one (60) 
METHOD A: 
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Pyrrolidine (1.1 mg, 0.015 mmol, 10 mol%) was added to a solution of adduct 
59 (48 mg, 0.15 mmol, 1 equiv.) in dichloromethane (0.3 mL) and the resulting solution 
was stirred at room temperature for 3 h. Then the mixture was directly submitted to a 
flash column chromatography (CH2Cl2/EtOAc 95:5) from which the spirocyclic 
compound 60 was obtained essentially pure. White solid. Yield: 78% (68 mg, 0.117 
mmol). 
 
METHOD B: 
 
Pyrrolidine (1.4 mg, 0.02 mmol, 10 mol%) was added to a solution of acrolein 
(27 µL, 0.4 mmol, 2 equiv.) and adduct 51Ae (67 mg, 0.2 mmol, 1 equiv.) in 
dichloromethane (0.4 mL) and the resulting solution was stirred at room temperature for 
3 h. Then the mixture was directly submitted to a flash column chromatography 
(CH2Cl2/EtOAc 95:5) from which the spirocyclic compound 60 was obtained 
essentially pure as a white solid. Yield: 83% (64 mg, 0.166 mmol). Structure confirmed 
by X-ray analysis. [α]D23= +184.0º (c = 2.00, 99% ee, CH2Cl2). 1H NMR (300 MHz, 
CDCl3) δ 7.84 (d, J = 8.0 Hz, 1H), 7.38–7.30 (m, 2H), 7.19 (t, J = 7.9 Hz, 1H), 7.13–
7.05 (m, 1H), 7.05–6.95 (m, 2H), 6.92 (d, J = 7.5 Hz, 1H), 6.02 (td, J = 11.4, 4.4 Hz, 
1H), 4.70–4.58 (m, 1H), 4.26 (d, J = 11.6 Hz, 1H), 2.66–2.46 (m, 4H), 2.40–2.21 (m, 
1H), 2.15–2.06 (m, 1H), 1.96–1.82 (m, 1H). 13C NMR (75 MHz, CDCl3) δ 214.6, 
139.9, 136.9, 136.5, 134.1, 130.7, 130.2, 129.8, 128.7, 128.5, 128.0, 127.5, 87.5, 77.0, 
61.7, 50.7, 44.3, 30.5, 28.0, 27.8. MS: calculated for C21H20NO4ClNa (M + Na
+), 
408.0977; found, 408.0979.  
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5.4.17.3. Synthesis of tricyclic compounds 61-64 
(1S,3aR,9bS)-1-(2-Chlorophenyl)-2,3,3a,4,5,9b-hexahydro-1H-benzo[e]indole 
(61)278 
 
Nitroalkane 51Aa (132 mg, 0.40 mmol, 1 equiv.) was suspended on MeOH (4 
mL) and Pd (10% wt. on charcoal) (26 mg, 20% weight) was added. The reaction 
mixture was stirred under hydrogen atmosphere (45 atm) at 80 ºC for 24 h. The 
resulting mixture was filtered over a 2 cm path of celite and the solvent was eliminated 
under reduced pressure. The product was purified by flash column chromatography 
(CH2Cl2/MeOH 90:10) to afford the amine as a colourless oil. Diastereomeric ratio 
10:1. Yield: 80% (90 mg, 0.32 mmol). [α]D23= +6.6º (c = 2.00, 99% ee, dr = 10:1, 
CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 7.60 (d, J = 7.8 Hz, 1H), 7.37–7.30 (m, 2H), 
7.25–7.17 (m, 1H), 7.13–7.05 (m, 2H), 6.99–6.91 (m, 1H), 6.63 (s, 1H), 6.58 (d, J = 7.7 
Hz, 1H), 4.08 (q, J = 7.5 Hz, 1H), 3.83 (q, J = 9.2 Hz, 1H), 3.70–3.59 (m, 2H), 3.31–
3.19 (m, 1H), 3.04–2.91 (m, 1H), 2.82–2.70 (m, 1H), 2.15–1.99 (m, 2H). 13C NMR (75 
MHz, CDCl3) δ 138.2, 135.9, 134.6, 129.8, 128.7, 128.4, 128.2, 128.0, 127.4, 126.3, 
126.1, 57.7, 51.4, 49.4, 48.5, 26.8, 26.7. MS: calculated for C18H19NCl (M + H
+), 
284.1206; found, 284.1224. 
 
((1S,3aR,9bS)-1-(2-Chlorophenyl)-1,2,3a,4,5,9b-hexahydro-3H-benzo[e]indol-3-
yl)(3,5-dinitrophenyl)methanone (64) 
 
N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC) (38 mg, 
0.2 mmol, 1.3 equiv.) and 1-hydroxybenzotriazole hydrate (HOBT) (27 mg, 0.18 mmol, 
1.2 equiv.) were added to a stirred solution of 3,5-dinitrobenzoic acid (32 mg, 0.15 
                                                 
278 X. Dong, H. Teng, M. Tong, H. Huan, H. Tao, C. Wang, Chem. Commun. 2010, 46, 6840–6842. 
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mmol, 1 equiv.), diisopropylethylamine (80 µL, 0.23 mmol, 3 equiv.) and amine 61 
(0.15 mmol, 1 equiv.) in CH2Cl2 (2 mL). The reaction mixture was allowed to stir at 
room temperature overnight and the reaction was quenched adding water (2 mL). The 
aqueous phase was extracted with dichloromethane (3 x 2 mL) and the combined 
organic phases were washed with brine (5 mL), dried over MgSO4 and the solvent was 
eliminated under reduced pressure. The product was purified by flash column 
chromatography (hexane/EtOAc 85:15) to afford the amide as a white solid. 
Diastereomeric ratio 5:1. Yield: 76% (73 mg, 0.152 mmol). Relative stereochemistry of 
major isomer determined by NOESY. 1H NMR (300 MHz, CDCl3) δ 9.06 (s, 1H), 8.71 
(s, 2H), 7.43–7.29 (m, 3H), 7.29–7.21 (m, 1H), 7.20–7.11 (m, 2H), 7.08–6.96 (m, 1H), 
6.75 (d, J = 7.7 Hz, 1H), 4.93–4.80 (m, 1H), 4.13–4.04 (m, 1H), 3.92 (dd, J = 10.2, 8.0 
Hz, 1H), 3.79 (t, J = 7.8 Hz, 1H), 3.57 (dd, J = 10.4, 7.3 Hz, 1H), 2.98–2.87 (m, 2H), 
2.45–2.33 (m, 1H), 2.27–2.12 (m, 1H). 13C NMR (75 MHz, CDCl3) δ 164.7, 148.4, 
140.0, 137.1, 136.3, 135.0, 134.4, 130.3, 128.8, 128.7, 128.4, 128.1, 127.5, 127.3, 
126.8, 126.3, 119.8, 57.6, 54.4, 48.3, 45.9, 27.2, 24.8. MS: calculated for C25H21NO5Cl 
(M + H+), 478.1170; found, 478.1172. 
 
(1R,9bS)-9b-Benzyl-1-phenyl-2,4,5,9b-tetrahydro-1H-benzo[e]indole (62)279 
 
To a suspension of nitroalkane 51Ba (0.25 mmol) on EtOH (2.5 mL) zinc 
powder (235 mg, 3.75 mmol, 15 equiv.) was added and the suspension was stirred at 40 
ºC for 10 min. Then aqueous HCl (4 M) (1.6 mL) was added and the reaction mixture 
was allowed to stir for 24 h making sure the pH was between 0 and 1. The reaction 
mixture was concentrated under vacuum, aqueous NaOH (3 M) (5 mL) were added and 
the reaction mixture was stirred for further 5 min. CH2Cl2 (20 mL) was then added and 
the suspension was filtrated on celite. The aqueous and organic layer were separated and 
the aqueous phase was extracted with CH2Cl2 (10 mL). The combined organic layers 
were washed with brine, dried over MgSO4 and the solvent was eliminated under 
reduced pressure. The product was purified by flash column chromatography (EtOAc) 
to afford the imine 62 as a white solid. Yield: 88% (75 mg, 0.22 mmol). [α]D23= –27.9º 
(c = 1.00, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 7.47–7.33 (m, 5H), 7.24–7.14 (m, 
                                                 
279 X. Dong, H. Teng, M. Tong, H. Huan, H. Tao, C. Wang, Chem. Commun. 2010, 46, 6840–6842. 
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2H), 7.11–6.95 (m, 5H), 6.62–6.55 (m, 2H), 4.31 (ddd, J = 14.7, 11.2, 3.4 Hz, 1H), 4.16 
(dd, J = 15.0, 7.4 Hz, 1H), 3.50 (dd, J = 11.2, 7.4 Hz, 1H), 3.15 (d, J = 13.0 Hz, 1H), 
2.90–2.63 (m, 3H), 2.42 (ddd, J = 12.9, 5.3, 2.2 Hz, 1H), 1.40 (dddd, J = 12.8, 10.1, 
7.1, 3.0 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ 183.3, 140.6, 137.4, 136.9, 136.2, 
130.7, 129.9, 128.8, 128.1, 128.0, 127.9, 127.4, 126.5, 126.4, 126.1, 61.9, 58.2, 57.6, 
41.4, 31.4, 29.8. MS: calculated for C25H24NO3 (M + H
+), 338.1909; found, 338.1919. 
 
(1R,9bS)-9b-Benzyl-1-phenyl-2,4,5,9b-tetrahydro-1H-benzo[e]indole N-oxide (63) 
 
Nitroalkane 51Ba (0.3 mmol) was disolved in EtOAc (0.45 mL) and Pd (10% 
wt. on charcoal) (24 mg, 20% weight). The reaction mixture was stirred under hydrogen 
atmosphere (1 atm) at room temperature for 3 days. The resulting mixture was filtered 
over a 2 cm path of celite and the solvent was eliminated under reduced pressure. The 
product was purified by flash column chromatography (CH2Cl2/MeOH 80:20) to afford 
the imine N-oxide 63 as a white solid. Yield: 80% (85 mg, 0.24 mmol). [α]D23= –24.6º 
(c = 0.10, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 7.52–7.40 (m, 5H), 7.24–7.15 (m, 
2H), 7.09 (d, J = 7.3 Hz, 2H), 7.01 (t, J = 7.3 Hz, 3H), 6.54 (d, J = 7.0 Hz, 2H), 4.79 
(td, J = 13.1, 3.2 Hz, 1H), 4.21 (dd, J = 13.2, 8.6 Hz, 1H), 3.83 (dd, J = 12.0, 8.5 Hz, 
1H), 3.32 (d, J = 12.9 Hz, 1H), 3.07 (ddd, J = 15.3, 6.9, 3.2 Hz, 1H), 2.84 (d, J = 12.9 
Hz, 1H), 2.72 (ddd, J = 17.1, 10.6, 7.0 Hz, 1H), 2.32 (ddd, J = 16.4, 7.3, 3.1 Hz, 1H), 
1.38 (dddd, J = 14.3, 10.1, 7.4, 2.6 Hz, 1H). 13C NMR (75 MHz, CDCl3) δ 151.3, 
139.2, 136.3, 136.1, 134.2, 130.5, 129.9, 128.9, 128.6, 128.3, 128.0, 127.1, 126.7, 
126.4, 65.6, 54.1, 53.1, 43.4, 28.3, 21.3. MS: calculated for C25H24NO (M + H
+), 
354.1858; found, 354.1862. 
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5.4.18. α-Amination of β-tetralones and related ketones 
5.4.18.1. General procedure 
 
Catalyst C27 (4.4 mg, 5 mol%) was added to a solution of the corresponding 
nucleophile 49, 65 or 66 (0.15 mmol, 1 equiv.) and di-tert-butyl azodicarboxylate (50) 
(0.30 mmol, 2 equiv.) in CH2Cl2 at 0 ºC. The resulting solution was stirred at the same 
temperature until the reaction was completed (monitored by TLC hexane/EtOAc 80:20) 
and the mixture was directly submitted to a flash column chromatography 
(hexane/EtOAc 90:10), affording the corresponding α-amination adducts as essentially 
pure compound. 
 
The racemic version of the reaction was performed following the asymmetric 
reaction procedure except the reaction was conducted at room temperature and TEA (20 
mol%) was used as the catalyst. 
 
5.4.18.2. Characterization data for compounds 52 and 67 
di-tert-Butyl (S)-1-(1-benzyl-2-oxo-1,2,3,4-tetrahydronaphthalen-1-yl)hydrazine-
1,2-dicarboxylate (52B) 
The adduct was obtained by using 1-benzyl-β-tetralone (49B) (35 mg, 
0.15 mmol, 1 equiv.), di-tert-butyl azodicarboxylate (69 mg, 0.30 
mmol, 2 equiv.) and catalyst C27 (4.4 mg, 5 mol%) and carrying out 
the reaction at 0 ºC. Yellow oil. Yield: 86% (60 mg, 0.129 mmol). 
[α]D22= –296.6º (c = 3.00, 98% ee, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 8.35 (d, J = 
7.8 Hz, 1H), 7.36 (t, J = 7.6 Hz, 1H), 7.27 – 7.10 (m, 2H), 7.01 (t, J = 7.5 Hz, 2H), 6.86 
(d, J = 7.5 Hz, 1H), 6.78 (s, 1H), 6.50 (d, J = 7.2 Hz, 2H), 3.60 (d, J = 12.0 Hz, 1H), 
2.97 (d, J = 12.0 Hz, 1H), 2.65 – 2.38 (m, 2H), 2.31 – 2.09 (m, 1H), 1.54 (s, 9H), 1.30 – 
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1.21 (m, 1H), 1.18 (s, 9H). 13C NMR (75 MHz, CDCl3) δ 214.6, 156.3, 154.5, 139.3, 
135.2, 133.8, 130.9, 127.8, 127.2, 127.0, 1269, 82.3, 81.0, 71.1, 46.6, 37.4, 28.3, 27.9, 
25.8. MS: calculated for C27H34N2O5Na (M + Na
+), 489.2365; found, 489.2374. The 
enantiomeric purity was determined by chiral HPLC analysis (Daicel Chiralpak IC, 
hexane/isopropanol, 98:2; flux = 1 mL/min; retention times: 8.9 min (minor), 17.3 min 
(major)). 
di-tert-Butyl (S)-1-(1-(3-methylbut-2-en-1-yl)-2-oxo-1,2,3,4-tetrahydronaphthalen-
1-yl)hydrazine-1,2-dicarboxylate (52C) 
The adduct was obtained by using 1-(3-methylbut-2-en-1-yl)-tetralone 
(49C) (30 mg, 0.15 mmol, 1 equiv.), di-tert-butyl azodicarboxylate (69 
mg, 0.30 mmol, 2 equiv.) and catalyst C27 (4.4 mg, 5 mol%) and 
carrying out the reaction at 0 ºC. Yellow oil. Yield: 84% (56 mg, 0.126 
mmol). [α]D23= –32.9º (c = 1.50, 90% ee, CH2Cl2). 1H NMR (300 
MHz, CDCl3) δ 8.09 (d, J = 7.8 Hz, 1H), 7.34 – 7.25 (m, 1H), 7.21 – 7.15 (m, 1H), 7.14 
– 7.08 (m, 1H), 6.64 (s, 1H), 4.80 (t, J = 6.7 Hz, 1H), 3.23 – 2.96 (m, 2H), 2.77 – 2.65 
(m, 3H), 2.52 – 2.40 (m, 1H), 1.59 – 1.43 (m, 15H), 1.30 – 1.18 (m, 9H).13C NMR (75 
MHz, CDCl3) δ 212.8, 156.0, 154.8, 135.7, 127.4, 127.2, 127.0, 126.6, 117.2, 82.0, 808, 
37.0, 36.9, 28.3, 28.1, 27.9, 27.6, 25.8, 17.5. MS: calculated for C25H36N2O5Na (M + 
Na+), 467.2522; found, 467.2529. The enantiomeric purity was determined by chiral 
HPLC analysis (Daicel Chiralpak ADH, hexane/isopropanol, 90:10; flux = 1 mL/min; 
retention times: 4.9 min (minor), 11.3 min (major)). 
di-tert-Butyl (S)-1-(1-(cyanomethyl)-2-oxo-1,2,3,4-tetrahydronaphthalen-1-
yl)hydrazine-1,2-dicarboxylate (52D) 
The adduct was obtained by using 2-(2-oxo-1,2,3,4-
tetrahydronaphthalen-1-yl)acetonitrile (49D) (28 mg, 0.15 mmol, 1 
equiv.), di-tert-butyl azodicarboxylate (69 mg, 0.30 mmol, 2 equiv.) 
and catalyst C27 (4.4 mg, 5 mol%) and carrying out the reaction at 0 
ºC. Yellow oil. Yield: 84% (52 mg, 0.126 mmol). [α]D22= –55.9º (c = 
2.00, 96% ee, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 8.21 – 7.86 (m, 1H), 7.48 – 7.30 
(m, 2H), 7.28 – 7.18 (m, 1H), 6.66 (s, 1H), 3.72 – 2.57 (m, 6H), 1.50 (d, J = 14.4 Hz, 
9H), 1.36 – 1.25 (m, 9H). 13C NMR (75 MHz, CDCl3) δ 207.4, 155.9, 134.6, 129.5, 
128.9, 128.4, 127.6, 126.9, 116.0, 83.2, 81.8, 68.8, 36.3, 28.1, 27.9, 27.8, 26.6. MS: 
calculated for C22H30N3O5 (M + H
+), 416.2185; found, 416.2191. The enantiomeric 
purity was determined by chiral HPLC analysis (Daicel Chiralpak IA, 
hexane/isopropanol, 90:10; flux = 1 mL/min; retention times: 11.4 min (minor), 20.6 
min (major)). 
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di-tert-Butyl (S)-1-(2-oxo-1-(prop-2-yn-1-yl)-1,2,3,4-tetrahydronaphthalen-1-
yl)hydrazine-1,2-dicarboxylate (52E) 
The adduct was obtained by using 1-(Prop-2-yn-1-yl)-tetralone 49E 
(28 mg, 0.15 mmol, 1 equiv.), di-tert-butyl azodicarboxylate (69 mg, 
0.30 mmol, 2 equiv.) and catalyst C27 (4.4 mg, 5 mol%) and carrying 
out the reaction at 0 ºC. Yellow oil. Yield: 83% (52 mg, 0.125 mmol). 
[α]D23= –48.8º (c = 2.00, 99% ee, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 8.08 (d, J = 
7.7 Hz, 1H), 7.37 – 7.23 (m, 1H), 7.26 – 7.10 (m, 2H), 6.64 (s, 1H), 3.29 – 3.16 (m, 
2H), 3.02 – 2.73 (m, 3H), 1.97 (s, 1H), 1.52 – 1.46 (m, 9H), 1.28 – 1.19 (m, 9H). 13C 
NMR (75 MHz, CDCl3) δ 209.0, 155.8, 154.4, 134.3, 127.5, 127.3, 127.1, 82.3, 80.9, 
78.7, 72.3, 36.9, 28.8, 28.2, 27.8. MS: calculated for C23H30N2O5Na (M + Na
+), 
437.0252; found, 437.0251. The enantiomeric purity was determined by chiral HPLC 
analysis (Daicel Chiralpak ADH, hexane/isopropanol, 90:10; flux = 1 mL/min; retention 
times: 7.0 min (minor), 14.7 min (major)). 
di-tert-Butyl (S)-1-(4-benzyl-3-oxochroman-4-yl)hydrazine-1,2-dicarboxylate (67) 
The adduct was obtained by using 4-benzylchroman-3-one 65 (28 mg, 
0.15 mmol, 1 equiv.), di-tert-butyl azodicarboxylate (69 mg, 0.30 
mmol, 2 equiv.) and catalyst C27 (4.4 mg, 5 mol%) and carrying out 
the reaction at –60 ºC. Yellow oil. Yield: 89% (63 mg, 0.134 mmol). 
[α]D23= –98.7º (c = 1.50, 94% ee, CH2Cl2). 1H NMR (300 MHz, CDCl3) δ 8.26 (d, J = 
8.5 Hz, 1H), 7.27 – 6.90 (m, 6H), 6.77 – 6.47 (m, 3H), 4.34 (d, J = 17.9 Hz, 1H), 3.97 
(d, J = 17.9 Hz, 1H), 3.50 (d, J = 12.2 Hz, 1H), 3.02 (d, J = 12.2 Hz, 1H), 1.56 (s, 9H), 
1.33 – 1.19 (m, 9H). 13C NMR (75 MHz, CDCl3) δ 210.6, 156.2, 152.8, 132.9, 130.4, 
128.6, 127.9, 127.4, 127.2, 122.8, 116.6, 82.8, 81.3, 71.6, 45.5, 28.2, 27.9. MS: 
calculated for C26H32N2O6Na (M + Na
+), 491.218; found, 491.2154. The enantiomeric 
purity was determined by chiral HPLC analysis (Daicel Chiralpak ADH, 
hexane/isopropanol, 90:10; flux = 1 mL/min; retention times: 5.9 min (minor), 10.8 min 
(major)). 
 
5.4.19. ORTEP diagram of compound 19Eb 
CCDC-1025058 contains the supplementary crystallographic data for the 
structural analysis of 19Eb. These data can be obtained free of charge from The 
Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. 
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5.4.20. ORTEP diagram of compound 46 
CCDC-1821643 contains the supplementary crystallographic data for the 
structural analysis of 46. These data can be obtained free of charge from The Cambridge 
Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. 
  
 
5.4.21. ORTEP diagram of compound 57 
CCDC-1511199 contains the supplementary crystallographic data for the 
structural analysis of 57. These data can be obtained free of charge from The Cambridge 
Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. 
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5.4.22. ORTEP diagram of compound 60 
CCDC-1511200 contains the supplementary crystallographic data for the 
structural analysis of 60. These data can be obtained free of charge from The Cambridge 
Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. 
 
 
5.4.23. ORTEP diagram of compound 63 
CCDC-1511201 contains the supplementary crystallographic data for the 
structural analysis of 63. These data can be obtained free of charge from The Cambridge 
Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. 
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5.4.24. Representative NMR spectra 
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5.4.25. HPLC chromatograms 
Chiralpack IA, 1 mL/min, hexane/isopropanol 95:5, λ = 260 nm 
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Chiralpack IC, 1 mL/min, hexane/isopropanol 90:10, λ = 260 nm 
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Chiralpack IC, 1 mL/min, hexane/isopropanol 85:15, λ = 260 nm 
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Chiralpack IA, 1 mL/min, hexane/isopropanol 98:2, λ = 260 nm 
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Chiralpack IC, 1 mL/min, hexane/isopropanol 95:5, λ = 260 nm 
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Chiralpack IB, 1 mL/min, hexane/isopropanol 98:2, λ = 260 nm 
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Chiralpack IC, 1 mL/min, hexane/isopropanol 80:20, λ = 260 nm 
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Chiralpack IA, 1 mL/min, hexane/isopropanol 90:10, λ = 250 nm 
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Chiralpack IB, 1 mL/min, hexane/isopropanol 95:5, λ = 250 nm 
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Chiralpack IC, 1 mL/min, hexane/isopropanol 90:10, λ = 250 nm 
 
 
 
 
  
Chapter 5 
474 
 
Chiralpack IA, 1 mL/min, hexane/isopropanol 95:5, λ = 260 nm 
 
 
Retention Time % Area 
17.491 45.97 
21.395 44.22 
24.485 4.74 
27.986 5.07 
 
Retention Time % Area 
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Chiralpack IA+AY-H, 0.5 mL/min, hexane/isopropanol 80:20, λ = 260 nm 
 
 
 
Retention Time % Area 
33,284 50,35 
42,516 4,22 
53,950 36,27 
57,823 9,16 
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Chiralpack IA+AY-H, 0.5 mL/min, hexane/isopropanol 80:20, λ = 260 nm 
 
 
Retention Time % Area 
51.661 57.16 
60.834 6.86 
86.115 33.10 
112.001 2.88 
 
  
Retention Time % Area 
51.041 25.70 
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Chiralpack IC, 0.5 mL/min, hexane:ethanol 70:30, λ = 260 nm 
 
 
 
 
Chiralpack IC, 1 mL/min, hexane/isopropanol 80:20, λ = 260 nm 
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Chiralpack IC, 1 mL/min, hexane/isopropanol 80:20, λ = 260 nm 
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Chiralpack IC, 1 mL/min, hexane:etanol 95:5, λ = 260 nm 
 
Retention Time % Area 
34.717 49.90 
37.393 50.10 
 
 
Retention Time % Area 
40.844 71.95 
44.092 28.05 
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Chiralpack IC, 1 mL/min, hexane/isopropanol 95:5, λ = 220 nm 
 
Retention Time % Area 
31.806 54.81 
37.093 45.19 
 
 
Retention Time % Area 
31.031 66.00 
35.809 34.00 
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Chiralpack IA, 1 mL/min, hexane/isopropanol 70:30, λ = 250 nm 
 
Retention Time % Area 
19,141 48,09 
20,838 51,91 
 
 
 
Retention Time % Area 
17,621 1,21 
18,949 98,79 
 
 
  
Chapter 5 
482 
 
Chiralpack IA, 1 mL/min, hexane/isopropanol 70:30, λ = 260 nm 
 
Retention Time % Area 
14,781 47,81 
16,583 52,19 
 
 
 
Retention Time % Area 
15,034 89,78 
16,881 10,22 
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Chiralpack IC, 1 mL/min, hexane/isopropanol 50:50, λ = 250 nm 
 
Retention Time % Area 
33,686 49,64 
50,006 50,36 
 
 
 
Retention Time % Area 
33,378 2,19 
49,492 97,81 
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Chiralpack AD-H, 1 mL/min, hexane/isopropanol 30:70, λ = 250 nm 
 
Retention Time % Area 
20.478 49.70 
26.428 50.30 
 
 
 
Retention Time % Area 
20.579 6.07 
26.452 93.93 
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Chiralpack AD-H, 1 mL/min, hexane/isopropanol 30:70, λ = 250 nm 
 
Retention Time % Area 
16.537 49.80 
23.126 50.20 
 
 
 
Retention Time % Area 
16.697 4.09 
23.185 95.91 
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Chiralpack AD-H, 1 mL/min, hexane/isopropanol 70:30, λ = 210 nm 
 
Retention Time % Area 
9.363 49.69 
10.368 50.31 
 
 
 
Retention Time % Area 
9.336 19.50 
10.362 80.50 
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Chiralpack IA, 1 mL/min, hexane/isopropanol 95:5, λ = 220 nm 
 
Retention Time % Area 
10,200 27,70 
12,405 22,89 
13,054 22,61 
22,482 26,80 
 
Retention Time % Area 
10,360 0,09 
12,557 77,43 
13,777 0,07 
23,292 22,41 
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Chiralpack IA, 1 mL/min, hexane/isopropanol 90:10, λ = 220 nm 
 
Retention Time % Area 
9.646 29.71 
11.463 20.44 
12.858 20.22 
36.400 29.63 
 
 
Retention Time % Area 
9.502 0.23 
11.252 79.64 
12.633 0.07 
34.160 20.05 
 
  
Experimental section 
 
489 
 
Chiralpack IA, 1 mL/min, hexane/isopropanol 90:10, λ = 220 nm 
 
Retention Time % Area 
9.830 25.34 
14.923 24.63 
17.876 24.51 
31.031 25.52 
 
 
Retention Time % Area 
18.174 73.87 
31.561 26.13 
 
 
  
Chapter 5 
490 
 
Chiralpack IA, 1 mL/min, hexane/isopropanol 95:5, λ = 220 nm 
 
Retention Time % Area 
8.813 26.77 
13.154 23.21 
15.581 23.22 
27.605 26.79 
 
 
Retention Time % Area 
14.888 78.39 
21.536 21.61 
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Chiralpack IC, 1 mL/min, hexane/isopropanol 90:10, λ = 210 nm 
 
Retention Time % Area 
8.744 23.21 
9.926 24.54 
17.496 26.01 
21.989 26.23 
 
 
Retention Time % Area 
9.971 3.31 
17.511 96.32 
22.055 0.37 
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Chiralpack IC, 1 mL/min, hexane/isopropanol 90:10, λ = 210 nm 
 
Retention Time % Area 
9.662 31.15 
10.658 31.02 
14.341 37.84 
 
 
Retention Time % Area 
9.821 0.54 
10.828 48.92 
14.258 50.55 
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Chiralpack IC, 1 mL/min, hexane/isopropanol 90:10, λ = 220 nm 
 
Retention Time % Area 
12,724 27,90 
14,131 31,16 
21,967 20,46 
22,911 20,48 
 
Retention Time % Area 
12,719 0,12 
14,124 22,02 
21,906 77,78 
22,928 0,07 
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Chiralpack IC, 1 mL/min, hexane/isopropanol 90:10, λ = 210 nm 
 
Retention Time % Area 
15,944 9,03 
18,423 9,66 
30,265 40,61 
34,355 40,70 
 
Retention Time % Area 
15,910 0,19 
18,437 22,81 
30,301 76,72 
34,524 0,28 
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Chiralpack IC, 1 mL/min, hexane/isopropanol 90:10, λ = 210 nm 
 
Retention Time % Area 
14,905 26,96 
15,741 29,14 
30,784 22,18 
32,477 21,72 
 
Retention Time % Area 
15,117 0,25 
15,921 35,27 
30,684 64,26 
32,631 0,23 
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Chiralpack IA, 1 mL/min, hexane/isopropanol 95:5, λ = 220 nm 
 
Retention Time % Area 
9,925 2,89 
10,556 2,68 
11,505 48,56 
14,377 45,86 
 
 
Retention Time % Area 
9,942 0,64 
11,834 4,14 
14,752 95,22 
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Chiralpack IC 1 mL/min, hexane/isopropanol 90:10, λ = 210 nm 
 
Retention Time % Area 
21,817 49,96 
29,729 50,04 
 
 
 
Retention Time % Area 
21,417 94,76 
29,329 5,24 
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Chiralpack IC 1 mL/min, hexane/isopropanol 90:10, λ = 210 nm 
 
Retention Time % Area 
12,653 51,09 
19,602 48,91 
 
 
 
Retention Time % Area 
12,490 95,70 
19,409 4,30 
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Chiralpack IA 1 mL/min, hexane/isopropanol 90:10, λ = 210 nm 
 
Retention Time % Area 
10,968 49,24 
15,381 50,76 
 
 
 
Retention Time % Area 
11,005 4,64 
15,443 95,36 
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Chiralpack IC 1 mL/min, hexane/isopropanol 90:10, λ = 210 nm 
 
Retention Time % Area 
17,578 47,01 
25,408 52,99 
 
 
 
Retention Time % Area 
17,098 94,82 
24,407 5,18 
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Chiralpack IA 1 mL/min, hexane/isopropanol 98:2, λ = 210 nm 
 
Retention Time % Area 
9,204 48,90 
12,010 51,10 
 
 
 
Retention Time % Area 
9,420 6,16 
12,149 93,84 
 
 
  
Chapter 5 
502 
 
Chiralpack IC 1 mL/min, hexane/isopropanol 90:10, λ = 210 nm 
 
Retention Time % Area 
19,277 50,68 
25,766 49,32 
 
 
 
Retention Time % Area 
19,065 99,39 
26,879 0,61 
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Chiralpack IA 1 mL/min, hexane/isopropanol 90:10, λ = 210 nm 
 
Retention Time % Area 
13.159 52.74 
15.221 47.26 
 
 
 
Retention Time % Area 
13.444 2.35 
15.354 97.65 
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Chiralpack IC 1 mL/min, hexane/isopropanol 90:10, λ = 210 nm 
 
Retention Time % Area 
12.719 49.11 
17.741 50.89 
 
 
 
Retention Time % Area 
12.808 94.81 
17.937 5.19 
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Chiralpack IC 1 mL/min, hexane/isopropanol 98:2, λ = 210 nm 
 
Retention Time % Area 
12,770 49,70 
18,594 50,30 
 
 
 
Retention Time % Area 
12,741 1,09 
18,315 98,91 
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Chiralpack IC 1 mL/min, hexane/isopropanol 90:10, λ = 210 nm 
 
 
Retention Time % Area 
11.201 50.39 
18.408 49.61 
 
 
 
Retention Time % Area 
11.358 94.29 
18.688 5.71 
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Chiralpack IC, 1 mL/min, hexane/isopropanol 98:2, λ = 210 nm 
 
Retention Time % Area 
9.284 48.87 
18.933 51.13 
 
 
 
Retention Time % Area 
9.284 48.87 
18.933 51.13 
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Chiralpack IA, 1 mL/min, hexane/isopropanol 90:10, λ = 210 nm 
 
Retention Time % Area 
11.170 50.50 
20.562 49.50 
 
 
 
Retention Time % Area 
11.389 1.97 
20.596 98.03 
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Chiralpack AD-H, 1 mL/min, hexane/isopropanol 90:10, λ = 210 nm 
 
Retention Time % Area 
4,879 49,87 
11,335 50,13 
 
 
 
Retention Time % Area 
4,887 4,96 
11,283 95,04 
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Chiralpack AD-H, 1 mL/min, hexane/isopropanol 90:10, λ = 210 nm 
 
Retention Time % Area 
4,879 49,87 
11,335 50,13 
 
 
 
Retention Time % Area 
4,887 4,96 
11,283 95,04 
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Chiralpack AD-H, 1 mL/min, hexane/isopropanol 90:10, λ = 220 nm 
 
Retention Time % Area 
10,120 50,74 
14,735 49,26 
 
 
 
Retention Time % Area 
7,039 0,63 
14,696 99,37 
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Chiralpack IC, 1 mL/min, hexane/isopropanol 80:20, λ = 210 nm 
Retention Time % Area 
17.470 25.64 
26.287 25.50 
29.210 24.63 
35.657 24.22 
 
Retention Time % Area 
17.344 55.18 
26.120 0.11 
29.015 44.62 
35.498 0.09 
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Chiralpack IA, 1 mL/min, hexane/isopropanol 95:5, λ = 210 nm 
 
Retention Time % Area 
10.624 17.80 
10.902 18.88 
14.340 31.21 
23.170 32.11 
 
 
Retention Time % Area 
10.587 19.05 
14.370 80.95 
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Chiralpack IA, 1 mL/min, hexane/isopropanol 90:10, λ = 210 nm 
 
Retention Time % Area 
7.129 50.43 
8.303 49.57 
 
 
 
Retention Time % Area 
7.164 99.29 
8.377 0.71 
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Chiralpack AD-H, 1 mL/min, hexane/isopropanol 90:10, λ = 220 nm 
 
Retention Time % Area 
5,943 50,26 
11,261 49,74 
 
 
 
Retention Time % Area 
5,892 2,95 
10,768 97,05 
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5.5. Experimental section of chapter 4 
5.5.1. Oxazolidinone route 
5.5.1.1. Preparation of imine 76280 
 
L-Tyrosine (1.0 g, 5.5 mmol, 1 equiv.) and NaOH (220 mg, 5.5 mmol, 1 equiv.) 
were dissolved in dry methanol (20 mL) in a flame-dried round bottom flask gently 
warming the mixture and benzaldehyde (0.56 mL, 5.5 mmol, 1 equiv.) was added. The 
resulting solution was refluxed for 1 h, cooled to room temperature and isopropanol (20 
mL was added so the product would precipitate. The resulting solid was filtrated, 
collected and stored in a vacuum oven at 50 ºC overnight affording compound 76 as a 
white solid. Yield: 96% (1.5 g, 5.3 mmol). 1H NMR (300 MHz, Methanol-d4) δ 7.79 (s, 
1H), 7.65 (dd, J = 7.3, 2.4 Hz, 2H), 7.41 – 7.30 (m, 3H), 6.95 (d, J = 8.5 Hz, 2H), 6.58 
(d, J = 8.6 Hz, 2H), 3.90 (dd, J = 9.5, 4.1 Hz, 1H), 3.26 – 3.20 (m, 1H), 2.94 (dd, J = 
13.6, 9.7 Hz, 1H). 
 
5.5.1.2. Preparation of imine 77 and transformation into compounds 78-80 
Sodium (S,E)-2-(benzylideneamino)-3-(4-methoxyphenyl)propanoate (77)281 
 
o-Methyl-L-tyrosine (1.0 g, 5.1mmol, 1 equiv.) was dissolved in a 1 M NaOH 
aqueous solution (5.1 mL, 5.1 mmol, 1 equiv.) stirring and gently heating. The water 
was then evaporated under reduced pressure and the residue was stored in a vacuum 
oven at 50 ºC overnight before being suspended in dry EtOH (10 mL) in a flame-dried 
                                                 
280 Adapted from: R. Roy, M. C. Saha, P. S. Roy, Transition Met. Chem. 1990, 15, 51-57. 
281 F. Alonso, S. G. Davies, A. S. Elend, A. D. Smith, Org. Biomol. Chem. 2009, 7, 518–526. 
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round bottom flask and adding benzaldehyde (0.55 mL, 5.4 mmol, 1.05 equiv.). The 
reaction mixture was stirred overnight, concentrated under reduced pressure, suspended 
in pentane and filtrated to obtain the desired imine as a white solid. Yield: 82% (1.3 g, 
4.2 mmol). 1H NMR (400 MHz, Methanol-d4) δ 7.83 (s, 1H), 7.67 (d, J = 7.8 Hz, 2H), 
7.38 (d, J = 6.9 Hz, 2H), 7.08 (d, J = 8.6 Hz, 2H), 6.73 (d, J = 8.6 Hz, 2H), 3.94 (dd, J = 
9.7, 4.1 Hz, 1H), 3.70 (s, 3H), 3.28 (dd, J = 4.1 Hz, 1H), 3.01 (dd, J = 13.5, 9.8 Hz, 1H). 
 
(S)-4-(4-Methoxybenzyl)oxazolidine-2,5-dione (78) 
 
The previously obtained imine 76 (200 mg, 0.66 mmol, 1 equiv.) was suspended 
in dry CH2Cl2 (5 mL) in a flame-dried round bottom flask and cooled to –78 ºC. Then 
phosgene (15% wt. in toluene) (2.4 mL, 3.3 mmol, 5 equiv.) was slowly added and the 
resulting mixture was allowed to slowly warm to room temperature and stirred 
overnight. The crude of the reaction was concentrated under reduced pressure and was 
subjected to flash column chromatography (petrol ether/EtOAc 60:40) obtaining N-
carboxyanhydride 78 as the major product. White solid. Yield: 31% (45 mg, 0.20 
mmol). 1H NMR (500 MHz, Acetone-d6) δ 8.00 (s, 1H), 7.17 (d, J = 8.6 Hz, 2H), 6.87 
(d, J = 8.6 Hz, 2H), 4.79 (t, J = 5.3 Hz, 1H), 3.76 (s, 3H), 3.14 (dd, J = 14.3, 4.7 Hz, 
1H), 3.08 (dd, J = 14.3, 5.8 Hz, 1H). 13C NMR (126 MHz, Acetone-d6) δ 171.2, 159.9, 
152.5, 131.7, 127.5, 114.7, 59.6, 55.4, 36.8. MS: calculated for C11H11NO4Na (M + 
Na+), 244.0580; found 244.0580. 
 
(S)-3-Benzoyl-4-(4-methoxybenzyl)-2-phenyloxazolidin-5-one (79) 
 
The previously obtained imine 77 (200 mg, 0.66 mmol, 1 equiv.) was suspended 
in dry CH2Cl2 (5 mL) in a flame-dried round bottom flask and cooled to 0 ºC. Then 
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benzoyl chloride (0.76 mL, 6.6 mmol, 10 equiv.) was slowly added and the resulting 
mixture was allowed to slowly warm to room temperature and stirred overnight. The 
crude of the reaction was washed with water and brine, dried over Na2SO4 and 
concentrated under reduced pressure. The resulting product was purified by flash 
column chromatography (petrol ether/EtOAc 80:20) obtaining the desired product 79 as 
a white solid in a 2:1 dr. Yield: 70% (180 mg, 0.46 mmol). Major isomer: 1H NMR 
(400 MHz, CDCl3) δ 7.61 – 6.73 (m, 14H), 5.94 (s, 1H), 5.25 (b, 1H), 3.87 (s, 3H), 3.80 
– 3.04 (b, 2H). Minor isomer: 1H NMR (400 MHz, CDCl3) δ 7.61 – 6.73 (m, 15H), 5.08 
(b, 1H), 3.82 (s, 3H), 3.80 – 3.04 (b, 2H). MS: calculated for C24H22NO4 (M + H+), 
388.1543; found 388.1554. 
 
 
2,5-Dioxopyrrolidin-1-yl (S)-4-(4-methoxybenzyl)-5-oxo-2-phenyloxazolidine-3-
carboxylate (80) 
 
The previously obtained imine 77 (200 mg, 0.66 mmol, 1 equiv.) and N,N’-
disuccinimidyl carbonate (DSC) (338 mg, 1.32 mmol, 2 equiv.) were cooled in a flame-
dried round bottom flask to –78 ºC and dry CH2Cl2 (5 mL) was slowly added. The 
resulting mixture was allowed to slowly warm to room temperature and stirred 
overnight. The crude of the reaction was washed with water and brine, dried over 
Na2SO4 and concentrated under reduced pressure. The resulting product was purified by 
flash column chromatography (petrol ether/EtOAc 80:20) obtaining the desired product 
as a white solid, which showed low stability. Yield: 35% (98 mg, 0.23 mmol). 1H NMR 
(400 MHz, CDCl3) δ 7.91 (s, 1H), 7.70 (d, J = 6.7 Hz, 2H), 7.46 – 7.34 (m, 3H), 7.11 
(d, J = 8.6 Hz, 2H), 6.79 (d, J = 8.6 Hz, 2H), 4.44 (dd, J = 9.0, 4.5 Hz, 1H), 3.75 (s, 
3H), 3.44 (dd, J = 14.0, 4.5 Hz, 1H), 3.25 (dd, J = 13.8, 9.2 Hz, 1H), 2.85 (s, 4H). 
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5.5.2. Imidazolidinone route 
5.5.2.1. Preparation of spirocyclic compound 73 
Imidazolidinone 73 was synthesised from intermediate 81 provided by L. 
Eagling according to the following synthetic sequence:282 
 
1st step: Palladium on active carbon (10% wt.) (200 mg, 20% wt.) was added to a 
solution of the benzyl ether 81 (0.95 g, 2.3 mmol) in dry THF in a flame-dried round 
bottom flask and the mixture was stirred at room temperature for 1 h under hydrogen 
atmosphere. The reaction mixture was filtered over a pad of celite and the solvent was 
eliminated under reduced pressure obtaining the desired alcohol 71 as a white solid. 
Yield: 83% (620 mg, 1.9 mmol). 1H NMR (400 MHz, CDCl3) δ 7.05 (d, J = 8.4 Hz, 
2H), 6.72 (bs, 2H), 4.86 (d, J = 36.8 Hz, 1H), 4.69 (d, J = 44.5 Hz, 1H), 4.40 (d, J = 
12.1 Hz, 1H), 3.74 (dd, J = 54.3, 17.6 Hz, 1H), 3.24 (dd, J = 34.7, 14.3 Hz, 1H), 2.82 (d, 
J = 49.2 Hz, 3H), 0.97 (d, J = 28.3 Hz, 9H). 
2nd  step: Triethylamine (0.37 mL, 3.6 mmol, 2 equiv.) and potassium iodide (340 mg, 
2.0 mmol, 1.1 equiv.) were added to a solution of the previously obtained phenol 71 
(600 mg, 1.8 mmol, 1 equiv.) in a 4:1 mixture of CH2Cl2 and toluene (3.5 mL) in a 
flame-dried round bottom flask and the reaction mixture was stirred at 60 ºC for 72 h. 
The solvent was then eliminated under reduced pressure and the residue was dissolved 
in dihloromethane (5 mL), washed with water (3 x 5 mL) dried over Na2SO4 and 
concentrated under reduced pressure. The resulting product was purified by flash 
                                                 
282 Previously developed in the Clayden group. 
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column chromatography (petrol ether/EtOAc 70:30) obtaining the desired product 72 as 
a white solid. Yield: 81% (420 mg, 1.5 mmol). 1H NMR (400 MHz, CDCl3) δ 6.93 (d, J 
= 9.7 Hz, 1H), 6.72 (d, J = 9.7 Hz, 1H), 6.48 (d, J = 9.6 Hz, 1H), 6.41 (d, J = 10.1 Hz, 
1H), 4.86 (s, 1H), 4.46 (t, J = 8.2 Hz, 1H), 3.04 (s, 3H), 2.62 (dd, J = 13.5, 7.2 Hz, 1H), 
2.47 (dd, J = 13.2, 9.2 Hz, 1H), 1.04 (s, 9H). 
3rd step: Cerium chloride heptahydrate (780 mg, 2.1 mmol, 1.5 equiv.) and sodium 
borohydride (81 mg, 2.1 mmol, 1.5 equiv.) were added to a solution of the previously 
obtained spirocycle 72 (380 mg, 1.4 mmol, 1 equiv.) at 0 ºC in dry methanol in a flame-
dried round bottom flask and the reaction mixture was stirred at the same temperature 
for 2 h. The reaction was quenched with water and diluted with CH2Cl2. The organic 
phase was washed with brine, dried over Na2SO4 and concentrated under reduced 
pressure. The two diastereomers could be separated by flash column chromatography 
(CH2Cl2/MeOH 95:5) obtaining the product as a white solid in a 3:1 73/73’ proportion. 
Total yield: 67% (270 mg, 0.94 mmol). Store under argon, slowly oxidizes back to the 
ketone with time. Major isomer (74): 1H NMR (400 MHz, CDCl3) δ 6.21 (ddd, J = 
10.0, 3.8, 1.4 Hz, 1H), 6.12 (ddd, J = 9.8, 3.8, 1.5 Hz, 1H), 5.92 (d, J = 9.4 Hz, 1H), 
5.64 (d, J = 10.4 Hz, 1H), 4.79 (s, 1H), 4.47 (s, 1H), 4.36 (t, J = 8.2 Hz, 1H), 2.99 (s, 
3H), 2.47 (dd, J = 13.2, 7.7 Hz, 1H), 2.15 (dd, J = 13.2, 8.8 Hz, 1H), 1.01 (s, 9H). 13C 
NMR (126 MHz, CDCl3) δ 178.0, 172.3, 131.6, 130.8, 129.4, 128.1, 81.8, 61.4, 56.8, 
50.5, 38.9, 38.3, 31.4, 25.8. Minor isomer (74’): 1H NMR (400 MHz, CDCl3) δ 6.16 (d, 
J = 9.6 Hz, 1H), 6.05 (d, J = 10.8 Hz, 1H), 5.90 (d, J = 9.9 Hz, 1H), 5.61 (d, J = 10.0 
Hz, 1H), 4.80 (s, 1H), 4.68 (s, 1H), 4.36 (t, J = 8.2 Hz, 1H), 3.00 (s, 3H), 2.53 – 2.45 
(m, 1H), 2.25 – 2.16 (m, 1H), 1.60 (d, J = 8.9 Hz, 1H), 1.02 (s, 9H). 13C NMR (126 
MHz, CDCl3) δ 177.5, 172.3, 131.5, 129.8, 128.0, 126.3, 81.6, 61.8, 56.8, 50.2, 38.5, 
38.3, 31.3, 25.8. 
 
5.5.2.2. Synthesis of disodium arogenate (70)283 
 
                                                 
283 Adapted from: W. H. Pirkle, R. Heire, M. H. Hyun, Chirality. 1992, 4, 302–307. 
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The major diastereomer of the above obtained alcohol (73) (50 mg, 0.17 mmol, 
1 equiv.) was dissolved in a mixture of H2O (0.75 mL) and dioxane (0.25 mL), and 
barium hydroxide (87 mg, 0.51 mmol, 3 equiv.) were added. The reaction mixture was 
stirred at 90 ºC for 4 h, after which the reaction mixture was cooled to room temperature 
and sodium carbonate anhydrous (110 mg, 1.0 mmol, 6 equiv.) and water (3 mL) were 
added. The resulting barium carbonate salt was separated by filtration and the aqueous 
layer was washed with CH2Cl2 (3 x 4 mL). The aqueous phase was concentrated under 
reduced pressure and the product was purified by reverse phase chromatography (0.1 M 
TFA/acetonitrile 99:1 to 0:100) being the last thing to exit the column. The 
spectroscopic data resulted coincidental with the one found in the literature.284 1H NMR 
(400 MHz, D2O) δ 6.06 – 5.97 (m, 3H), 5.90 (d, J = 10.3 Hz, 1H), 4.63 – 4.52 (m, 1H), 
3.14 – 3.08 (m, 1H), 2.23 – 2.07 (m, 1H), 1.89 (dd, J = 14.1, 7.4 Hz, 1H). 
 
5.5.3. Acyclic route 
5.5.3.1. Preparation of ester intermediate 82285 
 
The commervially available O-benzyl methyltyrosinate hydrochloride (1.0 g, 3.1 
mmol, 1 equiv.) was dissolved in dry MeOH (15 mL) and neutralised with sodium 
hydroxide powder (130 mg, 3.3 mmol, 1.05 equiv.). Trimethylacetaldehyde (0.47 mL, 
4.34 mmol, 1.4 equiv.) was added and the solution was stirred at room temperature for 
10 min before cooling it to 0 ºC and adding sodium borohydride (95 mg, 2.5 mmol, 0.8 
equiv.). The resulting mixture was stirred at the same temperature for 1 h and the 
remaining sodium borohydride was treated adding water (5 mL). The methanol was 
eliminated under reduced pressure and EtOAc (15 mL) was added. The organic phase 
was separated, washed with water and brine, dried over Na2SO4 and concentrated under 
reduced pressure. The product was purified by flash column chromatography (petrol 
ether/EtOAc 85:15) obtaining the desired compound 82 as a white solid. Yield: 55% 
(610 mg, 1.7 mmol). 1H NMR (400 MHz, CDCl3) δ 7.47 – 7.27 (m, 5H), 7.11 (d, J = 
                                                 
284 S. Danishefsky, J. Morris, L. A. Clizbe, J. Am. Chem. Soc. 1981, 103, 1602-1604. 
285 G. Verardo, P. Geatti, E. Pol, A. G. Giumanini, Can. J. Chem. 2002, 80, 779-788. 
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8.6 Hz, 2H), 6.89 (d, J = 8.6 Hz, 2H), 5.04 (s, 2H), 3.63 (s, 3H), 3.39 (t, J = 6.9 Hz, 1H), 
2.88 (dd, J = 6.8, 2.5 Hz, 2H), 2.38 (d, J = 11.2 Hz, 1H), 2.11 (d, J = 11.2 Hz, 1H), 0.85 
(s, 9H). 
5.5.3.2. Preparation of amide intermediate 86 
 
1st step:286 Dimethylamine (2 M in THF) (0.55 mL, 1.1 mmol, 1.0 equiv.) was added to 
a solution of Boc-O-benzyl-L-tyrosine hydrosuccinimide ester (500 mg, 1.1 mmol, 1.0 
equiv.) in dry dichloromethane (2 mL) and the resulting solution was stirred for 2 h. The 
mixture was concentrated under reduced pressure and product was purified by flash 
column chromatography (petrol ether/EtOAc 80:20) obtaining compound 84 as a 
colourless oil. Yield: Cuantitative. 1H NMR (400 MHz, CDCl3) δ 7.50 – 7.27 (m, 5H), 
7.09 (d, J = 8.4 Hz, 2H), 6.88 (d, J = 8.6 Hz, 2H), 5.39 (d, J = 8.6 Hz, 1H), 4.82 – 4.69 
(m, 1H), 2.96 – 2.85 (m, 2H), 2.84 (s, 3H), 1.41 (s, 9H). 
2nd step:286 The above obtained Boc-protected amine 84 (400 mg, 1.0 mmol, 1.0 equiv.) 
was dissolved in a 1:1 mixture of CH2Cl2 and trifluoroacetic acd (5 mL) and was stirred 
at room temperature for 1 h. The solvent was eliminated under reduced pressure and the 
residue dissolved in CH2Cl2 (5 mL). The organic phase was washed with an aqueous 
solution of NaOH (1 M) (2 x 5 mL) and brine (5 mL), dried over Na2SO4 and 
concentrated under reduced pressure obtaining the desired compound 85 as a white 
solid. Yield: Cuantitative. 1H NMR (400 MHz, CDCl3) δ 7.47 – 7.28 (m, 5H), 7.10 (d, J 
= 8.6 Hz, 2H), 6.91 (d, J = 8.6 Hz, 2H), 5.05 (s, 2H), 3.91 (t, J = 7.1 Hz, 1H), 2.90 (s, 
3H), 2.92 – 2.84 (m, 1H), 2.73 (s, 3H), 2.76 – 2.69 (m, 1H), 1.82 (s, 2 H). 
                                                 
286 L. Ribeiro, N. Silva, J. Iley, J. Rautio, T. Järvinen, H. Mota-Filipe, R. Moreira and E. Mendes, Arch. 
Pharm. Chem. 2007, 340, 32-40. 
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3rd step:285 The previously obtained amine 85 (300 mg, 1.0 mmol, 1 equiv.) was 
dissolved in dry MeOH (15 mL) trimethylacetaldehyde (0.15 mL, 1.4 mmol, 1.4 equiv.) 
was added. The solution was stirred at room temperature for 10 min before cooling it to 
0 ºC and adding sodium borohydride (30 mg, 0.8 mmol, 0.8 equiv.). The resulting 
mixture was stirred at the same temperature for 1 h and the remaining sodium 
borohydride was treated adding H2O (2 mL). The methanol was eliminated under 
reduced pressure and EtOAc (5 mL) was added. The organic phase was separated, 
washed with water and brine, dried over Na2SO4 and concentrated under reduced 
pressure. The product was purified by flash column chromatography (petrol 
ether/EtOAc 50:50) obtaining the desired amide 86 as a white solid. Yield: 62% (230 
mg, 0.62 mmol). 1H NMR (400 MHz, CDCl3) δ 7.46 – 7.26 (m, 5H), 7.13 (d, J = 8.6 
Hz, 2H), 6.87 (d, J = 8.7 Hz, 2H), 5.05 (s, 2H), 3.61 (dd, J = 8.5, 6.1 Hz, 1H), 2.90 (dd, 
J = 13.2, 6.1 Hz, 1H), 2.85 (s, 3H), 2.71 (dd, J = 13.2, 8.5 Hz, 1H), 2.56 (s, 3H), 2.31 (d, 
J = 10.9 Hz, 1H), 2.03 (d, J = 10.9 Hz, 1H), 0.88 (s, 9H). 
 
5.5.3.3. Synthesis of NCA 83 
 
Pyridine (45 µL, 0.56 mmol, 1 equiv) and phosgene (15% wt. in toluene) (1.2 
mL, 1.7 mmol, 3 equiv.) were added in this order to a solution of the previously 
obtained ester 82 or amide 86 (0.56 mmol, 1 equiv.) in CH2Cl2 (5 mL) at –78 ºC. The 
resulting mixture was allowed to warm to room temperature and stirred for 4 h. The 
solvent and the remaining phosgene were eliminated under reduced pressure and the 
product was purified by flash column chromatography (petrol ether/EtOAc 90:10) 
obtaining the pure NCA as a white solid. Yield from ester 82: 65% (134 mg, 0.36 
mmol). Yield from amide 86: 40% (82 mg, 0.22 mmol). 1H NMR (500 MHz, CDCl3) δ 
7.40 (dt, J = 14.8, 7.2 Hz, 4H), 7.33 (s, 1H), 7.03 (d, J = 8.7 Hz, 2H), 6.91 (d, J = 8.7 
Hz, 2H), 5.03 (s, 2H), 4.62 (t, J = 4.2 Hz, 1H), 3.60 (d, J = 14.4 Hz, 1H), 3.18 (d, J = 
4.2 Hz, 2H), 2.87 (d, J = 14.4 Hz, 1H), 1.00 (s, 9H). 13C NMR (126 MHz, CDCl3) δ 
168.5, 158.6, 152.4, 136.7, 130.4, 128.6, 128.0, 127.5, 124.6, 115.4, 70.0, 62.4, 52.8, 
34.1, 33.4, 28.0. MS: calculated for C22H25NNaO4 (M + Na
+), 390.1676; found 
390.1679. 
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5.5.4. Hydantoin route 
5.5.4.1. Synthesis of hydantoins 87 and 88 
(S)-3-(tert-Butyl)-5-(4-((tert-butyldimethylsilyl)oxy)benzyl)-2,4-dioxoimidazolidine 
-1-carbonyl chloride (75) 
 
Pyridine (64 µL, 0.80 mmol, 1.5 equiv.) was added to a triphosgene (80 mg, 
0.27 mmol, 0.5 equiv.) solution in dry dichloromethane (3 mL) in a flame-dried round 
bottom flask at –78 ºC and the resulting solution was stirred at the same temperature for 
10 min before adding hydantoin 74 provided by L. Eagling (200 mg, 1.53 mmol, 1 
equiv.) in CH2Cl2 (2 mL). The resulting mixture was slowly warmed to room 
temperature and was stirred at that temperature for 5 h. The solvent was partially 
eliminated under reduced pressure and the product was purified by flash column 
chromatography (petrol ether/EtOAc 90:10) obtaining the desired product 75 as 
colourless oil. Yield: 63% (423 mg, 0.96 mmol). 1H NMR (400 MHz, CDCl3) δ 6.93 (d, 
J = 8.4 Hz, 2H), 6.76 (d, J = 8.4 Hz, 2H), 4.60 (dd, J = 4.7, 2.6 Hz, 1H), 3.46 (dd, J = 
14.4, 4.8 Hz, 1H), 3.21 (dd, J = 14.4, 2.5 Hz, 1H), 1.36 (s, 9H), 0.96 (s, 9H), 0.15 (s, 
6H). 13C NMR (126 MHz, CDCl3) δ 169.5, 155.5, 150.7, 143.6, 130.9, 124.9, 120.4, 
61.1, 59.8, 34.2, 28.0, 25.6, 18.2, –4.5. MS: calculated for C21H31ClN2NaO4Si (M + 
Na+), 461.1639; found 461.1634. 
 
(S)-3-(tert-Butyl)-5-(4-hydroxybenzyl)imidazolidine-2,4-dione (87)287 
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The above obtained compound 75 (45 mg, 0.1 mmol, 1 equiv.) was dissolved in 
dry THF (1 mL) and tetrabutylammonium fluoride (1 M in THF) (105 µL, 0.105 mmol, 
1.05 equiv.) was added at 0 ºC. The resulting solution was stirred at the same 
temperature for 30 min before the reaction was quenched by adding brine and extracted 
with CH2Cl2. The organic phase was dried over Na2SO4 and concentrated under reduced 
pressure. The product was purified by flash column chromatography (petrol 
ether/EtOAc 50:50) obtaining compound 87 as a white solid. Yield: 60% (16 mg, 0.060 
mmol). 1H NMR (500 MHz, Methanol-d4) δ 7.00 (d, J = 8.4 Hz, 2H), 6.68 (d, J = 8.4 
Hz, 2H), 4.07 (t, J = 4.3 Hz, 1H), 3.00 – 2.84 (m, 2H), 1.34 (s, 9H). 13C NMR (126 
MHz, Methanol-d4) δ 176.6, 173.0, 157.7, 132.2, 126.5, 116.0, 58.4, 37.4, 28.8, 20.9. 
MS: calculated for C14H18NNaO3 (M + Na
+), 285.1215; found 185.12. 
 
Methyl (S)-3-(tert-butyl)-5-(4-hydroxybenzyl)-2,4-dioxoimidazolidine-1-
carboxylate (88) 
 
The carbonyl chloride above obtained (75) (45 mg, 0.1 mmol, 1 equiv.) was 
dissolved in dry MeOH (1 mL) in a flame-dried round bottom flask under nitrogen 
atmosphere and hydrogen chloride (1.25 M in MeOH) (0.2 mL, 0.25 mmol, 2.5 equiv.) 
was added. The resulting solution was stirred at room temperature for 16 h and the 
solvent was eliminated under reduced pressure obtaining the desired product as a white 
solid. Yield: 60% (19 mg, 0.060 mmol). 1H NMR (400 MHz, CDCl3) δ 6.90 (d, J = 5.7 
Hz, 2H), 6.74 (d, J = 5.8 Hz, 2H), 6.21 (s, 1H), 4.49 (s, 1H), 3.95 (s, 2H), 3.37 (d, J = 
13.4 Hz, 1H), 3.15 (d, J = 13.6 Hz, 1H), 1.33 (s, 9H). 13C NMR (126 MHz, CDCl3) δ 
171.0, 155.8, 152.5, 150.8, 130.9, 124.4, 115.4, 59.4, 59.1, 54.0, 34.5, 28.1. MS: 
calculated for C16H20N2NaO5 (M + Na
+), 343.1264; found 343.1265. 
 
5.5.4.2. Synthesis of hydantoin 92 
Hydantoin 92 was prepared according to the following synthetic sequence: 
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1st step: tert-Butyl isocyanate (0.45 mL, 3.9 mmol, 1.1 equiv.) was added to a stirred 
solution of O-benzyl methyltyrosinate hydrochloride (1.1 g, 3.5 mmol, 1 equiv.) and 
triethylamine (1.4 mL, 10.5 mmol, 3 equiv.) in CH2Cl2 (15 mL) in a flame-dried round 
bottom flask under nitrogen atmosphere and the reaction mixture was stirred at room 
temperature overnight. The organic phase was washed with a saturated solution of 
NH4Cl (3 x 10 mL), a saturated solution of NaHCO3 (3 x 10 mL) and brine (10 mL), 
dried over Na2SO4 and the solvent was eliminated under reduced pressure to afford the 
pure urea 89 as a white solid. Yield: Quantitative. 1H NMR (400 MHz, CDCl3) δ 7.47 – 
7.29 (m, 5H), 7.02 (d, J = 8.5 Hz, 2H), 6.89 (d, J = 8.5 Hz, 2H), 5.03 (s, 2H), 4.72 – 
4.63 (m, 1H), 4.50 (d, J = 7.8 Hz, 1H), 4.20 (s, 1H), 3.71 (s, 3H), 3.10 – 2.94 (m, 2H), 
1.30 (s, 9H). 
2nd step: Potassium tert-butoxyde (390 mg, 3.9 mmol, 1.1 equiv.) was added to a stirred 
solution of the urea 89 obtained in the previous step (1.3 g, 3.5 mmol, 1 equiv.) in THF 
(12 mL) in a flame-dried round bottom flask under nitrogen atmosphere and the reaction 
mixture was stirred at room temperature for 2 h. The reaction was then quenched by 
adding a saturated solution of NH4Cl (10 mL). The organic phase was separated and 
washed with a saturated solution of NaHCO3 (10 mL) and brine (10 mL), dried over 
Na2SO4 and concentrated under reduced pressure. The product was purified by flash 
column chromatography (petrol ether/EtOAc 70:30) obtaining the desired compound 90 
as a white solid. Yield: 58% (512 mg, 2.0 mmol). 1H NMR (400 MHz, CDCl3) δ 7.47 – 
7.28 (m, 5H), 7.10 (d, J = 8.5 Hz, 2H), 6.91 (d, J = 8.5 Hz, 2H), 5.47 (s, 1H), 5.04 (s, 
2H), 4.02 (dd, J = 7.4, 3.3 Hz, 1H), 3.10 (dd, J = 14.0, 3.6 Hz, 1H), 2.81 (dd, J = 14.0, 
7.8 Hz, 1H), 1.49 (s, 9H). 
3rd step: Pyridine (0.24 mL, 3.0 mmol, 1.5 equiv.) was added to a triphosgene (297 mg, 
1.0 mmol, 0.5 equiv.) solution in dry dichloromethane (15 mL) in a flame-dried round 
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bottom flask at –78 ºC and the resulting solution was stirred at the same temperature for 
10 min before adding the hydantoin 90 obtained in the previous step (715 mg, 2.0 
mmol, 1 equiv.) in CH2Cl2 (5 mL). The resulting mixture was slowly warmed to room 
temperature and was stirred at that temperature for further 4 h. The solvent was partially 
eliminated under reduced pressure and the product was purified by flash column 
chromatography (petrol ether/EtOAc 80:20) obtaining the desired compound 91 as 
colourless oil. Yield: 43% (360 mg, 0.86 mmol). 1H NMR (400 MHz, CDCl3) δ 7.45 – 
7.27 (m, 5H), 7.00 (d, J = 8.5 Hz, 1H), 6.90 (d, J = 8.5 Hz, 1H), 5.11 – 4.98 (m, 2H), 
4.60 (dd, J = 4.6, 2.6 Hz, 1H), 3.47 (dd, J = 14.4, 4.7 Hz, 1H), 3.24 (dd, J = 14.4, 2.5 
Hz, 1H), 1.34 (s, 9H). 13C NMR (126 MHz, CDCl3) δ 169.5, 158.5, 150.7, 143.6, 136.7, 
130.9, 128.6, 128.0, 127.3, 124.5, 115.2, 69.9, 61.1, 59.9, 34.2, 28.0. MS: calculated for 
C22H23ClN2NaO4 (M + Na
+), 437.1239; found 437.1243. 
4th step: Palladium on active carbon (10% wt.) (2 mg, 20% wt.) was added to a solution 
of compound 91 above obtained (20 mg, 0.05 mmol) in dry THF in a flame-dried round 
bottom flask and the mixture was stirred at room temperature for 1 h under hydrogen 
atmosphere. The reaction mixture was filtered over a pad of celite and the solvent was 
eliminated under reduced pressure obtaining the desired product 92 as a white solid. 
Yield: 50% (8.1 mg, 0.025 mmol). 1H NMR (400 MHz, CDCl3) δ 6.95 (d, J = 8.5 Hz, 
2H), 6.76 (d, J = 8.5 Hz, 2H), 5.06 (s, 1H), 4.60 (dd, J = 4.7, 2.7 Hz, 1H), 3.46 (dd, J = 
14.5, 4.8 Hz, 1H), 3.23 (dd, J = 14.5, 2.5 Hz, 1H), 1.37 (s, 9H). MS: calculated for 
C15H17ClN2NaO4 (M + Na
+), 347.0769; found 347.0767. 
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Catalytic Enantioselective Quick Route to Aldol-Tethered 1,6- and
1,7-Enynes from w-Unsaturated Aldehydes
Jesﬄs M. Garca,[b] Jos M. Odriozola,[b] Jesﬄs Razkin,[b] Irati Lapuerta,[a] Amaiur Odriozola,[a]
IÇaki Urruzuno,[a] Silvia Vera,[a] Mikel Oiarbide,*[a] and Claudio Palomo*[a]
Abstract: An effective asymmetric route to functionalized
1,6- and 1,7-enynes has been developed based on a direct
cross-aldol reaction between w-unsaturated aldehydes and
propargylic aldehydes (a,b-ynals) promoted by combined
a,a-dialkylprolinol ether/Brønsted acid catalysis. This syner-
gistic activation strategy is key to accessing the correspond-
ing aldol adducts with high stereoselectivity, both enantio-
and diastereoselectivity. The aldol reaction also proceeds
well with propargylic ketones (a,b-ynones) thus enabling
a stereocontrolled access to the corresponding tertiary alco-
hols. The utility of these adducts, which are difficult to pre-
pare through standard methodology, is demonstrated by
their transformation into trisubstituted bicyclic enones using
standard Pauson–Khand conditions.
Introduction
A pivotal role in the construction of molecular complexity is
usually played by relatively simple molecular building-blocks of
stereodefined structure that present several sites amenable for
chemical manipulations.[1] For example, oxygenated structure
1 (n=1 or 2, Scheme 1) exhibits a 1,6- or 1,7-enyne carbon
backbone tethered by a central aldol unit and may serve as
useful intermediate in synthesis.[2] Oxygenated 1,w-enynes are
immediate precursors of bicyclic [m.3.0] ring systems which are
found in many natural sesquiterpene products.[3] In this con-
text, [3.3.0]-octane and [4.3.0]-nonane skeletons, common to
the family of picrotoxanes,[4] have conveniently been prepared
from the corresponding 5-oxy-1,6-enynes[5] and 6-oxy-1,7-
enynes.[6] Related bicyclic [5.3.0] and [6.3.0] ring systems can
also be found in guaianolides and ophiobulins, respectively, as
well as other related compounds.[3]
These key oxygenated 1,w-enyne intermediates share a prop-
argylic alcohol structural unit. Main catalytic routes to synthe-
size propargylic alcohols stereoselectively are the reduction of
the corresponding ynones, the nucleophilic alkylation of alkyn-
yl aldehydes (a,b-ynals), and the addition of terminal alkynes
to aldehydes.[7] Although these two latter approaches, wherein
the new stereocenter and the CC bond are created simulta-
neously, have been applied to the synthesis of oxygenated
1,w-enyne structures successfully (Scheme 1a),[5, 6d] they usually
allow for the generation of a sole stereocenter; in addition,
these methods are not easy to implement for concomitant in-
troduction of additional functionality (i.e. that shown in 1) due
in part to difficulties in preparing the required reagents or lim-
ited functional group compatibility. Hence, there is a need to
develop new methods, preferably direct and catalytic, for syn-
thesizing propargylic alcohols stereoselectively, thus expanding
the range of currently available propargylic systems and deriv-
atives thereof.
Quite recently, we have communicated the first direct aldol
addition of aldehydes to a,b-ynals promoted by a dialkylproli-
nol ether/transition metal/Brønsted acid cooperative catalysis
system.[8] The preliminary experiments demonstrated some
benefits of this novel approach to propargylic alcohols,[9] such
as wide substrate tolerance and high stereoselectivity (both
enantio- and anti/syn selectivity). Herein we describe the viabil-
Scheme 1. Catalytic enantioselective approaches to oxygenated 1,w-enynes.
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ity of this approach (Scheme 1) in the synthesis of enantioen-
riched 5- and 6-oxy-1,6-enynes bearing an additional carbonyl
group, and the synthetic utility of these building-blocks in the
preparation of oxygenated carbocycles.
Results and Discussion
Background and catalyst screening
In contrast to the existing methods for the catalyst-promoted
production of propargylic alcohols, one inherent advantage of
the aldol reaction strategy involving a,b-ynals (Scheme 1b) is
that the new carbon–carbon bond-forming event is concomi-
tant with the generation of two contiguous stereogenic cen-
ters. Furthermore, a carbonyl group is also installed in the
same synthetic operation which would allow for additional
chemical manipulation if required, all under rather smooth re-
action conditions. However, before our studies were carried
out only few examples dealing with the aldol addition reaction
of a,b-ynals had been reported and most of them evidenced
difficulties in controlling either diastereoselectivity or enantio-
selectivity, or both.[10,11] In our preliminary study we identified
the a,a-dialkylprolinol silyl ether/CuI/PhCO2H combination as
effective catalyst system in promoting the reaction between
simple aliphatic aldehydes and a,b-ynals. With a 20/10/
20 mol% loading of each catalyst component, respectively, in
THF at low (60 8C) temperature, the corresponding aldol ad-
ducts were obtained in good yields (isolated as the corre-
sponding alcohol or dimethyl acetal), anti/syn ratios usually
above 10:1, and excellent enantioselectivity.[8] In those experi-
ments, not only did each catalyst component appear to be
crucial for successful reactivity and stereoselectivity, but also
the substituent groups at the a position of the prolinol ether
catalyst seemed to play a fundamental role in controlling reac-
tion anti/syn selectivity. Thus, when the reactions were carried
out using the parent a,a-diarylprolinol silyl ethers as the amine
catalyst instead, under otherwise identical conditions, eroded
anti/syn selectivity was attained.
According to these precedents, our study commenced by
evaluating the influence of all these reaction parameters on
the outcome of the target aldehyde–aldehyde cross-aldol reac-
tion, exemplified by 2+3a (Table 1). The reaction carried out
under previously established conditions (catalyst combination:
5/CuI/PhCO2H; Table 1, entry 2) led, upon subsequent acetali-
zation, to the desired adduct 4a in good yield and very high
diastereo- and enantioselectivity (anti/syn 11:1; 96% ee). The
reaction in the absence of benzoic acid resulted sluggish or
unpractical (less than 30% conversion after 48 h of reaction),
thus corroborating the crucial role played by the Brønsted acid
cocatalyst. However, the influence of CuI on both the reaction
yield and stereoselectivity was less significant for this reaction
(Table 1, entries 1/3 vs. 2/4). We next evaluated the influence
of the amine catalyst structure by carrying out parallel reac-
tions with catalysts 6–10. Variation of the silyl group from
SiPh3 to SiMePh2, SiMe2Ph, and SiMe3 indicated a correlation
between the size of the alcohol protecting group of the cata-
lyst and the reaction stereoselectivity. Thus, while similar yields
and enantioselectivity levels were attained with either catalyst
5, 6, or 7, both catalysts 6 and 7, bearing SiMePh2 and SiMe2Ph
groups (Table 1, entries 3 and 5, respectively), led to lower
anti/syn ratio of the aldol adducts compared with 5. The same
trend was observed with sterically less demanding catalyst 8,
which also led to somewhat lower enantioselectivity (Table 1,
entry 6). On the other hand, a switch of the substituent groups
at a-position of the prolinol ether from dialkyl to diaryl (cata-
lysts 9 and 10)12 also eroded the anti/syn ratio (Table 1, en-
tries 7 and 9 vs. 1). From these observations it was apparent
that combined use of both amine and Brønsted acid catalyst
components was crucial for the target reaction, while 5 was
the optimum amine catalyst with variation on its structure at
either the silyl group or the a-substituent affecting negatively
the reaction anti/syn selectivity.
Reaction scope: a,b-ynals and a,b-ynones
Results from different aldehyde substrate combinations are
shown in Table 2. In general, the reaction of 4-pentenal with
a survey of a,b-ynals in the absence of any metal cocatalyst af-
forded the corresponding dimethyl acetals 4 in useful yields,
with anti/syn ratios generally within the range 8:1 to 20:1, and
excellent enantioselectivities for the major anti isomer. The re-
actions with b-aryl ynals usually proceed within 36–48 h,
whereas b-alkyl ynals provided the product within 24 h of reac-
tion. These reactions include propargylic aldehydes bearing
aryl, heteroaryl, branched and unbranched alkyl, alkenyl, and
chloroalkyl R1 groups. Similarly, the reaction with 5-hexenal
Table 1. Catalyst screening for the direct cross-aldol reaction between 2
and phenylpropynal 3a.[a]
Entry Amine Metal Conv. [%][b] Yield [%][c] anti/syn[d] ee [%][e]
1 5 – 96 61 8:1 98
2 5 CuI 96 67 11:1 96
3 6 – 95 n.d. 4:1 96
4 6 CuI 79 n.d. 4:1 94
5 7 – 92 66 4:1 97
6 8 – 90 67 4:1 94
7 9 – 93 68 1:1 99
8 9 CuI 72 51 1.5:1 99
9 10 – 93 66 4:1 98
10 10 CuI 33 n.d. 6:1 91
[a] Reactions conducted on a 0.5 mmol scale in 0.5 mL of THF (2/3a/amine/
PhCO2H/CuI molar ratio=1.5:1:0.2:0.2:0.1). [b] Determined by
1H NMR spec-
troscopy on reaction aliquots before workup. [c] Combined yield of anti/syn
adducts after chromatography; n.d.=not determined. [d] Determined by
1H NMR spectroscopy and corroborated by HPLC. [e] Determined by chiral
HPLC.
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(11) served well to afford the corresponding 6-oxy-1,7-enyne
adducts 12 with satisfactory levels of chemical and stereo-
chemical efficiency. Importantly, in all of these instances, sepa-
ration of the major anti isomer from the diastereomeric mix-
ture was easily accomplished by flash chromatography on
silica gel. In a variation of the above method, aldol adducts
could also be isolated as the corresponding diols such as 13a
and 13d by in situ treatment with NaBH4. Assignment of the
configuration for thus-obtained adducts was made by correla-
tion with previous data.[8] In general, the reactions were carried
out at 0.5 mmol scale, but increasing the scale up to 5 mmol
led to essentially same chemical and stereochemical results as
determined for compounds 4e, 13a, and 13d. On the other
hand, it is important to note that for reactions leading to ad-
ducts 4e, 4g, 4h, parallel experiments carried out in the pres-
ence of CuI (10 mol%) served to corroborate that, in contrast
to our previous observations,[8] for these types of donor alde-
hydes the metal salt additive provokes essentially no change
on the reactions’ anti/syn selectivity and enantioselectivity. It
thus seems that the a,a-dialkylprolinol ether catalyst is the
main stereocontrol element of these reactions. In this respect,
we confirmed that the active catalysts in the above reactions
are the silylated prolinol derivatives and not the corresponding
free prolinols that might eventually arise from hydrolysis.
These latter species led, depending on the reaction conditions,
to no reaction at all or to a different reaction outcome.[13] The
crucial role of the amine catalyst structure was also evident in
aldol reactions of a,b-ynals other than 3a, where a,a-diarylpro-
linol ether catalysts 9 and 10 showed, once again, to be less
efficient in terms of both reactivity and diastereoselectivity rel-
ative to catalyst 5.[14] Although at present we do not have a ra-
tional explanation that correlates these changes in catalyst
structure with the observed variations in reactivity and diaste-
reoselectivity, our results indicate that the aryl to alkyl shift in
the amine catalyst side chain is important and may, in certain
situations, be highly effective.[15]
The present methodology could also be extended to the
construction of chiral tertiary propargylic alcohols bearing an
adjacent stereogenic center by aldol reaction with propargylic
ketoesters.[16] In this context, although the aminocatalytic aldol
reaction of ketones with a,b-ynones is known,[16a] examples of
direct aldehyde–ynone aldol reactions remain elusive, likely be-
cause the occurrence of the competitive aldehyde self-aldol
side reaction can not be avoided with common primary and
secondary amine catalysts. Accordingly, it was gratifying that
when using propargylic ketoesters 17–19 as the acceptor car-
bonyl under the above conditions (20 mol% of each cocatalyst
amine and benzoic acid, 60 8C) high stereoselectivities were
obtained, although the reactions progressed slowly (typically,
35% conversion after 20 h). The relatively lower solubility of
these ynones as compared with the parent ynals may account
for this result. However, practical reaction conversions could
be obtained by carrying out the aldol reaction at 40 8C in-
stead, under otherwise identical conditions, followed by subse-
quent acetalyzation. In this way, good yields and high diaster-
eo- and enantioselectivies of the corresponding acetal prod-
ucts were obtained (Table 3). Thus, although this increase in re-
action temperature caused homoaldolization of aldehyde 2 to
occur to a limited extent (about 10% with respect to the
cross-aldol process), adducts 20, 21, and 22 were isolated in
yields of 74%, 77% and 65%, respectively, and syn/anti ratios
typically from 5:1 to 8:1. In each case the major syn isomer
was separated from the mixture by simple column chromatog-
raphy and determined to possess an enantiomeric excess of
93–94% ee. Other aldehydes such as 14, 15, and 16 participat-
ed equally well in the reaction with ynone 17 giving the ex-
pected adducts 23, 24, and 25 in diastereomeric ratios (d.r.) up
to 8:1. In each case the syn-aldol product was obtained in
good enantioselectivity. Selection of the solvent proved to
have some effect on the outcome of the above reactions.
Thus, changing the solvent from THF to CH2Cl2 generally re-
sulted in reactions becoming faster, with practical results at-
tained even at 60 8C. For instance, the reaction of 2 with
ynone 17 in CH2Cl2 led, after acetalyzation, to product 20 in
72% yield, syn/anti selectivity of 7:1 and 95% ee for the major
syn isomer. Again, the successful realization of this catalytic
Table 2. Oxygenated enynes from direct aldol reaction of unsaturated al-
dehydes with a,b-ynals.[a]
[a] Reactions conducted on a 0.5 mmol scale in 0.5 mL of THF (aldehyde/
ynal//5/PhCO2H molar ratio=1.5-1.2:1:0.2:0.2). d.r. values in parentheses
correspond to reactions conducted in the presence of 10 mol% CuI. Com-
bined yields of anti/syn adducts after chromatography. [b] Reaction run at
5 mmol scale.
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aldol assembly leading to tertiary alcohols is tightly bound to
the use of our catalyst 5. For example, the reaction of aldehyde
14 with 17 promoted by either a,a-diarylprolinol ether catalyst
9 or 10 provided the aldol adduct 23, essentially as an equi-
molar mixture of diastereomers.
Configuration of the adducts was established by a single
crystal X-ray analysis of compound 23 and by assuming a uni-
form reaction mechanism.[17] Further proof of stereochemical
uniformity was obtained by correlation of both adducts 20
and 24 to the same reduction product 26 through simple hy-
drogenation over Pd on charcoal (Scheme 2). It is worth noting
that 26 is the acetal form of the adduct formally derived from
the cross-aldol reaction between two enolizable carbonyl com-
pounds, pentanal acting as the ene component and methyl 2-
oxo-4-phenylbutyrate, acting as the carbonyl component.
Pauson–Khand reaction
The suitability of thus-obtained enyne adducts for participating
in an intramolecular Pauson–Khand cycloaddition reaction was
investigated next.[18] In this respect, it has been previously
noted that propargylic alcohol based enynes are not well
suited substrates for Pauson–Khand reactions,[5c] presumably
because inactivation of Co2(CO)8 occurs through interaction
with the free hydroxyl group of the substrate. To remediate
this deficiency, protection of the hydroxyl group as tert-butyldi-
methylsilyl (TBDMS) ether has been shown sufficient, providing
the Pauson–Khand cycloadducts with variable diastereoselec-
tivity that depends upon the nature of the substituent at the
C-terminus of the alkyne moiety.[6a,d] By applying this same pro-
tecting protocol, we had observed that the Pauson–Khand re-
action of O-TBDMS enyne 29 led to cycloadducts 34/34’ as
a 3:1 mixture of diastereomers isolated in 67% yield. With the
aim to control more effectively the diastereoselectivity of this
reaction, several silyl protecting groups were screened, Table 4.
It turned out that the bulky tris(trimethylsilyl)silyl and triisopro-
pylsilyl (TIPS) groups (compounds 30 and 31) were far more ef-
ficient than TBDMS, and cycloadducts 35 and 36 were pro-
duced, from 30 and 31 respectively, essentially as single diaste-
reomer.
The diastereomeric ratio of bicyclic products on the crude
reaction mixtures was established by integrating the Ha and Hb
signals on 1H NMR spectra and the identity of each isomer was
deduced by chemical shift correlation (Figure 1). Thus, it has
been well established that, for these types of ring junctions
with Ha and Hc in a trans relationship, Ha resonates more up-
field than in the corresponding cis isomer.[19] Accordingly, for
adducts 32/32’, obtained from enyne 27 (R=SiMe3), we as-
signed structure 32 to the major isomer, which shows Ha
signal at 4.8 ppm, and 32’ to the minor isomer (Ha signal at
5.2 ppm). Eventually, we observed that the chemical shifts of
proton Hb also follow same trend, appearing more upfield in
the major isomer (5.1 ppm) as compared to the minor isomer
Table 3. Direct aldol reactions leading to tertiary propargylic alcohols.[a]
Aldehyde Ynone (R1) Product Yield [%][b] syn/anti[c] ee [%][c]
20 74 6:1 94
20[d] 72 7:1 95
21 77 8:1 93
22 65 5:1 94
23 83 5:1 93
24 65 8:1 93
25 70 5:1 95
[a] Reactions conducted on a 0.5 mmol scale in 0.5 mL of THF with
1.5 equivalents of donor aldehyde. [b] Yield of combined syn/anti mixture
of acetal product. [c] Determined by chiral HPLC analysis of the crude
acetal. [d] Reaction carried out in CH2Cl2 at 60 8C for 48 h.
Scheme 2. Elaboration of adducts.
Table 4. Effect of silyl protecting group on Pauson–Khand reaction stereose-
lectivity.[a]
Enyne PG Product Yield, [%][b] Isomeric Ratio[c]
27 SiMe3 32/32’ 65 5:1
28 SiPh3 33/33’ 66 4:1
29 SiMe2tBu 34/34’ 67 3:1
30 Si(SiMe3)3 35/35’ 60 >20:1
31 SiiPr3 36/36’ 65 >20:1
[a] Reactions conducted on a 0.5 mmol scale in 0.5 mL of CH2Cl2 at RT over-
night. [b] Combined yield of diastereomers after chromatography. [c] Deter-
mined by 1H NMR. PG=protecting group.
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(5.6 ppm). The same pattern was reproduced in the rest of cy-
cloadducts 34-36, as illustrated in the case of products 33/33’
(Ha and Hb signals at 4.2 ppm and 3.8 ppm for major isomer;
4.4 ppm and 4.1 ppm for minor). The absence of any signifi-
cant NOE effect between protons Ha and Hc in desilylated de-
rivative 37 further supports these assignments.[20] Thus, the
sense of stereoinduction in the above reactions is in accord
with literature precedents for this type of Pauson–Khand trans-
formation.[5,18,19]
With results of the above screening in hand, we decided to
carry out the Pauson–Khand reaction of selected oxygenated
enyne adducts 4 in their O-TIPS-protected forms.[21] The reac-
tions could be easily monitored by TLC until disappearance of
the initially formed Co complex, usually between 20 h and
24 h, and the adducts were isolated by column chromatogra-
phy in yields within the range 55–85%. With one exception
(see below), in all cases studied the reaction proceeded satis-
factorily, leading to bicyclic products 38-45 as essentially single
stereoisomer (Table 5). It thus seems that the high fidelity with
which chirality is transferred during these intramolecular
Pauson–Khand reactions is independent of the nature of the R
substituent on the alkyne moiety. Similarly, 1,7-enyne 12j pro-
vided the [4.3.0]-cycloadduct 45 in 54% yield, again as sole
diastereomer. An exception to this general pattern was ob-
served with the O-TIPS derivative of adduct 4i, bearing a bulky
iPr3Si substituent on the alkyne, which, upon exposure to the
same Pauson–Khand reaction conditions, did not lead to the
expected cycloadduct.
In contrast, the Pauson–Khand reaction of the TIPS ether de-
rivative 13a, under otherwise identical conditions, proceeded
less selectively than for the parent acetal 31, leading to a 5:1
diastereomeric mixture of adducts 46/46’ isolated in 48% yield
(Scheme 3). As expected, the Pauson–Khand reaction with ter-
tiary propargylic alcohols was also found to be less selective.
For example, submission of 20-O-TMS (trimethylsilyl) ether[22]
to the above reaction conditions provided the mixture of dia-
stereomers 47/47’ isolated in yields of 32% and 21%, respec-
tively.
Finally, exposure of cycloadducts 36, 42, and 43 to Mori’s
conditions (FeCl3/SiO2)
[23] in methylene chloride as solvent was
found to provide the unprotected aldehydes 48, 49, and 50
(Scheme 4). Although hydrolysis was not complete under
these conditions, the respective unreacted dimethyl acetal
(20–35%) could be separated by column chromatography very
easily and recycled, leading to the above aldehyde products,
isolated in yields of 80%, 83%, and 87%, respectively,
based on recovered acetal. Synthesis of aldehyde 48
by an alternative hydrolysis–oxidation sequence,
starting from adduct 46, served to corroborate the
chemical identity and purity of thus-obtained alde-
hyde products.
Conclusion
In summary, a direct and highly stereocontrolled
route to 1,6- and 1,7-enynes with a central aldol core
is demonstrated for the first time to be feasible by
means of a catalytic cross-aldol reaction between w-unsaturat-
ed aldehydes and propargylic aldehydes. Crucial for efficient
control of the cross-aldol reaction diastereoselectivity is the
use of an a,a-dialkylprolinol ether as the amine catalyst in co-
operation with a Brønsted acid cocatalyst. The method is quite
general with respect to the propargylic aldehyde substrate and
can even be extended to propargylic ketoesters, giving rise to
the corresponding tertiary alcohols in good yields and enantio-
and diastereoselectivities. Transformation of the resulting 1,6-
and 1,7-enyne structures to the corresponding trisubstituted
[3.3.0] and [4.3.0] bicyclic enones with essentially perfect dia-
stereoselectivity (d.r.>20:1) has also been achieved, enabled
by O-TIPS protection as key prior step for effective stereocon-
trol in the intramolecular Pauson–Khand reaction.
Figure 1. Configurative assignment for Pauson–Khand adducts.
Table 5. Pauson–Khand cycloadducts from propargylic alcohol-based
enynes.[a]
[a] Reactions conducted on a 0.5 mmol scale in 0.5 mL of CH2Cl2 at RT
overnight. d.r. determined by 1H NMR spectroscopy.
Chem. Eur. J. 2014, 20, 15543 – 15554 www.chemeurj.org  2014 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim15547
Full Paper
Experimental Section
General remarks: The 1H and 13C NMR spectra were recorded on
Bruker Advance-300 and 400, and are reported in ppm from an in-
ternal tetramethylsilane (TMS) standard. Analytical high-per-
formance liquid chromatography (HPLC) was performed on a Wa-
ters 600E apparatus, equipped with 2996 and 2998 photodiode
array UV detector, using Daicel Chiralpak AD-H, OD-H, AY-H, IC and
IA columns. Optical rotations were recorded on a Jasco P-2000 po-
larimeter. MS spectra were recorded on an ESI-ion trap Mass spec-
trometer (Agilent 1100 series LC/MSD, SL model). Combustion anal-
yses were performed on a Carlo Erba CHNS-O EA1108 elemental
analyzer. All solvents were of p.a. quality and were dried by stan-
dard procedures prior to use if necessary. Unless otherwise speci-
fied, materials were obtained from commercial sources and used
without purification. 4-Pentenal and 5-hexenal were distilled prior
to use. Propargylic aldehydes were synthesized using previously
described procedures,[8] except 2-octynal and phenyl propynal,
which are commercially available. Preparation of 5-hexenal and
propargylic ketoesters is reported in the Supporting Information.
General procedure for the catalytic direct cross-aldol reactions
of a,b-ynals : To a solution of the amine catalyst 5 (47 mg,
0.1 mmol, 20 mol%) in THF (0.5 mL) at 60 8C were successively
added the corresponding donor aldehyde (2, 11, or 14--16 ;
1.5 equiv), benzoic acid (12 mg, 0.1 mmol, 20 mol%) and the corre-
sponding ynal 3 (0.5 mmol, 1 equiv). The resulting solution was
stirred at 60 8C for 24–48 h and then treated according to two al-
ternative protocols:
Method A (isolation of aldol as the 1,3-diol derivative 13): To the
above mixture, a suspension of NaBH4 (4.5 mmol, 8 equiv) in EtOH
(1 mL) was added dropwise at 60 8C, and after reaction comple-
tion monitored by 1H NMR (typically 30–60 min), the mixture was
quenched with brine (4 mL), and
allowed to reach room tempera-
ture. After extraction with CH2Cl2
(36 mL), the combined organic
phases were washed with brine,
dried over MgSO4, and concentrat-
ed under reduced pressure. The re-
sulting crude mixture was purified
by flash column chromatography
on silica gel.
Method B (isolation of aldol as the
dimethyl acetal 4/12): To the
above mixture, MeOH (4.5 mL), tri-
methyl orthoformate (0.16 mL,
1.5 mmol) and p-toluenesulfonic
acid (20.0 mg, 0.1 mmol, 20 mol%)
were successively added at 60 8C.
The mixture was allowed to reach
0 8C and, after 2 h of stirring, the
reaction was quenched with saturated NaHCO3 (5 mL)
and extracted with ethyl acetate (24 mL). The com-
bined organic layers were washed with brine, dried over
MgSO4 and concentrated. The residue was purified by
flash column chromatography on silica gel, thus allowing
in each case separation of anti (major) and syn (minor)
aldol diastereomers. Data for major anti isomer:
(3S,4R)-4-(Dimethoxymethyl)-1-phenylhept-6-en-1-yn-
3-ol (4a): [a]24D =8.2 (c=1.05, 98% ee, in CH2Cl2) ;
1H NMR (400 MHz, CDCl3): d=7.51–7.31 (m, 5H), 5.94
(ddt, J(H,H)=17.2, 10.1, 7.2 Hz, 1H), 5.27–5.07 (m, 2H),
4.80 (d, J(H,H)=5.9 Hz, 1H), 4.64 (d, J(H,H)=4.9 Hz, 1H),
3.50 (s, 3H), 3.49 (s, 3H), 2.55–2.37 (m, 2H), 2.20 (ddd,
J(H,H)=10.7, 7.4, 5.7 Hz, 1H); 13C NMR (100 MHz, CDCl3): d=1 36.5,
131.6, 128.3, 128.2, 122.4, 117.0, 106.7, 88.9, 85.7, 63.0, 55.9, 54.8,
46.3, 30.3; MS (ESI): m/z calcd for C16H21O3: 261.1446 [M+H
+] ;
found: 261.1440. The enantiomeric purity of the major diastereo-
mer was determined by HPLC analysis of the crude material (Daicel
Chiralpak Ad-H, hexane/isopropanol 95/5, flow rate: 1 mLmin1; re-
tention times: 19.8 min (minor) and 22.0 min (major)).
(3S,4R)-4-(Dimethoxymethyl)-1-(4-methoxyphenyl)hept-6-en-1-
yn-3-ol (4b): [a]22D = +23.9 (c=1.00, 96% ee, CH2Cl2) ;
1H NMR (400
MHz, CDCl3): d=7.37–7.33 (m, 2H), 6.83–6.79 (m, 2H), 5.88 (m, 1H),
5.14 (m, 1H), 5.05 (m, 1H), 4.73 (d, J(H,H)=6 Hz, 1H), 4.57 (d,
J(H,H)=5.2 Hz, 1H), 3.77 (s, 3H), 3.43 (s, 3H), 3.42 (s, 3H), 2.46-2.33
(m, 2H), 2.16-2.10 (m, 1H); 13C NMR (100 MHz, CDCl3): d=159.6,
136.6, 133.0, 116.9, 114.8, 113.8, 106.6, 87.4, 85.6, 63.0, 55.8, 55.2,
54.7, 46.3, 30.2; elemental analysis calcd (%) for C17H22O4 (290.36):
C 70.32, H 7.65; found: C 70.01, H 7.58. The enantiomeric purity of
the major diastereomer was determined by HPLC analysis of the
crude material (Daicel Chiralpak IC-3, hexane/isopropanol 92/8,
flow rate: 1 mLmin1, retention times: 20.02 min (major) and
21.70 min (minor)).
(4R,5S)-4-(Dimethoxymethyl)-9-phenylnon-1-en-6-yn-5-ol (4c):
[a]22D = +10.4 (c=1.00, 96% ee, CH2Cl2) ;
1H NMR (400 MHz, CDCl3):
d=7.23–7.13 (m, 5H), 5.74 (m, 1H), 5.00 (d, J(H,H)=17.2 Hz, 1H),
4.95 (d, J(H,H)=10 Hz, 1H), 4.42 (brs, 1H), 4.33 (d, J(H,H)=4.8 Hz,
1H), 3.30 (s, 3H), 3.29 (s, 3H), 3.22 (m, 1H), 2.76 (t, J(H,H)=7.4 Hz,
2H), 2.48 (dt, J(H,H)=7.4, 1.6 Hz, 2H), 2.24–2.15 (m, 2H), 1.92-1.86
(m, 1H); 13C NMR (100 MHz, CDCl3): d=140.5, 136.6, 128.3, 128.2,
126.2, 116.7, 106.4, 85.4, 80.4, 62.6, 55.6, 54.6, 46.1, 34.9, 30.1, 20.6;
elemental analysis calcd (%) for C18H24O3 (288.39): C 74.96, H 8.40;
found: C 74.91, H 7.44. The enantiomeric purity of the major diaste-
reomer was determined by HPLC analysis of the crude material
Scheme 3. Pauson–Khand reaction of enyne 13a and tertiary alcohol 20.
Scheme 4. Hydrolysis of the acetal moiety.
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(Daicel Chiralpak IA, hexane/isopropanol 98/2, flow rate:
0.7 mLmin1, retention times: 20.21 min (major) and 22.35 min
(minor)).
(4R,5S)-4-(Dimethoxymethyl)dodec-1-en-6-yn-5-ol (4d): [a]25D = +
11.42 (c=1.00, 96% ee, CH2Cl2) ;
1H NMR (400 MHz, CDCl3): d=5.81
(m, 1H), 5.06 (m, 1H), 4.99 (m, 1H), 4.47 (d, J(H,H)=4.8 Hz, 1H),
4.46–4.44 (m, 1H), 3.38 (s, 3H), 3.36 (s, 3H), 3.38–3.25 (m, 1H),
2.36–2.23 (m, 2H), 2.18 (dt, J(H,H)=7.2, 2 Hz, 2H), 2.00–1.94 (m,
1H), 1.47 (q, J(H,H)=7.2 Hz, 2H), 1.37–1.22 (m, 4H), 0.85 (t, J(H,H)=
7 Hz, 3H); 13C NMR (100 MHz, CDCl3): d=136.7, 116.6, 106.6, 86.4,
79.7, 62.7, 55.6, 54.6, 46.2, 31.0, 30.1, 28.3, 22.1, 18.6, 13.9; elemen-
tal analysis calcd (%) for C15H26O3 (254.37): C 70.82, H 10.32; found:
C 70.78, H 10.27. The enantiomeric purity of the major diastereo-
mer was determined by HPLC analysis of the corresponding O-ben-
zoylated derivative (Daicel Chiralpak IC-3, hexane/isopropanol 99/1,
flow rate: 1 mLmin1, retention times: 6.04 min (major) and
7.16 min (minor)).
((4R,5S)-4-(dimetoxymethyl)-9-methyldec-1-en-6-yn-5-ol (4e):
[a]25D = +14,3 (c=1, 99% ee, CH2Cl2) ;
1H NMR (300 MHz, CDCl3) d=
6.14–5.70 (m, 1H), 5.18–4.95 (m, 2H), 4.62–4.44 (m, 2H), 3.43 (s,
3H), 3.41 (s, 3H), 2.47–2.25 (m, 2H), 2.13 (dd, J(H,H)=6.5, 2.0 Hz,
2H), 2.08–1.97 (m, 1H), 1.82 (dt, J(H,H)=13.2, 6.6 Hz, 1H), 0.98 (d,
J(H,H)=6.6 Hz, 6H); 13C NMR (75 MHz, CDCl3) d=135.71, 115.80,
105.65, 84.37, 79.64, 61.82, 54.79, 53.64, 45.31, 29.18, 27.01, 26.95,
21.00; HRMS (ESI): m/z calcd for C13H21O2: 209.1536 [MCH3O];
found: 209.1523. The enantiomeric purity of the major diastereo-
mer was determined by HPLC analysis of the corresponding O-ben-
zoylated derivative (Daicel Chiralpak IC, hexane/isopropanol 98/2,
flow rate=0.75 mLmin1, retention times: 6.5 min (major) and
7.5 min (minor).
(4R,5S)-10-Chloro-4-(dimethoxymethyl)dec-1-en-6-yn-5-ol (4f):
[a]22D =3.85 (c=1, 92% ee, CH2Cl2) ; 1H NMR (500 MHz, CDCl3): d=
5.85 (d, J(H,H)=7.3 Hz, 1H), 5.09 (dd, J(H,H)=32.7, 13.0 Hz, 2H),
4.51 (d, J(H,H)=4.7 Hz, 2H), 3.66 (t, J(H,H)=6.3 Hz, 2H), 3.43 (d,
J(H,H)=8.9 Hz, 6H), 2.44 (d, J(H,H)=5.0 Hz, 2H), 2.34 (d, J(H,H)=
11.0 Hz, 2H), 1.99 (dd, J(H,H)=17.4, 10.9 Hz, 3H); 13C NMR (126
MHz, CDCl3): d=136.6, 117.2, 106.8, 84.4, 81.1, 62.9, 56.1, 54.9, 46.4,
43.8, 31.4, 30.57, 16.4; HRMS (ESI): m/z calcd for C11H14ClO:
197.0733 [M-(CH3O)2] ; found: 197.0755. The enantiomeric purity of
the major diastereomer was determined by chiral HPLC analysis of
the corresponding O-benzoylated derivative (Daicel Chiralpak IC
hexane/isopropanol 98/2, flow rate=1 mLmin1, retention times:
5.4 min (minor) and 6.8 min (major).
(5S,6R)-6-(Dimethoxymethyl)-2-methyl-1,8-dien-3-yn-5-ol (4g):
[a]22D = +34.8 (c=1, 99% ee, CH2Cl2) ;
1H NMR (300 MHz, CDCl3): d=
5.86 (ddd, J(H,H)=17.1, 7.2, 2.9 Hz, 1H), 5.23 (p, J(H,H)=1.6 Hz,
1H), 5.16 (q, J(H,H)=1.5 Hz, 1H), 5.13–5.04 (m, 2H), 4.64 (t, J(H,H)=
6.0 Hz, 1H), 4.53 (d, J(H,H)=4.9 Hz, 1H), 3.43 (d, J(H,H)=4.1 Hz,
6H), 3.41–3.34 (m, 2H), 2.44–2.31 (m, 2H), 2.07 (ddd, J(H,H)=8.8,
6.4, 4.8 Hz, 1H), 1.93–1.89 (m, 3H); 13C NMR (75 MHz, CDCl3): d=
136.5, 122.1, 117.1, 106.7, 88.0, 87.1, 63.0, 56.0, 54.9, 46.3, 30.3,
23.5; HRMS (ESI): m/z calcd for C12H17O2: 193.1223 [MCH3O];
found: 193.1229. The enantiomeric purity of the major diastereo-
mer was determined by HPLC analysis (Daicel Chiralpak IC hexane/
isopropanol 98/2, flow rate=0.5 mLmin1, retention times:
31.2 min (major) and 37.2 min (minor).
(3S,4R)-4-(Dimethoxymethyl)-1-(thiophen-3-yl)hept-6-en-1-yn-3-
ol (4h): [a]25D = +21,6 (c=1, 99% ee, CH2Cl2) ;
1H NMR (500 MHz,
CDCl3): d=7.44 (s, 1H), 7.26 (s, 1H), 7.11 (d, J(H,H)=3.9 Hz, 1H),
6.03–5.74 (m, 1H), 5.16 (d, J(H,H)=16.0 Hz, 1H), 5.08 (d, J(H,H)=
9.6 Hz, 1H), 4.74 (s, 1H), 4.58 (d, J(H,H)=4.7 Hz, 1H), 3.46 (s, 3H),
3.45 (s, 3H), 2.48–2.33 (m, 2H), 2.15–1.12 (m, 1H); 13C NMR (75
MHz, CDCl3): d=136.5, 131.6, 128.3, 128.2, 122.4, 117.0, 106.7, 88.9,
85.7, 63.0, 55.9, 54.8, 46.3, 30.3; HRMS (ESI): m/z calcd for
C13H15O2S: 235.0787 [MCH3O]; found: 235.0784. The enantiomeric
purity of the major diastereomer was determined by HPLC analysis
(Daicel Chiralpak Ad-H hexane/isopropanol 95/5, flow rate=
0.5 mLmin1, retention times: 25.8 min (minor) and 28.7 min
(major)).
(3S,4R)-4-(Dimethoxymethyl)-1-(triisopropylsilyl)hept-6-en-1-yn-
3-ol (4i): [a]25D = +11.9 (c=1, 99% ee, CH2Cl2) ;
1H NMR (500 MHz,
CDCl3): d=5.90 (d, J(H,H)=7.6 Hz, 1H), 5.17 (d, J(H,H)=17.0 Hz,
1H), 5.08 (d, J(H,H)=10.0 Hz, 1H), 4.64 (d, J(H,H)=4.8 Hz, 1H),
4.62–4.55 (m, 1H), 3.45 (d, J(H,H)=1.4 Hz, 6H), 2.41 (d, J(H,H)=
7.4 Hz, 2H), 2.07 (s, 1H), 1.11 (s, 18H); 13C NMR (126 MHz, CDCl3):
d=136.9, 117.2, 107.6, 106.8, 63.1, 56.2, 54.9, 46.3, 29.7, 18.8, 11.4;
HRMS (ESI): m/z calcd for C17H29OSi: 277.1988 [M(CH3O)2] ; found:
277.1999. The enantiomeric purity of the major diastereomer was
determined by chiral HPLC analysis of its O-triphenylsilyl ether de-
rivative (Daicel Chiralpak AY-H, hexane/isopropanol 98/2, flow
rate=0.5 mLmin1, retention times: 4.9 min (major) and 15 min
(minor)).
(3S,4R)-4-(Dimethoxymethyl)-1-phenyloct-7-en-1-yn-3-ol (12a):
[a]22D =9.8 (c=1, 98% ee, CH2Cl2; 1H NMR (300 MHz, CDCl3): d=
7.47–7.41 (m, 2H), 7.34–7.28 (m, 3H), 5.83 (ddt, J(H,H)=16.9, 10.2,
6.6 Hz, 1H), 5.12–4.96 (m, 2H), 4.75 (t, J(H,H)=6.0 Hz, 1H), 4.65 (d,
J(H,H)=4.3 Hz, 1H), 3.47 (d, J(H,H)=2.6 Hz, 6H), 2.34–2.02 (m, 4H),
1.78–1.67 (m, 2H); 13C NMR (75 MHz, CDCl3): d=138.66, 131.80,
128.49, 128.43, 115.10, 107.60, 89.25, 85.62, 56.29, 55.47, 45.58,
31.73, 24.40; HRMS (ESI): m/z calcd for C17H22O3+Na
+ : 297.1467
[M+Na+] ; found: 297.1473. The enantiomeric purity of the major
diastereomer was determined by HPLC analysis (Daicel Chiralpak
Od-H hexane/isopropanol 98/2, flow rate=0.5 mLmin1, retention
times: 22.2 min (minor) and 51.7 min (major)).
(3S,4R)-1-(3-Chlorophenyl)-4-(dimethoxymethyl)oct-7-en-1-yn-3-
ol (12j): [a]22D =69.9 (c=1, 98% ee, CH2Cl2) ; 1H NMR (300 MHz,
CDCl3): d=7.42 (t, J(H,H)=1.5 Hz, 1H), 7.31 (tt, J(H,H)=6.1, 1.6 Hz,
2H), 7.24 (s, 1H), 7.21 (s, 1H), 5.09 (q, J(H,H)=1.6 Hz, 1H), 5.06–
4.96 (m, 1H), 4.74 (t, J(H,H)=5.9 Hz, 1H), 4.61 (d, J(H,H)=4.3 Hz,
1H), 3.52–3.48 (m, 1H), 3.47 (d, J(H,H)=1.1 Hz, 5H), 2.29–2.14 (m,
2H), 2.11–2.01 (m, 1H), 1.75–1.66 (m, 2H); 13C NMR (75 MHz,
CDCl3): d=138.5, 134.1, 131.5, 129.8, 129.6, 128.6, 124.5, 115.0,
107.3, 90.5, 84.1, 63.1, 56.1, 55.3, 45.5, 31.7, 24.5; HRMS (ESI): m/z
calcd for C16H18ClO2: 277.0990 [MCH3O]; found: 277.0993. The
enantiomeric purity of the major diastereomer was determined by
HPLC analysis (Daicel Chiralpak Od-H hexane/isopropanol 98/2,
flow rate=0.5 mLmin1, retention times: 16.5 min (minor) and
28.0 min (major)).
(2S,3S)-2-allyl-5-phenylpent-4-yne-1,3-diol (13a): [a]25D =6.88
(c=1, 99% ee, CH2Cl2) ;
1H NMR (300 MHz, Chloroform-d) d=7.52–
7.39 (m, 2H), 7.38–7.28 (m, 3H), 5.98–5.75 (m, 1H), 5.23–5.02 (m,
2H), 4.74 (t, J=5.5 Hz, 1H), 4.12–4.03 (m, 1H), 3.86–3.70 (m, 1H),
2.55–2.39 (m, 1H), 2.35–2.22 (m, 1H), 2.03–1.91 (m, 1H); 13C NMR
(100 MHz, CDCl3) d=136.1, 131.6, 128.4, 128.2, 117.1, 88.9, 85.9,
65.7, 63.6, 45.7, 32.4. HRMS (ESI): m/z calcd for C14H17O2: 217.1237
[M+H+] ; found: 217.1229. The enantiomeric purity of the major
diastereoisomer was determined by HPLC analysis (Daicel Chiralpak
IB, hexane/isopropanol 98/2, flow rate: 1 mLmin1, retention time
48.17 min (minor) and 84.87 min (major).
(2S,3S)-2-allyldec-4-yne-1,3-diol (13d): [a]25D =11.57(c=1, 99% ee,
CH2Cl2) ;
1H NMR (300 MHz, Chloroform-d) d=5.95–5.69 (m, 1H),
5.18–4.96 (m, 2H), 4.49 (d, J=5.7 Hz, 1H), 3.98 (dd, J=11.1, 3.3 Hz,
1H), 3.71 (dd, J=11.1, 6.1 Hz, 1H), 2.47–2.30 (m, 1H), 2.20 (m, 3H),
1.91–1.76 (m, 1H), 1.62–1.44 (m, 2H), 1.44–1.22 (m, 4H), 0.90 (t, J=
7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) d=136.3, 116.4, 86.2, 80.1,
65.2, 63.4, 45.9, 32.2, 30.9, 28.2, 21.9, 18.5, 13.7; HRMS (ESI): m/z
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calcd for C13H23O2: 211.177 [M+H
+] ; found: 211.1608. The enantio-
meric purity of the major diastereoisomer was determined by
HPLC analysis of the corresponding O-silylated derivative (Daicel
Chiralpak IA, hexane/isopropanol 95/5, flow rate: 0.5 mLmin1, re-
tention times: 10.10 min (major) and 15.34 min (minor).
General Procedure for the catalytic Cross-Aldol reactions with
a,b-ynones: To a solution of the amine catalyst 5 (47 mg,
0.1 mmol, 20 mol%), benzoic acid (12 mg, 0.1 mmol, 20 mol%) and
the corresponding a,b-ynone 17–19 (0.5 mmol, 1 equiv) in THF
(0.5 mL) at 40 8C was added the corresponding donor aldehyde
(2, 14–16) (0.6 mmol, 1.2 equiv). The resulting solution was stirred
at 40 8C for 48 h and then 4.5 mL of MeOH, trimethyl orthofor-
mate (0.16 mL, 1.5 mmol) and p-toluenesulfonic acid (20.0 mg,
0.1 mmol, 20 mol%) were successively added at 40 8C. The mix-
ture was allowed to reach 0 8C and, after 2 h of stirring, the reac-
tion was quenched with NaHCO3 sat. (5 mL) and extracted with
ethyl acetate (24 mL). The combined organic layers were washed
with brine, dried over MgSO4 and concentrated. The residue was
purified by flash column chromatography on silica gel (hexane/THF
92.5:7.5) thus allowing in each case separation of syn (major) and
anti (minor) diastereomers. Data of syn isomer:
(2R,3R)-Methyl 3-(dimethoxymethyl)-2-hydroxy-2-(phenylethy-
nyl)hex-5-enoate (20): [a]21D =83.0 (c=1, 94% ee, CH2Cl2) ;
1H NMR (300 MHz, CDCl3): d=7.50–7.40 (m, 2H), 7.37–7.22 (m, 3H),
6.05 (td, J(H,H)=10.1, 5.0 Hz, 1H), 5.17–4.96 (m, 2H), 4.42 (d,
J(H,H)=7.0 Hz, 1H), 4.04 (s, 1H), 3.83 (s, 3H), 3.36 (s, 3H), 3.35 (s,
3H), 2.77–2.66 (m, 1H), 2.62–2.50 (m, 2H); 13C NMR (75 MHz,
CDCl3): d=173.14, 137.53, 132.25, 129.14, 128.65, 122.46, 116.36,
106.32, 87.83, 86.14, 73.68, 57.35, 54.19, 53.77, 48.57, 32.24; HRMS
(ESI): m/z calcd for C16H15O3: 255.1021 [M(CH3O)2, H+] ; found:
255.1039. The enantiomeric purity of the major diastereomer was
determined by HPLC analysis (Daicel Chiralpak IC hexane/isopropa-
nol 98/2, flow rate=1 mLmin1, retention times: 11.6 min (major)
and 13.1 min (minor)).
(2R,3R)-Methyl 3-(dimethoxymethyl)-2-((4-fluorophenyl)ethynyl)-
2-hydroxyhex-5-enoate (21): [a]21D =80.9 (c=1, 93% ee, CH2Cl2) ;
1H NMR (300 MHz, CDCl3): d=7.41 (dd, J(H,H)=8.9, 5.4 Hz, 2H),
6.99 (t, J(H,H)=8.7 Hz, 2H), 6.15–5.90 (m, 1H), 5.15–4.99 (m, 2H),
4.39 (d, J(H,H)=6.9 Hz, 1H), 4.04 (s, 1H), 3.82 (s, 3H), 3.35 (s, 3H),
3.34 (s, 3H), 2.76–2.64 (m, 1H), 2.62–2.44 (m, 2H); 13C NMR (75
MHz, CDCl3): d=172.61, 164.36, 161.05, 137.04, 133.79, 133.68,
115.91, 115.67, 115.37, 105.83, 87.14, 84.60, 73.18, 56.89, 53.75,
53.31, 48.08, 31.73; HRMS (ESI): m/z calcd for C16H14FO3: 273.0927
[M(CH3O)2,H+] ; found: 273.0916. The enantiomeric purity of the
major diastereomer was determined by HPLC analysis (Daicel Chir-
alpak IC hexane/isopropanol 95/5, flow rate=1 mLmin1, retention
times: 7.3 min (major) and 8.0 min (minor)).
(2R,3R)-Methyl 2-((3-chlorophenyl)ethynyl)-3-(dimethoxymeth-
yl)-2-hydroxyhex-5-enoate (22): [a]21D =18.31 (c=1, 94% ee,
CH2Cl2) ;
1H NMR (300 MHz, CDCl3): d=7.42 (t, J(H,H)=1.8 Hz, 1H),
7.34–7.28 (m, 2H), 7.25–7.20 (m, 1H), 6.02 (td, J(H,H)=10.1, 5.0 Hz,
1H), 5.16–4.97 (m, 2H), 4.40 (d, J(H,H)=6.9 Hz, 1H), 4.05 (s, 1H),
3.84 (s, 3H), 3.37 (s, 3H), 3.35 (s, 3H), 2.74–2.65 (m, 1H), 2.62–2.48
(m, 2H); 13C NMR (75 MHz, CDCl3): d=172.48, 136.94, 134.11,
131.66, 129.95, 129.50, 129.04, 125.49, 116.06, 105.84, 88.64, 84.23,
73.22, 56.96, 53.83, 53.41, 48.07, 31.77; HRMS (ESI): m/z calcd for
C14H10ClO3: 261.0318 [M(CH3O)2,C2H5]; found: 261.0763. The
enantiomeric purity of the major diastereomer was determined by
HPLC analysis (Daicel Chiralpak IA hexane/isopropanol 98/2, flow
rate=1 mLmin1, retention times: 9.5 min (major) and 11.5 min
(minor)).
(R)-Methyl 2-((R)-1,1-dimethoxy-3-phenylpropan-2-yl)-2-hydroxy-
4-phenylbut-3-ynoate (23): m.p. 123–127 8C; [a]D
25=69.5 (c=1,
95% ee, CH2Cl2) ;
1H NMR (500 MHz, CDCl3): d=7.41–7.38 (m, 2H),
7.36–7.27 (m, 6H), 7.22–7.13 (m, 2H), 4.33 (d, J(H,H)=6.2 Hz, 1H),
3.81 (s, 3H), 3.52 (s, 1H), 3.41 (dd, J(H,H)=7.4, 6.1 Hz, 1H), 3.34 (s,
3H), 3.10 (s, 3H), 2.93 (dd, J(H,H)=14.4, 7.9 Hz, 1H), 2.89–2.81 (m,
1H); 13C NMR (75 MHz, CDCl3): d=172.56, 140.84, 132.01, 131.92,
129.24, 129.15, 129.08, 128.71, 128.63, 128.49, 128.22, 128.18,
125.89, 106.21, 87.70, 85.88, 73.63, 56.73, 53.46, 53.21, 50.11, 33.31;
HRMS (ESI): m/z calcd for C20H17O3: 305.1178 [M(CH3O)2,H];
found: 305.1189. The enantiomeric purity of the major diastereo-
mer was determined by HPLC analysis (Daicel Chiralpak IA hexane/
isopropanol 95/5, flow rate=0.5 mLmin1, retention times:
20.2 min (major) and 27.5 min (minor)).
(2R,3R)-Methyl 3-(dimethoxymethyl)-2-hydroxy-2-(phenylethy-
nyl)hexanoate (24): [a]23D = +21.0 (c=1, 93% ee, CH2Cl2) ;
1H NMR
(300 MHz, CDCl3): d=7.45–7.40 (m, 2H), 7.34–7.27 (m, 3H), 4.39 (d,
J(H,H)=7.4 Hz, 1H), 4.01 (d, J(H,H)=0.4 Hz, 1H), 3.83 (s, 3H), 3.37
(s, 3H), 3.36 (s, 3H), 2.45 (dt, J(H,H)=7.3, 4.8 Hz, 1H), 1.89 (ddd,
J(H,H)=11.9, 8.4, 3.5 Hz, 1H), 1.73–1.50 (m, 3H), 0.96 (t, J(H,H)=
7.2 Hz, 3H); 13C NMR (75 MHz, CDCl3): d=173.40, 132.19, 129.04,
128.62, 125.88, 122.56, 107.00, 88.10, 85.53, 73.92, 58.71–57.40,
54.31, 53.69, 48.50, 30.70, 30.00, 22.13, 14.95; HRMS (ESI): m/z calcd
for C17H21O4: 289.1434 [MCH3O]; found: 289.1427. The enantio-
meric purity of the major diastereomer was determined by HPLC
analysis (Daicel Chiralpak IA and Daicel Chiralpak IC hexane/isopro-
panol 95/5, flow rate=0.5 mLmin1, retention times: 29.7 min
(major) and 34.6 min (minor)).
(2R,3R)-Methyl-3-(dimethoxymethyl)-2-hydroxy-4-methyl-2-(phe-
nylethynyl) pentanoate (25): [a]21D =33.4 (c=1, 95% ee, CH2Cl2) ;
1H NMR (300 MHz, CDCl3): d=7.46–7.40 (m, 2H), 7.33–7.26 (m, 3H),
4.52 (d, J(H,H)=8.1 Hz, 1H), 3.98 (d, J(H,H)=0.7 Hz, 1H), 3.83 (s,
3H), 3.36 (s, 3H), 3.35 (s, 3H), 2.68–2.56 (m, 1H), 2.47–2.40 (m, 1H),
1.16 (dd, J(H,H)=7.1, 3.2 Hz, 6H); 13C NMR (75 MHz, CDCl3): d=
173.32, 131.73, 129.01, 128.59, 128.24, 128.17, 105.16, 88.05, 85.74,
74.19, 57.13, 53.31, 53.23, 51.61, 27.70, 23.23, 19.06; HRMS (ESI): m/
z calcd for C16H17O3: 257.1178 [M(CH3O)2] ; found: 257.1216. The
enantiomeric purity of the major diastereomer was determined by
HPLC analysis (Daicel Chiralpak IA hexane/isopropanol 95/5, flow
rate=1 mLmin1, retention times: 9.2 min (major) and 11.2 min
(minor)).
Synthesis of (2S,3R)-Methyl 3-(dimethoxymethyl)-2-hydroxy-2-
phenethylhexanoate (26) from 20/24 : To a solution of 20 or 24
(0.2 mmol) in EtOH (0.8 mL) Pd 10% w/w on activated carbon
(20 wt%) was added. The mixture was allowed to stir under H2 at-
mosphere (1 atm) for 16 h. The mixture was then filtered over
celite (2 cm) and the solvent was eliminated under vacuum yield-
ing the desired product as colorless oil. 1H NMR (300 MHz, CDCl3):
d=7.31–7.24 (m, 2H), 7.23–7.14 (m, 3H), 4.28 (d, J(H,H)=5.8 Hz,
1H), 3.75 (s, 3H), 3.73 (d, J(H,H)=0.8 Hz, 1H), 3.35 (s, 3H), 3.35 (s,
3H), 2.76 (td, J(H,H)=12.8, 4.6 Hz, 1H), 2.35–2.20 (m, 1H), 2.15–
2.01 (m, 2H), 1.99–1.85 (m, 1H), 1.60–1.43 (m, 3H), 1.41–1.25 (m,
1H), 0.89 (t, J(H,H)=6.9 Hz, 3H); 13C NMR (75 MHz, CDCl3): d=
176.92, 141.82, 128.43, 128.35, 125.85, 78.29, 56.69, 54.62, 52.23,
47.62, 39.39, 29.74, 27.37, 22.18, 14.57; HRMS (ESI): m/z calcd for
C17H25O4: 293.1749 [MCH3O]; found: 293.1768.
Typical procedure for the silylation of adducts 4 : To a solution of
alcohol 4 (0.5 mmol) in CH2Cl2 (2 mL) at 10 8C were successively
added diisopropylethylamine (DIPEA; 194 mg, 1.5 mmol, 3 equiv)
and triisopropylsilyl trifluoromethanesulfonate (184 mg, 0.6 mmol,
1.2 equiv). The resulting mixture was stirred at 10 8C for 1 h, dilut-
ed with CH2Cl2 (15 mL), and the organic solution was washed with
saturated NH4Cl (210 mL) and saturated NaHCO3 (210 mL). The
organic layer was dried over MgSO4 and concentrated. The residue
was purified by flash column chromatography on silica gel (eluting
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with hexane/ethyl acetate 20:1) to isolate the pure silyl ether com-
pound as a yellow oil.
General Procedure for the intramolecular Pauson–Khand reac-
tion : [Co2(CO)8] (341 mg, 1 mmol, 2 equiv) was added to a solution
of the corresponding silylated propargylic alcohol (0.5 mmol) in
CH2Cl2 (2 mL) at room temperature and was stirred for 30 min.
Then trimethylamine N-oxide (TMANO) (226 mg, 3 mmol, 6 equiv)
was added at 10 8C and the mixture was allowed to warm to
room temperature and stirred at room temperature until the initial-
ly formed Co complex disappeared (20–24 h), at which time usually
a purple precipitate had formed. The mixture was passed through
a small plug of silica gel and the filtrate was concentrated in vacuo.
The residue was purified by flash column chromatography on silica
gel (eluting with hexane/ethyl acetate 20:1) to isolate the pure
compound as a yellow oil.
(4S,5R,6aR)-5-(Dimethoxymethyl)-3-phenethyl-4-(triisopropyl-
silyloxy)-4,5,6,6a-tetrahydropentalen-2(1H)-one (36): Prepared
according to the General Procedure starting from silylated com-
pound 31 (208 mg, 0.5 mmol). Yield: 144 mg (65%); 1H NMR (400
MHz, CDCl3): d=7.43–7.31 (m, 5H), 5.08 (s, 1H), 4.12 (d, J(H,H)=
6.4 Hz, 1H), 3.37 (s, 3H), 3.36 (m, 1H, hidden), 3.35 (s, 3H), 2.88
(dd, J(H,H)=18.3, 6.6 Hz, 1H), 2.75–2.69 (m, 1H), 2.47–2.39 (m, 1H),
2.27 (dd, J(H,H)=18.3, 2.7 Hz, 1H), 1.30–1.16 (m, 1H), 0.98–0.93 (m,
21H); 13C NMR (100 MHz, CDCl3): d=209.3, 180.3, 134.3, 131.5,
128.5, 128.3, 127.9, 106.3, 69.7, 54.9, 53.9, 53.3, 42.8, 39.1, 30.2,
17.9, 17.8, 12.3; elemental analysis calcd (%) for C26H40O4Si (444.68):
C 70.23, H 9.07; found: C 70.28, H 9.12.
(4S,5R,6aR)-5-(dimethoxymethyl)-3-(4-methoxyphenyl)-4-(triiso-
propylsilyloxy)-4,5,6,6a-tetrahydropentalen-2(1H)-one (38): Pre-
pared according to the General Procedure starting from the O-trii-
sopropylsilyl derivative of 4b (223 mg, 0.5 mmol). Yield: 164 mg
(69%); 1H NMR (400 MHz, CDCl3): d=7.39–7.31 (m, 2H), 6.90–6.83
(m, 2H), 5.02 (brs, 1H), 4.03 (d, J(H,H)=6.8 Hz, 1H), 3.78 (s, 3H),
3.30 (s, 3H), 3.29 (s, 3H), 3.33–3.24 (m, 1H, hidden), 2.80 (dd,
J(H,H)=18.3, 6.6 Hz, 1H), 2.65 (m, 1H), 2.36 (m, 1H), 2.19 (dd,
J(H,H)=18.3, 2.6 Hz, 1H), 1.14 (m, 1H), 0.95–0.90 (m, 21H);
13C NMR (100 MHz, CDCl3): d=209.5, 179.0, 159.4, 133.7, 129.6,
123.8, 113.7, 106.2, 69.9, 55.2, 54.8, 53.7, 53.3, 42.8, 38.9, 30.2, 17.9,
17.8, 12.3; elemental analysis calcd (%) for C27H42O5Si (474.70):
C 68.31, H 8.92; found: C 68.36, H 8.89. The enantiomeric purity of
the major diastereomer was determined by HPLC analysis of the
crude material (Phenomenex Lux 3m Cellulose-4, hexane/isopropa-
nol 93/7, flow rate: 1 mLmin1, retention times: 10.07 min (minor)
and 13.04 min (major)).
(4S,5R,6aR)-5-(Dimethoxymethyl)-3-phenethyl-4-(triisopropylsily-
loxy)-4,5,6,6a-tetrahydropentalen-2(1H)-one (39): Prepared ac-
cording to the General Procedure starting from the O-triisopropyl-
silyl derivative of 4c (222 mg, 0.5 mmol). Yield: 201 mg (85%);
[a]25D = +68.4 (c=1.00, CH2Cl2) ;
1H NMR (400 MHz, CDCl3): d=7.30–
7.08 (m, 5H), 4.56 (brs, 1H), 3.61 (d, J(H,H)=8 Hz, 1H), 3.29 (s, 3H),
3.26 (s, 3H), 3.17 (m, 1H), 2.86–2.53 (m, 5H), 2.47 (m, 1H), 2.25 (m,
1H), 2.06 (dd, J(H,H)=18.4, 1.8 Hz, 1H), 1.12–1.04 (m, 21H), 0.79
(m, 1H); 13C NMR (100 MHz, CDCl3): d=211.3, 179.4, 141.7, 134.4,
128.5, 128.4, 126.0, 105.5, 69.6, 54.1, 53.4, 52.5, 42.3, 39.3, 33.5,
31.0, 26.6, 18.0, 17.9, 12.4; elemental analysis calcd (%) for
C28H44O4Si (472.73): C 71.14, H 9.38; found: C 71.18, H 9.34. The
enantiomeric purity of the major diastereomer was determined by
HPLC analysis of the crude material (Phenomenex Lux 3m Cellu-
lose-2, hexane/isopropanol 99/1, flow rate: 1 mLmin1, retention
times: 13.42 min (minor) and 15.53 min (major)).
(4S,5R,6aR)-5-(Dimethoxymethyl)-3-pentyl-4-(triisopropylsily-
loxy)-4,5,6,6a-tetrahydropentalen-2(1H)-one (40): Prepared ac-
cording to the General Procedure starting from the O-triisopropyl-
silyl ether derivative of 4d (205 mg, 0.5 mmol). Yield: 110 mg
(50%); [a]24D = +87.8 (c=1.00, CH2Cl2) ;
1H NMR (400 MHz, CDCl3):
d=4.79 (brs, 1H), 3.93 (d, J(H,H)=7.6 Hz, 1H), 3.31 (s, 3H), 3.27 (s,
3H), 3.17 (m, 1H), 2.67–2.58 (m, 2H), 2.32–2.00 (m, 5H), 1.44–1.35
(m, 2H), 1.31–1.16 (m, 4H), 1.08–0.99 (m, 21H), 0.86 (d, J(H,H)=
6.8 Hz, 3H); 13C NMR (100 MHz, CDCl3): d=211.6, 178.5, 135.6,
105.9, 69.8, 54.5, 53.4, 53.0, 42.5, 39.0, 32.0, 30.5, 27.8, 24.2, 22.4,
18.0, 17.9, 14.0, 12.4; elemental analysis calcd (%) for C25H46O4Si
(438.72): C 68.44, H 10.57; found: C 68.38, H 10.60. The enantiomer-
ic purity of the major diastereomer was determined by HPLC analy-
sis of the crude material (Phenomenex Lux 3m Cellulose-1, hexane/
isopropanol 99.9/0.1, flow rate: 1 mLmin1, retention times:
16.56 min (minor) and 20.35 min (major)).
(4S,5R,6aR)-5-(Dimethoxymethyl)-3-isobutyl-4-(triisopropylsily-
loxy)-4,5,6,6a-tetrahydropentalen-2(1H)-one (41): Prepared ac-
cording to the General Procedure starting from the O-triisopropyl-
silyl ether derivative of 4e (127 mg, 0.32 mmol). Yield: 87 mg
(64%); 1H NMR (300 MHz, CDCl3): d=4.82 (s, 1H), 4.01 (d, J(H,H)=
7.4 Hz, 1H), 3.34 (s, 3H), 3.29 (s, 3H), 2.67 (dd, J(H,H)=18.3, 6.4 Hz,
2H), 2.36–2.27 (m, 1H), 2.26–2.18 (m, 1H), 2.11–2.01 (m, 1H), 1.97
(d, J(H,H)=13.1 Hz, 1H), 1.91–1.81 (m, 1H), 1.09–1.02 (m, 21H),
1.00–0.92 (m, 2H), 0.88 (d, J(H,H)=6.5 Hz, 3H), 0.80 (d, J(H,H)=
6.5 Hz, 3H); 13C NMR (75 MHz, CDCl3) d=211.52, 179.21, 134.74,
105.89, 69.79, 54.49, 53.72, 52.93, 42.41, 39.36, 33.05, 30.83, 27.08,
22.88, 22.39, 18.04, 17.98, 12.46; HRMS (ESI): m/z calcd for
C24H44O4Si+H
+ : 425.3087 [M+H+] ; found: 425.3053.
(4S,5R,6aR)-5-(Dimethoxymethyl)-3-(thiophen-3-yl)-4-(triisopro-
pylsilyloxy)-4,5,6,6a-tetrahydropentalen-2(1H)-one (42): Prepared
according to the General Procedure starting from the O-triisopro-
pylsilyl ether derivative of 4h (76 mg, 0.18 mmol). Yield: 52 mg
(65%); 1H NMR (300 MHz, CDCl3): d=7.70–7.65 (m, 1H), 7.35–7.28
(m, 2H), 5.16 (s, 1H), 4.04 (d, J(H,H)=6.5 Hz, 1H), 3.33 (s, 3H), 3.32
(s, 3H), 2.83 (dd, J(H,H)=18.3, 6.6 Hz, 1H), 2.70 (dd, J(H,H)=14.8,
6.6 Hz, 1H), 2.46–2.33 (m, 1H), 2.21 (dd, J(H,H)=18.3, 2.7 Hz, 1H),
1.23–1.10 (m, 2H), 1.03–0.90 (m, 21H); 13C NMR (75 MHz, CDCl3):
d=209.23, 178.48, 126.99, 125.15, 124.31, 106.18, 70.14, 54.89,
53.80, 53.20, 42.84, 38.95, 30.14, 17.92, 17.84, 12.33; HRMS (ESI):
m/z calcd for C24H38O4SSi+H
+ : 451,2338 [M+H+] ; found:
451,2318.
(4S,5R)-3-(3-Chloropropyl)-5-(dimethoxymethyl)-4-((triisopropyl-
silyl)oxy)-4,5,6,6a-tetrahydropentalen-2(1H)-one (43): Prepared
according to the General Procedure starting from the O-triisopro-
pylsilyl ether derivative of 4f (0.22 mmol). Yield: 53.6 mg (60%);
1H NMR (300 MHz, CDCl3): d=4.86 (s, 1H), 4.05 (d, J(H,H)=6.6, 1H),
3.53 (d, J(H,H)=5.9, 1H), 3.42 (s, 1H), 3.35 (s, 3H), 3.31 (s, 3H), 2.68
(dd, J(H,H)=18.4, 6.5 Hz, 2H), 2.34 (dd, J(H,H)=24.2, 10.3 Hz, 3H),
2.00–1.88 (m, 3H), 1.09 (s, 11H), 1.04 (d, J(H,H)=5.2 Hz, 12H);
13C NMR (75 MHz, CDCl3): d=211.63, 180.43, 133.83, 106.28, 69.69,
55.16, 54.00, 53.69, 44.80, 42.55, 39.61, 30.53, 30.43, 21.70, 18.22,
12.62; HRMS (ESI): m/z calcd for C23H41ClO4Si+H
+ : 444. 2545 [M+
H+] ; found: 445.2541.
(4S,5R)-5-(Dimethoxymethyl)-3-(prop-1-en-2-yl)-4-((triisopropylsi-
lyl)oxy)-4,5,6,6a-tetrahydropentalen-2(1H)-one (44): Prepared ac-
cording to the General Procedure starting from O-triisopropylsilyl
derivated of 4g (0.2 mmol). Yield: 44 mg (55%); 1H NMR (300 MHz,
CDCl3): d=5.13 (s, 2H), 4.99 (s, 1H), 4.25–4.19 (m, 1H), 3.97 (d,
J(H,H)=7.0 Hz, 1H), 3.32 (d, J(H,H)=10.1 Hz, 7H), 2.78–2.58 (m,
3H), 2.40–2.28 (m, 2H), 2.11 (d, J(H,H)=18.4 Hz, 2H), 1.96 (s, 3H),
1.05 (d, J(H,H)=7.4 Hz, 26H); 13C NMR (75 MHz, CDCl3): d=179.03,
131.03, 128.95, 117.03, 106.14, 70.17, 53.17, 43.04, 38.80, 30.02,
23.91, 22.06, 18.17; HRMS (ESI): m/z calcd for C23H41O4Si+H
+ :
409.2774 [M+H+] ; found: 409.2769.
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(4S,5R)-3-(3-Chlorophenyl)-5-(dimethoxymethyl)-4-((triisopropyl-
silyl)oxy)-5,6,7,7a-tetrahydro-1H-inden-2(4H)-one (45): Prepared
according to the General Procedure starting from O-triisopropylsilyl
derivated of 12j (0.37 mmol).Yield: 98.2 mg (54%); 1H NMR (300
MHz, CDCl3): d=7.42 (d, J(H,H)=1.9 Hz, 1H), 7.36–7.24 (m, 3H),
5.13 (d, J(H,H)=2.7 Hz, 1H), 4.29 (d, J(H,H)=9.2 Hz, 1H), 3.32 (d,
J(H,H)=5.6 Hz, 6H), 3.29–3.19 (m, 1H), 2.74 (dd, J(H,H)=19.1,
6.7 Hz, 1H), 2.43–2.34 (m, 1H), 2.25–2.03 (m, 3H), 1.78 (d, J(H,H)=
14.3 Hz, 1H), 1.39–1.24 (m, 2H), 0.89 (d, J(H,H)=5.1 Hz, 18H);
13C NMR (75 MHz, CDCl3): d=134.2, 132.8, 129.4, 129.1, 128.0,
127.3, 101.9, 65.0, 53.5, 52.2, 45.8, 41.8, 35.9, 31.0, 17.9, 12.2; HRMS
(ESI): m/z calcd for C27H42O4ClSi+H
+ : 493.2541 [M+H+] ; found:
493.2530.
Pauson–Khand reaction from diol 13a: synthesis of (4S,5S,6aR)-
5-(((tert-butyldimethylsilyl)oxy)methyl)-3-phenyl-4- ((triisopro-
pylsilyl)oxy)-4,5,6,6a-tetrahydropentalen-2(1H)-one (46): To a so-
lution of diol 13a (0.5 mmol) in anhydrous CH2Cl2 (2.5 mL) at 0 8C
were successively added Et3N (83.5 mL, 0.6 mmol, 1.2 equiv) and
tert-butyldimethylsilyl chloride (90.4 mg, 0.6 mmol, 1.2 equiv). The
resulting mixture was stirred at room temperature and controlled
by TLC. Then, DIPEA (0.26 ml, 1.5 mmol, 3 equiv) and triisopropylsil-
yl trifluoromethanesulfonate (18 mg, 0.6 mmol, 1.2 equiv) were
added at 108C and the mixture was stirred at that temperature
for 1h. It was diluted with CH2Cl2 (15ml) and the organic solution
was washed with saturated NH4Cl (210 ml) and saturated
NaHCO3 (210 mL), dried over MgSO4 and concentrated. The resi-
due was purified by flash column chromatography on silica gel
(eluting with hexane/ethyl acetate 98:2) to isolate the pure disily-
lated compound as colorless oil. Yield: 97.3 mg (40%) 1H NMR (300
MHz, Chloroform-d) d=7.44–7.35 (m, 2H), 7.35–7.27 (m, 3H), 5.95–
5.78 (m, 1H), 5.13–4.96 (m, 3H), 3.72 (dd, J=10.1, 4.8 Hz, 1H), 3.62
(dd, J=10.1, 7.9 Hz, 1H), 2.63–2.51 (m, 1H), 2.11–1.94 (m, 2H), 1.10
(dd, J=15.7, 4.1 Hz, 21H), 0.91 (d, J=9.1 Hz, 9H), 0.06 (d, J=
3.2 Hz, 6H).
The resulting disilylated compound was submitted to the general
Pauson-Khan condiditions above (room temperature, 16 h) to
afford 46, after purification by flash column chromatography on
silica gel (eluting with hexane/ethyl acetate 20:1), as a 5:1 mixture
of diastereomers. Combined yield: 49.4 mg (48%). Data for major
isomer: 1H NMR (300 MHz, Chloroform-d) d=7.47–7.28 (m, 5H),
5.10 (s, 1H), 3.55 (dd, J=10.3, 5.1 Hz, 1H), 3.48–3.32 (m, 1H), 3.22
(dd, J=10.2, 8.5 Hz, 1H), 2.88 (dd, J=18.2, 6.7 Hz, 1H), 2.65–2.49
(m, 1H), 2.50–2.35 (m, 1H), 2.20 (dd, J=18.3, 2.8 Hz, 1H), 1.03–0.80
(m, 31H), 0.03 (d, J=6.2 Hz, 6H); 13C NMR (75 MHz, CDCl3) d=
209.7, 181.1, 135.4, 131.8, 128.9, 128.6, 128.4, 70.9, 65.0, 52.8, 43.9,
39.1, 31.4, 26.2, 18.4, 18.3, 12.7, 5.2. HRMS (ESI): m/z calcd for
C30H51O3Si2 : 515.3381 [M+H
+] ; found: 515.3377.
Pauson–Khand reaction from tertiary alcohol 20: synthesis of
(1R,2R,3aR)-Methyl-2-(dimethoxymethyl)-5-oxo-6-phenyl-1-(tri-
methylsilyloxy)-1,2,3,3a,4,5-hexahydropentalene-1-carboxylate
(47): To a solution of tertiary alcohol 20 (0.5 mmol) in CH2Cl2 (2 mL)
at 10 8C were successively added TEA (0.2 mL, 1.5 mmol, 3 equiv),
DMAP (6.11 mg, 0.05 mmol, 0.1 equiv) and trimethylchlorosilane
(134 mL, 1 mmol, 2 equiv). The resulting mixture was stirred at
room temperature for 4 h, diluted with CH2Cl2 (15 mL) and the or-
ganic solution was washed with saturated NH4Cl (210 mL) and
saturated NaHCO3 (210 mL). The organic layer was dried over
MgSO4 and concentrated. The residue was purified by flash column
chromatography on silica gel (eluting with hexane/ethyl acetate
20:1). The resulting silylated compound (colorless oil) was submit-
ted to the general Pauson–Khand conditions above (room temper-
ature, 16 h) to afford, after purification by flash column chromatog-
raphy on silica gel (eluting with hexane/ethyl acetate 19:1), a color-
less oil consisting of a 1.5:1 mixture of diastereomers. Combined
yield: 97 mg (53%). Data for major isomer: 1H NMR (300 MHz,
CDCl3): d=7.37 (ddd, J(H,H)=8.7, 7.8, 6.1 Hz, 3H), 7.26–7.16 (m,
2H), 4.54 (d, J(H,H)=8.5 Hz, 1H), 3.54–3.43 (m, 1H), 3.30 (s, 3H),
3.30 (s, 3H), 3.07–2.89 (m, 2H), 2.86 (s, 3H), 2.36 (dd, J(H,H)=18.0,
3.7 Hz, 1H), 2.16 (ddd, J(H,H)=13.4, 11.4, 9.3 Hz, 1H), 1.72 (ddd,
J(H,H)=13.7, 10.2, 5.3 Hz, 1H), 0.32 (s, 9H); 13C NMR (75 MHz,
CDCl3): d=208.46, 177.45, 171.07, 135.10, 130.31, 129.18, 128.24,
128.00, 104.78, 80.90, 55.52, 53.41, 52.04, 51.15, 44.69, 39.79, 29.02,
2.45; HRMS (ESI): m/z calcd for C24H44O4Si+H
+ : 419.1890 [M+H+] ;
found: 419.1869.
Hydrolysis of the acetals 36, 42, 43: To a solution of acetal 36, 42
or 43 (0.80 mmol) in CH2Cl2 (40 mL) 7.4 wt% FeCl3 on SiO2 (80 mg)
was added, and the resulting suspension was stirred vigorously for
1 h. Then aqueous NaHCO3 (1 mL) was added, and the organic
phase was washed with brine, dried over MgSO4 and concentrated.
Flash column chromatography on silica gel of the residue afforded
pure aldehyde 48–50, with recovery of the unreacted starting ma-
terial (20–35%).
(1S,2R,3aR)-5-oxo-6-phenyl-1-(triisopropylsilyloxy)-1,2,3,3a,4,5-
hexahydropentalene-2-carbaldehyde (48): Flash column chroma-
tography on silica gel (hexane:ethyl acetate, 95:5) of the residue
afforded pure aldehyde 48 (yellow oil, 206 mg, 65%) along with re-
covery of unreacted starting material 36 (54 mg, 15%). Effective
yield of isolated 48 based on recovered starting material : 80%.
1H NMR (300 MHz, CDCl3) d=9.74 (d, J(H,H)=1.1 Hz, 1H), 7.44–7.30
(m, 5H), 5.42 (s, 1H), 3.45 (ddd, J(H,H)=16.2, 9.4, 2.8 Hz, 1H), 3.39–
3.30 (m, 1H), 2.90 (dd, J(H,H)=18.4, 6.6 Hz, 1H), 2.60 (dt, J(H,H)=
12.8, 9.1 Hz, 1H), 2.30 (dd, J(H,H)=18.4, 2.8 Hz, 1H), 1.51 (ddd,
J(H,H)=12.9, 9.8, 7.5 Hz, 1H), 1.07–0.84 (m, 21H). 13C NMR (75 MHz,
CDCl3) d=208.27, 199.58, 177.17, 135.67, 130.73, 128.58, 128.40,
128.26, 67.96, 62.93, 42.60, 39.27, 29.32, 17.95, 17.85, 12.29. HRMS
(ESI): m/z calcd for C24H35O3Si : 399.2355 [M+H
+] ; found: 399.2328.
((1S,2R,3aR)-5-oxo-6-(thiophen-3-yl)-1-((triisopropylsilyl)oxy)-
1,2,3,3a,4,5-hexahydropentalene-2-carbaldehyde (49): Flash
column chromatography on silica gel (hexane/tetrahydrofuran,
95:5) of the residue afforded aldehyde 49 (colorless oil, 113.3 mg,
35%) along with recovery of unreacted starting material 42 (48%).
Treatment of thus-recovered material under identical conditions af-
forded an additional 40.2 mg of 49. Total yield of 49 : 153.5 mg
(83% based on recovered starting material). 1H NMR (300 MHz,
chloroform-d) d=9.72 (s, 1H), 7.87–7.67 (m, 1H), 7.35 (d, J=2.4 Hz,
2H), 5.53 (s, 1H), 3.57–3.22 (m, 2H), 2.88 (dd, J=18.3, 6.6 Hz, 1H),
2.60 (dt, J=12.8, 9.1 Hz, 1H), 2.27 (dd, J=18.4, 2.9 Hz, 1H), 1.51–
1.39 (m, 1H), 1.15–0.87 (m, 21H). 13C NMR (75 MHz, CDCl3) d=
208.6, 200.0, 175.7, 131.2, 130.7, 127.5, 125.8, 125.5, 68.7, 63.2, 42.9,
39.7, 29.78, 18.4, 12.8. HRMS (ESI): m/z calcd for C22H33O3SSi [M+
H]+ : 405.1920 [M+H+] ; found: 405.1902.
(1S,2R,3aR)-6-(3-chloropropyl)-5-oxo-1-((triisopropylsilyl)oxy)-
1,2,3,3a,4,5-hexahydropentalene-2-carbaldehyde (50): Flash
column chromatography on silica gel (hexane:tetrahydrofuran,
95:5) of the residue afforded the aldehyde 50 (colorless oil,
134.1 mg, 42%) along with recovery of unreacted starting 43
(45%). Treatment of thus recovered material under identical condi-
tions afforded an additional 67.5 mg of 50. Total yield of 50
201.6 mg (87% based on recovered starting material). 1H NMR (300
MHz, Chloroform-d) d=9.75 (s, 1H), 5.30 (s, 1H), 3.53 (dt, J=11.1,
5.6 Hz, 1H), 3.39–3.25 (m, 3H), 2.73 (dd, J=18.4, 6.5 Hz, 1H), 2.53–
2.33 (m, 3H), 2.13 (dd, J=18.5, 2.6 Hz, 1H), 2.01–1.81 (m, 2H), 1.45
(ddd, J=13.0, 9.6, 7.2 Hz, 1H), 1.07 (dd, J=8.9, 5.8 Hz, 21H).
13C NMR (75 MHz, CDCl3) d=210.8, 199.5, 178.3, 134.8, 70.7, 55.4,
44.6, 42.3, 39.6, 32.4, 30.0, 21.5, 18.0, 12.3. HRMS (ESI): m/z calcd for
C21H36O3SiCl [M+H]+ : 399.2122 [M+H
+] ; found: 399.2140.
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Sequential chemoselective deprotection of 46/oxidation to 48:
Adduct 46 (1 mmol) was added to a solution of AcOH/MeOH/H2O
(v/v: 3.5:6:1.5; 11 ml) and the mixture was stirred at room tempera-
ture until disappearance of the starting material. MeOH was re-
moved and CH2Cl2 was added. Then, the combined organic layers
were washed by 1m NaOH (210 ml), dried over MgSO4 and con-
centrated. The residue was purified by flash column chromatogra-
phy on silica gel (eluting with hexane/ethyl acetate 19:1). 1H NMR
(300 MHz, Chloroform-d) d=7.49–7.30 (m, 5H), 5.03 (s, 1H), 3.60
(dd, J=10.6, 5.7 Hz, 1H), 3.42 (dd, J=10.6, 7.7 Hz, 2H), 2.87 (dd,
J=18.3, 6.6 Hz, 1H), 2.58 (d, J=7.3 Hz, 1H), 2.49 (dd, J=12.4,
9.0 Hz, 1H), 2.22 (dd, J=18.6, 3.1 Hz, 1H), 0.96 (d, 22H). 13C NMR
(75 MHz, CDCl3) d=209.26, 180.23, 135.11, 131.28, 128.07, 70.55,
64.45, 52.58, 43.09, 39.07, 31.55, 17.98, 12.36. HRMS (ESI): m/z calcd
for C24H37O3Si [M+H]+ : 401.2512 [M+H
+] ; found: 401.2495. To
a solution of the resulting material (200 mg, 0.5 mmol) in CH2Cl2
(5 mL) was added Molecular Sieves (0.4 mg) and the mixture was
stirred at 0 8C for 5 min. Pyridinium chlorochromate (PCC, 185 mg,
0.85 mmol) was added in portions and after stirring the reaction
mixture at room temperature for 4 h, diethyl ether (5 mL) was
added and the mixture was stirred for an additional 30 min. The
solid precipitate was filtered through a pad of silica gel and celite,
washed several times with diethyl ether, dried over MgSO4 and
concentrated. The crude material was purified by silica gel chroma-
tography to give aldehyde 48 with identical physical and spectro-
scopic data as the product obtained above from hydrolysis of 36.
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Bifunctional Brønsted Base Catalyst Enables Regio-, Diastereo-, and
Enantioselective Ca-Alkylation of b-Tetralones and Related Aromatic-
Ring-Fused Cycloalkanones
IÇaki Urruzuno, Odei Mugica, Mikel Oiarbide, and Claudio Palomo*
In memory of Jos8 Barluenga
Abstract: The catalytic asymmetric synthesis of both
a-substituted and a,a-disubstituted (quaternary) b-tetralones
through direct a-functionalization of the corresponding
b-tetralone precursor remains elusive. A designed Brønsted
base-squaramide bifunctional catalyst promotes the conjugate
addition of either unsubstituted or a-monosubstituted
b-tetralones to nitroalkenes. Under these reaction conditions,
not only enolization, and thus functionalization, occurs at the
a-carbon atom of the b-tetralone exclusively, but adducts
including all-carbon quaternary centers are also formed in
highly diastereo- and enantioselective manner.
Syntheses of many bioactive compounds with polycyclic
structures, including homoerythrina alkaloids,[1] morphan
derivatives,[2] glucocorticoid receptors,[3] and stradiols,[4]
among others,[5] have employed b-tetralones. However, this
interest did not translate into a variety of approaches for the
asymmetric synthesis of substituted b-tetralones. Most
approaches for the a/a’-functionalization of b-tetralones so
far documented exploit the idea of Stork et al.[6] which
involves condensation with a chiral amine and subsequent
C-alkylation of the resulting enamine, typically by addition to
a Michael acceptor.[7] One complication, for any nonsymmet-
ric cycloalkanone, is that enolization may occur at either the
a or a’ site. In this context, Blarer and Seebach[8] reported that
the reaction with nitrostyrenes of the enamine derived from
(S)-2-methoxymethylpyrrolidine, and the respective b-tetra-
lone produced in moderate yields the a’-adduct predomi-
nantly (a/a’ from 1:4 to 1:20) with generally good diastereo-
and enantioselectivity after hydrolysis of the resulting imi-
nium species (Scheme 1a). Alternatively, the groups of Pfau
and dQAngelo reported the condensation of b-tetralones with
(S)-1-phenylethylamine and subsequent Michael reaction to
afford the a-substituted adducts preferentially,[9] but with
exceptions.[9a]
Apart from these stoichiometric multistep approaches, we
are unaware of catalytic methods for the enantioselective
a-functionalization of b-tetralones leading to an all-carbon
quaternary stereocenter.[10] Chen and co-workers have
reported direct reaction of b-tetralones with a,b-unsaturated
aldehydes by iminium activation,[11] but stereogenicity at Ca is
lost upon spontaneous hemiketal formation. Herein we report
the direct site-, diastereo-, and enantioselective Ca-alkylation
of b-tetralones by conjugate addition reaction enabled by
newly designed Brønsted base catalysts. The new C@C bond is
formed at the a-carbon atom exclusively, and adducts,
including those with an a-quaternary center, are formed in
a highly stereoselective manner.
Our consideration was that the fused aromatic ring in
b-tetralones might induce preferential enolization at Ca
rather than Ca’, and that in the presence of a Brønsted base
relatively high concentrations of the enolic form would be
expected, thus eventually driving the catalytic process for-
ward. Nonetheless, this assumption was accompanied by
a second significant challenge, namely the effective control of
both the absolute and relative stereochemistry during con-
Scheme 1. Enantioselective a/a’-functionalization of b-tetralones.
EWG=electron-withdrawing group.
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struction of the quaternary carbon stereocenter. In fact, while
some success has been achieved in the enantioselective
synthesis of a-quaternary carbonyl compounds by Brønsted
base-catalyzed Michael reactions[12, 13] of a-aryl cyclopenta-
nones,[14a] the corresponding a-aryl cyclohexanones behaved
sluggishly.[14, 15] We started by screening a set of chiral
bifunctional Brønsted base catalysts for the reaction of 1B
with the nitrostyrene 5a (Scheme 2). It was found that while
in each case the a,a-dialkyl b-tetralone 6Ba was formed
exclusively and with essentially perfect diastereoselectivity
regardless of the chiral catalyst employed (Table 1),[16] the
enantioselectivities were highly catalyst-dependent. The
bifunctional squaramide-cinchona Brønsted base catalysts
pioneered by Rawal and co-workers[17,18] were the most
effective. Thus, by using the catalysts C1[17] and C2[19] the
product 6Ba was formed exclusively, albeit in moderate
enantioselectivity (73 and 72% ee, respectively).
Next we examined the catalysts C3[20]/C4 bearing an
amide unit, which would provide a site not only for catalyst
fine tuning, but also for additional hydrogen bonding
(Table 1).[21] Both C3 and C4 catalyzed the reaction of 1B
with 5a, but produced no improvement in the ee value. After
several variations of the amide group, we were delighted to
find that acceptable selectivity was achieved with the new
catalystsC5 andC6 (85 and 80% ee, respectively). In contrast,
the N-methylated catalyst C7 led to a moderate 60% ee, thus
indicating that the amide NH in the former catalysts is
important. Lowering the reaction temperature allowed fur-
ther improvement in the selectivity (90% ee at @10 8C for
C6), although C5 behaved sluggishly at subzero temperatures
because of limited solubility. The same trend in the behavior
of C1–C7 was observed for the reaction of 1B with the
nitroalkene 5b.[16]
As Table 2 illustrates, results with differently b-substituted
nitroalkenes[22] were uniformly good when using C6. Thus, the
stereoselectivity of the reactions seems to be independent of
the electronic properties of the nitroalkene, and products
6Ba, 6Bb, 6Bd, and 6Be were formed from the respective
nitrostyrenes 5 in yields around 80% and with ee values in the
range of 90–91%. Nitroalkenes having heteroaromatic or
alkynyl b-substituents (5h, 5 i) also led to the corresponding
products (6Bh, 6Bi) with similarly good yield and enantiose-
lectivity. Remarkably, even the less reactive b-alkyl-substi-
tuted nitroalkenes, such as 5j and 5k, afforded the corre-
sponding addition adducts (6Bj, 9Bk) with equally good
yields and ee values. The stereochemical outcome of the
reaction is also independent of the a-substituent of the
b-tetralone employed. The tetralones 1C, 1D, and 1E reacted
with the respective nitroalkenes 5 to afford the adducts 6Ca,
6Dg, and 6Ef, respectively, in good yields and with ee values
of up to 99%. The reaction also tolerates the b-tetralones 2D,
3B, and 4B, bearing, respectively the 6-methoxy-, 6-chloro-,
Scheme 2. Catalytic addition of b-tetralones to nitroalkenes.
BB=Brønsted base.
Table 1: Screening of catalysts for the reaction of 1B with 5a.[a]
[a] Reactions carried out at 0.30 mmol scale, using 1.2 equiv of 5a and
10 mol% catalyst in 0.6 mL CH2Cl2 at room temperature. Yield is that of
the isolated product 6Ba after chromatography. The ee value was
determined by chiral-phase HPLC.
Table 2: Scope of the reaction with respect to the a-substituted
b-tetralones 1–4 with nitroalkenes 5 catalyzed by C6.[a]
[a] Reactions carried out at 0.30 mmol scale, using 1.2 equiv of trans-
nitroalkene 5 and 10 mol% C6, unless otherwise stated, in 0.6 mL
CH2Cl2. d.r.>20:1 in all entries as determined by
1H NMR (300 MHz)
analysis of the crude reaction mixture. Yield is that of the product
isolated after chromatographic purification. The ee value was determined
by chiral-phase HPLC. [b] Reaction conducted at @20 8C. [c] Obtained as
a 1.5:1 mixture of diastereomers (94% ee for minor isomer). [d] Using
catalyst C4.
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and 7-methoxy groups at the aromatic ring, which were
equally efficient (adducts 7Da, 8Bc, and 9Bk). In the case of
7Da, C4 produced the best reaction outcome. Importantly, in
every case no traces of products from the reaction at the
a’-carbon atom of the b-tetralone were formed.
Next, the behavior of the a-unsubstituted b-tetralone 1A
was investigated and the reactions under similar reaction
conditions were found, again, to be completely regioselective
(Table 3). The products 10–18 were obtained from both aryl-
and alkyl-substituted nitroalkenes in yields in the 80–88%
range and, importantly, no products from a sequential addi-
tion of two equivalents of nitroalkene, either at Ca/a’ of the
ketone or at Ca of the nitro group, were detected. With the
exception of the 2-furyl-substituted nitroalkene 5h (product
15), in all other cases diastereoselectivity was good (d.r.+ 4:1)
and enantioselectivity essentially perfect for both diastereo-
mers. For these reactions both C2 and C6 were found to be
equally effective at a 2 mol% loading. It should be noted that
the thus obtained a-monosubstituted b-tetralones were prone
toward epimerization under basic conditions at room temper-
ature. For example, the compound 14, which was isolated
essentially as a single diastereomer (d.r.> 20:1), led, after
exposure to 5 mol% of C2 at room temperature in methylene
chloride for 3 hours, to an almost equimolar mixture of
diastereomers. In the absence of base, however, no epimeri-
zation was observed after a prolonged time (20 h) even at
80 8C.
Eventually, the suitability of this highly site- and stereo-
selective a-functionalization strategy was also investigated for
related ketone substrates. As results in Figure 1 show,
aromatic ring-fused cycloalkanones with an oxygen hetero-
atom in the cycle, or larger seven-membered cycloalkanones,
were equally competent substrates undergoing the corre-
sponding addition reaction at Ca exclusively, and with very
high stereoselectivity. In particular cases, the enolizable
compounds 19 and 20 were obtained as a mixture of two
diastereomers, probably as a result of easy epimerization
under the reaction conditions used. In contrast, in the case of
employing a diketone substrate, the adduct 24 from a sequen-
tial Michael/intramolecular Henry reaction was obtained,
again, as essentially a single diastereomer and very high
enantioselectivity.
The excellent regio- and stereoselectivity achieved in the
above reactions are of particular interest in that several
options for further elaboration of the adducts are now made
feasible. For instance (Scheme 3), the adduct 10 (3:1 ratio of
diastereomers), upon treatment with 5a in the presence of
10 mol% of C2 provided the tricyclic systems 25/25’ in 60%
Table 3: Reaction of the b-tetralone 1A with nitroalkenes catalyzed by
either C2 or C6.[a]
Product, R T [8C] t [h] Yield [%][b] d.r.[c] ee [%][d]
10, Ph @20 8 83 4:1 99
11, 4-MeOC6H4 @20 8 85 8:1 99
12, 4-BrC6H4 @20 8 88 4:1 99
13, 3-MeOC6H4 @20 8 80 4:1 99
14, 2-ClC6H4 @20 8 86 >20:1 99
15, 2-furyl @20 8 84 1:1 98
16, CH3(CH2)2 RT 16 81 5:1 99
17, C6H11 RT 24 80 4:1 99
18, Ph(CH2)2 RT 16 83 5:1 99
[a] Reactions carried out at 0.30 mmol scale, using 1.2 equiv of trans-
nitroalkene and 2 mol% of either C2 or C6 in 0.6 mL CH2Cl2. [b] Yield of
product isolated after chromatographic purification. [c] Determined by
1H NMR (300 MHz) analysis of the crude reaction mixture. [d] Both
diastereomers obtained with the same ee value as determined by chiral-
phase HPLC.
Scheme 3. Elaboration of adducts into a variety of polycyclic mole-
cules.
Figure 1. Adducts from the direct reaction of a survey of arene-fused
cycloalkanones with nitroolefins in the presence of 10 mol% C6 (for
details, see the Supporting Information). [a] 2 mol% of catalyst C2
used. Both diastereomers obtained with the same ee value.
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combined yield. Remarkably, only two out of the possible 26
stereoisomers of 25 were formed.[23] An interesting aspect is
that apparently no cyclization product derived from theminor
isomer of 10 was detected. Moreover, the isomeric compo-
sition of isolated product 25/25’ was around 3:1 regardless of
the initial mixture of starting 10 employed (3:1 in first run; 1:1
in second run). These results suggest that formation of the
tricycles 25/25’ through aMichael/Henry cascade[24, 25] not only
proceeds in high stereoselectivity, but also involves some
kinetic resolution process. Similarly, treatment of 14 (d.r.>
20:1) with 5 j in the presence of C2 afforded the products 26/
26’ in a 2:1 ratio. The absolute configuration of 25 was
determined by single-crystal X-ray structure analysis,[26] and
that of 25’ by NOESY experiments.[16] The configuration of
26/26’ was assigned by analogy. In a different example, when
14 was treated with acrolein in the presence of C2 at room
temperature, the Michael addition product 27 was isolated in
80% yield. The aldol-reaction-mediated cyclization of 27 to
28 could be carried out smoothly at room temperature by
exposure to 10 mol% pyrrolidine. Alternatively, direct trans-
formation of 14 into the spirocyclic aldol 28 was achieved by
treatment with acrolein in the presence of 10 mol% pyrro-
lidine. In both cases 28 was produced as essentially a single
diastereomer. The course of the above cascade reaction is
quite surprising considering that cycloalkanones under similar
reaction conditions are reported to furnish substituted
decalins instead.[27] Importantly, as far as we know, no other
catalytic enantioselective approach that allows regioselective
production of tetralone-derived a-spirocycles are available
until now.[5, 28] In addition, hexahydro-benzo[e]indoles, heter-
ocyclic cores present in various biologically active com-
pounds,[29] could also be prepared. For example, reduction of
the nitro group in adduct 6Ba with either Zn/H+ or H2/Pd
provided, respectively, 31 and 32, whilst reduction of 14 led to
29, all with good yields. The absolute configurations for the
compounds 28 and 32 were determined by single-crystal
X-ray structure analysis[26] and that of their precursor adducts
was established by extrapolation.
In summary, we report the first examples of catalytic
regio-, diastereo-, and enantioselective a-alkylation of both
a-unsubstituted and a-substituted b-tetralones with Michael
acceptors.[30] The synthetic utility of the method is demon-
strated by easy conversion of adducts into diverse polycyclic
compounds featuring up to six stereogenic centers or new
spirocyclic system. This realization was feasible thanks to
a readily available subclass of cinchona-alkaloid-derived
bifunctional catalysts bearing a carboxamide group as an
additional moiety for catalyst fine tuning. Importantly, the
method proved to be applicable beyond b-tetralones, and the
direct a-functionalization of other aromatic ring-fused cyclo-
alkanones are equally affordable and selective. Investigations
to further broadening the substrate scope of the approach are
ongoing.
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